diff --git "a/input/TCGA/TCGA_Prostate_Cancer_(PRAD)/TCGA.PRAD.sampleMap_PRAD_clinicalMatrix" "b/input/TCGA/TCGA_Prostate_Cancer_(PRAD)/TCGA.PRAD.sampleMap_PRAD_clinicalMatrix" new file mode 100644--- /dev/null +++ "b/input/TCGA/TCGA_Prostate_Cancer_(PRAD)/TCGA.PRAD.sampleMap_PRAD_clinicalMatrix" @@ -0,0 +1,567 @@ +sampleID _INTEGRATION _PATIENT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy age_at_initial_pathologic_diagnosis bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode biochemical_recurrence bone_scan_results clinical_M clinical_T days_to_birth days_to_bone_scan_performed days_to_collection days_to_death days_to_diagnostic_computed_tomography_performed days_to_diagnostic_mri_performed days_to_first_biochemical_recurrence days_to_initial_pathologic_diagnosis days_to_last_followup days_to_new_tumor_event_after_initial_treatment days_to_psa days_to_second_biochemical_recurrence days_to_third_biochemical_recurrence diagnostic_ct_abd_pelvis_performed diagnostic_ct_abd_pelvis_result diagnostic_mri_performed diagnostic_mri_result followup_case_report_form_submission_reason followup_treatment_success form_completion_date gender gleason_score histological_type history_of_neoadjuvant_treatment icd_10 icd_o_3_histology icd_o_3_site informed_consent_verified initial_pathologic_diagnosis_method initial_weight intermediate_dimension is_ffpe laterality longest_dimension lost_follow_up lymphnodes_examined new_neoplasm_event_occurrence_anatomic_site new_neoplasm_event_type new_neoplasm_occurrence_anatomic_site_text new_tumor_event_after_initial_treatment number_of_lymphnodes_examined number_of_lymphnodes_positive_by_he oct_embedded other_dx pathologic_N pathologic_T pathology_report_file_name patient_death_reason patient_id person_neoplasm_cancer_status primary_pattern primary_therapy_outcome_success psa_value radiation_therapy residual_tumor sample_type sample_type_id secondary_pattern shortest_dimension source_of_patient_death_reason targeted_molecular_therapy tertiary_pattern tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site tumor_level tumor_progression_post_ht tumor_tissue_site type_ofprogression_of_disease_ht vial_number vital_status year_of_initial_pathologic_diagnosis zone_of_origin _GENOMIC_ID_TCGA_PRAD_exp_HiSeqV2_exon _GENOMIC_ID_TCGA_PRAD_gistic2thd _GENOMIC_ID_TCGA_PRAD_hMethyl450 _GENOMIC_ID_TCGA_PRAD_mutation _GENOMIC_ID_TCGA_PRAD_mutation_broad_gene _GENOMIC_ID_TCGA_PRAD_exp_HiSeqV2 _GENOMIC_ID_TCGA_PRAD_PDMRNAseq _GENOMIC_ID_TCGA_PRAD_miRNA_HiSeq _GENOMIC_ID_TCGA_PRAD_RPPA _GENOMIC_ID_TCGA_PRAD_gistic2 _GENOMIC_ID_TCGA_PRAD_exp_HiSeqV2_percentile _GENOMIC_ID_TCGA_PRAD_PDMRNAseqCNV _GENOMIC_ID_data/public/TCGA/PRAD/miRNA_HiSeq_gene _GENOMIC_ID_TCGA_PRAD_mutation_bcm_gene _GENOMIC_ID_TCGA_PRAD_mutation_curated_broad_gene _GENOMIC_ID_TCGA_PRAD_exp_HiSeqV2_PANCAN +TCGA-2A-A8VL-01 TCGA-2A-A8VL-01 TCGA-2A-A8VL TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 51 TCGA-2A-A8VL-F71759 TCGA-2A-A8VL TCGA-2A-A8VL-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -18658 21 1273 0 621 585 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 140 NO Left NO YES NO 15 0 true No N0 T2b TCGA-2A-A8VL.FC65B44D-EDAD-4A48-A564-8721C5CD3AA8.pdf A8VL TUMOR FREE 3 0.05 NO R0 Primary Tumor 01 3 NO 4 NO YES 2A Middle|Base Prostate A LIVING 2010 Peripheral Zone e10fe58f-7ceb-4ad8-bce3-5ffbefc05cb5 TCGA-2A-A8VL-01A-21D-A376-01 TCGA-2A-A8VL-01A-21D-A378-05 TCGA-2A-A8VL-01A-21D-A377-08 e10fe58f-7ceb-4ad8-bce3-5ffbefc05cb5 TCGA-2A-A8VL-01 TCGA-2A-A8VL-01 1487FD23-ED22-4942-86D6-CF19837F63B9 TCGA-2A-A8VL-01A-21D-A376-01 e10fe58f-7ceb-4ad8-bce3-5ffbefc05cb5 TCGA-2A-A8VL-01 TCGA-2A-A8VL-01 TCGA-2A-A8VL-01A-21D-A377-08 e10fe58f-7ceb-4ad8-bce3-5ffbefc05cb5 +TCGA-2A-A8VO-01 TCGA-2A-A8VO-01 TCGA-2A-A8VO TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-2A-A8VO-F71780 TCGA-2A-A8VO TCGA-2A-A8VO-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -20958 22 1290 11 84 0 1701 1332 YES No Evidence of Extraprostatic Extension YES Extraprostatic Extension Localized (e.g. seminal vesicles) Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 110 NO Bilateral NO NO NO true No T3a TCGA-2A-A8VO.B699D2D8-1EB6-4BFE-A468-D1FFA5F32D98.pdf A8VO TUMOR FREE 3 0.05 NO R1 Primary Tumor 01 3 NO 4 NO YES 2A Apex|Middle|Base Prostate A LIVING 2010 Overlapping / Multiple Zones 20a779a3-04ab-4080-b11d-ed7b22fcd2da TCGA-2A-A8VO-01A-11D-A376-01 TCGA-2A-A8VO-01A-11D-A378-05 TCGA-2A-A8VO-01A-11D-A377-08 20a779a3-04ab-4080-b11d-ed7b22fcd2da TCGA-2A-A8VO-01 TCGA-2A-A8VO-01 FF23B458-D1F8-4001-A8E3-7F8785435C76 TCGA-2A-A8VO-01A-11D-A376-01 20a779a3-04ab-4080-b11d-ed7b22fcd2da TCGA-2A-A8VO-01 TCGA-2A-A8VO-01 TCGA-2A-A8VO-01A-11D-A377-08 20a779a3-04ab-4080-b11d-ed7b22fcd2da +TCGA-2A-A8VT-01 TCGA-2A-A8VT-01 TCGA-2A-A8VT TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 47 TCGA-2A-A8VT-F71798 TCGA-2A-A8VT TCGA-2A-A8VT-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2c -17365 4 923 -2 4 0 1373 995 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Stable Disease 2015-3-31 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 140 NO Bilateral NO YES NO 16 2 true No N1 T4 TCGA-2A-A8VT.9A772AE3-EDB9-4AAB-8883-6BA9CBCA71CD.pdf A8VT TUMOR FREE 4 Complete Remission/Response 0.05 YES R1 Primary Tumor 01 5 YES NO YES 2A Apex|Middle|Base Prostate A LIVING 2011 Overlapping / Multiple Zones 2e80aebe-77b5-496c-bde9-494b9b94ee3f TCGA-2A-A8VT-01A-11D-A376-01 TCGA-2A-A8VT-01A-11D-A378-05 TCGA-2A-A8VT-01A-11D-A377-08 2e80aebe-77b5-496c-bde9-494b9b94ee3f TCGA-2A-A8VT-01 TCGA-2A-A8VT-01 931CEBFB-011C-4797-8E05-8012D3ADC601 TCGA-2A-A8VT-01A-11D-A376-01 2e80aebe-77b5-496c-bde9-494b9b94ee3f TCGA-2A-A8VT-01 TCGA-2A-A8VT-01 TCGA-2A-A8VT-01A-11D-A377-08 2e80aebe-77b5-496c-bde9-494b9b94ee3f +TCGA-2A-A8VV-01 TCGA-2A-A8VV-01 TCGA-2A-A8VV TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 52 TCGA-2A-A8VV-F71800 TCGA-2A-A8VV TCGA-2A-A8VV-01A NO Equivocal M0 T2b -19065 167 1155 29 204 0 671 560 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 140 NO Right NO YES NO 16 0 true No N0 T2b TCGA-2A-A8VV.E42BC148-77A7-4FEB-9ACE-8BC2FFD33BF7.pdf A8VV TUMOR FREE 3 0.05 NO R0 Primary Tumor 01 3 NO 4 NO YES 2A Apex|Middle Prostate A LIVING 2010 Peripheral Zone 45eca81f-9ce2-4de6-b970-65959d76398c TCGA-2A-A8VV-01A-11D-A376-01 TCGA-2A-A8VV-01A-11D-A378-05 TCGA-2A-A8VV-01A-11D-A377-08 45eca81f-9ce2-4de6-b970-65959d76398c TCGA-2A-A8VV-01 TCGA-2A-A8VV-01 443A2276-226E-4D27-936C-3B25B14E7121 TCGA-2A-A8VV-01A-11D-A376-01 45eca81f-9ce2-4de6-b970-65959d76398c TCGA-2A-A8VV-01 TCGA-2A-A8VV-01 TCGA-2A-A8VV-01A-11D-A377-08 45eca81f-9ce2-4de6-b970-65959d76398c +TCGA-2A-A8VX-01 TCGA-2A-A8VX-01 TCGA-2A-A8VX TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 70 TCGA-2A-A8VX-F71804 TCGA-2A-A8VX TCGA-2A-A8VX-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2c -25904 32 922 32 89 0 1378 1033 YES Extraprostatic Extension Localized (e.g. seminal vesicles) YES Extraprostatic Extension Localized (e.g. seminal vesicles) Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 160 NO Bilateral NO YES NO 16 0 true No N0 T3b TCGA-2A-A8VX.418E80EE-4886-43F5-9FB9-2619BC89351E.pdf A8VX TUMOR FREE 4 0.05 NO R0 Primary Tumor 01 4 NO NO YES 2A Middle Prostate A LIVING 2011 Peripheral Zone 0ff237d2-9283-44c7-bfae-c2020c73b94c TCGA-2A-A8VX-01A-11D-A376-01 TCGA-2A-A8VX-01A-11D-A378-05 TCGA-2A-A8VX-01A-11D-A377-08 0ff237d2-9283-44c7-bfae-c2020c73b94c TCGA-2A-A8VX-01 TCGA-2A-A8VX-01 1A003DC8-7045-4F90-A768-F2E88FE31242 TCGA-2A-A8VX-01A-11D-A376-01 0ff237d2-9283-44c7-bfae-c2020c73b94c TCGA-2A-A8VX-01 TCGA-2A-A8VX-01 0ff237d2-9283-44c7-bfae-c2020c73b94c +TCGA-2A-A8W1-01 TCGA-2A-A8W1-01 TCGA-2A-A8W1 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 54 TCGA-2A-A8W1-F71808 TCGA-2A-A8W1 TCGA-2A-A8W1-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -19964 27 888 0 112 -122 NO NO Scheduled Follow-up Submission 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 140 NO Left NO YES NO 12 0 true No N0 T3a TCGA-2A-A8W1.3A4CC21B-D751-49EA-BCFB-785B683423A0.pdf A8W1 4 0.05 R1 Primary Tumor 01 3 NO YES 2A Middle|Base Prostate A LIVING 2011 Peripheral Zone 6b22709e-8b89-4a67-9530-3004467b91f6 TCGA-2A-A8W1-01A-11D-A376-01 TCGA-2A-A8W1-01A-11D-A378-05 TCGA-2A-A8W1-01A-11D-A377-08 6b22709e-8b89-4a67-9530-3004467b91f6 TCGA-2A-A8W1-01 TCGA-2A-A8W1-01 D7CB443D-93C9-44D5-BAE3-7213ED9AFA1B TCGA-2A-A8W1-01A-11D-A376-01 6b22709e-8b89-4a67-9530-3004467b91f6 TCGA-2A-A8W1-01 TCGA-2A-A8W1-01 TCGA-2A-A8W1-01A-11D-A377-08 6b22709e-8b89-4a67-9530-3004467b91f6 +TCGA-2A-A8W3-01 TCGA-2A-A8W3-01 TCGA-2A-A8W3 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 69 TCGA-2A-A8W3-F71815 TCGA-2A-A8W3 TCGA-2A-A8W3-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T2b -25557 13 882 13 -14 198 0 863 198 771 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission 2015-3-31 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 150 NO Left NO YES Biochemical evidence of disease YES 3 0 true No N0 T3a TCGA-2A-A8W3.EC74AC3A-610D-46E0-A4DA-1904E42E1EF8.pdf A8W3 TUMOR FREE 4 .36 NO R0 Primary Tumor 01 5 NO NO YES 2A Apex|Middle|Base Prostate A LIVING 2011 Peripheral Zone a6841939-e9fa-43cf-9f64-b1b3c57a2576 TCGA-2A-A8W3-01A-11D-A376-01 TCGA-2A-A8W3-01A-11D-A378-05 TCGA-2A-A8W3-01A-11D-A377-08 a6841939-e9fa-43cf-9f64-b1b3c57a2576 TCGA-2A-A8W3-01 TCGA-2A-A8W3-01 9A1F9418-B028-436F-AE81-76CC55BC5C26 TCGA-2A-A8W3-01A-11D-A376-01 a6841939-e9fa-43cf-9f64-b1b3c57a2576 TCGA-2A-A8W3-01 TCGA-2A-A8W3-01 TCGA-2A-A8W3-01A-11D-A377-08 a6841939-e9fa-43cf-9f64-b1b3c57a2576 +TCGA-2A-AAYF-01 TCGA-2A-AAYF-01 TCGA-2A-AAYF TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-2A-AAYF-F71830 TCGA-2A-AAYF TCGA-2A-AAYF-01A NO M0 T1c -20866 897 186 0 1364 972 NO YES Extraprostatic Extension Localized (e.g. seminal vesicles) Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 150 NO Right NO NO NO true No T3a TCGA-2A-AAYF.106166DD-946C-4DD0-85CA-5400104959DB.pdf AAYF TUMOR FREE 3 Complete Remission/Response .05 NO R0 Primary Tumor 01 4 NO NO YES 2A Apex|Middle|Base Prostate A LIVING 2011 Overlapping / Multiple Zones fe001be4-0c13-4754-8888-3961c98ccfe9 TCGA-2A-AAYF-01A-11D-A41J-01 TCGA-2A-AAYF-01A-11D-A41L-05 TCGA-2A-AAYF-01A-11D-A41K-08 fe001be4-0c13-4754-8888-3961c98ccfe9 TCGA-2A-AAYF-01 TCGA-2A-AAYF-01 2EEECFF8-7822-40F0-97C8-109349680B9C TCGA-2A-AAYF-01A-11D-A41J-01 fe001be4-0c13-4754-8888-3961c98ccfe9 TCGA-2A-AAYF-01 TCGA-2A-AAYF-01 fe001be4-0c13-4754-8888-3961c98ccfe9 +TCGA-2A-AAYO-01 TCGA-2A-AAYO-01 TCGA-2A-AAYO TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-2A-AAYO-F71840 TCGA-2A-AAYO TCGA-2A-AAYO-01A NO M0 T1c -21183 854 180 0 1272 922 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 80 NO Bilateral NO NO NO true No T2c TCGA-2A-AAYO.3889AA76-F350-4DA4-987B-79E8D2349262.pdf AAYO TUMOR FREE 3 Complete Remission/Response .05 NO R0 Primary Tumor 01 3 NO NO YES 2A Apex|Middle Prostate A LIVING 2011 Overlapping / Multiple Zones 024fc1c9-4502-4293-a555-9bb7e5536f45 TCGA-2A-AAYO-01A-11D-A41J-01 TCGA-2A-AAYO-01A-11D-A41L-05 TCGA-2A-AAYO-01A-11D-A41K-08 024fc1c9-4502-4293-a555-9bb7e5536f45 TCGA-2A-AAYO-01 TCGA-2A-AAYO-01 178E05AC-820A-47B5-9541-4E0CA13BFBF2 TCGA-2A-AAYO-01A-11D-A41J-01 024fc1c9-4502-4293-a555-9bb7e5536f45 TCGA-2A-AAYO-01 TCGA-2A-AAYO-01 024fc1c9-4502-4293-a555-9bb7e5536f45 +TCGA-2A-AAYU-01 TCGA-2A-AAYU-01 TCGA-2A-AAYU TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 56 TCGA-2A-AAYU-F71848 TCGA-2A-AAYU TCGA-2A-AAYU-01A NO M0 T1c -20582 693 52 0 615 269 NO YES Extraprostatic Extension Localized (e.g. seminal vesicles) Scheduled Follow-up Submission 2015-3-31 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 140 NO Left NO YES NO 28 0 true No N0 T3a TCGA-2A-AAYU.6CD9378F-F5A6-4214-8685-3D56ED6ADB0B.pdf AAYU TUMOR FREE 3 Complete Remission/Response .05 NO R1 Primary Tumor 01 3 NO 4 NO YES 2A Apex|Middle|Base Prostate A LIVING 2012 Overlapping / Multiple Zones a16dcbd7-29fc-4dc3-8b6b-43a06c355e9d TCGA-2A-AAYU-01A-11D-A41J-01 TCGA-2A-AAYU-01A-11D-A41L-05 TCGA-2A-AAYU-01A-11D-A41K-08 a16dcbd7-29fc-4dc3-8b6b-43a06c355e9d TCGA-2A-AAYU-01 TCGA-2A-AAYU-01 38546E10-2A73-4CF8-B1F7-C70FDFFC57E3 TCGA-2A-AAYU-01A-11D-A41J-01 a16dcbd7-29fc-4dc3-8b6b-43a06c355e9d TCGA-2A-AAYU-01 TCGA-2A-AAYU-01 a16dcbd7-29fc-4dc3-8b6b-43a06c355e9d +TCGA-4L-AA1F-01 TCGA-4L-AA1F-01 TCGA-4L-AA1F TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-4L-AA1F TCGA-4L-AA1F-01A NO Abnormal (not related to prostate cancer) M1a T2c -23665 0 64 4 5 0 350 350 YES Extraprostatic Extension Localized (e.g. seminal vesicles) YES Extraprostatic Extension Localized (e.g. seminal vesicles) 2014-11-14 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 380 NO Bilateral YES NO 4 0 false No N0 T3b TCGA-4L-AA1F.A9DCC04F-A189-408C-9EE0-9F36F388068D.pdf AA1F TUMOR FREE 4 Complete Remission/Response 3.5 NO R1 Primary Tumor 01 4 YES YES NO 4L Middle Prostate A LIVING 2013 Overlapping / Multiple Zones 824f212a-b8a3-429e-a8f1-df83302fa1cf TCGA-4L-AA1F-01A-11D-A41J-01 TCGA-4L-AA1F-01A-11D-A41L-05 TCGA-4L-AA1F-01A-11D-A41K-08 824f212a-b8a3-429e-a8f1-df83302fa1cf TCGA-4L-AA1F-01 TCGA-4L-AA1F-01 E46ACD7E-6629-4640-806B-53A68045B5A6 TCGA-4L-AA1F-01A-11D-A41J-01 824f212a-b8a3-429e-a8f1-df83302fa1cf TCGA-4L-AA1F-01 TCGA-4L-AA1F-01 824f212a-b8a3-429e-a8f1-df83302fa1cf +TCGA-CH-5737-01 TCGA-CH-5737-01 TCGA-CH-5737 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 73 TCGA-CH-5737 TCGA-CH-5737-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -26753 91 91 91 0 91 [Discrepancy] YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension 2012-3-16 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 1.2 YES 8 0 No N0 T2c TCGA-CH-5737.dbf280bb-fb7c-422f-b772-a62381c19afa.pdf 5737 TUMOR FREE 4 14.69 R0 Primary Tumor 01 3 0.4 YES NO CH Prostate A LIVING 2007 Peripheral Zone b966ca07-fd34-4428-a460-1ba57a3e519d TCGA-CH-5737-01A-11D-1574-01 TCGA-CH-5737-01A-11D-1578-05 TCGA-CH-5737-01A-11D-1576-08 TCGA-CH-5737-01A-11D-1576-08 b966ca07-fd34-4428-a460-1ba57a3e519d TCGA-CH-5737-01 TCGA-CH-5737-01 8F22ABA7-7F51-4F7B-BD3B-E4A9A194A146 TCGA-CH-5737-01A-11D-1574-01 b966ca07-fd34-4428-a460-1ba57a3e519d TCGA-CH-5737-01 TCGA-CH-5737-01 TCGA-CH-5737-01A-11D-1576-08 TCGA-CH-5737-01A-11D-1576-08 b966ca07-fd34-4428-a460-1ba57a3e519d +TCGA-CH-5738-01 TCGA-CH-5738-01 TCGA-CH-5738 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 72 TCGA-CH-5738-F28982 TCGA-CH-5738 TCGA-CH-5738-01A NO M0 -26329 0 212 195 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 1.3 NO NO No [Discrepancy] TCGA-CH-5738.3e17e46c-0c96-4930-b8ac-7acee8d40750.pdf 5738 TUMOR FREE 3 Complete Remission/Response 0.01 NO R0 Primary Tumor 01 3 0.4 NO 4 YES NO CH Prostate A LIVING 2006 e5db7986-223c-4ee2-a4c8-c4e8bbb510f3 TCGA-CH-5738-01A-11D-1574-01 TCGA-CH-5738-01A-11D-1578-05 TCGA-CH-5738-01A-11D-1576-08 TCGA-CH-5738-01A-11D-1576-08 e5db7986-223c-4ee2-a4c8-c4e8bbb510f3 TCGA-CH-5738-01 TCGA-CH-5738-01 65BA7F91-6227-4E96-9C20-EE84A8BFF2A5 TCGA-CH-5738-01A-11D-1574-01 e5db7986-223c-4ee2-a4c8-c4e8bbb510f3 TCGA-CH-5738-01 TCGA-CH-5738-01 TCGA-CH-5738-01A-11D-1576-08 TCGA-CH-5738-01A-11D-1576-08 e5db7986-223c-4ee2-a4c8-c4e8bbb510f3 +TCGA-CH-5739-01 TCGA-CH-5739-01 TCGA-CH-5739 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-CH-5739-F28977 TCGA-CH-5739 TCGA-CH-5739-01A NO M0 -23953 0 671 586 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Left 0.9 YES NO 8 0 No N0 T3a TCGA-CH-5739.6db82b14-85e4-40c4-9827-a588c4a25ce8.pdf 5739 TUMOR FREE 3 Complete Remission/Response 0.02 NO R0 Primary Tumor 01 4 0.4 NO YES NO CH Prostate A LIVING 2006 Peripheral Zone 26c39f49-cf54-41d6-8c46-c089f4a57002 TCGA-CH-5739-01A-11D-1574-01 TCGA-CH-5739-01A-11D-1578-05 TCGA-CH-5739-01A-11D-1576-08 TCGA-CH-5739-01A-11D-1576-08 26c39f49-cf54-41d6-8c46-c089f4a57002 TCGA-CH-5739-01 TCGA-CH-5739-01 16485141-1F4F-49FC-A8A8-85229B96D859 TCGA-CH-5739-01A-11D-1574-01 26c39f49-cf54-41d6-8c46-c089f4a57002 TCGA-CH-5739-01 TCGA-CH-5739-01 TCGA-CH-5739-01A-11D-1576-08 TCGA-CH-5739-01A-11D-1576-08 26c39f49-cf54-41d6-8c46-c089f4a57002 +TCGA-CH-5740-01 TCGA-CH-5740-01 TCGA-CH-5740 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-CH-5740 TCGA-CH-5740-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -20880 31 31 0 31 [Discrepancy] NO YES No Evidence of Extraprostatic Extension 2012-3-21 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Bilateral 1 YES 4 0 No N0 T2c TCGA-CH-5740.25992d81-7441-4d60-a773-457618dcedbc.pdf 5740 TUMOR FREE 3 1.6 R0 Primary Tumor 01 4 0.3 YES NO CH Prostate A LIVING 2009 59173676-8eca-4a03-b37c-c726208a961a TCGA-CH-5740-01A-11D-1574-01 TCGA-CH-5740-01A-11D-1578-05 TCGA-CH-5740-01A-11D-1576-08 TCGA-CH-5740-01A-11D-1576-08 59173676-8eca-4a03-b37c-c726208a961a TCGA-CH-5740-01 TCGA-CH-5740-01 3E98A3E2-8D5D-4383-B8DE-EA3A0DEF3BE4 TCGA-CH-5740-01A-11D-1574-01 59173676-8eca-4a03-b37c-c726208a961a TCGA-CH-5740-01 TCGA-CH-5740-01 TCGA-CH-5740-01A-11D-1576-08 TCGA-CH-5740-01A-11D-1576-08 59173676-8eca-4a03-b37c-c726208a961a +TCGA-CH-5741-01 TCGA-CH-5741-01 TCGA-CH-5741 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 56 TCGA-CH-5741-F29006 TCGA-CH-5741 TCGA-CH-5741-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -20759 30 30 0 395 339 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 1.1 YES NO 5 1 No N1 T3b TCGA-CH-5741.87c977cc-2a28-49c9-adaf-f67c0bc208c2.pdf 5741 TUMOR FREE 4 Complete Remission/Response 0.02 YES R1 Primary Tumor 01 5 0.4 YES YES NO CH Prostate A LIVING 2008 Overlapping / Multiple Zones 639c8d3c-8719-49ca-8812-af6480b164ae TCGA-CH-5741-01A-11D-1574-01 TCGA-CH-5741-01A-11D-1578-05 TCGA-CH-5741-01A-11D-1576-08 TCGA-CH-5741-01A-11D-1576-08 639c8d3c-8719-49ca-8812-af6480b164ae TCGA-CH-5741-01 TCGA-CH-5741-01 F9B2036F-7247-4D9E-8793-3E1418064091 TCGA-CH-5741-01A-11D-1574-01 639c8d3c-8719-49ca-8812-af6480b164ae TCGA-CH-5741-01 TCGA-CH-5741-01 TCGA-CH-5741-01A-11D-1576-08 TCGA-CH-5741-01A-11D-1576-08 639c8d3c-8719-49ca-8812-af6480b164ae +TCGA-CH-5743-01 TCGA-CH-5743-01 TCGA-CH-5743 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 66 TCGA-CH-5743-F29001 TCGA-CH-5743 TCGA-CH-5743-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -24321 29 29 0 425 425 394 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 1.2 YES New Primary Tumor YES 1 0 No N0 T2c TCGA-CH-5743.e4f18f30-a6f0-4262-8f34-ce32db5cbe4a.pdf 5743 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.4 NO YES NO CH Prostate A LIVING 2008 Peripheral Zone 8f097693-4c17-42f4-b319-dd3b4ae93005 TCGA-CH-5743-01A-21D-1574-01 TCGA-CH-5743-01A-21D-1578-05 TCGA-CH-5743-01A-21D-1576-08 TCGA-CH-5743-01A-21D-1576-08 8f097693-4c17-42f4-b319-dd3b4ae93005 TCGA-CH-5743-01 TCGA-CH-5743-01 6C0A6447-8972-4D51-A953-658CF56860E6 TCGA-CH-5743-01A-21D-1574-01 8f097693-4c17-42f4-b319-dd3b4ae93005 TCGA-CH-5743-01 TCGA-CH-5743-01 TCGA-CH-5743-01A-21D-1576-08 8f097693-4c17-42f4-b319-dd3b4ae93005 +TCGA-CH-5744-01 TCGA-CH-5744-01 TCGA-CH-5744 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-CH-5744 TCGA-CH-5744-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -23621 60 60 0 60 48 YES No Evidence of Extraprostatic Extension NO 2012-3-16 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 0.5 YES 3 0 No N0 T2c TCGA-CH-5744.797db4c8-a9d9-4404-a520-9be024ced9d5.pdf 5744 TUMOR FREE 4 9.63 R0 Primary Tumor 01 3 0.2 5 YES NO CH Prostate A LIVING 2008 Peripheral Zone abf9624e-048a-412b-a0a8-331bb6fc5e16 TCGA-CH-5744-01A-11D-1574-01 TCGA-CH-5744-01A-11D-1578-05 TCGA-CH-5744-01A-11D-1576-08 TCGA-CH-5744-01A-11D-1576-08 abf9624e-048a-412b-a0a8-331bb6fc5e16 TCGA-CH-5744-01 TCGA-CH-5744-01 6A474A8E-78CD-4DFF-96B2-19A9C3F27541 TCGA-CH-5744-01A-11D-1574-01 abf9624e-048a-412b-a0a8-331bb6fc5e16 TCGA-CH-5744-01 TCGA-CH-5744-01 TCGA-CH-5744-01A-11D-1576-08 TCGA-CH-5744-01A-11D-1576-08 abf9624e-048a-412b-a0a8-331bb6fc5e16 +TCGA-CH-5745-01 TCGA-CH-5745-01 TCGA-CH-5745 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-CH-5745 TCGA-CH-5745-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -24837 91 0 91 84 NO NO 2012-3-16 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO 0.8 YES 5 0 No N0 T3a TCGA-CH-5745.43e941e9-cfbd-45bc-91bb-28e5f5d9b767.pdf 5745 TUMOR FREE 3 4.3 R0 Primary Tumor 01 4 0.4 YES NO CH Prostate A LIVING 2008 Overlapping / Multiple Zones 4ca3b9ec-cd21-46fc-9a44-05d5225f0c57 TCGA-CH-5745-01A-11D-1578-05 TCGA-CH-5745-01A-11D-1576-08 TCGA-CH-5745-01A-11D-1576-08 4ca3b9ec-cd21-46fc-9a44-05d5225f0c57 TCGA-CH-5745-01 TCGA-CH-5745-01 0F81C1A9-AF7E-44C9-8E30-F3AB5933967F 4ca3b9ec-cd21-46fc-9a44-05d5225f0c57 TCGA-CH-5745-01 TCGA-CH-5745-01A-11D-1576-08 4ca3b9ec-cd21-46fc-9a44-05d5225f0c57 +TCGA-CH-5746-01 TCGA-CH-5746-01 TCGA-CH-5746 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-CH-5746-F28996 TCGA-CH-5746 NO Normal (no evidence of prostate cancer) [cM0] M0 -20941 59 59 0 731 693 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral YES NO 2 0 No N0 T2c 5746 TUMOR FREE 3 Complete Remission/Response 0.1 YES R1 Primary Tumor 01 4 NO YES NO CH Prostate LIVING 2007 e129e211-8237-4842-a5f5-c3dc05607527 TCGA-CH-5746-01A-11D-1574-01 TCGA-CH-5746-01A-11D-1578-05 TCGA-CH-5746-01A-11D-1576-08 TCGA-CH-5746-01A-11D-1576-08 e129e211-8237-4842-a5f5-c3dc05607527 TCGA-CH-5746-01 TCGA-CH-5746-01 TCGA-CH-5746-01A-11D-1574-01 e129e211-8237-4842-a5f5-c3dc05607527 TCGA-CH-5746-01 TCGA-CH-5746-01 TCGA-CH-5746-01A-11D-1576-08 TCGA-CH-5746-01A-11D-1576-08 e129e211-8237-4842-a5f5-c3dc05607527 +TCGA-CH-5748-01 TCGA-CH-5748-01 TCGA-CH-5748 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-CH-5748 TCGA-CH-5748-01A -23649 0 31 NO NO 2012-3-21 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 1.3 YES 2 0 No N0 T3a TCGA-CH-5748.7d2d5d7d-481b-445d-8505-42564e11fce4.pdf 5748 WITH TUMOR 4 R1 Primary Tumor 01 3 0.4 YES NO CH Prostate A LIVING 2009 8d91b55d-0a51-44d3-bcc7-d6d95027683a TCGA-CH-5748-01A-11D-1574-01 TCGA-CH-5748-01A-11D-1578-05 TCGA-CH-5748-01A-11D-1576-08 TCGA-CH-5748-01A-11D-1576-08 8d91b55d-0a51-44d3-bcc7-d6d95027683a TCGA-CH-5748-01 TCGA-CH-5748-01 F750FE39-81B7-498B-BB7E-651A578395C3 TCGA-CH-5748-01A-11D-1574-01 8d91b55d-0a51-44d3-bcc7-d6d95027683a TCGA-CH-5748-01 TCGA-CH-5748-01 TCGA-CH-5748-01A-11D-1576-08 TCGA-CH-5748-01A-11D-1576-08 8d91b55d-0a51-44d3-bcc7-d6d95027683a +TCGA-CH-5750-01 TCGA-CH-5750-01 TCGA-CH-5750 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 72 TCGA-CH-5750-F29002 TCGA-CH-5750 TCGA-CH-5750-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -26389 31 31 0 396 337 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 0.9 YES NO 7 0 No N0 T2c TCGA-CH-5750.4cbd15a8-2912-4a6d-bdc3-38a4ae4e1381.pdf 5750 TUMOR FREE 3 Complete Remission/Response 0.02 NO R0 Primary Tumor 01 4 0.3 NO YES NO CH Prostate A LIVING 2008 Peripheral Zone 3d9ba7bd-ff22-44cf-ae6a-7588f5aa857f TCGA-CH-5750-01A-11D-1574-01 TCGA-CH-5750-01A-11D-1578-05 TCGA-CH-5750-01A-11D-1576-08 TCGA-CH-5750-01A-11D-1576-08 3d9ba7bd-ff22-44cf-ae6a-7588f5aa857f TCGA-CH-5750-01 TCGA-CH-5750-01 CD65E017-AF63-4C06-8DCF-A85B8602827E TCGA-CH-5750-01A-11D-1574-01 3d9ba7bd-ff22-44cf-ae6a-7588f5aa857f TCGA-CH-5750-01 TCGA-CH-5750-01 TCGA-CH-5750-01A-11D-1576-08 TCGA-CH-5750-01A-11D-1576-08 3d9ba7bd-ff22-44cf-ae6a-7588f5aa857f +TCGA-CH-5751-01 TCGA-CH-5751-01 TCGA-CH-5751 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES NO 68 TCGA-CH-5751-F28978 TCGA-CH-5751 TCGA-CH-5751-01A NO Equivocal M0 -24957 92 92 92 0 1065 365 1004 YES Equivocal YES Equivocal Scheduled Follow-up Submission Stable Disease 2012-2-15 MALE 10 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.5 YES Bone Distant Metastasis YES 3 1 No N1 T4 TCGA-CH-5751.c4240096-b982-4b8a-b871-677a94cfd6cc.pdf 5751 WITH TUMOR 5 Complete Remission/Response 0.01 NO R1 Primary Tumor 01 5 0.5 YES YES NO CH YES Prostate Distant Metastasis A LIVING 2006 Overlapping / Multiple Zones 063f416b-291b-4242-acb4-9587a2dc3244 TCGA-CH-5751-01A-11D-1574-01 TCGA-CH-5751-01A-11D-1578-05 TCGA-CH-5751-01A-11D-1576-08 TCGA-CH-5751-01A-11D-1576-08 063f416b-291b-4242-acb4-9587a2dc3244 TCGA-CH-5751-01 05E7E615-27D5-4FAC-AB73-59CE4E5AAC57 TCGA-CH-5751-01A-11D-1574-01 063f416b-291b-4242-acb4-9587a2dc3244 TCGA-CH-5751-01 TCGA-CH-5751-01A-11D-1576-08 TCGA-CH-5751-01A-11D-1576-08 063f416b-291b-4242-acb4-9587a2dc3244 +TCGA-CH-5752-01 TCGA-CH-5752-01 TCGA-CH-5752 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-CH-5752-F28987 TCGA-CH-5752 TCGA-CH-5752-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -24290 30 30 0 943 868 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 0.9 YES NO 9 0 No N0 T3a TCGA-CH-5752.d3549715-b952-479c-8edf-86e424811095.pdf 5752 TUMOR FREE 4 Complete Remission/Response 0.02 YES R0 Primary Tumor 01 4 0.5 YES YES NO CH Prostate A LIVING 2006 Overlapping / Multiple Zones 30861ba6-6539-47a5-82df-5f89d8101d05 TCGA-CH-5752-01A-11D-1574-01 TCGA-CH-5752-01A-11D-1578-05 TCGA-CH-5752-01A-11D-1576-08 TCGA-CH-5752-01A-11D-1576-08 30861ba6-6539-47a5-82df-5f89d8101d05 TCGA-CH-5752-01 TCGA-CH-5752-01 F80CE98E-5CF5-4CC1-8AE3-AFCF5CDA4DC2 TCGA-CH-5752-01A-11D-1574-01 30861ba6-6539-47a5-82df-5f89d8101d05 TCGA-CH-5752-01 TCGA-CH-5752-01 TCGA-CH-5752-01A-11D-1576-08 TCGA-CH-5752-01A-11D-1576-08 30861ba6-6539-47a5-82df-5f89d8101d05 +TCGA-CH-5753-01 TCGA-CH-5753-01 TCGA-CH-5753 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 70 TCGA-CH-5753 TCGA-CH-5753-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -25780 31 31 0 31 31 YES No Evidence of Extraprostatic Extension NO 2012-3-21 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.7 NO Bilateral 1 YES 10 3 Yes N1 T3b TCGA-CH-5753.4e86e7fc-a1c5-4d3b-a0b3-23187adfd096.pdf 5753 TUMOR FREE 4 4.53 R0 Primary Tumor 01 5 0.2 YES NO CH Prostate A LIVING 2008 Overlapping / Multiple Zones 2031e5cb-18c3-421e-b8af-d5dab73e3a89 TCGA-CH-5753-01A-11D-1574-01 TCGA-CH-5753-01A-11D-1578-05 TCGA-CH-5753-01A-11D-1576-08 TCGA-CH-5753-01A-11D-1576-08 2031e5cb-18c3-421e-b8af-d5dab73e3a89 TCGA-CH-5753-01 TCGA-CH-5753-01 0F729F85-0E45-4F8B-9E26-7F9589111251 TCGA-CH-5753-01A-11D-1574-01 2031e5cb-18c3-421e-b8af-d5dab73e3a89 TCGA-CH-5753-01 TCGA-CH-5753-01 TCGA-CH-5753-01A-11D-1576-08 TCGA-CH-5753-01A-11D-1576-08 2031e5cb-18c3-421e-b8af-d5dab73e3a89 +TCGA-CH-5754-01 TCGA-CH-5754-01 TCGA-CH-5754 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-CH-5754 TCGA-CH-5754-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -23803 62 62 0 62 62 YES No Evidence of Extraprostatic Extension NO 2012-3-21 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 1.2 YES 11 3 No N1 T3b TCGA-CH-5754.6c02cb0e-6826-46f0-8a9f-90f43cc1405c.pdf 5754 WITH TUMOR 4 37.36 R1 Primary Tumor 01 5 0.2 3 YES NO CH Prostate A LIVING 2008 Peripheral Zone 51cd07b8-f680-4bc2-a207-d0317f5f9358 TCGA-CH-5754-01A-11D-1574-01 TCGA-CH-5754-01A-11D-1578-05 TCGA-CH-5754-01A-11D-1576-08 TCGA-CH-5754-01A-11D-1576-08 51cd07b8-f680-4bc2-a207-d0317f5f9358 TCGA-CH-5754-01 TCGA-CH-5754-01 8D5A8DE4-0020-4BDC-A119-E1A7698707BF TCGA-CH-5754-01A-11D-1574-01 51cd07b8-f680-4bc2-a207-d0317f5f9358 TCGA-CH-5754-01 TCGA-CH-5754-01 TCGA-CH-5754-01A-11D-1576-08 TCGA-CH-5754-01A-11D-1576-08 51cd07b8-f680-4bc2-a207-d0317f5f9358 +TCGA-CH-5761-01 TCGA-CH-5761-01 TCGA-CH-5761 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-CH-5761 TCGA-CH-5761-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -22433 28 28 28 0 28 39 YES Equivocal YES Equivocal 2012-3-16 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Left 1 YES 5 0 No N0 T3b TCGA-CH-5761.205f9f59-486c-4211-aa60-0a5b4f746a74.pdf 5761 TUMOR FREE 5 8.49 R0 Primary Tumor 01 4 0.2 3 YES NO CH Prostate A LIVING 2007 Peripheral Zone e0f1b805-f155-47d8-a97e-7e611382cb76 TCGA-CH-5761-01A-11D-1574-01 TCGA-CH-5761-01A-11D-1578-05 TCGA-CH-5761-01A-11D-1576-08 TCGA-CH-5761-01A-11D-1576-08 e0f1b805-f155-47d8-a97e-7e611382cb76 TCGA-CH-5761-01 TCGA-CH-5761-01 ADAC7F52-F712-4716-970F-A1A57B09AAC1 TCGA-CH-5761-01A-11D-1574-01 e0f1b805-f155-47d8-a97e-7e611382cb76 TCGA-CH-5761-01 TCGA-CH-5761-01 TCGA-CH-5761-01A-11D-1576-08 TCGA-CH-5761-01A-11D-1576-08 e0f1b805-f155-47d8-a97e-7e611382cb76 +TCGA-CH-5761-11 TCGA-CH-5761-11 TCGA-CH-5761 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-CH-5761 NO Normal (no evidence of prostate cancer) [cM0] M0 -22433 28 28 28 0 28 39 YES Equivocal YES Equivocal 2012-3-16 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Left YES 5 0 No N0 T3b 5761 TUMOR FREE 5 8.49 R0 Solid Tissue Normal 11 4 3 YES NO CH Prostate LIVING 2007 Peripheral Zone e3d00d08-5395-48b0-bd95-0c945e2a33fe TCGA-CH-5761-11A-01D-1578-05 e3d00d08-5395-48b0-bd95-0c945e2a33fe TCGA-CH-5761-11 e3d00d08-5395-48b0-bd95-0c945e2a33fe TCGA-CH-5761-11 e3d00d08-5395-48b0-bd95-0c945e2a33fe +TCGA-CH-5762-01 TCGA-CH-5762-01 TCGA-CH-5762 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-CH-5762-F28975 TCGA-CH-5762 TCGA-CH-5762-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -22068 92 92 0 1339 1313 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-14 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 1.2 YES NO 7 0 No N0 T3b TCGA-CH-5762.21608393-74f2-4a7b-aaf4-9b02cb7afc94.pdf 5762 WITH TUMOR 4 Complete Remission/Response .01 YES R1 Primary Tumor 01 3 0.4 NO YES NO CH Prostate A LIVING 2005 Peripheral Zone bb36bff9-44fd-4f93-a82f-8c23658c335c TCGA-CH-5762-01A-11D-1574-01 TCGA-CH-5762-01A-11D-1578-05 TCGA-CH-5762-01A-11D-1576-08 TCGA-CH-5762-01A-11D-1576-08 bb36bff9-44fd-4f93-a82f-8c23658c335c TCGA-CH-5762-01 TCGA-CH-5762-01 B0A6FB3E-767B-424F-9DE3-51780E3190BD TCGA-CH-5762-01A-11D-1574-01 bb36bff9-44fd-4f93-a82f-8c23658c335c TCGA-CH-5762-01 TCGA-CH-5762-01 TCGA-CH-5762-01A-11D-1576-08 TCGA-CH-5762-01A-11D-1576-08 bb36bff9-44fd-4f93-a82f-8c23658c335c +TCGA-CH-5762-11 TCGA-CH-5762-11 TCGA-CH-5762 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-CH-5762-F28975 TCGA-CH-5762 TCGA-CH-5762-11A NO Normal (no evidence of prostate cancer) [cM0] M0 -22068 92 92 0 1339 1313 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-14 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 1.1 YES NO 7 0 No N0 T3b 5762 WITH TUMOR 4 Complete Remission/Response .01 YES R1 Solid Tissue Normal 11 3 0.2 NO YES NO CH Prostate A LIVING 2005 Peripheral Zone TCGA-CH-5762-11A-01D-1578-05 +TCGA-CH-5763-01 TCGA-CH-5763-01 TCGA-CH-5763 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-CH-5763-F28974 TCGA-CH-5763 TCGA-CH-5763-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -24380 0 0 0 365 360 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-14 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 1.5 YES NO 5 0 Yes N0 T3a TCGA-CH-5763.8722bfbe-6db5-41ca-9ac4-004b999a772d.pdf 5763 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.4 NO YES NO CH Prostate A LIVING 2008 Peripheral Zone 40eb0b4a-3863-403f-a90b-919bfa24237e TCGA-CH-5763-01A-11D-1574-01 TCGA-CH-5763-01A-11D-1578-05 TCGA-CH-5763-01A-11D-1576-08 TCGA-CH-5763-01A-11D-1576-08 40eb0b4a-3863-403f-a90b-919bfa24237e TCGA-CH-5763-01 TCGA-CH-5763-01 6818B0E0-1156-48C3-9FBE-C38F045E740E TCGA-CH-5763-01A-11D-1574-01 40eb0b4a-3863-403f-a90b-919bfa24237e TCGA-CH-5763-01 TCGA-CH-5763-01 TCGA-CH-5763-01A-11D-1576-08 TCGA-CH-5763-01A-11D-1576-08 40eb0b4a-3863-403f-a90b-919bfa24237e +TCGA-CH-5763-11 TCGA-CH-5763-11 TCGA-CH-5763 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-CH-5763-F28974 TCGA-CH-5763 TCGA-CH-5763-11A NO Normal (no evidence of prostate cancer) [cM0] M0 -24380 0 0 0 365 360 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-14 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 1.6 YES NO 5 0 Yes N0 T3a 5763 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 4 0.1 NO YES NO CH Prostate A LIVING 2008 Peripheral Zone TCGA-CH-5763-11A-01D-1578-05 +TCGA-CH-5764-01 TCGA-CH-5764-01 TCGA-CH-5764 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-CH-5764 TCGA-CH-5764-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -24257 31 31 0 31 29 YES No Evidence of Extraprostatic Extension NO 2012-3-16 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.3 NO Bilateral 1.5 YES 8 0 Yes N0 T3b TCGA-CH-5764.e7f4fceb-1960-44f0-8e0b-fde2337011ce.pdf 5764 TUMOR FREE 4 13.95 R0 Primary Tumor 01 3 0.3 YES NO CH Prostate A LIVING 2008 Peripheral Zone 5bd95b46-d04b-49a9-964a-dd49570f4960 TCGA-CH-5764-01A-21D-1574-01 TCGA-CH-5764-01A-21D-1578-05 TCGA-CH-5764-01A-21D-1576-08 TCGA-CH-5764-01A-21D-1576-08 5bd95b46-d04b-49a9-964a-dd49570f4960 TCGA-CH-5764-01 TCGA-CH-5764-01 84F92AD0-2522-43F9-A6A6-51590A00CABD TCGA-CH-5764-01A-21D-1574-01 5bd95b46-d04b-49a9-964a-dd49570f4960 TCGA-CH-5764-01 TCGA-CH-5764-01 TCGA-CH-5764-01A-21D-1576-08 TCGA-CH-5764-01A-21D-1576-08 5bd95b46-d04b-49a9-964a-dd49570f4960 +TCGA-CH-5764-11 TCGA-CH-5764-11 TCGA-CH-5764 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-CH-5764 TCGA-CH-5764-11A NO Normal (no evidence of prostate cancer) [cM0] M0 -24257 31 31 0 31 29 YES No Evidence of Extraprostatic Extension NO 2012-3-16 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 0.8 YES 8 0 Yes N0 T3b 5764 TUMOR FREE 4 13.95 R0 Solid Tissue Normal 11 3 0.2 YES NO CH Prostate A LIVING 2008 Peripheral Zone TCGA-CH-5764-11A-01D-1578-05 +TCGA-CH-5765-01 TCGA-CH-5765-01 TCGA-CH-5765 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-CH-5765-F28995 TCGA-CH-5765 TCGA-CH-5765-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -20364 31 31 0 700 694 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 1.4 YES NO 7 0 No N0 T3a TCGA-CH-5765.bf80f60e-d5c8-4a5b-b523-358c51ad7d2c.pdf 5765 TUMOR FREE 3 Complete Remission/Response 0.02 NO R0 Primary Tumor 01 4 0.4 NO YES NO CH Prostate A LIVING 2007 b8cc1fb1-5944-431c-aeec-a4301721f667 TCGA-CH-5765-01A-11D-1574-01 TCGA-CH-5765-01A-11D-1578-05 TCGA-CH-5765-01A-11D-1576-08 TCGA-CH-5765-01A-11D-1576-08 b8cc1fb1-5944-431c-aeec-a4301721f667 TCGA-CH-5765-01 TCGA-CH-5765-01 8DBE9F5E-D6A3-4ADC-8FFA-DFCD1A93FBA0 TCGA-CH-5765-01A-11D-1574-01 b8cc1fb1-5944-431c-aeec-a4301721f667 TCGA-CH-5765-01 TCGA-CH-5765-01 TCGA-CH-5765-01A-11D-1576-08 TCGA-CH-5765-01A-11D-1576-08 b8cc1fb1-5944-431c-aeec-a4301721f667 +TCGA-CH-5765-11 TCGA-CH-5765-11 TCGA-CH-5765 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-CH-5765-F28995 TCGA-CH-5765 TCGA-CH-5765-11A NO Normal (no evidence of prostate cancer) [cM0] M0 -20364 31 31 0 700 694 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 1.1 YES NO 7 0 No N0 T3a 5765 TUMOR FREE 3 Complete Remission/Response 0.02 NO R0 Solid Tissue Normal 11 4 0.2 NO YES NO CH Prostate A LIVING 2007 TCGA-CH-5765-11A-01D-1578-05 +TCGA-CH-5766-01 TCGA-CH-5766-01 TCGA-CH-5766 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-CH-5766 TCGA-CH-5766-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -20392 31 31 0 31 39 YES No Evidence of Extraprostatic Extension NO 2012-3-16 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 0.8 YES 4 1 No N1 T3a TCGA-CH-5766.f6f3fdff-8296-449a-9a1c-d23803cf078a.pdf 5766 TUMOR FREE 4 13.9 R0 Primary Tumor 01 3 0.4 YES NO CH Prostate A LIVING 2007 Peripheral Zone f44cdc06-35ed-42dc-b4b2-fdd19399c7d3 TCGA-CH-5766-01A-11D-1574-01 TCGA-CH-5766-01A-11D-1578-05 TCGA-CH-5766-01A-11D-1576-08 TCGA-CH-5766-01A-11D-1576-08 f44cdc06-35ed-42dc-b4b2-fdd19399c7d3 TCGA-CH-5766-01 TCGA-CH-5766-01 02514EB6-8CF8-4DED-9761-895DA6563B93 TCGA-CH-5766-01A-11D-1574-01 f44cdc06-35ed-42dc-b4b2-fdd19399c7d3 TCGA-CH-5766-01 TCGA-CH-5766-01 TCGA-CH-5766-01A-11D-1576-08 TCGA-CH-5766-01A-11D-1576-08 f44cdc06-35ed-42dc-b4b2-fdd19399c7d3 +TCGA-CH-5766-11 TCGA-CH-5766-11 TCGA-CH-5766 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-CH-5766 TCGA-CH-5766-11A NO Normal (no evidence of prostate cancer) [cM0] M0 -20392 31 31 0 31 39 YES No Evidence of Extraprostatic Extension NO 2012-3-16 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 1 YES 4 1 No N1 T3a 5766 TUMOR FREE 4 13.9 R0 Solid Tissue Normal 11 3 0.2 YES NO CH Prostate A LIVING 2007 Peripheral Zone TCGA-CH-5766-11A-01D-1578-05 +TCGA-CH-5767-01 TCGA-CH-5767-01 TCGA-CH-5767 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-CH-5767-F28999 TCGA-CH-5767 TCGA-CH-5767-01A NO M0 -24287 0 458 377 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 1.3 YES NO 19 0 No N0 T2c TCGA-CH-5767.237374e0-5b18-407c-ae42-898a95c14fa2.pdf 5767 TUMOR FREE 4 Complete Remission/Response 0.04 NO R0 Primary Tumor 01 3 0.2 NO YES NO CH Prostate A LIVING 2007 Peripheral Zone 07f49527-0833-481f-b172-cb67601f8b03 TCGA-CH-5767-01A-11D-1785-01 TCGA-CH-5767-01A-11D-1787-05 TCGA-CH-5767-01A-11D-1786-08 TCGA-CH-5767-01A-11D-1786-08 07f49527-0833-481f-b172-cb67601f8b03 TCGA-CH-5767-01 TCGA-CH-5767-01 97F044F9-0CAA-46A2-B22A-97FD42326745 TCGA-CH-5767-01A-11D-1785-01 07f49527-0833-481f-b172-cb67601f8b03 TCGA-CH-5767-01 TCGA-CH-5767-01 TCGA-CH-5767-01A-11D-1786-08 TCGA-CH-5767-01A-11D-1786-08 07f49527-0833-481f-b172-cb67601f8b03 +TCGA-CH-5767-11 TCGA-CH-5767-11 TCGA-CH-5767 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-CH-5767-F28999 TCGA-CH-5767 TCGA-CH-5767-11B NO M0 -24287 0 458 377 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.2 NO Bilateral 1.4 YES NO 19 0 No N0 T2c 5767 TUMOR FREE 4 Complete Remission/Response 0.04 NO R0 Solid Tissue Normal 11 3 0.2 NO YES NO CH Prostate B LIVING 2007 Peripheral Zone 6eb0d270-797d-49ab-9bda-a5f0a70a6695 TCGA-CH-5767-11B-01D-1787-05 6eb0d270-797d-49ab-9bda-a5f0a70a6695 TCGA-CH-5767-11 6eb0d270-797d-49ab-9bda-a5f0a70a6695 TCGA-CH-5767-11 6eb0d270-797d-49ab-9bda-a5f0a70a6695 +TCGA-CH-5768-01 TCGA-CH-5768-01 TCGA-CH-5768 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 72 TCGA-CH-5768-F28998 TCGA-CH-5768 TCGA-CH-5768-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -26480 30 30 0 731 634 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 1.1 YES NO 16 0 No N0 T3a TCGA-CH-5768.619201a3-bfe0-473c-83f2-76028455fcb5.pdf 5768 TUMOR FREE 2 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.3 NO 3 YES NO CH Prostate A LIVING 2007 Overlapping / Multiple Zones 78808f76-820b-439f-8223-38f2899cad5f TCGA-CH-5768-01A-11D-1574-01 TCGA-CH-5768-01A-11D-1578-05 TCGA-CH-5768-01A-11D-1576-08 TCGA-CH-5768-01A-11D-1576-08 78808f76-820b-439f-8223-38f2899cad5f TCGA-CH-5768-01 TCGA-CH-5768-01 AB12065D-3680-4DE2-942D-ECCD6C5C5281 TCGA-CH-5768-01A-11D-1574-01 78808f76-820b-439f-8223-38f2899cad5f TCGA-CH-5768-01 TCGA-CH-5768-01 TCGA-CH-5768-01A-11D-1576-08 TCGA-CH-5768-01A-11D-1576-08 78808f76-820b-439f-8223-38f2899cad5f +TCGA-CH-5768-11 TCGA-CH-5768-11 TCGA-CH-5768 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 72 TCGA-CH-5768-F28998 TCGA-CH-5768 TCGA-CH-5768-11A NO Normal (no evidence of prostate cancer) [cM0] M0 -26480 30 30 0 731 634 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 1.2 YES NO 16 0 No N0 T3a 5768 TUMOR FREE 2 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 4 0.3 NO 3 YES NO CH Prostate A LIVING 2007 Overlapping / Multiple Zones 3c3a7016-6270-4c87-af7d-53b46f7f8fd1 TCGA-CH-5768-11A-01D-1578-05 3c3a7016-6270-4c87-af7d-53b46f7f8fd1 TCGA-CH-5768-11 3c3a7016-6270-4c87-af7d-53b46f7f8fd1 TCGA-CH-5768-11 3c3a7016-6270-4c87-af7d-53b46f7f8fd1 +TCGA-CH-5769-01 TCGA-CH-5769-01 TCGA-CH-5769 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 48 TCGA-CH-5769 TCGA-CH-5769-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -17807 62 62 0 62 60 YES No Evidence of Extraprostatic Extension NO 2012-3-16 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 1 YES 8 0 No N0 T3b TCGA-CH-5769.7d49b105-6652-41b9-8e3a-e806a14de604.pdf 5769 WITH TUMOR 5 11.16 R1 Primary Tumor 01 4 0.4 YES NO CH Prostate A LIVING 2007 2d12fd80-ba3f-49c3-aa15-1f67b9bbd443 TCGA-CH-5769-01A-11D-1574-01 TCGA-CH-5769-01A-11D-1578-05 TCGA-CH-5769-01A-11D-1576-08 TCGA-CH-5769-01A-11D-1576-08 2d12fd80-ba3f-49c3-aa15-1f67b9bbd443 TCGA-CH-5769-01 TCGA-CH-5769-01 545B68DC-C3D2-42E6-8ACC-61E81CEEB8B2 TCGA-CH-5769-01A-11D-1574-01 2d12fd80-ba3f-49c3-aa15-1f67b9bbd443 TCGA-CH-5769-01 TCGA-CH-5769-01 TCGA-CH-5769-01A-11D-1576-08 TCGA-CH-5769-01A-11D-1576-08 2d12fd80-ba3f-49c3-aa15-1f67b9bbd443 +TCGA-CH-5769-11 TCGA-CH-5769-11 TCGA-CH-5769 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 48 TCGA-CH-5769 TCGA-CH-5769-11A NO Normal (no evidence of prostate cancer) [cM0] M0 -17807 62 62 0 62 60 YES No Evidence of Extraprostatic Extension NO 2012-3-16 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 80 0.4 NO Bilateral 1 YES 8 0 No N0 T3b 5769 WITH TUMOR 5 11.16 R1 Solid Tissue Normal 11 4 0.2 YES NO CH Prostate A LIVING 2007 4e169e09-37da-42c9-bed4-2649212d9c6b TCGA-CH-5769-11A-01D-1578-05 4e169e09-37da-42c9-bed4-2649212d9c6b TCGA-CH-5769-11 4e169e09-37da-42c9-bed4-2649212d9c6b TCGA-CH-5769-11 4e169e09-37da-42c9-bed4-2649212d9c6b +TCGA-CH-5771-01 TCGA-CH-5771-01 TCGA-CH-5771 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-CH-5771-F29003 TCGA-CH-5771 TCGA-CH-5771-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -23101 31 31 0 396 396 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 1.3 YES NO 2 0 No N0 T2c TCGA-CH-5771.7c775a61-67f6-42a1-84e6-5cf8cd66a038.pdf 5771 TUMOR FREE 4 Complete Remission/Response 0.03 NO R0 Primary Tumor 01 3 0.3 NO 5 YES NO CH Prostate A LIVING 2008 a771088e-45e1-4e67-8e3e-88c65d0b0618 TCGA-CH-5771-01A-21D-1574-01 TCGA-CH-5771-01A-21D-1578-05 TCGA-CH-5771-01A-21D-1576-08 TCGA-CH-5771-01A-21D-1576-08 a771088e-45e1-4e67-8e3e-88c65d0b0618 TCGA-CH-5771-01 TCGA-CH-5771-01 AA8280D0-C22E-45CF-B8E1-C2F060CB04FC TCGA-CH-5771-01A-21D-1574-01 a771088e-45e1-4e67-8e3e-88c65d0b0618 TCGA-CH-5771-01 TCGA-CH-5771-01 TCGA-CH-5771-01A-21D-1576-08 TCGA-CH-5771-01A-21D-1576-08 a771088e-45e1-4e67-8e3e-88c65d0b0618 +TCGA-CH-5771-11 TCGA-CH-5771-11 TCGA-CH-5771 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-CH-5771-F29003 TCGA-CH-5771 TCGA-CH-5771-11A NO Normal (no evidence of prostate cancer) [cM0] M0 -23101 31 31 0 396 396 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.3 NO Bilateral 1.8 YES NO 2 0 No N0 T2c 5771 TUMOR FREE 4 Complete Remission/Response 0.03 NO R0 Solid Tissue Normal 11 3 0.2 NO 5 YES NO CH Prostate A LIVING 2008 TCGA-CH-5771-11A-01D-1578-05 +TCGA-CH-5772-01 TCGA-CH-5772-01 TCGA-CH-5772 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-CH-5772-F29004 TCGA-CH-5772 TCGA-CH-5772-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -23194 90 90 90 0 486 424 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.3 NO Bilateral 0.9 YES NO 6 0 Yes N0 T3a TCGA-CH-5772.78506402-8bc2-45de-8374-5ddfdc7066eb.pdf 5772 TUMOR FREE 4 Complete Remission/Response 0.03 YES R1 Primary Tumor 01 5 0.3 NO 3 YES NO CH Prostate A LIVING 2008 77e1b878-fcff-4541-9cb5-85e0dce7b721 TCGA-CH-5772-01A-11D-1574-01 TCGA-CH-5772-01A-11D-1578-05 TCGA-CH-5772-01A-11D-1576-08 TCGA-CH-5772-01A-11D-1576-08 77e1b878-fcff-4541-9cb5-85e0dce7b721 TCGA-CH-5772-01 TCGA-CH-5772-01 4AD27CF8-24A8-499A-B363-B39DED558CD7 TCGA-CH-5772-01A-11D-1574-01 77e1b878-fcff-4541-9cb5-85e0dce7b721 TCGA-CH-5772-01 TCGA-CH-5772-01 TCGA-CH-5772-01A-11D-1576-08 TCGA-CH-5772-01A-11D-1576-08 77e1b878-fcff-4541-9cb5-85e0dce7b721 +TCGA-CH-5772-11 TCGA-CH-5772-11 TCGA-CH-5772 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-CH-5772-F29004 TCGA-CH-5772 TCGA-CH-5772-11A NO Normal (no evidence of prostate cancer) [cM0] M0 -23194 90 90 90 0 486 424 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.2 NO Bilateral 1.4 YES NO 6 0 Yes N0 T3a 5772 TUMOR FREE 4 Complete Remission/Response 0.03 YES R1 Solid Tissue Normal 11 5 0.2 NO 3 YES NO CH Prostate A LIVING 2008 TCGA-CH-5772-11A-01D-1578-05 +TCGA-CH-5788-01 TCGA-CH-5788-01 TCGA-CH-5788 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 69 TCGA-CH-5788-F28991 TCGA-CH-5788 TCGA-CH-5788-01A YES Normal (no evidence of prostate cancer) [cM0] M0 -25233 31 31 786 0 821 786 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Progressive Disease 2012-2-15 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 0.8 YES 21 6 No N1 T3b TCGA-CH-5788.41e797ae-db60-4653-9e61-4050ec9c05b2.pdf 5788 WITH TUMOR 4 Progressive Disease 3.58 NO R0 Primary Tumor 01 3 0.2 YES 5 YES NO CH Base Prostate A LIVING 2007 9caa440e-a8a6-4851-b62e-4ebb09412fad TCGA-CH-5788-01A-11D-1574-01 TCGA-CH-5788-01A-11D-1578-05 TCGA-CH-5788-01A-11D-1576-08 TCGA-CH-5788-01A-11D-1576-08 9caa440e-a8a6-4851-b62e-4ebb09412fad TCGA-CH-5788-01 TCGA-CH-5788-01 4B319620-E1EC-4186-A856-257A95BD5D16 TCGA-CH-5788-01A-11D-1574-01 9caa440e-a8a6-4851-b62e-4ebb09412fad TCGA-CH-5788-01 TCGA-CH-5788-01 TCGA-CH-5788-01A-11D-1576-08 TCGA-CH-5788-01A-11D-1576-08 9caa440e-a8a6-4851-b62e-4ebb09412fad +TCGA-CH-5789-01 TCGA-CH-5789-01 TCGA-CH-5789 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-CH-5789-F28990 TCGA-CH-5789 TCGA-CH-5789-01A NO M0 -22494 61 0 304 229 YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 1 NO 4 0 No N0 T3a TCGA-CH-5789.50e47b92-4c6a-4fca-8d01-0b4abc61bd0e.pdf 5789 TUMOR FREE 3 Complete Remission/Response 0.02 NO R0 Primary Tumor 01 4 0.4 NO YES NO CH Prostate A LIVING 2006 Peripheral Zone f659e8f2-3d29-4170-bd40-84e54c70fcd4 TCGA-CH-5789-01A-11D-1574-01 TCGA-CH-5789-01A-11D-1578-05 TCGA-CH-5789-01A-11D-1576-08 TCGA-CH-5789-01A-11D-1576-08 f659e8f2-3d29-4170-bd40-84e54c70fcd4 TCGA-CH-5789-01 TCGA-CH-5789-01 12F2FBEB-2CF8-4C5D-90C6-F960AACA4092 TCGA-CH-5789-01A-11D-1574-01 f659e8f2-3d29-4170-bd40-84e54c70fcd4 TCGA-CH-5789-01 TCGA-CH-5789-01 TCGA-CH-5789-01A-11D-1576-08 TCGA-CH-5789-01A-11D-1576-08 f659e8f2-3d29-4170-bd40-84e54c70fcd4 +TCGA-CH-5790-01 TCGA-CH-5790-01 TCGA-CH-5790 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-CH-5790-F28986 TCGA-CH-5790 TCGA-CH-5790-01A NO M0 -23529 0 974 914 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 1 YES NO 5 0 Yes N0 T2c TCGA-CH-5790.0f2f0a80-6a25-4374-96ad-0dbd6d136906.pdf 5790 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.3 NO YES NO CH Prostate A LIVING 2006 743ad0e2-903e-4438-a575-1f06c286c079 TCGA-CH-5790-01A-11D-1574-01 TCGA-CH-5790-01A-11D-1578-05 TCGA-CH-5790-01A-11D-1576-08 TCGA-CH-5790-01A-11D-1576-08 743ad0e2-903e-4438-a575-1f06c286c079 TCGA-CH-5790-01 TCGA-CH-5790-01 0F699258-4F1D-478B-B860-5108C509E56D TCGA-CH-5790-01A-11D-1574-01 743ad0e2-903e-4438-a575-1f06c286c079 TCGA-CH-5790-01 TCGA-CH-5790-01 TCGA-CH-5790-01A-11D-1576-08 TCGA-CH-5790-01A-11D-1576-08 743ad0e2-903e-4438-a575-1f06c286c079 +TCGA-CH-5791-01 TCGA-CH-5791-01 TCGA-CH-5791 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 72 TCGA-CH-5791-F28985 TCGA-CH-5791 TCGA-CH-5791-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -26390 61 0 1004 396 882 NO NO Scheduled Follow-up Submission Partial Remission/Response 2012-2-15 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 0.8 YES New Primary Tumor YES 2 0 Yes N0 T3a TCGA-CH-5791.009bf26f-b3df-4f10-b496-a4304af1e091.pdf 5791 3 Complete Remission/Response 0.18 NO R1 Primary Tumor 01 4 0.2 NO YES NO CH Prostate A LIVING 2006 Peripheral Zone 47faa91b-1bfa-4283-bc9d-dfa958252d6f TCGA-CH-5791-01A-11D-1574-01 TCGA-CH-5791-01A-11D-1578-05 TCGA-CH-5791-01A-11D-1576-08 TCGA-CH-5791-01A-11D-1576-08 47faa91b-1bfa-4283-bc9d-dfa958252d6f TCGA-CH-5791-01 TCGA-CH-5791-01 A78ED02E-3618-49BE-8920-F4BA943CC7A4 TCGA-CH-5791-01A-11D-1574-01 47faa91b-1bfa-4283-bc9d-dfa958252d6f TCGA-CH-5791-01 TCGA-CH-5791-01 TCGA-CH-5791-01A-11D-1576-08 TCGA-CH-5791-01A-11D-1576-08 47faa91b-1bfa-4283-bc9d-dfa958252d6f +TCGA-CH-5792-01 TCGA-CH-5792-01 TCGA-CH-5792 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-CH-5792 TCGA-CH-5792-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -21002 91 0 91 91 NO NO 2012-3-21 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 1.4 YES 6 0 No N0 T3a TCGA-CH-5792.72de5993-cad1-4ba0-9ea5-c545799a2f6e.pdf 5792 WITH TUMOR 4 11.49 R1 Primary Tumor 01 5 0.4 YES NO CH Prostate A LIVING 2009 4db58676-4bfe-46de-9db9-8270d67b49fe TCGA-CH-5792-01A-11D-1574-01 TCGA-CH-5792-01A-11D-1578-05 TCGA-CH-5792-01A-11D-1576-08 TCGA-CH-5792-01A-11D-1576-08 4db58676-4bfe-46de-9db9-8270d67b49fe TCGA-CH-5792-01 TCGA-CH-5792-01 0AC4DEF1-BF7D-4C6C-BFFD-95873ABD655D TCGA-CH-5792-01A-11D-1574-01 4db58676-4bfe-46de-9db9-8270d67b49fe TCGA-CH-5792-01 TCGA-CH-5792-01 TCGA-CH-5792-01A-11D-1576-08 TCGA-CH-5792-01A-11D-1576-08 4db58676-4bfe-46de-9db9-8270d67b49fe +TCGA-CH-5794-01 TCGA-CH-5794-01 TCGA-CH-5794 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-CH-5794-F28994 TCGA-CH-5794 TCGA-CH-5794-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -23924 62 62 0 882 821 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-15 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 1.1 YES NO 4 0 No N0 T2b TCGA-CH-5794.2bdbd62b-c2a0-4cdd-8187-6cf1db227e7e.pdf 5794 TUMOR FREE 3 Complete Remission/Response 0.01 NO R0 Primary Tumor 01 4 0.4 NO YES NO CH Prostate A LIVING 2006 Peripheral Zone 5c6bca7d-7dcc-4908-add3-c56606b313a7 TCGA-CH-5794-01A-11D-1574-01 TCGA-CH-5794-01A-11D-1578-05 TCGA-CH-5794-01A-11D-1576-08 TCGA-CH-5794-01A-11D-1576-08 5c6bca7d-7dcc-4908-add3-c56606b313a7 TCGA-CH-5794-01 TCGA-CH-5794-01 538DEA11-0D68-4013-B3EC-BEDAED2F90FA TCGA-CH-5794-01A-11D-1574-01 5c6bca7d-7dcc-4908-add3-c56606b313a7 TCGA-CH-5794-01 TCGA-CH-5794-01 TCGA-CH-5794-01A-11D-1576-08 TCGA-CH-5794-01A-11D-1576-08 5c6bca7d-7dcc-4908-add3-c56606b313a7 +TCGA-EJ-5494-01 TCGA-EJ-5494-01 TCGA-EJ-5494 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 50 TCGA-EJ-5494-F71910 TCGA-EJ-5494 TCGA-EJ-5494-01A NO M0 T2a -18596 0 1477 184 Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.7 NO YES NO 17 0 No N0 T3a TCGA-EJ-5494.e52eefbc-e27d-4a5d-a261-d06a2dcf5d53.pdf 5494 TUMOR FREE 4 Complete Remission/Response NO R0 Primary Tumor 01 3 0.3 NO 4 YES NO EJ Apex|Middle Prostate A LIVING 2009 fb687a9b-dcb1-46e9-b175-fd28c7242c2b TCGA-EJ-5494-01A-01D-1574-01 TCGA-EJ-5494-01A-01D-1578-05 TCGA-EJ-5494-01A-01D-1576-08 TCGA-EJ-5494-01A-01D-1576-08 fb687a9b-dcb1-46e9-b175-fd28c7242c2b TCGA-EJ-5494-01 TCGA-EJ-5494-01 BA260C91-7D20-4B44-B383-19314D60631D TCGA-EJ-5494-01A-01D-1574-01 fb687a9b-dcb1-46e9-b175-fd28c7242c2b TCGA-EJ-5494-01 TCGA-EJ-5494-01 TCGA-EJ-5494-01A-01D-1576-08 TCGA-EJ-5494-01A-01D-1576-08 fb687a9b-dcb1-46e9-b175-fd28c7242c2b +TCGA-EJ-5495-01 TCGA-EJ-5495-01 TCGA-EJ-5495 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-EJ-5495-F71913 TCGA-EJ-5495 TCGA-EJ-5495-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -24904 26 0 1760 606 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 1.3 NO YES NO 18 1 No N1 T3b TCGA-EJ-5495.5c549c39-b223-49eb-aa93-0298cdf33370.pdf 5495 TUMOR FREE 5 Complete Remission/Response 0.13 NO R0 Primary Tumor 01 3 0.4 NO 4 YES NO EJ Middle|Base Prostate A LIVING 2009 c07b7746-e340-4679-99bb-531c2d93b4e5 TCGA-EJ-5495-01A-01D-1574-01 TCGA-EJ-5495-01A-01D-1578-05 TCGA-EJ-5495-01A-01D-1576-08 TCGA-EJ-5495-01A-01D-1576-08 c07b7746-e340-4679-99bb-531c2d93b4e5 TCGA-EJ-5495-01 TCGA-EJ-5495-01 E7B35738-2222-4A08-AA6B-8352D26BEC92 TCGA-EJ-5495-01A-01D-1574-01 c07b7746-e340-4679-99bb-531c2d93b4e5 TCGA-EJ-5495-01 TCGA-EJ-5495-01 TCGA-EJ-5495-01A-01D-1576-08 TCGA-EJ-5495-01A-01D-1576-08 c07b7746-e340-4679-99bb-531c2d93b4e5 +TCGA-EJ-5496-01 TCGA-EJ-5496-01 TCGA-EJ-5496 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-EJ-5496-F60309 TCGA-EJ-5496 TCGA-EJ-5496-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -21897 15 15 0 595 595 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-5 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 2 YES YES 26 0 No N0 T2c TCGA-EJ-5496.80e82784-0bca-4657-9c9f-e9b860dc09bc.pdf 5496 TUMOR FREE 3 0.1 R0 Primary Tumor 01 4 0.3 4 YES NO EJ Apex|Middle|Base Prostate A LIVING 2009 Overlapping / Multiple Zones 1059fbc0-46bf-4135-99d0-080ec225391b TCGA-EJ-5496-01A-01D-1574-01 TCGA-EJ-5496-01A-01D-1578-05 TCGA-EJ-5496-01A-01D-1576-08 TCGA-EJ-5496-01A-01D-1576-08 1059fbc0-46bf-4135-99d0-080ec225391b TCGA-EJ-5496-01 TCGA-EJ-5496-01 B724F938-FEE2-4AD6-99C3-838742A70AF9 TCGA-EJ-5496-01A-01D-1574-01 1059fbc0-46bf-4135-99d0-080ec225391b TCGA-EJ-5496-01 TCGA-EJ-5496-01 TCGA-EJ-5496-01A-01D-1576-08 TCGA-EJ-5496-01A-01D-1576-08 1059fbc0-46bf-4135-99d0-080ec225391b +TCGA-EJ-5497-01 TCGA-EJ-5497-01 TCGA-EJ-5497 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 47 TCGA-EJ-5497-F60311 TCGA-EJ-5497 TCGA-EJ-5497-01A NO M0 T2c -17523 0 405 204 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-5 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 1.5 YES YES 10 0 No N0 T2c TCGA-EJ-5497.4c6ab617-53f7-4556-a1a0-b44df4f67b6b.pdf 5497 TUMOR FREE 3 0.1 R0 Primary Tumor 01 4 0.5 3 YES NO EJ Middle Prostate A LIVING 2009 Overlapping / Multiple Zones 86961468-9e93-469a-b812-03ef327bf5fb TCGA-EJ-5497-01A-02D-1574-01 TCGA-EJ-5497-01A-02D-1578-05 TCGA-EJ-5497-01A-02D-1576-08 TCGA-EJ-5497-01A-02D-1576-08 86961468-9e93-469a-b812-03ef327bf5fb TCGA-EJ-5497-01 TCGA-EJ-5497-01 C7EF553E-B25E-42A5-8C05-6F16BBAFC14B TCGA-EJ-5497-01A-02D-1574-01 86961468-9e93-469a-b812-03ef327bf5fb TCGA-EJ-5497-01 TCGA-EJ-5497-01 TCGA-EJ-5497-01A-02D-1576-08 TCGA-EJ-5497-01A-02D-1576-08 86961468-9e93-469a-b812-03ef327bf5fb +TCGA-EJ-5498-01 TCGA-EJ-5498-01 TCGA-EJ-5498 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 56 TCGA-EJ-5498-F71919 TCGA-EJ-5498 TCGA-EJ-5498-01A NO Normal (no evidence of prostate cancer) [cM0] T2c -20472 12 12 0 1720 537 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.7 NO Bilateral 1.4 NO YES NO 26 0 No N0 T2c TCGA-EJ-5498.53d058fd-5faa-43ab-8a5e-b6f95134970b.pdf 5498 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 0.5 NO 3 YES NO EJ Middle Prostate A LIVING 2010 Overlapping / Multiple Zones 2bc25263-18b8-4ed5-b986-e9b54f734596 TCGA-EJ-5498-01A-01D-1574-01 TCGA-EJ-5498-01A-01D-1578-05 TCGA-EJ-5498-01A-01D-1576-08 TCGA-EJ-5498-01A-01D-1576-08 2bc25263-18b8-4ed5-b986-e9b54f734596 TCGA-EJ-5498-01 TCGA-EJ-5498-01 C2B3E926-0662-4245-AFA5-C19AEDF7A673 TCGA-EJ-5498-01A-01D-1574-01 2bc25263-18b8-4ed5-b986-e9b54f734596 TCGA-EJ-5498-01 TCGA-EJ-5498-01 TCGA-EJ-5498-01A-01D-1576-08 TCGA-EJ-5498-01A-01D-1576-08 2bc25263-18b8-4ed5-b986-e9b54f734596 +TCGA-EJ-5499-01 TCGA-EJ-5499-01 TCGA-EJ-5499 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-EJ-5499-F60312 TCGA-EJ-5499 TCGA-EJ-5499-01A NO M0 T2b -22286 0 1415 533 Scheduled Follow-up Submission Complete Remission/Response 2014-6-5 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.9 NO Bilateral 1.1 NO YES NO 19 0 No N0 T3a TCGA-EJ-5499.f69e29da-24d1-45f2-9b4f-a32f9e5479a4.pdf 5499 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 0.4 NO 3 YES NO EJ Apex|Middle|Base Prostate A LIVING 2010 Overlapping / Multiple Zones b1d3e9ee-f0d0-4efd-a505-ea1a9f7fa6df TCGA-EJ-5499-01A-01D-1574-01 TCGA-EJ-5499-01A-01D-1578-05 TCGA-EJ-5499-01A-01D-1576-08 TCGA-EJ-5499-01A-01D-1576-08 b1d3e9ee-f0d0-4efd-a505-ea1a9f7fa6df TCGA-EJ-5499-01 TCGA-EJ-5499-01 C30416C0-12F3-4C0E-BF4C-73F7F7BA4106 TCGA-EJ-5499-01A-01D-1574-01 b1d3e9ee-f0d0-4efd-a505-ea1a9f7fa6df TCGA-EJ-5499-01 TCGA-EJ-5499-01 TCGA-EJ-5499-01A-01D-1576-08 TCGA-EJ-5499-01A-01D-1576-08 b1d3e9ee-f0d0-4efd-a505-ea1a9f7fa6df +TCGA-EJ-5501-01 TCGA-EJ-5501-01 TCGA-EJ-5501 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-EJ-5501-F60313 TCGA-EJ-5501 TCGA-EJ-5501-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -20409 9 9 0 1365 729 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-5 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1 NO YES NO 11 0 No N0 T3b TCGA-EJ-5501.630dee46-15db-4a16-84ee-a9d25fcccb80.pdf 5501 TUMOR FREE 4 0.1 R0 Primary Tumor 01 3 0.3 5 YES NO EJ Middle|Base Prostate A LIVING 2010 Overlapping / Multiple Zones b896a143-8a90-424e-9124-45edb6f3f26d TCGA-EJ-5501-01A-01D-1574-01 TCGA-EJ-5501-01A-01D-1578-05 TCGA-EJ-5501-01A-01D-1576-08 TCGA-EJ-5501-01A-01D-1576-08 b896a143-8a90-424e-9124-45edb6f3f26d TCGA-EJ-5501-01 TCGA-EJ-5501-01 6979871B-9E73-4200-AED2-92DE897C3053 TCGA-EJ-5501-01A-01D-1574-01 b896a143-8a90-424e-9124-45edb6f3f26d TCGA-EJ-5501-01 TCGA-EJ-5501-01 TCGA-EJ-5501-01A-01D-1576-08 TCGA-EJ-5501-01A-01D-1576-08 b896a143-8a90-424e-9124-45edb6f3f26d +TCGA-EJ-5502-01 TCGA-EJ-5502-01 TCGA-EJ-5502 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 50 TCGA-EJ-5502-F71921 TCGA-EJ-5502 TCGA-EJ-5502-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2c -18447 7 7 0 1171 603 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.7 NO YES NO 11 0 No N0 T2c TCGA-EJ-5502.173e45e9-e2ab-4a1d-8bcc-15374f1ae511.pdf 5502 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 0.3 NO 3 YES NO EJ Middle|Base Prostate A LIVING 2010 Overlapping / Multiple Zones 416bc8ff-9dd9-4b0c-b0f7-66cb8a437aad TCGA-EJ-5502-01A-01D-1574-01 TCGA-EJ-5502-01A-01D-1578-05 TCGA-EJ-5502-01A-01D-1576-08 TCGA-EJ-5502-01A-01D-1576-08 416bc8ff-9dd9-4b0c-b0f7-66cb8a437aad TCGA-EJ-5502-01 TCGA-EJ-5502-01 EA44DC8F-0260-437E-BCD3-DC2BD19DD9CE TCGA-EJ-5502-01A-01D-1574-01 416bc8ff-9dd9-4b0c-b0f7-66cb8a437aad TCGA-EJ-5502-01 TCGA-EJ-5502-01 TCGA-EJ-5502-01A-01D-1576-08 TCGA-EJ-5502-01A-01D-1576-08 416bc8ff-9dd9-4b0c-b0f7-66cb8a437aad +TCGA-EJ-5503-01 TCGA-EJ-5503-01 TCGA-EJ-5503 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 50 TCGA-EJ-5503-F60037 TCGA-EJ-5503 TCGA-EJ-5503-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -18395 31 31 0 1391 530 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-5-28 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.3 NO YES NO 21 0 No N0 T3a TCGA-EJ-5503.81ca6538-6023-4e21-bd59-0b248e5642ac.pdf 5503 TUMOR FREE 5 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 0.4 NO 4 YES NO EJ Middle|Base Prostate A LIVING 2010 Overlapping / Multiple Zones aa181d66-d198-43ab-920e-a351454194a0 TCGA-EJ-5503-01A-01D-1574-01 TCGA-EJ-5503-01A-01D-1578-05 TCGA-EJ-5503-01A-01D-1576-08 TCGA-EJ-5503-01A-01D-1576-08 aa181d66-d198-43ab-920e-a351454194a0 TCGA-EJ-5503-01 TCGA-EJ-5503-01 DA70ADB1-141C-472A-BE95-D7B1DD00C689 TCGA-EJ-5503-01A-01D-1574-01 aa181d66-d198-43ab-920e-a351454194a0 TCGA-EJ-5503-01 TCGA-EJ-5503-01 TCGA-EJ-5503-01A-01D-1576-08 TCGA-EJ-5503-01A-01D-1576-08 aa181d66-d198-43ab-920e-a351454194a0 +TCGA-EJ-5504-01 TCGA-EJ-5504-01 TCGA-EJ-5504 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-EJ-5504-F71923 TCGA-EJ-5504 TCGA-EJ-5504-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T2c -24072 25 25 77 0 1427 77 YES Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1] NO Scheduled Follow-up Submission Progressive Disease 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Bilateral 0.9 NO YES NO 18 1 No N1 T3a TCGA-EJ-5504.74f98316-075f-45e1-9bca-3d885a070fa8.pdf 5504 WITH TUMOR 4 Progressive Disease 1.0 NO R1 Primary Tumor 01 3 0.4 NO 5 YES NO EJ Apex|Middle|Base Prostate A LIVING 2010 Overlapping / Multiple Zones 70779173-6a72-45e4-bf43-91ee9baba55f TCGA-EJ-5504-01A-01D-1574-01 TCGA-EJ-5504-01A-01D-1578-05 TCGA-EJ-5504-01A-01D-1576-08 TCGA-EJ-5504-01A-01D-1576-08 70779173-6a72-45e4-bf43-91ee9baba55f TCGA-EJ-5504-01 TCGA-EJ-5504-01 0D99F039-663F-4BA6-8F9C-DD72439BE2CA TCGA-EJ-5504-01A-01D-1574-01 70779173-6a72-45e4-bf43-91ee9baba55f TCGA-EJ-5504-01 TCGA-EJ-5504-01 TCGA-EJ-5504-01A-01D-1576-08 TCGA-EJ-5504-01A-01D-1576-08 70779173-6a72-45e4-bf43-91ee9baba55f +TCGA-EJ-5505-01 TCGA-EJ-5505-01 TCGA-EJ-5505 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-EJ-5505-F46206 TCGA-EJ-5505 TCGA-EJ-5505-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -21164 12 12 0 922 448 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-3 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 1 NO YES NO 24 0 No N0 T2c TCGA-EJ-5505.b8c31900-c8a8-45a7-a71a-fa356bf78511.pdf 5505 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 0.6 NO 3 YES NO EJ Apex|Middle|Base Prostate A LIVING 2010 b304cf7b-274d-4617-9830-459601eedc10 TCGA-EJ-5505-01A-01D-1574-01 TCGA-EJ-5505-01A-01D-1578-05 TCGA-EJ-5505-01A-01D-1576-08 TCGA-EJ-5505-01A-01D-1576-08 b304cf7b-274d-4617-9830-459601eedc10 TCGA-EJ-5505-01 TCGA-EJ-5505-01 FB410C59-87B2-422F-9CA2-78D5DCBDCA3C TCGA-EJ-5505-01A-01D-1574-01 b304cf7b-274d-4617-9830-459601eedc10 TCGA-EJ-5505-01 TCGA-EJ-5505-01 TCGA-EJ-5505-01A-01D-1576-08 TCGA-EJ-5505-01A-01D-1576-08 b304cf7b-274d-4617-9830-459601eedc10 +TCGA-EJ-5506-01 TCGA-EJ-5506-01 TCGA-EJ-5506 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-EJ-5506-F71924 TCGA-EJ-5506 TCGA-EJ-5506-01A NO M0 T3b -24617 0 1381 356 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.5 NO YES NO 7 1 No N1 T3b TCGA-EJ-5506.4b6b88e5-b9f5-4bed-8320-b227a30bd1a9.pdf 5506 TUMOR FREE 5 Complete Remission/Response 0.1 NO RX Primary Tumor 01 3 0.5 NO 4 YES NO EJ Apex|Middle|Base Prostate A LIVING 2010 e67b3b01-fdd5-49de-8829-84298c131a5f TCGA-EJ-5506-01A-01D-1574-01 TCGA-EJ-5506-01A-01D-1578-05 TCGA-EJ-5506-01A-01D-1576-08 TCGA-EJ-5506-01A-01D-1576-08 e67b3b01-fdd5-49de-8829-84298c131a5f TCGA-EJ-5506-01 TCGA-EJ-5506-01 B6C93974-DA24-476B-A742-2F25DA08AE0F TCGA-EJ-5506-01A-01D-1574-01 e67b3b01-fdd5-49de-8829-84298c131a5f TCGA-EJ-5506-01 TCGA-EJ-5506-01 TCGA-EJ-5506-01A-01D-1576-08 TCGA-EJ-5506-01A-01D-1576-08 e67b3b01-fdd5-49de-8829-84298c131a5f +TCGA-EJ-5507-01 TCGA-EJ-5507-01 TCGA-EJ-5507 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 54 TCGA-EJ-5507-F71926 TCGA-EJ-5507 TCGA-EJ-5507-01A NO M0 T2c -19759 0 1457 182 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 1.4 NO YES NO 21 2 No N1 T3b TCGA-EJ-5507.153de441-fbe9-4c8b-9a84-9cdf9c5edcf2.pdf 5507 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 5 0.3 NO 4 YES NO EJ Apex|Middle|Base Prostate A LIVING 2010 487c555b-81bb-4b70-8219-9abac8394b9f TCGA-EJ-5507-01A-01D-1574-01 TCGA-EJ-5507-01A-01D-1578-05 TCGA-EJ-5507-01A-01D-1576-08 TCGA-EJ-5507-01A-01D-1576-08 487c555b-81bb-4b70-8219-9abac8394b9f TCGA-EJ-5507-01 TCGA-EJ-5507-01 4E3D63A2-D726-4EBD-B4BA-49DC9D345796 TCGA-EJ-5507-01A-01D-1574-01 487c555b-81bb-4b70-8219-9abac8394b9f TCGA-EJ-5507-01 TCGA-EJ-5507-01 TCGA-EJ-5507-01A-01D-1576-08 TCGA-EJ-5507-01A-01D-1576-08 487c555b-81bb-4b70-8219-9abac8394b9f +TCGA-EJ-5508-01 TCGA-EJ-5508-01 TCGA-EJ-5508 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-EJ-5508-F71929 TCGA-EJ-5508 TCGA-EJ-5508-01A NO M0 T1c -23758 0 1965 907 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 0.7 NO YES NO 17 0 No N0 T3a TCGA-EJ-5508.d2590559-0eb6-479e-ba3a-b59c3429ca6d.pdf 5508 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.3 NO 4 YES NO EJ Middle|Base Prostate A LIVING 2008 f4463436-536d-412e-824c-0c623a244da5 TCGA-EJ-5508-01A-02D-1574-01 TCGA-EJ-5508-01A-02D-1578-05 TCGA-EJ-5508-01A-02D-1576-08 TCGA-EJ-5508-01A-02D-1576-08 f4463436-536d-412e-824c-0c623a244da5 TCGA-EJ-5508-01 TCGA-EJ-5508-01 64181246-E4A9-4A96-B510-12D30DB1E16C TCGA-EJ-5508-01A-02D-1574-01 f4463436-536d-412e-824c-0c623a244da5 TCGA-EJ-5508-01 TCGA-EJ-5508-01 TCGA-EJ-5508-01A-02D-1576-08 TCGA-EJ-5508-01A-02D-1576-08 f4463436-536d-412e-824c-0c623a244da5 +TCGA-EJ-5509-01 TCGA-EJ-5509-01 TCGA-EJ-5509 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-EJ-5509-F60376 TCGA-EJ-5509 TCGA-EJ-5509-01A NO M0 T2a -23368 0 1464 1102 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-6 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 1 NO YES NO 10 0 No N0 T2c TCGA-EJ-5509.672ff51d-12ba-402a-b6d6-87cc9c91e7ad.pdf 5509 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.2 NO 3 YES NO EJ Apex|Middle|Base Prostate A LIVING 2009 1c809dd1-f790-458d-9722-c3262afcd416 TCGA-EJ-5509-01A-01D-1574-01 TCGA-EJ-5509-01A-01D-1578-05 TCGA-EJ-5509-01A-01D-1576-08 TCGA-EJ-5509-01A-01D-1576-08 1c809dd1-f790-458d-9722-c3262afcd416 TCGA-EJ-5509-01 TCGA-EJ-5509-01 88604FC1-618E-4581-99DA-AB89129977E3 TCGA-EJ-5509-01A-01D-1574-01 1c809dd1-f790-458d-9722-c3262afcd416 TCGA-EJ-5509-01 TCGA-EJ-5509-01 TCGA-EJ-5509-01A-01D-1576-08 TCGA-EJ-5509-01A-01D-1576-08 1c809dd1-f790-458d-9722-c3262afcd416 +TCGA-EJ-5510-01 TCGA-EJ-5510-01 TCGA-EJ-5510 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 48 TCGA-EJ-5510-F71933 TCGA-EJ-5510 TCGA-EJ-5510-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -17895 14 14 0 1887 738 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 1.3 NO YES NO 17 0 No N0 T2c TCGA-EJ-5510.9f549743-cbb3-46bb-9356-40f80e961b4d.pdf 5510 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 0.4 NO 3 YES NO EJ Prostate A LIVING 2009 787d4d9f-1c69-406f-8e1c-2458d77085e7 TCGA-EJ-5510-01A-01D-1574-01 TCGA-EJ-5510-01A-01D-1578-05 TCGA-EJ-5510-01A-01D-1576-08 TCGA-EJ-5510-01A-01D-1576-08 787d4d9f-1c69-406f-8e1c-2458d77085e7 TCGA-EJ-5510-01 TCGA-EJ-5510-01 BA5FB8F4-DF35-48CB-888D-0A80C184A03F TCGA-EJ-5510-01A-01D-1574-01 787d4d9f-1c69-406f-8e1c-2458d77085e7 TCGA-EJ-5510-01 TCGA-EJ-5510-01 TCGA-EJ-5510-01A-01D-1576-08 TCGA-EJ-5510-01A-01D-1576-08 787d4d9f-1c69-406f-8e1c-2458d77085e7 +TCGA-EJ-5511-01 TCGA-EJ-5511-01 TCGA-EJ-5511 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-EJ-5511-F60377 TCGA-EJ-5511 TCGA-EJ-5511-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -20409 18 0 1476 788 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-6 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.2 NO Bilateral 2 NO YES NO 15 0 No N0 T3a TCGA-EJ-5511.4e4d79fc-ecc3-4533-ac69-9bdec44a080c.pdf 5511 TUMOR FREE 3 Complete Remission/Response 0.04 NO R0 Primary Tumor 01 4 0.3 NO 4 YES NO EJ Apex|Middle|Base Prostate A LIVING 2009 488dc8bd-9e74-48b2-a407-914f6e0ba0b6 TCGA-EJ-5511-01A-01D-1574-01 TCGA-EJ-5511-01A-01D-1578-05 TCGA-EJ-5511-01A-01D-1576-08 TCGA-EJ-5511-01A-01D-1576-08 488dc8bd-9e74-48b2-a407-914f6e0ba0b6 TCGA-EJ-5511-01 TCGA-EJ-5511-01 6FC09B2E-53B1-4802-BF39-076F080FCC06 TCGA-EJ-5511-01A-01D-1574-01 488dc8bd-9e74-48b2-a407-914f6e0ba0b6 TCGA-EJ-5511-01 TCGA-EJ-5511-01 TCGA-EJ-5511-01A-01D-1576-08 TCGA-EJ-5511-01A-01D-1576-08 488dc8bd-9e74-48b2-a407-914f6e0ba0b6 +TCGA-EJ-5512-01 TCGA-EJ-5512-01 TCGA-EJ-5512 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 46 TCGA-EJ-5512-F71934 TCGA-EJ-5512 TCGA-EJ-5512-01A NO M0 T1c -17127 0 1733 782 Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.1 NO YES NO 13 0 No N0 T2c TCGA-EJ-5512.8b273389-2655-4ac1-bcf0-b64505fe7b3d.pdf 5512 TUMOR FREE 3 Complete Remission/Response 0 NO R0 Primary Tumor 01 4 0.5 NO 3 YES NO EJ Apex|Middle|Base Prostate A LIVING 2009 d0617c13-ba48-44d9-807f-29a9ee7ebf39 TCGA-EJ-5512-01A-01D-1574-01 TCGA-EJ-5512-01A-01D-1578-05 TCGA-EJ-5512-01A-01D-1576-08 TCGA-EJ-5512-01A-01D-1576-08 d0617c13-ba48-44d9-807f-29a9ee7ebf39 TCGA-EJ-5512-01 TCGA-EJ-5512-01 09112836-8FB3-4DCE-B041-DE03ED385768 TCGA-EJ-5512-01A-01D-1574-01 d0617c13-ba48-44d9-807f-29a9ee7ebf39 TCGA-EJ-5512-01 TCGA-EJ-5512-01 TCGA-EJ-5512-01A-01D-1576-08 TCGA-EJ-5512-01A-01D-1576-08 d0617c13-ba48-44d9-807f-29a9ee7ebf39 +TCGA-EJ-5514-01 TCGA-EJ-5514-01 TCGA-EJ-5514 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-EJ-5514-F71935 TCGA-EJ-5514 TCGA-EJ-5514-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -24165 7 0 1829 724 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.4 NO YES NO 12 0 No N0 T2c TCGA-EJ-5514.5b64ad18-513e-422d-a847-d1862dd0e453.pdf 5514 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 5 0.4 NO 4 YES NO EJ Prostate A LIVING 2009 10892e71-cd86-4bcf-9da9-5faa081d1b0a TCGA-EJ-5514-01A-01D-1574-01 TCGA-EJ-5514-01A-01D-1578-05 TCGA-EJ-5514-01A-01D-1576-08 TCGA-EJ-5514-01A-01D-1576-08 10892e71-cd86-4bcf-9da9-5faa081d1b0a TCGA-EJ-5514-01 TCGA-EJ-5514-01 12F1A7B6-283C-4F2B-A3A8-E434E56DEA6F TCGA-EJ-5514-01A-01D-1574-01 10892e71-cd86-4bcf-9da9-5faa081d1b0a TCGA-EJ-5514-01 TCGA-EJ-5514-01 TCGA-EJ-5514-01A-01D-1576-08 TCGA-EJ-5514-01A-01D-1576-08 10892e71-cd86-4bcf-9da9-5faa081d1b0a +TCGA-EJ-5515-01 TCGA-EJ-5515-01 TCGA-EJ-5515 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-EJ-5515-F60378 TCGA-EJ-5515 TCGA-EJ-5515-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -22097 30 30 0 1832 1061 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-6 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Right 2 NO YES NO 20 0 No N0 T3a TCGA-EJ-5515.1029ba11-efb4-42b7-871c-c97192a40e12.pdf 5515 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.4 NO 4 YES NO EJ Apex|Middle|Base Prostate A LIVING 2009 7e81cb8c-9d91-4679-8a96-12365c19119b TCGA-EJ-5515-01A-01D-1574-01 TCGA-EJ-5515-01A-01D-1578-05 TCGA-EJ-5515-01A-01D-1576-08 TCGA-EJ-5515-01A-01D-1576-08 7e81cb8c-9d91-4679-8a96-12365c19119b TCGA-EJ-5515-01 TCGA-EJ-5515-01 34C05945-D438-422F-8673-E8BCBCF9E78B TCGA-EJ-5515-01A-01D-1574-01 7e81cb8c-9d91-4679-8a96-12365c19119b TCGA-EJ-5515-01 TCGA-EJ-5515-01 TCGA-EJ-5515-01A-01D-1576-08 TCGA-EJ-5515-01A-01D-1576-08 7e81cb8c-9d91-4679-8a96-12365c19119b +TCGA-EJ-5516-01 TCGA-EJ-5516-01 TCGA-EJ-5516 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 49 TCGA-EJ-5516-F71936 TCGA-EJ-5516 TCGA-EJ-5516-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -17980 0 0 1889 730 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Bilateral 1.6 NO YES NO 6 0 No N0 T3a TCGA-EJ-5516.b15c052e-04f9-49d7-bca9-dddf59a7e9da.pdf 5516 TUMOR FREE 3 Complete Remission/Response 0.12 NO R0 Primary Tumor 01 4 0.3 NO 3 YES NO EJ Prostate A LIVING 2009 6320daab-3fdb-45d2-bbc8-bbba33e4af37 TCGA-EJ-5516-01A-01D-1574-01 TCGA-EJ-5516-01A-01D-1578-05 TCGA-EJ-5516-01A-01D-1576-08 TCGA-EJ-5516-01A-01D-1576-08 6320daab-3fdb-45d2-bbc8-bbba33e4af37 TCGA-EJ-5516-01 TCGA-EJ-5516-01 480DA000-4D66-4E54-9F00-4ADCB83B6A7E TCGA-EJ-5516-01A-01D-1574-01 6320daab-3fdb-45d2-bbc8-bbba33e4af37 TCGA-EJ-5516-01 TCGA-EJ-5516-01 TCGA-EJ-5516-01A-01D-1576-08 TCGA-EJ-5516-01A-01D-1576-08 6320daab-3fdb-45d2-bbc8-bbba33e4af37 +TCGA-EJ-5517-01 TCGA-EJ-5517-01 TCGA-EJ-5517 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-EJ-5517-F71937 TCGA-EJ-5517 TCGA-EJ-5517-01A NO M0 T1c -20422 0 1889 187 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.4 NO YES NO 4 0 No N0 T2c TCGA-EJ-5517.67b66178-bd1b-44a8-9a30-762b0fc7c1ba.pdf 5517 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 0.2 NO 2 YES NO EJ Prostate A LIVING 2008 bfdc11be-a30b-498b-bdf6-4b98ec4f1ea1 TCGA-EJ-5517-01A-01D-1574-01 TCGA-EJ-5517-01A-01D-1578-05 TCGA-EJ-5517-01A-01D-1576-08 TCGA-EJ-5517-01A-01D-1576-08 bfdc11be-a30b-498b-bdf6-4b98ec4f1ea1 TCGA-EJ-5517-01 TCGA-EJ-5517-01 C7B12E0C-ACAF-403B-89AB-4998E1072A96 TCGA-EJ-5517-01A-01D-1574-01 bfdc11be-a30b-498b-bdf6-4b98ec4f1ea1 TCGA-EJ-5517-01 TCGA-EJ-5517-01 TCGA-EJ-5517-01A-01D-1576-08 TCGA-EJ-5517-01A-01D-1576-08 bfdc11be-a30b-498b-bdf6-4b98ec4f1ea1 +TCGA-EJ-5518-01 TCGA-EJ-5518-01 TCGA-EJ-5518 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 66 TCGA-EJ-5518-F71938 TCGA-EJ-5518 TCGA-EJ-5518-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T3b -24313 32 2104 0 2118 2104 1195 NO NO Scheduled Follow-up Submission Progressive Disease 2015-3-31 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Bilateral 1.9 NO [Discrepancy] Bone Distant Metastasis YES 3 0 No N0 T4 TCGA-EJ-5518.8299ff67-bed6-462f-87ad-3c8be45e1453.pdf 5518 WITH TUMOR 4 Progressive Disease 0.1 NO R1 Primary Tumor 01 5 0.3 NO 4 YES NO EJ Prostate A LIVING 2008 Overlapping / Multiple Zones 01d4c289-6d85-4119-86f5-bcf3de30d0f7 TCGA-EJ-5518-01A-01D-1574-01 TCGA-EJ-5518-01A-01D-1578-05 TCGA-EJ-5518-01A-01D-1576-08 TCGA-EJ-5518-01A-01D-1576-08 01d4c289-6d85-4119-86f5-bcf3de30d0f7 TCGA-EJ-5518-01 TCGA-EJ-5518-01 95F2803A-BFFF-43D8-9818-F042F82A052A TCGA-EJ-5518-01A-01D-1574-01 01d4c289-6d85-4119-86f5-bcf3de30d0f7 TCGA-EJ-5518-01 TCGA-EJ-5518-01 TCGA-EJ-5518-01A-01D-1576-08 TCGA-EJ-5518-01A-01D-1576-08 01d4c289-6d85-4119-86f5-bcf3de30d0f7 +TCGA-EJ-5519-01 TCGA-EJ-5519-01 TCGA-EJ-5519 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-EJ-5519-F60379 TCGA-EJ-5519 TCGA-EJ-5519-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T2c -23669 13 84 0 1962 1153 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-6 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.2 NO Bilateral 1.2 NO YES NO 12 3 No N1 T3b TCGA-EJ-5519.57861c52-0d80-484a-a800-65c3481327db.pdf 5519 TUMOR FREE 4 Complete Remission/Response 0.2 NO R0 Primary Tumor 01 4 0.4 NO 3 YES NO EJ Apex|Middle|Base Prostate A LIVING 2008 Overlapping / Multiple Zones 4be2bce2-2032-41a4-af3a-5f01a698e143 TCGA-EJ-5519-01A-01D-1574-01 TCGA-EJ-5519-01A-01D-1578-05 TCGA-EJ-5519-01A-01D-1576-08 TCGA-EJ-5519-01A-01D-1576-08 4be2bce2-2032-41a4-af3a-5f01a698e143 TCGA-EJ-5519-01 TCGA-EJ-5519-01 A213FE4D-5339-4167-869C-F23252C89EEF TCGA-EJ-5519-01A-01D-1574-01 4be2bce2-2032-41a4-af3a-5f01a698e143 TCGA-EJ-5519-01 TCGA-EJ-5519-01 TCGA-EJ-5519-01A-01D-1576-08 TCGA-EJ-5519-01A-01D-1576-08 4be2bce2-2032-41a4-af3a-5f01a698e143 +TCGA-EJ-5521-01 TCGA-EJ-5521-01 TCGA-EJ-5521 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-EJ-5521-F71942 TCGA-EJ-5521 TCGA-EJ-5521-01A NO M0 T1c -23304 0 2279 240 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Right 1.2 NO YES NO 2 0 No N0 T3a TCGA-EJ-5521.0c816088-3fe4-4646-abaa-94095efd0b26.pdf 5521 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.3 NO 3 YES NO EJ Middle|Base Prostate A LIVING 2008 f18be8ba-45a0-4db4-90e7-9f0998eb959e TCGA-EJ-5521-01A-01D-1574-01 TCGA-EJ-5521-01A-01D-1578-05 TCGA-EJ-5521-01A-01D-1576-08 TCGA-EJ-5521-01A-01D-1576-08 f18be8ba-45a0-4db4-90e7-9f0998eb959e TCGA-EJ-5521-01 TCGA-EJ-5521-01 0B7031DA-2008-4320-9C04-C23D9FA44F24 TCGA-EJ-5521-01A-01D-1574-01 f18be8ba-45a0-4db4-90e7-9f0998eb959e TCGA-EJ-5521-01 TCGA-EJ-5521-01 TCGA-EJ-5521-01A-01D-1576-08 TCGA-EJ-5521-01A-01D-1576-08 f18be8ba-45a0-4db4-90e7-9f0998eb959e +TCGA-EJ-5522-01 TCGA-EJ-5522-01 TCGA-EJ-5522 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 51 TCGA-EJ-5522-F60380 TCGA-EJ-5522 TCGA-EJ-5522-01A NO M0 T2a -18802 0 2079 1403 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-6 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.9 NO Bilateral 1.3 NO YES NO 22 0 No N0 T2c TCGA-EJ-5522.756659d2-5e97-40d4-aa4e-c6d777153d0c.pdf 5522 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.3 NO 3 YES NO EJ Apex|Middle|Base Prostate A LIVING 2008 Overlapping / Multiple Zones f1441277-65a1-486c-b8e1-2b947734cb17 TCGA-EJ-5522-01A-01D-1574-01 TCGA-EJ-5522-01A-01D-1578-05 TCGA-EJ-5522-01A-01D-1576-08 TCGA-EJ-5522-01A-01D-1576-08 f1441277-65a1-486c-b8e1-2b947734cb17 TCGA-EJ-5522-01 TCGA-EJ-5522-01 F38D9CB6-E73A-4260-8602-22BFA64FD07A TCGA-EJ-5522-01A-01D-1574-01 f1441277-65a1-486c-b8e1-2b947734cb17 TCGA-EJ-5522-01 TCGA-EJ-5522-01 TCGA-EJ-5522-01A-01D-1576-08 TCGA-EJ-5522-01A-01D-1576-08 f1441277-65a1-486c-b8e1-2b947734cb17 +TCGA-EJ-5524-01 TCGA-EJ-5524-01 TCGA-EJ-5524 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-EJ-5524-F71944 TCGA-EJ-5524 TCGA-EJ-5524-01A NO M0 T2b -20854 0 1882 811 NO NO Scheduled Follow-up Submission Progressive Disease 2015-3-31 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.7 NO YES NO 17 0 No N0 T3a TCGA-EJ-5524.1f767c93-41f5-45d1-917f-3f1fc5330fb9.pdf 5524 WITH TUMOR 4 Progressive Disease 0.1 NO R0 Primary Tumor 01 5 0.2 NO 3 YES NO EJ Base Prostate A LIVING 2009 c88d608d-79c7-41af-a3b3-e27b413cba28 TCGA-EJ-5524-01A-01D-1574-01 TCGA-EJ-5524-01A-01D-1578-05 TCGA-EJ-5524-01A-01D-1576-08 TCGA-EJ-5524-01A-01D-1576-08 c88d608d-79c7-41af-a3b3-e27b413cba28 TCGA-EJ-5524-01 TCGA-EJ-5524-01 30854379-BFCC-46F4-81B5-8BA4136F47E9 TCGA-EJ-5524-01A-01D-1574-01 c88d608d-79c7-41af-a3b3-e27b413cba28 TCGA-EJ-5524-01 TCGA-EJ-5524-01 TCGA-EJ-5524-01A-01D-1576-08 TCGA-EJ-5524-01A-01D-1576-08 c88d608d-79c7-41af-a3b3-e27b413cba28 +TCGA-EJ-5525-01 TCGA-EJ-5525-01 TCGA-EJ-5525 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 67 TCGA-EJ-5525-F46762 TCGA-EJ-5525 TCGA-EJ-5525-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T3a -24535 -6 -6 338 0 1115 546 521 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Progressive Disease 2013-8-16 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.6 NO YES Bone Distant Metastasis YES 8 0 No N0 T2c TCGA-EJ-5525.ab82e8b9-a3ba-48ef-ac3e-fd35c67a13e4.pdf 5525 WITH TUMOR 4 Progressive Disease 3.0 NO R0 Primary Tumor 01 5 0.2 NO 3 YES NO EJ Apex|Base Prostate A LIVING 2009 ad22630d-693d-46c9-b785-5343b08679b5 TCGA-EJ-5525-01A-01D-1574-01 TCGA-EJ-5525-01A-01D-1578-05 TCGA-EJ-5525-01A-01D-1576-08 TCGA-EJ-5525-01A-01D-1576-08 ad22630d-693d-46c9-b785-5343b08679b5 TCGA-EJ-5525-01 TCGA-EJ-5525-01 D2D649A9-54E5-4091-9C84-6D76D51AD9F1 TCGA-EJ-5525-01A-01D-1574-01 ad22630d-693d-46c9-b785-5343b08679b5 TCGA-EJ-5525-01 TCGA-EJ-5525-01 TCGA-EJ-5525-01A-01D-1576-08 TCGA-EJ-5525-01A-01D-1576-08 ad22630d-693d-46c9-b785-5343b08679b5 +TCGA-EJ-5526-01 TCGA-EJ-5526-01 TCGA-EJ-5526 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 56 TCGA-EJ-5526-F71950 TCGA-EJ-5526 TCGA-EJ-5526-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -20558 19 19 0 1909 1909 175 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Progressive Disease 2015-3-31 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Bilateral 1.5 NO YES Biochemical evidence of disease YES 27 1 No N1 T3a TCGA-EJ-5526.5afeeeba-2a19-4042-acdc-8dad10ca31f9.pdf 5526 WITH TUMOR 4 Progressive Disease 0.1 NO R0 Primary Tumor 01 4 0.3 NO 3 YES NO EJ Middle|Base Prostate A LIVING 2009 8536a0fb-4aed-4db0-80b0-994606c87ace TCGA-EJ-5526-01A-01D-1574-01 TCGA-EJ-5526-01A-01D-1578-05 TCGA-EJ-5526-01A-01D-1576-08 TCGA-EJ-5526-01A-01D-1576-08 8536a0fb-4aed-4db0-80b0-994606c87ace TCGA-EJ-5526-01 TCGA-EJ-5526-01 B6A40EC1-49E5-46DC-B8C1-FE2489A3640D TCGA-EJ-5526-01A-01D-1574-01 8536a0fb-4aed-4db0-80b0-994606c87ace TCGA-EJ-5526-01 TCGA-EJ-5526-01 TCGA-EJ-5526-01A-01D-1576-08 TCGA-EJ-5526-01A-01D-1576-08 8536a0fb-4aed-4db0-80b0-994606c87ace +TCGA-EJ-5527-01 TCGA-EJ-5527-01 TCGA-EJ-5527 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 69 TCGA-EJ-5527-F71952 TCGA-EJ-5527 TCGA-EJ-5527-01A NO M0 T2a -25234 0 1778 217 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.7 NO Bilateral 1.5 NO YES NO 9 0 No N0 T3a TCGA-EJ-5527.b4c74b9e-b639-4488-aef1-8bf008324f73.pdf 5527 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 0.3 NO 3 YES NO EJ Apex|Middle Prostate A LIVING 2009 2bd35c12-2701-45c4-a6ea-981667028597 TCGA-EJ-5527-01A-01D-1574-01 TCGA-EJ-5527-01A-01D-1578-05 TCGA-EJ-5527-01A-01D-1576-08 TCGA-EJ-5527-01A-01D-1576-08 2bd35c12-2701-45c4-a6ea-981667028597 TCGA-EJ-5527-01 TCGA-EJ-5527-01 8134B0C5-9EDD-4E20-8CE5-E07292233534 TCGA-EJ-5527-01A-01D-1574-01 2bd35c12-2701-45c4-a6ea-981667028597 TCGA-EJ-5527-01 TCGA-EJ-5527-01 TCGA-EJ-5527-01A-01D-1576-08 TCGA-EJ-5527-01A-01D-1576-08 2bd35c12-2701-45c4-a6ea-981667028597 +TCGA-EJ-5530-01 TCGA-EJ-5530-01 TCGA-EJ-5530 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-EJ-5530-F46774 TCGA-EJ-5530 TCGA-EJ-5530-01A NO M0 T2c -22316 0 1832 586 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-16 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.8 NO Bilateral 2 NO YES NO 6 0 No N0 T2c TCGA-EJ-5530.03cb0863-99db-411a-a347-a8675a65cb5a.pdf 5530 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.3 NO 3 YES NO EJ Apex|Middle Prostate A LIVING 2008 314e8006-a060-4b71-a51e-ba450bbbb86c TCGA-EJ-5530-01A-01D-1574-01 TCGA-EJ-5530-01A-01D-1578-05 TCGA-EJ-5530-01A-01D-1576-08 TCGA-EJ-5530-01A-01D-1576-08 314e8006-a060-4b71-a51e-ba450bbbb86c TCGA-EJ-5530-01 TCGA-EJ-5530-01 FA2D5EAA-F949-4055-96A2-AA66B1BD92A4 TCGA-EJ-5530-01A-01D-1574-01 314e8006-a060-4b71-a51e-ba450bbbb86c TCGA-EJ-5530-01 TCGA-EJ-5530-01 TCGA-EJ-5530-01A-01D-1576-08 TCGA-EJ-5530-01A-01D-1576-08 314e8006-a060-4b71-a51e-ba450bbbb86c +TCGA-EJ-5531-01 TCGA-EJ-5531-01 TCGA-EJ-5531 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-EJ-5531-F60382 TCGA-EJ-5531 TCGA-EJ-5531-01A NO M0 T2b -22760 0 1273 724 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-6 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1 NO YES NO 35 0 No N0 T3a TCGA-EJ-5531.0f235aad-3f99-4ac4-919e-0a4290c02075.pdf 5531 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 0.8 NO 3 YES NO EJ Apex|Middle|Base Prostate A LIVING 2009 49dda006-76b0-4088-8221-2bbfb1ac22f7 TCGA-EJ-5531-01A-01D-1574-01 TCGA-EJ-5531-01A-01D-1578-05 TCGA-EJ-5531-01A-01D-1576-08 TCGA-EJ-5531-01A-01D-1576-08 49dda006-76b0-4088-8221-2bbfb1ac22f7 TCGA-EJ-5531-01 TCGA-EJ-5531-01 FA6526B7-E5CE-4F77-93F2-19EB45C6D0EC TCGA-EJ-5531-01A-01D-1574-01 49dda006-76b0-4088-8221-2bbfb1ac22f7 TCGA-EJ-5531-01 TCGA-EJ-5531-01 TCGA-EJ-5531-01A-01D-1576-08 TCGA-EJ-5531-01A-01D-1576-08 49dda006-76b0-4088-8221-2bbfb1ac22f7 +TCGA-EJ-5532-01 TCGA-EJ-5532-01 TCGA-EJ-5532 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-EJ-5532-F71956 TCGA-EJ-5532 TCGA-EJ-5532-01A NO M0 T1c -21110 0 1828 926 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.7 NO YES NO 8 0 No N0 T3a TCGA-EJ-5532.11afaa3c-a99c-4e43-b4cb-eb139c9b1dab.pdf 5532 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.4 NO 3 YES NO EJ Middle|Base Prostate A LIVING 2009 51d276c8-e669-48c9-92d8-676a348249d5 TCGA-EJ-5532-01A-01D-1574-01 TCGA-EJ-5532-01A-01D-1578-05 TCGA-EJ-5532-01A-01D-1576-08 TCGA-EJ-5532-01A-01D-1576-08 51d276c8-e669-48c9-92d8-676a348249d5 TCGA-EJ-5532-01 TCGA-EJ-5532-01 4B1CD569-388D-42B3-B26B-F71A360AB2D2 TCGA-EJ-5532-01A-01D-1574-01 51d276c8-e669-48c9-92d8-676a348249d5 TCGA-EJ-5532-01 TCGA-EJ-5532-01 TCGA-EJ-5532-01A-01D-1576-08 TCGA-EJ-5532-01A-01D-1576-08 51d276c8-e669-48c9-92d8-676a348249d5 +TCGA-EJ-5542-01 TCGA-EJ-5542-01 TCGA-EJ-5542 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-EJ-5542-F71959 TCGA-EJ-5542 TCGA-EJ-5542-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -21942 8 9 -21 0 1513 519 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.9 NO Bilateral 1.7 NO YES NO 17 0 Yes N0 T3a TCGA-EJ-5542.d6fe7cc6-45e5-4b6c-b1f4-1dd7fd3c27be.pdf 5542 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.4 NO 3 YES NO EJ Apex|Middle|Base Prostate A LIVING 2010 71b37147-df4c-40ef-b57a-57c2f692de06 TCGA-EJ-5542-01A-01D-1574-01 TCGA-EJ-5542-01A-01D-1578-05 TCGA-EJ-5542-01A-01D-1576-08 TCGA-EJ-5542-01A-01D-1576-08 71b37147-df4c-40ef-b57a-57c2f692de06 TCGA-EJ-5542-01 TCGA-EJ-5542-01 C8C9F531-0F7E-437F-A593-39612548858E TCGA-EJ-5542-01A-01D-1574-01 71b37147-df4c-40ef-b57a-57c2f692de06 TCGA-EJ-5542-01 TCGA-EJ-5542-01 TCGA-EJ-5542-01A-01D-1576-08 TCGA-EJ-5542-01A-01D-1576-08 71b37147-df4c-40ef-b57a-57c2f692de06 +TCGA-EJ-7115-01 TCGA-EJ-7115-01 TCGA-EJ-7115 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-EJ-7115-F64799 TCGA-EJ-7115 TCGA-EJ-7115-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -23986 10 10 0 2687 204 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.9 NO Bilateral 1.1 NO YES NO 21 0 No N0 T3a TCGA-EJ-7115.1638ac15-f8d6-4c88-b91e-e21033ae09db.pdf 7115 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 0.4 NO 2 YES NO EJ Prostate A LIVING 2006 c5dbae69-fb0e-458b-81ce-1f64c391cfe1 TCGA-EJ-7115-01A-11D-2112-01 TCGA-EJ-7115-01A-11D-2116-05 TCGA-EJ-7115-01A-11D-2114-08 c5dbae69-fb0e-458b-81ce-1f64c391cfe1 TCGA-EJ-7115-01 TCGA-EJ-7115-01 C57E396B-8F17-4ACF-A298-9CEE180D644C TCGA-EJ-7115-01A-11D-2112-01 c5dbae69-fb0e-458b-81ce-1f64c391cfe1 TCGA-EJ-7115-01 TCGA-EJ-7115-01 TCGA-EJ-7115-01A-11D-2114-08 TCGA-EJ-7115-01A-11D-2114-08 c5dbae69-fb0e-458b-81ce-1f64c391cfe1 +TCGA-EJ-7115-11 TCGA-EJ-7115-11 TCGA-EJ-7115 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-EJ-7115-F64799 TCGA-EJ-7115 NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -23986 10 10 0 2687 204 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 21 0 No N0 T3a 7115 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 3 NO 2 YES NO EJ Prostate LIVING 2006 b2b21d28-08c6-43e3-8b64-e9cdc913b15e b2b21d28-08c6-43e3-8b64-e9cdc913b15e TCGA-EJ-7115-11 b2b21d28-08c6-43e3-8b64-e9cdc913b15e TCGA-EJ-7115-11 b2b21d28-08c6-43e3-8b64-e9cdc913b15e +TCGA-EJ-7123-01 TCGA-EJ-7123-01 TCGA-EJ-7123 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-EJ-7123-F71960 TCGA-EJ-7123 TCGA-EJ-7123-01A NO M0 T1c -21741 0 2572 1491 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 0.7 NO YES NO 22 0 Yes N0 T2c TCGA-EJ-7123.1ba8d08d-0be5-46a6-9540-8f6d028e0dea.pdf 7123 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.1 NO 3 YES NO EJ Apex|Middle|Base Prostate A LIVING 2007 12e19460-da9a-4ff4-8664-801e7f8829b7 TCGA-EJ-7123-01A-11D-1959-01 TCGA-EJ-7123-01A-11D-1963-05 TCGA-EJ-7123-01A-11D-1961-08 12e19460-da9a-4ff4-8664-801e7f8829b7 TCGA-EJ-7123-01 TCGA-EJ-7123-01 TCGA-EJ-7123-01A-11D-1959-01 12e19460-da9a-4ff4-8664-801e7f8829b7 TCGA-EJ-7123-01 TCGA-EJ-7123-01 TCGA-EJ-7123-01A-11D-1961-08 TCGA-EJ-7123-01A-11D-1961-08 12e19460-da9a-4ff4-8664-801e7f8829b7 +TCGA-EJ-7123-11 TCGA-EJ-7123-11 TCGA-EJ-7123 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-EJ-7123-F71960 TCGA-EJ-7123 TCGA-EJ-7123-11A NO M0 T1c -21741 0 2572 1491 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 2 NO YES NO 22 0 Yes N0 T2c 7123 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 4 0.4 NO 3 YES NO EJ Apex|Middle|Base Prostate A LIVING 2007 8dfd97d6-25a9-4579-80a7-b3bb0ef53074 TCGA-EJ-7123-11A-01D-1963-05 8dfd97d6-25a9-4579-80a7-b3bb0ef53074 TCGA-EJ-7123-11 8dfd97d6-25a9-4579-80a7-b3bb0ef53074 TCGA-EJ-7123-11 8dfd97d6-25a9-4579-80a7-b3bb0ef53074 +TCGA-EJ-7125-01 TCGA-EJ-7125-01 TCGA-EJ-7125 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 44 TCGA-EJ-7125-F64801 TCGA-EJ-7125 TCGA-EJ-7125-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -16425 12 0 2850 1860 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1 NO YES NO 13 0 No N0 T2c TCGA-EJ-7125.3565cc83-8305-490f-a47a-dc71b36a9044.pdf 7125 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.4 NO 3 YES NO EJ Apex|Middle Prostate A LIVING 2005 a15d99f4-2e43-4fb8-93d5-6cc582b12237 TCGA-EJ-7125-01A-11D-1959-01 TCGA-EJ-7125-01A-11D-1963-05 TCGA-EJ-7125-01A-11D-1961-08 a15d99f4-2e43-4fb8-93d5-6cc582b12237 TCGA-EJ-7125-01 TCGA-EJ-7125-01 A83D9347-6980-4561-BEAE-55A44B4D254A TCGA-EJ-7125-01A-11D-1959-01 a15d99f4-2e43-4fb8-93d5-6cc582b12237 TCGA-EJ-7125-01 TCGA-EJ-7125-01 TCGA-EJ-7125-01A-11D-1961-08 TCGA-EJ-7125-01A-11D-1961-08 a15d99f4-2e43-4fb8-93d5-6cc582b12237 +TCGA-EJ-7125-11 TCGA-EJ-7125-11 TCGA-EJ-7125 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 44 TCGA-EJ-7125-F64801 TCGA-EJ-7125 NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -16425 12 0 2850 1860 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 13 0 No N0 T2c 7125 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 4 NO 3 YES NO EJ Apex|Middle Prostate LIVING 2005 ab016062-694f-4925-934e-0ea8b62bc2a9 TCGA-EJ-7125-11A-01D-1963-05 ab016062-694f-4925-934e-0ea8b62bc2a9 TCGA-EJ-7125-11 ab016062-694f-4925-934e-0ea8b62bc2a9 TCGA-EJ-7125-11 ab016062-694f-4925-934e-0ea8b62bc2a9 +TCGA-EJ-7218-01 TCGA-EJ-7218-01 TCGA-EJ-7218 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 71 TCGA-EJ-7218-F64802 TCGA-EJ-7218 TCGA-EJ-7218-01B NO M0 T2a -26181 2397 0 2542 1473 Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 850 NO Bilateral NO YES NO 3 0 true No N0 T2c TCGA-EJ-7218.D1D8A1D3-24B1-4787-8925-A5A8FC19DF74.pdf 7218 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO EJ Prostate B LIVING 2006 0502e061-ae1d-4384-b2a5-24091a92eeab TCGA-EJ-7218-01B-11D-A32A-01 TCGA-EJ-7218-01B-11D-A32C-05 TCGA-EJ-7218-01B-11D-A32B-08 0502e061-ae1d-4384-b2a5-24091a92eeab TCGA-EJ-7218-01 TCGA-EJ-7218-01 1E8641F0-B08C-4A21-BA40-7F11A5C3682B TCGA-EJ-7218-01B-11D-A32A-01 0502e061-ae1d-4384-b2a5-24091a92eeab TCGA-EJ-7218-01 TCGA-EJ-7218-01 TCGA-EJ-7218-01B-11D-A32B-08 0502e061-ae1d-4384-b2a5-24091a92eeab +TCGA-EJ-7312-01 TCGA-EJ-7312-01 TCGA-EJ-7312 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 58 TCGA-EJ-7312-F64805 TCGA-EJ-7312 TCGA-EJ-7312-01B NO M0 T3b -21292 832 0 1099 376 Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 320 NO Bilateral NO YES NO 3 0 true Yes, History of Prior Malignancy N0 T3b TCGA-EJ-7312.92D81258-C134-48A6-8B74-DE3789E1530F.pdf 7312 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 NO YES NO EJ Prostate B LIVING 2011 43077b04-13be-4fc0-a691-9cb49bdd50d5 TCGA-EJ-7312-01B-21D-A32A-01 TCGA-EJ-7312-01B-21D-A32C-05 TCGA-EJ-7312-01B-21D-A32B-08 43077b04-13be-4fc0-a691-9cb49bdd50d5 TCGA-EJ-7312-01 443ADFE3-1595-4B68-A511-940D255A7023 TCGA-EJ-7312-01B-21D-A32A-01 43077b04-13be-4fc0-a691-9cb49bdd50d5 TCGA-EJ-7312-01 43077b04-13be-4fc0-a691-9cb49bdd50d5 +TCGA-EJ-7314-01 TCGA-EJ-7314-01 TCGA-EJ-7314 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-EJ-7314-F64807 TCGA-EJ-7314 TCGA-EJ-7314-01A NO M0 T2c -22766 14 0 1150 295 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.5 NO YES NO 14 0 No N0 T3b TCGA-EJ-7314.bbd6fa31-f4d4-4c06-aa64-1e263ccd8844.pdf 7314 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 0.3 NO 5 YES NO EJ Apex|Middle|Base Prostate A LIVING 2011 cd77237d-0598-41cd-b12c-eea4b9c06e6d TCGA-EJ-7314-01A-31D-2112-01 TCGA-EJ-7314-01A-31D-2116-05 TCGA-EJ-7314-01A-31D-2114-08 cd77237d-0598-41cd-b12c-eea4b9c06e6d TCGA-EJ-7314-01 TCGA-EJ-7314-01 DC6ADA36-C498-434F-8E25-D17A78ED67F1 TCGA-EJ-7314-01A-31D-2112-01 cd77237d-0598-41cd-b12c-eea4b9c06e6d TCGA-EJ-7314-01 TCGA-EJ-7314-01 TCGA-EJ-7314-01A-31D-2114-08 TCGA-EJ-7314-01A-31D-2114-08 cd77237d-0598-41cd-b12c-eea4b9c06e6d +TCGA-EJ-7314-11 TCGA-EJ-7314-11 TCGA-EJ-7314 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-EJ-7314-F64807 TCGA-EJ-7314 NO M0 T2c -22766 14 0 1150 295 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 14 0 No N0 T3b 7314 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 3 NO 5 YES NO EJ Apex|Middle|Base Prostate LIVING 2011 cc827a61-5c7d-41a0-a677-35a52e5eb471 cc827a61-5c7d-41a0-a677-35a52e5eb471 TCGA-EJ-7314-11 cc827a61-5c7d-41a0-a677-35a52e5eb471 TCGA-EJ-7314-11 cc827a61-5c7d-41a0-a677-35a52e5eb471 +TCGA-EJ-7315-01 TCGA-EJ-7315-01 TCGA-EJ-7315 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-EJ-7315-F64804 TCGA-EJ-7315 TCGA-EJ-7315-01A NO M0 T2a -25154 0 1008 289 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.5 NO Bilateral 2.5 NO YES NO 7 0 No N0 T3a TCGA-EJ-7315.6afa83ac-9060-4b49-90a3-dc19824822e3.pdf 7315 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 0.5 NO 5 YES NO EJ Apex|Middle|Base Prostate A LIVING 2011 5e185249-6ea1-460b-b841-f40e94ea1ccd TCGA-EJ-7315-01A-31D-2112-01 TCGA-EJ-7315-01A-31D-2116-05 TCGA-EJ-7315-01A-31D-2114-08 5e185249-6ea1-460b-b841-f40e94ea1ccd TCGA-EJ-7315-01 TCGA-EJ-7315-01 952C4870-B6EB-4BE0-8769-AEE172D193F8 TCGA-EJ-7315-01A-31D-2112-01 5e185249-6ea1-460b-b841-f40e94ea1ccd TCGA-EJ-7315-01 TCGA-EJ-7315-01 TCGA-EJ-7315-01A-31D-2114-08 TCGA-EJ-7315-01A-31D-2114-08 5e185249-6ea1-460b-b841-f40e94ea1ccd +TCGA-EJ-7315-11 TCGA-EJ-7315-11 TCGA-EJ-7315 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-EJ-7315-F64804 TCGA-EJ-7315 TCGA-EJ-7315-11A NO M0 T2a -25154 0 1008 289 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.8 NO Bilateral 2.2 NO YES NO 7 0 No N0 T3a 7315 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 3 0.4 NO 5 YES NO EJ Apex|Middle|Base Prostate A LIVING 2011 85e48131-0ef8-4b94-986a-3829ccad6d25 85e48131-0ef8-4b94-986a-3829ccad6d25 TCGA-EJ-7315-11 85e48131-0ef8-4b94-986a-3829ccad6d25 TCGA-EJ-7315-11 85e48131-0ef8-4b94-986a-3829ccad6d25 +TCGA-EJ-7317-01 TCGA-EJ-7317-01 TCGA-EJ-7317 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 71 TCGA-EJ-7317-F64809 TCGA-EJ-7317 TCGA-EJ-7317-01A NO M0 T1c -26064 0 771 285 Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Bilateral 1.2 NO YES NO 40 0 No N0 T2c TCGA-EJ-7317.f1531404-e42a-47a0-bbd7-6b0bd5ebf56b.pdf 7317 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.3 NO 3 YES NO EJ Apex|Middle Prostate A LIVING 2011 64f48f1f-3d80-43fa-bd06-3a5881291ee3 TCGA-EJ-7317-01A-31D-2112-01 TCGA-EJ-7317-01A-31D-2116-05 TCGA-EJ-7317-01A-31D-2114-08 64f48f1f-3d80-43fa-bd06-3a5881291ee3 TCGA-EJ-7317-01 TCGA-EJ-7317-01 0D44E764-75EA-4F90-961A-15B05A137AAD TCGA-EJ-7317-01A-31D-2112-01 64f48f1f-3d80-43fa-bd06-3a5881291ee3 TCGA-EJ-7317-01 TCGA-EJ-7317-01 TCGA-EJ-7317-01A-31D-2114-08 TCGA-EJ-7317-01A-31D-2114-08 64f48f1f-3d80-43fa-bd06-3a5881291ee3 +TCGA-EJ-7317-11 TCGA-EJ-7317-11 TCGA-EJ-7317 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 71 TCGA-EJ-7317-F64809 TCGA-EJ-7317 TCGA-EJ-7317-11A NO M0 T1c -26064 0 771 285 Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.7 NO YES NO 40 0 No N0 T2c 7317 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 4 0.5 NO 3 YES NO EJ Apex|Middle Prostate A LIVING 2011 7e9f1df1-e76f-45a0-9f1b-9a0cbd626430 TCGA-EJ-7317-11A-01D-2116-05 7e9f1df1-e76f-45a0-9f1b-9a0cbd626430 TCGA-EJ-7317-11 7e9f1df1-e76f-45a0-9f1b-9a0cbd626430 TCGA-EJ-7317-11 7e9f1df1-e76f-45a0-9f1b-9a0cbd626430 +TCGA-EJ-7318-01 TCGA-EJ-7318-01 TCGA-EJ-7318 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 51 TCGA-EJ-7318-F64810 TCGA-EJ-7318 TCGA-EJ-7318-01B YES M0 T3a -18686 757 189 0 1029 189 Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 650 NO Bilateral NO NO NO true No T3a TCGA-EJ-7318.B31F5757-0D35-4436-8F26-9AFE229049CD.pdf 7318 TUMOR FREE 4 Partial Remission/Response .08 NO R0 Primary Tumor 01 3 NO YES NO EJ Prostate B LIVING 2011 0b50b27b-e429-41b1-8324-c9e03b6bbaaf TCGA-EJ-7318-01B-11D-A32A-01 TCGA-EJ-7318-01B-11D-A32C-05 TCGA-EJ-7318-01B-11D-A32B-08 0b50b27b-e429-41b1-8324-c9e03b6bbaaf TCGA-EJ-7318-01 TCGA-EJ-7318-01 1D0F6289-A6B8-4167-B043-BDEAD4FA9797 TCGA-EJ-7318-01B-11D-A32A-01 0b50b27b-e429-41b1-8324-c9e03b6bbaaf TCGA-EJ-7318-01 TCGA-EJ-7318-01 TCGA-EJ-7318-01B-11D-A32B-08 0b50b27b-e429-41b1-8324-c9e03b6bbaaf +TCGA-EJ-7321-01 TCGA-EJ-7321-01 TCGA-EJ-7321 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-EJ-7321-F64812 TCGA-EJ-7321 TCGA-EJ-7321-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -21108 10 0 824 128 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.4 NO YES NO 25 0 No N0 T3a TCGA-EJ-7321.9d0d3184-b73a-4f24-919d-0ba7d5d32ff2.pdf 7321 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 0.4 NO 4 YES NO EJ Prostate A LIVING 2011 951adcbd-7d7a-466c-bbac-7c7afb8b9df6 TCGA-EJ-7321-01A-31D-2259-01 TCGA-EJ-7321-01A-31D-2261-05 TCGA-EJ-7321-01A-31D-2260-08 951adcbd-7d7a-466c-bbac-7c7afb8b9df6 TCGA-EJ-7321-01 TCGA-EJ-7321-01 C3ADD46F-DA97-482C-AFE3-7CB575D960B9 TCGA-EJ-7321-01A-31D-2259-01 951adcbd-7d7a-466c-bbac-7c7afb8b9df6 TCGA-EJ-7321-01 TCGA-EJ-7321-01 TCGA-EJ-7321-01A-31D-2260-08 TCGA-EJ-7321-01A-31D-2260-08 951adcbd-7d7a-466c-bbac-7c7afb8b9df6 +TCGA-EJ-7321-11 TCGA-EJ-7321-11 TCGA-EJ-7321 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-EJ-7321-F64812 TCGA-EJ-7321 NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -21108 10 0 824 128 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 25 0 No N0 T3a 7321 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 3 NO 4 YES NO EJ Prostate LIVING 2011 fff1f232-8978-406d-a6fc-61df98382b86 fff1f232-8978-406d-a6fc-61df98382b86 TCGA-EJ-7321-11 fff1f232-8978-406d-a6fc-61df98382b86 TCGA-EJ-7321-11 fff1f232-8978-406d-a6fc-61df98382b86 +TCGA-EJ-7325-01 TCGA-EJ-7325-01 TCGA-EJ-7325 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-EJ-7325-F64803 TCGA-EJ-7325 TCGA-EJ-7325-01B NO M0 T3b -23029 855 0 1070 507 Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 480 NO Bilateral NO YES NO 9 0 true Yes, History of Prior Malignancy N0 T3b TCGA-EJ-7325.6E9EC98C-FD89-47DA-BF8A-B7F4229C9E09.pdf 7325 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO EJ Prostate B LIVING 2011 3c6d1cda-258e-42f4-ad31-16069e437ac3 TCGA-EJ-7325-01B-11D-A32A-01 TCGA-EJ-7325-01B-11D-A32C-05 TCGA-EJ-7325-01B-11D-A32B-08 3c6d1cda-258e-42f4-ad31-16069e437ac3 TCGA-EJ-7325-01 TCGA-EJ-7325-01 B4CB51C2-A8E4-45F6-AAC9-B2B88E89EC05 TCGA-EJ-7325-01B-11D-A32A-01 3c6d1cda-258e-42f4-ad31-16069e437ac3 TCGA-EJ-7325-01 TCGA-EJ-7325-01 3c6d1cda-258e-42f4-ad31-16069e437ac3 +TCGA-EJ-7327-01 TCGA-EJ-7327-01 TCGA-EJ-7327 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-EJ-7327-F64808 TCGA-EJ-7327 NO M0 T2a -22475 0 923 175 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 17 0 No N0 T3b 7327 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO 5 YES NO EJ Apex|Middle|Base Prostate LIVING 2011 bc6a091a-720d-4a70-b3de-66db6b240669 TCGA-EJ-7327-01A-11D-2112-01 TCGA-EJ-7327-01A-11D-2116-05 TCGA-EJ-7327-01A-11D-2114-08 bc6a091a-720d-4a70-b3de-66db6b240669 TCGA-EJ-7327-01 TCGA-EJ-7327-01 TCGA-EJ-7327-01A-11D-2112-01 bc6a091a-720d-4a70-b3de-66db6b240669 TCGA-EJ-7327-01 TCGA-EJ-7327-01 TCGA-EJ-7327-01A-11D-2114-08 TCGA-EJ-7327-01A-11D-2114-08 bc6a091a-720d-4a70-b3de-66db6b240669 +TCGA-EJ-7327-11 TCGA-EJ-7327-11 TCGA-EJ-7327 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-EJ-7327-F64808 TCGA-EJ-7327 TCGA-EJ-7327-11A NO M0 T2a -22475 0 923 175 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.5 NO Bilateral 1.9 NO YES NO 17 0 No N0 T3b 7327 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 4 0.7 NO 5 YES NO EJ Apex|Middle|Base Prostate A LIVING 2011 63cd2e90-2a03-406a-a094-b855c02b0c04 TCGA-EJ-7327-11A-01D-2116-05 63cd2e90-2a03-406a-a094-b855c02b0c04 TCGA-EJ-7327-11 63cd2e90-2a03-406a-a094-b855c02b0c04 TCGA-EJ-7327-11 63cd2e90-2a03-406a-a094-b855c02b0c04 +TCGA-EJ-7328-01 TCGA-EJ-7328-01 TCGA-EJ-7328 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 70 TCGA-EJ-7328-F64806 TCGA-EJ-7328 TCGA-EJ-7328-01A M0 T1c -25756 0 842 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Bilateral 1.8 NO YES NO 9 0 No N0 T3a TCGA-EJ-7328.30c9c833-ae7e-46de-951c-a488df1d723a.pdf 7328 TUMOR FREE 4 Complete Remission/Response NO R0 Primary Tumor 01 3 0.5 NO 5 YES NO EJ Middle|Base Prostate A LIVING 2011 bd8a26e3-ddaf-405d-9b32-bd6adb09024f TCGA-EJ-7328-01A-31D-2112-01 TCGA-EJ-7328-01A-31D-2116-05 TCGA-EJ-7328-01A-31D-2114-08 bd8a26e3-ddaf-405d-9b32-bd6adb09024f TCGA-EJ-7328-01 TCGA-EJ-7328-01 7E4BA80A-1D78-491D-BFB2-F624B8B4F89E TCGA-EJ-7328-01A-31D-2112-01 bd8a26e3-ddaf-405d-9b32-bd6adb09024f TCGA-EJ-7328-01 TCGA-EJ-7328-01 TCGA-EJ-7328-01A-31D-2114-08 TCGA-EJ-7328-01A-31D-2114-08 bd8a26e3-ddaf-405d-9b32-bd6adb09024f +TCGA-EJ-7328-11 TCGA-EJ-7328-11 TCGA-EJ-7328 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 70 TCGA-EJ-7328-F64806 TCGA-EJ-7328 M0 T1c -25756 0 842 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 9 0 No N0 T3a 7328 TUMOR FREE 4 Complete Remission/Response NO R0 Solid Tissue Normal 11 3 NO 5 YES NO EJ Middle|Base Prostate LIVING 2011 cbc2c758-bf49-4165-bbb1-30c046caf99c TCGA-EJ-7328-11A-01D-2116-05 cbc2c758-bf49-4165-bbb1-30c046caf99c TCGA-EJ-7328-11 cbc2c758-bf49-4165-bbb1-30c046caf99c TCGA-EJ-7328-11 cbc2c758-bf49-4165-bbb1-30c046caf99c +TCGA-EJ-7330-01 TCGA-EJ-7330-01 TCGA-EJ-7330 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-EJ-7330 TCGA-EJ-7330-01A NO M0 T1c -25050 0 191 191 NO NO 2012-4-5 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.3 NO Bilateral 1.5 YES 18 0 No N0 T3a TCGA-EJ-7330.d910cd86-89be-4fc9-8f9d-497692a6face.pdf 7330 TUMOR FREE 4 0.1 R0 Primary Tumor 01 3 0.4 5 YES NO EJ Apex|Middle|Base Prostate A LIVING 2011 07b4fdf4-19af-42f6-8c17-520047dce246 TCGA-EJ-7330-01A-11D-2112-01 TCGA-EJ-7330-01A-11D-2116-05 TCGA-EJ-7330-01A-11D-2114-08 07b4fdf4-19af-42f6-8c17-520047dce246 TCGA-EJ-7330-01 TCGA-EJ-7330-01 3BD9A152-B0AC-440D-B2B3-E465FF1BD0E1 TCGA-EJ-7330-01A-11D-2112-01 07b4fdf4-19af-42f6-8c17-520047dce246 TCGA-EJ-7330-01 TCGA-EJ-7330-01 TCGA-EJ-7330-01A-11D-2114-08 TCGA-EJ-7330-01A-11D-2114-08 07b4fdf4-19af-42f6-8c17-520047dce246 +TCGA-EJ-7330-11 TCGA-EJ-7330-11 TCGA-EJ-7330 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-EJ-7330 TCGA-EJ-7330-11A NO M0 T1c -25050 0 191 191 NO NO 2012-4-5 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 2.3 YES 18 0 No N0 T3a 7330 TUMOR FREE 4 0.1 R0 Solid Tissue Normal 11 3 0.4 5 YES NO EJ Apex|Middle|Base Prostate A LIVING 2011 15602b9c-e496-4b8b-a416-82db780d8f28 15602b9c-e496-4b8b-a416-82db780d8f28 TCGA-EJ-7330-11 15602b9c-e496-4b8b-a416-82db780d8f28 TCGA-EJ-7330-11 15602b9c-e496-4b8b-a416-82db780d8f28 +TCGA-EJ-7331-01 TCGA-EJ-7331-01 TCGA-EJ-7331 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-EJ-7331-F64813 TCGA-EJ-7331 TCGA-EJ-7331-01A YES M0 T1c -23458 189 0 742 189 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.4 NO Bilateral 1.9 NO YES NO 7 0 No N0 T2c TCGA-EJ-7331.84790d75-bbef-49b0-9486-94e049c13ddd.pdf 7331 TUMOR FREE 3 Complete Remission/Response 0.8 NO R0 Primary Tumor 01 4 0.3 NO 3 YES NO EJ Apex|Middle Prostate A LIVING 2011 0c4495e4-b826-45ee-9ad3-873266b4585b TCGA-EJ-7331-01A-11D-2112-01 TCGA-EJ-7331-01A-11D-2116-05 TCGA-EJ-7331-01A-11D-2114-08 0c4495e4-b826-45ee-9ad3-873266b4585b TCGA-EJ-7331-01 TCGA-EJ-7331-01 29032C53-2573-4E12-BD74-01229692E6B8 TCGA-EJ-7331-01A-11D-2112-01 0c4495e4-b826-45ee-9ad3-873266b4585b TCGA-EJ-7331-01 TCGA-EJ-7331-01 TCGA-EJ-7331-01A-11D-2114-08 TCGA-EJ-7331-01A-11D-2114-08 0c4495e4-b826-45ee-9ad3-873266b4585b +TCGA-EJ-7331-11 TCGA-EJ-7331-11 TCGA-EJ-7331 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-EJ-7331-F64813 TCGA-EJ-7331 TCGA-EJ-7331-11A YES M0 T1c -23458 189 0 742 189 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.4 NO Bilateral 2.5 NO YES NO 7 0 No N0 T2c 7331 TUMOR FREE 3 Complete Remission/Response 0.8 NO R0 Solid Tissue Normal 11 4 0.3 NO 3 YES NO EJ Apex|Middle Prostate A LIVING 2011 9356c4e0-eb35-4e70-85da-10ad2ae535a6 TCGA-EJ-7331-11A-01D-2116-05 9356c4e0-eb35-4e70-85da-10ad2ae535a6 TCGA-EJ-7331-11 9356c4e0-eb35-4e70-85da-10ad2ae535a6 TCGA-EJ-7331-11 9356c4e0-eb35-4e70-85da-10ad2ae535a6 +TCGA-EJ-7781-01 TCGA-EJ-7781-01 TCGA-EJ-7781 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-EJ-7781-F60365 TCGA-EJ-7781 TCGA-EJ-7781-01A NO M0 T1c -23937 0 1073 169 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-6 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 2 NO YES NO 17 0 No N0 T2c TCGA-EJ-7781.3582ff42-09f7-4ffb-9421-60f3cba1ff28.pdf 7781 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.3 NO 5 YES NO EJ Prostate A LIVING 2011 26cd2872-7067-4cd7-bf85-4f028d9a819d TCGA-EJ-7781-01A-11D-2112-01 TCGA-EJ-7781-01A-11D-2116-05 TCGA-EJ-7781-01A-11D-2114-08 26cd2872-7067-4cd7-bf85-4f028d9a819d TCGA-EJ-7781-01 TCGA-EJ-7781-01 1F6DDC7F-411E-4B6C-8EA5-A3B79D27E921 TCGA-EJ-7781-01A-11D-2112-01 26cd2872-7067-4cd7-bf85-4f028d9a819d TCGA-EJ-7781-01 TCGA-EJ-7781-01 TCGA-EJ-7781-01A-11D-2114-08 TCGA-EJ-7781-01A-11D-2114-08 26cd2872-7067-4cd7-bf85-4f028d9a819d +TCGA-EJ-7781-11 TCGA-EJ-7781-11 TCGA-EJ-7781 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-EJ-7781-F60365 TCGA-EJ-7781 NO M0 T1c -23937 0 1073 169 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-6 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 17 0 No N0 T2c 7781 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 4 NO 5 YES NO EJ Prostate LIVING 2011 d75a22a0-a230-4ac8-a3db-96ea29ca95b9 TCGA-EJ-7781-11A-01D-2116-05 d75a22a0-a230-4ac8-a3db-96ea29ca95b9 TCGA-EJ-7781-11 d75a22a0-a230-4ac8-a3db-96ea29ca95b9 TCGA-EJ-7781-11 d75a22a0-a230-4ac8-a3db-96ea29ca95b9 +TCGA-EJ-7782-01 TCGA-EJ-7782-01 TCGA-EJ-7782 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 71 TCGA-EJ-7782-F60366 TCGA-EJ-7782 TCGA-EJ-7782-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2c -25965 49 0 1167 350 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-6 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.2 NO Bilateral 1.5 NO YES NO 17 0 No N0 T2c TCGA-EJ-7782.d8500e84-1aa4-4a3b-874c-563d520dec03.pdf 7782 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.5 NO 4 YES NO EJ Prostate A LIVING 2010 0d9fb905-5374-4054-b799-9c4c4efd36d6 TCGA-EJ-7782-01A-11D-2112-01 TCGA-EJ-7782-01A-11D-2116-05 TCGA-EJ-7782-01A-11D-2114-08 0d9fb905-5374-4054-b799-9c4c4efd36d6 TCGA-EJ-7782-01 TCGA-EJ-7782-01 875D4449-957F-414F-8835-C9C0E35BA249 TCGA-EJ-7782-01A-11D-2112-01 0d9fb905-5374-4054-b799-9c4c4efd36d6 TCGA-EJ-7782-01 TCGA-EJ-7782-01 TCGA-EJ-7782-01A-11D-2114-08 TCGA-EJ-7782-01A-11D-2114-08 0d9fb905-5374-4054-b799-9c4c4efd36d6 +TCGA-EJ-7782-11 TCGA-EJ-7782-11 TCGA-EJ-7782 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 71 TCGA-EJ-7782-F60366 TCGA-EJ-7782 NO Normal (no evidence of prostate cancer) [cM0] M0 T2c -25965 49 0 1167 350 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-6 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 17 0 No N0 T2c 7782 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 4 NO 4 YES NO EJ Prostate LIVING 2010 e74de9a3-6dd4-42b7-b92c-eba3e3827bed TCGA-EJ-7782-11A-01D-2116-05 e74de9a3-6dd4-42b7-b92c-eba3e3827bed TCGA-EJ-7782-11 e74de9a3-6dd4-42b7-b92c-eba3e3827bed TCGA-EJ-7782-11 e74de9a3-6dd4-42b7-b92c-eba3e3827bed +TCGA-EJ-7783-01 TCGA-EJ-7783-01 TCGA-EJ-7783 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 70 TCGA-EJ-7783-F60370 TCGA-EJ-7783 TCGA-EJ-7783-01A YES M0 T2c -25600 81 0 787 172 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-6 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.3 NO Bilateral 1.4 NO YES NO 17 0 No N0 T3a TCGA-EJ-7783.8c4eab7f-e0e2-4cad-b06c-ae2d3ed11052.pdf 7783 TUMOR FREE 4 Complete Remission/Response 0.7 NO R0 Primary Tumor 01 3 0.3 NO 4 YES NO EJ Prostate A LIVING 2011 e6f20d5c-1cb3-4e65-aeaf-1cbe64e440bf TCGA-EJ-7783-01A-11D-2112-01 TCGA-EJ-7783-01A-11D-2116-05 TCGA-EJ-7783-01A-11D-2114-08 e6f20d5c-1cb3-4e65-aeaf-1cbe64e440bf TCGA-EJ-7783-01 TCGA-EJ-7783-01 1CECAFF4-5B92-46E3-990E-A69030E24E21 TCGA-EJ-7783-01A-11D-2112-01 e6f20d5c-1cb3-4e65-aeaf-1cbe64e440bf TCGA-EJ-7783-01 TCGA-EJ-7783-01 TCGA-EJ-7783-01A-11D-2114-08 TCGA-EJ-7783-01A-11D-2114-08 e6f20d5c-1cb3-4e65-aeaf-1cbe64e440bf +TCGA-EJ-7783-11 TCGA-EJ-7783-11 TCGA-EJ-7783 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 70 TCGA-EJ-7783-F60370 TCGA-EJ-7783 TCGA-EJ-7783-11A YES M0 T2c -25600 81 0 787 172 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-6 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.3 NO Bilateral 1.4 NO YES NO 17 0 No N0 T3a 7783 TUMOR FREE 4 Complete Remission/Response 0.7 NO R0 Solid Tissue Normal 11 3 0.4 NO 4 YES NO EJ Prostate A LIVING 2011 7afedcd4-d921-4996-9587-a8faa03dcea0 7afedcd4-d921-4996-9587-a8faa03dcea0 TCGA-EJ-7783-11 7afedcd4-d921-4996-9587-a8faa03dcea0 TCGA-EJ-7783-11 7afedcd4-d921-4996-9587-a8faa03dcea0 +TCGA-EJ-7784-01 TCGA-EJ-7784-01 TCGA-EJ-7784 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-EJ-7784-F60372 TCGA-EJ-7784 TCGA-EJ-7784-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2c -23183 0 0 0 781 167 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-6 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.1 NO YES NO 13 0 No N0 T2c TCGA-EJ-7784.d140c74d-8e74-43da-a181-63a7bbe718af.pdf 7784 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 0.3 NO 4 YES NO EJ Prostate A LIVING 2011 731721fa-4ced-445d-855f-e4ded85f9726 TCGA-EJ-7784-01A-11D-2112-01 TCGA-EJ-7784-01A-11D-2116-05 TCGA-EJ-7784-01A-11D-2114-08 731721fa-4ced-445d-855f-e4ded85f9726 TCGA-EJ-7784-01 TCGA-EJ-7784-01 CC78BF20-57A1-4F83-B519-6672553F20DD TCGA-EJ-7784-01A-11D-2112-01 731721fa-4ced-445d-855f-e4ded85f9726 TCGA-EJ-7784-01 TCGA-EJ-7784-01 TCGA-EJ-7784-01A-11D-2114-08 TCGA-EJ-7784-01A-11D-2114-08 731721fa-4ced-445d-855f-e4ded85f9726 +TCGA-EJ-7784-11 TCGA-EJ-7784-11 TCGA-EJ-7784 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-EJ-7784-F60372 TCGA-EJ-7784 NO Normal (no evidence of prostate cancer) [cM0] M0 T2c -23183 0 0 0 781 167 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-6 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 13 0 No N0 T2c 7784 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 3 NO 4 YES NO EJ Prostate LIVING 2011 bb77b27a-0450-4874-b46f-ab9505681648 TCGA-EJ-7784-11A-01D-2116-05 bb77b27a-0450-4874-b46f-ab9505681648 TCGA-EJ-7784-11 bb77b27a-0450-4874-b46f-ab9505681648 TCGA-EJ-7784-11 bb77b27a-0450-4874-b46f-ab9505681648 +TCGA-EJ-7785-01 TCGA-EJ-7785-01 TCGA-EJ-7785 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 54 TCGA-EJ-7785-F71967 TCGA-EJ-7785 TCGA-EJ-7785-01A NO M0 T2b -19939 0 1177 259 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1 NO YES NO 7 0 No N0 T3a TCGA-EJ-7785.01ed5c8e-64f0-4e58-bd52-92a0d4f4af2b.pdf 7785 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.3 NO 3 YES NO EJ Middle|Base Prostate A LIVING 2011 0cc5f629-5046-4d05-8a5f-923ce5c04b9e TCGA-EJ-7785-01A-11D-2112-01 TCGA-EJ-7785-01A-11D-2116-05 TCGA-EJ-7785-01A-11D-2114-08 0cc5f629-5046-4d05-8a5f-923ce5c04b9e TCGA-EJ-7785-01 TCGA-EJ-7785-01 25F1DC25-C819-4C02-8394-8226BDE2896D TCGA-EJ-7785-01A-11D-2112-01 0cc5f629-5046-4d05-8a5f-923ce5c04b9e TCGA-EJ-7785-01 TCGA-EJ-7785-01 TCGA-EJ-7785-01A-11D-2114-08 TCGA-EJ-7785-01A-11D-2114-08 0cc5f629-5046-4d05-8a5f-923ce5c04b9e +TCGA-EJ-7785-11 TCGA-EJ-7785-11 TCGA-EJ-7785 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 54 TCGA-EJ-7785-F71967 TCGA-EJ-7785 TCGA-EJ-7785-11A NO M0 T2b -19939 0 1177 259 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.5 NO Bilateral 2.2 NO YES NO 7 0 No N0 T3a 7785 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 4 0.4 NO 3 YES NO EJ Middle|Base Prostate A LIVING 2011 2d8faa2d-336f-46e9-992d-4a5a5dbc4ece TCGA-EJ-7785-11A-01D-2116-05 2d8faa2d-336f-46e9-992d-4a5a5dbc4ece TCGA-EJ-7785-11 2d8faa2d-336f-46e9-992d-4a5a5dbc4ece TCGA-EJ-7785-11 2d8faa2d-336f-46e9-992d-4a5a5dbc4ece +TCGA-EJ-7786-01 TCGA-EJ-7786-01 TCGA-EJ-7786 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-EJ-7786-F71968 TCGA-EJ-7786 TCGA-EJ-7786-01A NO M0 T1c -22793 0 1096 79 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.7 NO Bilateral 0.9 NO YES NO 5 0 No N0 T2c TCGA-EJ-7786.3b3ac042-2bb6-445b-a82b-eea969f0bd33.pdf 7786 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.6 NO 3 YES NO EJ Prostate A LIVING 2011 d444c3d1-235a-413c-8e5c-4f4465b378e1 TCGA-EJ-7786-01A-11D-2112-01 TCGA-EJ-7786-01A-11D-2116-05 TCGA-EJ-7786-01A-11D-2114-08 d444c3d1-235a-413c-8e5c-4f4465b378e1 TCGA-EJ-7786-01 TCGA-EJ-7786-01 CB2FF7FE-0571-494A-A39B-3CF58DDCA502 TCGA-EJ-7786-01A-11D-2112-01 d444c3d1-235a-413c-8e5c-4f4465b378e1 TCGA-EJ-7786-01 TCGA-EJ-7786-01 TCGA-EJ-7786-01A-11D-2114-08 TCGA-EJ-7786-01A-11D-2114-08 d444c3d1-235a-413c-8e5c-4f4465b378e1 +TCGA-EJ-7786-11 TCGA-EJ-7786-11 TCGA-EJ-7786 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-EJ-7786-F71968 TCGA-EJ-7786 NO M0 T1c -22793 0 1096 79 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 5 0 No N0 T2c 7786 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 4 NO 3 YES NO EJ Prostate LIVING 2011 c4aa58a3-f1ef-489f-be76-ce0f20a5446f TCGA-EJ-7786-11A-01D-2116-05 c4aa58a3-f1ef-489f-be76-ce0f20a5446f TCGA-EJ-7786-11 c4aa58a3-f1ef-489f-be76-ce0f20a5446f TCGA-EJ-7786-11 c4aa58a3-f1ef-489f-be76-ce0f20a5446f +TCGA-EJ-7788-01 TCGA-EJ-7788-01 TCGA-EJ-7788 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 53 TCGA-EJ-7788-F60375 TCGA-EJ-7788 TCGA-EJ-7788-01A NO M0 T3b -19623 0 859 52 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-6 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.2 NO Bilateral 2 NO YES NO 6 0 No N0 T3b TCGA-EJ-7788.b66a0868-e91c-4ebf-be9c-ba55e94552fd.pdf 7788 TUMOR FREE 3 Complete Remission/Response 0.2 NO R0 Primary Tumor 01 4 0.4 NO 5 YES NO EJ Middle|Base Prostate A LIVING 2011 83fedf64-9e72-4f9c-ab33-166dc0202cc9 TCGA-EJ-7788-01A-11D-2112-01 TCGA-EJ-7788-01A-11D-2116-05 TCGA-EJ-7788-01A-11D-2114-08 83fedf64-9e72-4f9c-ab33-166dc0202cc9 TCGA-EJ-7788-01 TCGA-EJ-7788-01 429F179D-1B60-4097-ADCC-C126936A19D6 TCGA-EJ-7788-01A-11D-2112-01 83fedf64-9e72-4f9c-ab33-166dc0202cc9 TCGA-EJ-7788-01 TCGA-EJ-7788-01 TCGA-EJ-7788-01A-11D-2114-08 TCGA-EJ-7788-01A-11D-2114-08 83fedf64-9e72-4f9c-ab33-166dc0202cc9 +TCGA-EJ-7789-01 TCGA-EJ-7789-01 TCGA-EJ-7789 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-EJ-7789-F71969 TCGA-EJ-7789 TCGA-EJ-7789-01A M0 T1c -24107 0 1105 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.5 NO Bilateral 1.8 NO YES NO 14 0 No N0 T3a TCGA-EJ-7789.7483212d-f96c-4afd-b817-74517b54de53.pdf 7789 TUMOR FREE 4 Complete Remission/Response NO R0 Primary Tumor 01 3 0.3 NO 5 YES NO EJ Base Prostate A LIVING 2011 784cb488-904d-49e4-b63e-bb0e5bacb6e3 TCGA-EJ-7789-01A-11D-2112-01 TCGA-EJ-7789-01A-11D-2116-05 TCGA-EJ-7789-01A-11D-2114-08 784cb488-904d-49e4-b63e-bb0e5bacb6e3 TCGA-EJ-7789-01 TCGA-EJ-7789-01 18796055-6F9D-478E-89FB-3FDC019C8119 TCGA-EJ-7789-01A-11D-2112-01 784cb488-904d-49e4-b63e-bb0e5bacb6e3 TCGA-EJ-7789-01 TCGA-EJ-7789-01 TCGA-EJ-7789-01A-11D-2114-08 TCGA-EJ-7789-01A-11D-2114-08 784cb488-904d-49e4-b63e-bb0e5bacb6e3 +TCGA-EJ-7789-11 TCGA-EJ-7789-11 TCGA-EJ-7789 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-EJ-7789-F71969 TCGA-EJ-7789 TCGA-EJ-7789-11A M0 T1c -24107 0 1105 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.8 NO YES NO 14 0 No N0 T3a 7789 TUMOR FREE 4 Complete Remission/Response NO R0 Solid Tissue Normal 11 3 0.5 NO 5 YES NO EJ Base Prostate A LIVING 2011 8666da07-07d0-417e-954b-c18e107bdeb1 TCGA-EJ-7789-11A-01D-2116-05 8666da07-07d0-417e-954b-c18e107bdeb1 TCGA-EJ-7789-11 8666da07-07d0-417e-954b-c18e107bdeb1 TCGA-EJ-7789-11 8666da07-07d0-417e-954b-c18e107bdeb1 +TCGA-EJ-7791-01 TCGA-EJ-7791-01 TCGA-EJ-7791 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-EJ-7791-F71964 TCGA-EJ-7791 TCGA-EJ-7791-01A NO M0 T1c -24621 0 1118 217 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.5 NO Bilateral 2 NO YES NO 18 0 No N0 T2c TCGA-EJ-7791.001c43cb-3e9b-43db-b6d0-61e67d058c9f.pdf 7791 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.3 NO 4 YES NO EJ Apex|Middle Prostate A LIVING 2011 14830a14-5495-4425-b6ef-78ccffafe03c TCGA-EJ-7791-01A-11D-2112-01 TCGA-EJ-7791-01A-11D-2116-05 TCGA-EJ-7791-01A-11D-2114-08 14830a14-5495-4425-b6ef-78ccffafe03c TCGA-EJ-7791-01 TCGA-EJ-7791-01 74CA9A60-9C42-4A7C-9407-DBAF152289EB TCGA-EJ-7791-01A-11D-2112-01 14830a14-5495-4425-b6ef-78ccffafe03c TCGA-EJ-7791-01 TCGA-EJ-7791-01 TCGA-EJ-7791-01A-11D-2114-08 TCGA-EJ-7791-01A-11D-2114-08 14830a14-5495-4425-b6ef-78ccffafe03c +TCGA-EJ-7792-01 TCGA-EJ-7792-01 TCGA-EJ-7792 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 53 TCGA-EJ-7792-F71965 TCGA-EJ-7792 TCGA-EJ-7792-01A NO M0 T1c -19454 0 1396 526 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.3 NO Bilateral 1.4 NO YES NO 35 0 No N0 T2c TCGA-EJ-7792.607fd612-7ab9-475b-8c22-fd7cdbaccb37.pdf 7792 TUMOR FREE 3 Complete Remission/Response 0.13 NO R0 Primary Tumor 01 4 0.3 NO 4 YES NO EJ Apex|Middle Prostate A LIVING 2010 310d0da6-5694-4dc0-82f7-3fe0f6699271 TCGA-EJ-7792-01A-11D-2112-01 TCGA-EJ-7792-01A-11D-2116-05 TCGA-EJ-7792-01A-11D-2114-08 310d0da6-5694-4dc0-82f7-3fe0f6699271 TCGA-EJ-7792-01 TCGA-EJ-7792-01 A8CB42CF-915F-4CC4-80CE-337A822EC406 TCGA-EJ-7792-01A-11D-2112-01 310d0da6-5694-4dc0-82f7-3fe0f6699271 TCGA-EJ-7792-01 TCGA-EJ-7792-01 TCGA-EJ-7792-01A-11D-2114-08 TCGA-EJ-7792-01A-11D-2114-08 310d0da6-5694-4dc0-82f7-3fe0f6699271 +TCGA-EJ-7792-11 TCGA-EJ-7792-11 TCGA-EJ-7792 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 53 TCGA-EJ-7792-F71965 TCGA-EJ-7792 TCGA-EJ-7792-11A NO M0 T1c -19454 0 1396 526 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Bilateral 1.7 NO YES NO 35 0 No N0 T2c 7792 TUMOR FREE 3 Complete Remission/Response 0.13 NO R0 Solid Tissue Normal 11 4 0.3 NO 4 YES NO EJ Apex|Middle Prostate A LIVING 2010 3f8c4a26-6796-4070-aea8-a7507103cfc7 TCGA-EJ-7792-11A-01D-2116-05 3f8c4a26-6796-4070-aea8-a7507103cfc7 TCGA-EJ-7792-11 3f8c4a26-6796-4070-aea8-a7507103cfc7 TCGA-EJ-7792-11 3f8c4a26-6796-4070-aea8-a7507103cfc7 +TCGA-EJ-7793-01 TCGA-EJ-7793-01 TCGA-EJ-7793 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 49 TCGA-EJ-7793-F60362 TCGA-EJ-7793 TCGA-EJ-7793-01A NO M0 T2c -17982 0 114 114 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-6 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.3 NO Bilateral 1.7 YES NO No T2c TCGA-EJ-7793.c9d3d69c-f362-454f-a8ff-cbda4d713c41.pdf 7793 TUMOR FREE 3 0.1 R0 Primary Tumor 01 4 0.3 4 YES NO EJ Apex|Middle Prostate A LIVING 2011 8a63eeeb-2e0d-466f-a446-ac6649cba90c TCGA-EJ-7793-01A-31D-2259-01 TCGA-EJ-7793-01A-31D-2261-05 TCGA-EJ-7793-01A-31D-2260-08 8a63eeeb-2e0d-466f-a446-ac6649cba90c TCGA-EJ-7793-01 TCGA-EJ-7793-01 97BBA440-7AFC-4EF1-B98D-EC635488B1D0 TCGA-EJ-7793-01A-31D-2259-01 8a63eeeb-2e0d-466f-a446-ac6649cba90c TCGA-EJ-7793-01 TCGA-EJ-7793-01 TCGA-EJ-7793-01A-31D-2260-08 TCGA-EJ-7793-01A-31D-2260-08 8a63eeeb-2e0d-466f-a446-ac6649cba90c +TCGA-EJ-7793-11 TCGA-EJ-7793-11 TCGA-EJ-7793 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 49 TCGA-EJ-7793-F60362 TCGA-EJ-7793 TCGA-EJ-7793-11A NO M0 T2c -17982 0 114 114 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-6 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.3 NO Bilateral 2 YES NO No T2c 7793 TUMOR FREE 3 0.1 R0 Solid Tissue Normal 11 4 0.5 4 YES NO EJ Apex|Middle Prostate A LIVING 2011 5b2c7f9e-d8f2-44db-8981-5acefbfd38c8 5b2c7f9e-d8f2-44db-8981-5acefbfd38c8 TCGA-EJ-7793-11 5b2c7f9e-d8f2-44db-8981-5acefbfd38c8 TCGA-EJ-7793-11 5b2c7f9e-d8f2-44db-8981-5acefbfd38c8 +TCGA-EJ-7794-01 TCGA-EJ-7794-01 TCGA-EJ-7794 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-EJ-7794-F71966 TCGA-EJ-7794 TCGA-EJ-7794-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2c -24478 35 35 0 1306 285 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 1.4 NO YES NO 11 0 No N0 T2c TCGA-EJ-7794.73164d62-bc3a-4dd3-8201-86c5f35ef168.pdf 7794 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.4 NO 3 YES NO EJ Prostate A LIVING 2010 cecb86b2-f20c-4fde-b9b6-c87e95f2e390 TCGA-EJ-7794-01A-11D-2112-01 TCGA-EJ-7794-01A-11D-2116-05 TCGA-EJ-7794-01A-11D-2114-08 cecb86b2-f20c-4fde-b9b6-c87e95f2e390 TCGA-EJ-7794-01 TCGA-EJ-7794-01 28E1D66C-1D4C-48FB-9583-1896B7759EFB TCGA-EJ-7794-01A-11D-2112-01 cecb86b2-f20c-4fde-b9b6-c87e95f2e390 TCGA-EJ-7794-01 TCGA-EJ-7794-01 TCGA-EJ-7794-01A-11D-2114-08 TCGA-EJ-7794-01A-11D-2114-08 cecb86b2-f20c-4fde-b9b6-c87e95f2e390 +TCGA-EJ-7794-11 TCGA-EJ-7794-11 TCGA-EJ-7794 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-EJ-7794-F71966 TCGA-EJ-7794 TCGA-EJ-7794-11A NO Normal (no evidence of prostate cancer) [cM0] M0 T2c -24478 35 35 0 1306 285 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 1.5 NO YES NO 11 0 No N0 T2c 7794 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 4 0.4 NO 3 YES NO EJ Prostate A LIVING 2010 6970283b-3673-49bc-9b2b-bd268140327f TCGA-EJ-7794-11A-01D-2116-05 6970283b-3673-49bc-9b2b-bd268140327f TCGA-EJ-7794-11 6970283b-3673-49bc-9b2b-bd268140327f TCGA-EJ-7794-11 6970283b-3673-49bc-9b2b-bd268140327f +TCGA-EJ-7797-01 TCGA-EJ-7797-01 TCGA-EJ-7797 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 53 TCGA-EJ-7797-F60374 TCGA-EJ-7797 TCGA-EJ-7797-01A NO M0 T1c -19616 0 983 187 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-6 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 1 NO YES NO 14 0 No N0 T2c TCGA-EJ-7797.d9d6f871-c436-469e-9d7f-9684c379a320.pdf 7797 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.4 NO 4 YES NO EJ Prostate A LIVING 2011 960c1e43-d2be-41f0-9f3a-8234cddb84be TCGA-EJ-7797-01A-11D-2259-01 TCGA-EJ-7797-01A-11D-2261-05 TCGA-EJ-7797-01A-11D-2260-08 960c1e43-d2be-41f0-9f3a-8234cddb84be TCGA-EJ-7797-01 TCGA-EJ-7797-01 B43E0A20-FE97-46E4-A509-CD8497EC0A2B TCGA-EJ-7797-01A-11D-2259-01 960c1e43-d2be-41f0-9f3a-8234cddb84be TCGA-EJ-7797-01 TCGA-EJ-7797-01 TCGA-EJ-7797-01A-11D-2260-08 TCGA-EJ-7797-01A-11D-2260-08 960c1e43-d2be-41f0-9f3a-8234cddb84be +TCGA-EJ-7797-11 TCGA-EJ-7797-11 TCGA-EJ-7797 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 53 TCGA-EJ-7797-F60374 TCGA-EJ-7797 NO M0 T1c -19616 0 983 187 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-6 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 14 0 No N0 T2c 7797 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 4 NO 4 YES NO EJ Prostate LIVING 2011 a461340b-d5cd-4600-9046-f3942bec1c19 a461340b-d5cd-4600-9046-f3942bec1c19 TCGA-EJ-7797-11 a461340b-d5cd-4600-9046-f3942bec1c19 TCGA-EJ-7797-11 a461340b-d5cd-4600-9046-f3942bec1c19 +TCGA-EJ-8468-01 TCGA-EJ-8468-01 TCGA-EJ-8468 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-EJ-8468-F64614 TCGA-EJ-8468 TCGA-EJ-8468-01A NO Normal (no evidence of prostate cancer) [cM0] T3a -23371 23 23 0 2347 1961 YES Scheduled Follow-up Submission Complete Remission/Response 2014-9-5 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Left 1.9 NO YES NO 7 0 No N0 T3a TCGA-EJ-8468.84d3bc2c-122e-45e7-b9af-e5f409c95a56.pdf 8468 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.4 NO 3 YES NO EJ Prostate A LIVING 2007 2c178e64-b87b-4887-b599-cc928e45db86 TCGA-EJ-8468-01A-21D-2391-01 TCGA-EJ-8468-01A-21D-2399-05 TCGA-EJ-8468-01A-21D-2395-08 2c178e64-b87b-4887-b599-cc928e45db86 TCGA-EJ-8468-01 TCGA-EJ-8468-01 67EC88F5-6AA2-403F-A61C-68BA66BAA9BC TCGA-EJ-8468-01A-21D-2391-01 2c178e64-b87b-4887-b599-cc928e45db86 TCGA-EJ-8468-01 TCGA-EJ-8468-01 TCGA-EJ-8468-01A-21D-2395-08 TCGA-EJ-8468-01A-21D-2395-08 2c178e64-b87b-4887-b599-cc928e45db86 +TCGA-EJ-8469-01 TCGA-EJ-8469-01 TCGA-EJ-8469 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 46 TCGA-EJ-8469-F64636 TCGA-EJ-8469 TCGA-EJ-8469-01A YES M0 T3a -17014 30 1925 0 2324 1925 1925 YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Partial Remission/Response 2014-9-8 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 2.3 NO YES Locoregional Recurrence YES 57 0 No N0 T3a TCGA-EJ-8469.15db2c5f-2ba9-4fc8-b941-ae57e265c757.pdf 8469 WITH TUMOR 4 Partial Remission/Response 3.1 NO RX Primary Tumor 01 5 0.5 NO 3 YES NO EJ Prostate A LIVING 2007 6fb7bc7b-2198-410d-998d-fb9a3f8cb3fe TCGA-EJ-8469-01A-11D-2391-01 TCGA-EJ-8469-01A-11D-2399-05 TCGA-EJ-8469-01A-11D-2395-08 6fb7bc7b-2198-410d-998d-fb9a3f8cb3fe TCGA-EJ-8469-01 TCGA-EJ-8469-01 D7E8BC9A-83B5-47EE-A1C9-CA1D8689DB42 TCGA-EJ-8469-01A-11D-2391-01 6fb7bc7b-2198-410d-998d-fb9a3f8cb3fe TCGA-EJ-8469-01 TCGA-EJ-8469-01 TCGA-EJ-8469-01A-11D-2395-08 TCGA-EJ-8469-01A-11D-2395-08 6fb7bc7b-2198-410d-998d-fb9a3f8cb3fe +TCGA-EJ-8470-01 TCGA-EJ-8470-01 TCGA-EJ-8470 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 58 TCGA-EJ-8470-F64637 TCGA-EJ-8470 TCGA-EJ-8470-01A M0 T2c -21209 0 1159 Scheduled Follow-up Submission Complete Remission/Response 2014-9-8 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.6 NO Bilateral 1.9 NO YES NO 21 0 No N0 T2c TCGA-EJ-8470.e53212bf-d686-4acc-8859-00cbdddd627c.pdf 8470 TUMOR FREE 4 Complete Remission/Response NO Primary Tumor 01 3 0.4 NO YES NO EJ Prostate A LIVING 2010 33f711ae-41c4-415e-8faf-3d7984c4b5cb TCGA-EJ-8470-01A-11D-2391-01 TCGA-EJ-8470-01A-11D-2399-05 TCGA-EJ-8470-01A-11D-2395-08 33f711ae-41c4-415e-8faf-3d7984c4b5cb TCGA-EJ-8470-01 TCGA-EJ-8470-01 07951FC5-7A6B-4735-B060-3FE8AA58B959 TCGA-EJ-8470-01A-11D-2391-01 33f711ae-41c4-415e-8faf-3d7984c4b5cb TCGA-EJ-8470-01 TCGA-EJ-8470-01 TCGA-EJ-8470-01A-11D-2395-08 TCGA-EJ-8470-01A-11D-2395-08 33f711ae-41c4-415e-8faf-3d7984c4b5cb +TCGA-EJ-8472-01 TCGA-EJ-8472-01 TCGA-EJ-8472 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-EJ-8472-F64638 TCGA-EJ-8472 TCGA-EJ-8472-01A YES M0 T3a -23104 196 0 756 196 Scheduled Follow-up Submission Complete Remission/Response 2014-9-8 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO 0.8 NO YES NO 12 0 No N0 T3a TCGA-EJ-8472.d45b6fd0-5e0a-4a20-ab47-c8cc1fb32c86.pdf 8472 TUMOR FREE 4 Partial Remission/Response 0.4 NO R0 Primary Tumor 01 4 0.2 NO 3 YES NO EJ Prostate A LIVING 2011 139abcca-ef3c-4520-9829-ebf4915d6b92 TCGA-EJ-8472-01A-11D-2391-01 TCGA-EJ-8472-01A-11D-2399-05 TCGA-EJ-8472-01A-11D-2395-08 139abcca-ef3c-4520-9829-ebf4915d6b92 TCGA-EJ-8472-01 TCGA-EJ-8472-01 TCGA-EJ-8472-01A-11D-2391-01 139abcca-ef3c-4520-9829-ebf4915d6b92 TCGA-EJ-8472-01 TCGA-EJ-8472-01 TCGA-EJ-8472-01A-11D-2395-08 TCGA-EJ-8472-01A-11D-2395-08 139abcca-ef3c-4520-9829-ebf4915d6b92 +TCGA-EJ-8474-01 TCGA-EJ-8474-01 TCGA-EJ-8474 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 69 TCGA-EJ-8474-F64640 TCGA-EJ-8474 TCGA-EJ-8474-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T3a -25561 51 7 0 766 766 YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2014-9-8 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 0.9 NO YES NO 15 0 No N0 T3a TCGA-EJ-8474.f68bb2bf-d38c-4d21-91cd-e714c71a6ff5.pdf 8474 TUMOR FREE 4 Complete Remission/Response 0.01 NO R0 Primary Tumor 01 4 0.3 NO YES NO EJ Prostate A LIVING 2011 1c78c6f8-4e3c-40f1-afb2-b83a316b4c1a TCGA-EJ-8474-01A-11D-2391-01 TCGA-EJ-8474-01A-11D-2399-05 TCGA-EJ-8474-01A-11D-2395-08 1c78c6f8-4e3c-40f1-afb2-b83a316b4c1a TCGA-EJ-8474-01 TCGA-EJ-8474-01 2E549886-7E39-4F40-AE00-325886B78B9E TCGA-EJ-8474-01A-11D-2391-01 1c78c6f8-4e3c-40f1-afb2-b83a316b4c1a TCGA-EJ-8474-01 TCGA-EJ-8474-01 TCGA-EJ-8474-01A-11D-2395-08 TCGA-EJ-8474-01A-11D-2395-08 1c78c6f8-4e3c-40f1-afb2-b83a316b4c1a +TCGA-EJ-A46B-01 TCGA-EJ-A46B-01 TCGA-EJ-A46B TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-EJ-A46B-F64641 TCGA-EJ-A46B TCGA-EJ-A46B-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -24305 10 114 10 0 657 157 YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2014-9-8 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 420 NO Bilateral NO YES NO 10 0 true Yes, History of Prior Malignancy N0 T3a TCGA-EJ-A46B.4B418B68-7866-45C1-8728-9D61BF5A9273.pdf A46B TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO 3 YES NO EJ Prostate A LIVING 2012 112e7329-5135-4307-bda5-d041bc04f0ea TCGA-EJ-A46B-01A-31D-A256-01 TCGA-EJ-A46B-01A-31D-A258-05 TCGA-EJ-A46B-01A-31D-A257-08 112e7329-5135-4307-bda5-d041bc04f0ea TCGA-EJ-A46B-01 TCGA-EJ-A46B-01 1BE1E342-BF2D-44B3-9A06-831B4561FA70 TCGA-EJ-A46B-01A-31D-A256-01 112e7329-5135-4307-bda5-d041bc04f0ea TCGA-EJ-A46B-01 TCGA-EJ-A46B-01 TCGA-EJ-A46B-01A-31D-A257-08 112e7329-5135-4307-bda5-d041bc04f0ea +TCGA-EJ-A46D-01 TCGA-EJ-A46D-01 TCGA-EJ-A46D TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 53 TCGA-EJ-A46D-F64643 TCGA-EJ-A46D TCGA-EJ-A46D-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2c -19466 42 181 0 626 122 Scheduled Follow-up Submission Complete Remission/Response 2014-9-8 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 940 NO Bilateral NO YES NO 6 0 true No N0 T2c TCGA-EJ-A46D.A0EF60EA-85C2-40AA-9162-E8C96748F94D.pdf A46D TUMOR FREE 3 Complete Remission/Response .03 NO Primary Tumor 01 5 NO 4 YES NO EJ Prostate A LIVING 2012 dbde3775-bbbc-4492-8449-6f04c4edc65d TCGA-EJ-A46D-01A-21D-A256-01 TCGA-EJ-A46D-01A-21D-A258-05 TCGA-EJ-A46D-01A-21D-A257-08 dbde3775-bbbc-4492-8449-6f04c4edc65d TCGA-EJ-A46D-01 TCGA-EJ-A46D-01 15A79981-3C10-431E-94BB-2F6F357BEEFF TCGA-EJ-A46D-01A-21D-A256-01 dbde3775-bbbc-4492-8449-6f04c4edc65d TCGA-EJ-A46D-01 TCGA-EJ-A46D-01 TCGA-EJ-A46D-01A-21D-A257-08 TCGA-EJ-A46D-01A-21D-A257-08 dbde3775-bbbc-4492-8449-6f04c4edc65d +TCGA-EJ-A46E-01 TCGA-EJ-A46E-01 TCGA-EJ-A46E TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-EJ-A46E-F64644 TCGA-EJ-A46E TCGA-EJ-A46E-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -21054 489 0 524 503 YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2014-9-8 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 760 NO Bilateral YES YES NO 9 0 true No N0 TCGA-EJ-A46E.F2A59B31-7CFE-4DA8-A7B7-229021357746.pdf A46E TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO EJ Prostate A LIVING 2011 369853c1-dc8d-45cc-8131-7ce625ac3020 TCGA-EJ-A46E-01A-31D-A256-01 TCGA-EJ-A46E-01A-31D-A258-05 TCGA-EJ-A46E-01A-31D-A257-08 369853c1-dc8d-45cc-8131-7ce625ac3020 TCGA-EJ-A46E-01 TCGA-EJ-A46E-01 85F7E0C3-9BA7-4C02-953E-D3AB67D54648 TCGA-EJ-A46E-01A-31D-A256-01 369853c1-dc8d-45cc-8131-7ce625ac3020 TCGA-EJ-A46E-01 TCGA-EJ-A46E-01 TCGA-EJ-A46E-01A-31D-A257-08 369853c1-dc8d-45cc-8131-7ce625ac3020 +TCGA-EJ-A46F-01 TCGA-EJ-A46F-01 TCGA-EJ-A46F TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-EJ-A46F-F64645 TCGA-EJ-A46F TCGA-EJ-A46F-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T2c -21160 166 286 166 215 0 783 215 YES Scheduled Follow-up Submission Complete Remission/Response 2014-9-8 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 580 NO Bilateral NO YES NO 23 1 true No N1 T3b TCGA-EJ-A46F.E424A7C8-4DDD-4ECC-A0B4-DF22A9996D01.pdf A46F TUMOR FREE 4 Partial Remission/Response 19.8 NO R0 Primary Tumor 01 4 NO 3 YES NO EJ Prostate A LIVING 2011 a4f08d6b-fdb9-406c-9e55-d03fa1a7ad78 TCGA-EJ-A46F-01A-31D-A256-01 TCGA-EJ-A46F-01A-31D-A258-05 TCGA-EJ-A46F-01A-31D-A257-08 a4f08d6b-fdb9-406c-9e55-d03fa1a7ad78 TCGA-EJ-A46F-01 TCGA-EJ-A46F-01 BF4BE828-8FC8-42E3-A77C-706D6AA1B3F8 TCGA-EJ-A46F-01A-31D-A256-01 a4f08d6b-fdb9-406c-9e55-d03fa1a7ad78 TCGA-EJ-A46F-01 TCGA-EJ-A46F-01 TCGA-EJ-A46F-01A-31D-A257-08 a4f08d6b-fdb9-406c-9e55-d03fa1a7ad78 +TCGA-EJ-A46G-01 TCGA-EJ-A46G-01 TCGA-EJ-A46G TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 71 TCGA-EJ-A46G-F64646 TCGA-EJ-A46G TCGA-EJ-A46G-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T3a -26219 28 219 0 668 93 Scheduled Follow-up Submission Complete Remission/Response 2014-9-8 MALE 8 Prostate Adenocarcinoma, Other Subtype No C61 8500/3 C61.9 YES Core needle biopsy 430 NO Bilateral NO YES NO 17 0 true Yes, History of Prior Malignancy N0 T3a TCGA-EJ-A46G.ACBA1CE1-E248-47D3-B03D-BE0C1B4A6F21.pdf A46G TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO 5 YES NO EJ Prostate A LIVING 2012 db968587-1271-4b4a-8195-f17a06085ae5 TCGA-EJ-A46G-01A-31D-A26L-01 TCGA-EJ-A46G-01A-31D-A26N-05 TCGA-EJ-A46G-01A-31D-A26M-08 db968587-1271-4b4a-8195-f17a06085ae5 TCGA-EJ-A46G-01 TCGA-EJ-A46G-01 DE0677A3-E5C4-42C4-8A19-C69F4269939D TCGA-EJ-A46G-01A-31D-A26L-01 db968587-1271-4b4a-8195-f17a06085ae5 TCGA-EJ-A46G-01 TCGA-EJ-A46G-01 TCGA-EJ-A46G-01A-31D-A26M-08 TCGA-EJ-A46G-01A-31D-A26M-08 db968587-1271-4b4a-8195-f17a06085ae5 +TCGA-EJ-A46H-01 TCGA-EJ-A46H-01 TCGA-EJ-A46H TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-EJ-A46H-F64713 TCGA-EJ-A46H NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -22059 -6 0 724 131 Scheduled Follow-up Submission Complete Remission/Response 2014-9-10 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 6 No N0 T2c A46H TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO EJ Prostate LIVING 2012 da936a2e-af10-4496-8fa7-00742c30c766 TCGA-EJ-A46H-01A-31D-A26L-01 TCGA-EJ-A46H-01A-31D-A26N-05 TCGA-EJ-A46H-01A-31D-A26M-08 da936a2e-af10-4496-8fa7-00742c30c766 TCGA-EJ-A46H-01 TCGA-EJ-A46H-01 TCGA-EJ-A46H-01A-31D-A26L-01 da936a2e-af10-4496-8fa7-00742c30c766 TCGA-EJ-A46H-01 TCGA-EJ-A46H-01 TCGA-EJ-A46H-01A-31D-A26M-08 da936a2e-af10-4496-8fa7-00742c30c766 +TCGA-EJ-A46I-01 TCGA-EJ-A46I-01 TCGA-EJ-A46I TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-EJ-A46I-F64714 TCGA-EJ-A46I TCGA-EJ-A46I-01A NO M0 T1c -21046 520 0 668 484 Scheduled Follow-up Submission Complete Remission/Response 2014-9-10 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES 150 NO Bilateral NO NO true No N0 T3a TCGA-EJ-A46I.741CC282-0593-45E4-BEEB-343339F891AA.pdf A46I TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO EJ Prostate A LIVING 2011 7c901d39-8b22-4fc7-8995-2511507b741e TCGA-EJ-A46I-01A-12D-A26L-01 TCGA-EJ-A46I-01A-12D-A26N-05 TCGA-EJ-A46I-01A-12D-A26M-08 7c901d39-8b22-4fc7-8995-2511507b741e TCGA-EJ-A46I-01 TCGA-EJ-A46I-01 TCGA-EJ-A46I-01A-12D-A26L-01 7c901d39-8b22-4fc7-8995-2511507b741e TCGA-EJ-A46I-01 TCGA-EJ-A46I-01 TCGA-EJ-A46I-01A-12D-A26M-08 TCGA-EJ-A46I-01A-12D-A26M-08 7c901d39-8b22-4fc7-8995-2511507b741e +TCGA-EJ-A65B-01 TCGA-EJ-A65B-01 TCGA-EJ-A65B TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-EJ-A65B-F64715 TCGA-EJ-A65B TCGA-EJ-A65B-01A NO M0 T3b -20204 359 0 710 536 Scheduled Follow-up Submission Complete Remission/Response 2014-9-10 MALE 9 Prostate Adenocarcinoma, Other Subtype No C61 8255/3 C61.9 YES Core needle biopsy 300 NO NO YES NO 13 0 true No N0 T3b TCGA-EJ-A65B.007E056B-1675-4639-9978-05C7EDEA1D74.pdf A65B TUMOR FREE 4 Complete Remission/Response .01 NO R1 Primary Tumor 01 5 NO YES NO EJ Prostate A LIVING 2012 55753ec3-4f9f-439b-908f-43e4053ca8cb TCGA-EJ-A65B-01A-12D-A30D-01 TCGA-EJ-A65B-01A-12D-A30F-05 TCGA-EJ-A65B-01A-12D-A30E-08 55753ec3-4f9f-439b-908f-43e4053ca8cb TCGA-EJ-A65B-01 TCGA-EJ-A65B-01 1BBABA32-99D6-4A4F-A64E-8958B9C4D334 TCGA-EJ-A65B-01A-12D-A30D-01 55753ec3-4f9f-439b-908f-43e4053ca8cb TCGA-EJ-A65B-01 TCGA-EJ-A65B-01 TCGA-EJ-A65B-01A-12D-A30E-08 55753ec3-4f9f-439b-908f-43e4053ca8cb +TCGA-EJ-A65D-01 TCGA-EJ-A65D-01 TCGA-EJ-A65D TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-EJ-A65D-F64716 TCGA-EJ-A65D TCGA-EJ-A65D-01A NO M0 T3a -24297 240 0 393 393 Scheduled Follow-up Submission Complete Remission/Response 2014-9-10 MALE 8 Prostate Adenocarcinoma, Other Subtype No C61 8500/3 C61.9 YES Core needle biopsy 270 NO Bilateral NO YES NO 34 0 true No N0 T3a TCGA-EJ-A65D.AD3DEFE9-4977-4334-A197-159F043C92A6.pdf A65D TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO EJ Prostate A LIVING 2012 6f5b0c12-0853-49c8-8421-58faa14b3955 TCGA-EJ-A65D-01A-11D-A30D-01 TCGA-EJ-A65D-01A-11D-A30F-05 TCGA-EJ-A65D-01A-11D-A30E-08 6f5b0c12-0853-49c8-8421-58faa14b3955 TCGA-EJ-A65D-01 TCGA-EJ-A65D-01 9F6C59B3-93D2-4CAA-861D-F503D1A23F61 TCGA-EJ-A65D-01A-11D-A30D-01 6f5b0c12-0853-49c8-8421-58faa14b3955 TCGA-EJ-A65D-01 TCGA-EJ-A65D-01 TCGA-EJ-A65D-01A-11D-A30E-08 6f5b0c12-0853-49c8-8421-58faa14b3955 +TCGA-EJ-A65E-01 TCGA-EJ-A65E-01 TCGA-EJ-A65E TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-EJ-A65E-F64717 TCGA-EJ-A65E TCGA-EJ-A65E-01A NO M0 T3b -24558 289 0 417 254 Scheduled Follow-up Submission Complete Remission/Response 2014-9-10 MALE 7 Prostate Adenocarcinoma, Other Subtype No C61 8255/3 C61.9 YES Core needle biopsy 240 NO Bilateral NO YES NO 23 0 true No N0 T3b TCGA-EJ-A65E.4B502278-393D-4B65-A424-B795547938ED.pdf A65E TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 NO YES NO EJ Prostate A LIVING 2012 d28ba0e6-a04b-4341-95c2-f03b6d894a5e TCGA-EJ-A65E-01A-11D-A323-01 TCGA-EJ-A65E-01A-11D-A29T-05 TCGA-EJ-A65E-01A-11D-A29Q-08 d28ba0e6-a04b-4341-95c2-f03b6d894a5e TCGA-EJ-A65E-01 TCGA-EJ-A65E-01 A9C1464F-B927-426E-A862-EDCEC264C79E TCGA-EJ-A65E-01A-11D-A323-01 d28ba0e6-a04b-4341-95c2-f03b6d894a5e TCGA-EJ-A65E-01 TCGA-EJ-A65E-01 TCGA-EJ-A65E-01A-11D-A29Q-08 TCGA-EJ-A65E-01A-11D-A29Q-08 d28ba0e6-a04b-4341-95c2-f03b6d894a5e +TCGA-EJ-A65F-01 TCGA-EJ-A65F-01 TCGA-EJ-A65F TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES 59 TCGA-EJ-A65F-F64718 TCGA-EJ-A65F TCGA-EJ-A65F-01A YES M0 T3b -21681 293 75 0 560 75 Scheduled Follow-up Submission Complete Remission/Response 2014-9-10 MALE 9 Prostate Adenocarcinoma, Other Subtype No C61 8255/3 C61.9 YES Core needle biopsy 360 NO Bilateral NO YES NO 4 0 true No N0 T3b TCGA-EJ-A65F.635A6F68-B3A7-4856-BE21-C2DC0AADAA59.pdf A65F TUMOR FREE 4 Complete Remission/Response 0.8 YES R0 Primary Tumor 01 5 NO YES NO EJ Prostate A LIVING 2012 3479eef9-e120-4723-b333-cd4623de6499 TCGA-EJ-A65F-01A-21D-A30W-01 TCGA-EJ-A65F-01A-21D-A30Z-05 TCGA-EJ-A65F-01A-21D-A30X-08 3479eef9-e120-4723-b333-cd4623de6499 TCGA-EJ-A65F-01 TCGA-EJ-A65F-01 B82CB5F3-1C0A-4993-8A5B-AE41FE7168A2 TCGA-EJ-A65F-01A-21D-A30W-01 3479eef9-e120-4723-b333-cd4623de6499 TCGA-EJ-A65F-01 TCGA-EJ-A65F-01 TCGA-EJ-A65F-01A-21D-A30X-08 TCGA-EJ-A65F-01A-21D-A30X-08 3479eef9-e120-4723-b333-cd4623de6499 +TCGA-EJ-A65G-01 TCGA-EJ-A65G-01 TCGA-EJ-A65G TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-EJ-A65G-F64719 TCGA-EJ-A65G TCGA-EJ-A65G-01A NO M0 T2c -20821 299 0 666 152 Scheduled Follow-up Submission Complete Remission/Response 2014-9-10 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Transurethral resection (TURBT) 140 NO Bilateral NO YES NO 24 0 true No N0 T2c TCGA-EJ-A65G.A04673B5-5B72-4D0F-B12A-BC2663A2855B.pdf A65G TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 5 NO YES NO EJ Prostate A LIVING 2012 32e41154-dbcb-474c-8605-67c0ae0ed85e TCGA-EJ-A65G-01A-21D-A323-01 TCGA-EJ-A65G-01A-21D-A29T-05 TCGA-EJ-A65G-01A-21D-A29Q-08 32e41154-dbcb-474c-8605-67c0ae0ed85e TCGA-EJ-A65G-01 TCGA-EJ-A65G-01 TCGA-EJ-A65G-01A-21D-A323-01 32e41154-dbcb-474c-8605-67c0ae0ed85e TCGA-EJ-A65G-01 TCGA-EJ-A65G-01 TCGA-EJ-A65G-01A-21D-A29Q-08 TCGA-EJ-A65G-01A-21D-A29Q-08 32e41154-dbcb-474c-8605-67c0ae0ed85e +TCGA-EJ-A65J-01 TCGA-EJ-A65J-01 TCGA-EJ-A65J TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-EJ-A65J-F64720 TCGA-EJ-A65J TCGA-EJ-A65J-01A NO M0 T3a -22904 218 0 451 91 Scheduled Follow-up Submission Complete Remission/Response 2014-9-10 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 970 NO Bilateral NO YES NO 11 0 true Yes, History of Prior Malignancy N0 T3a TCGA-EJ-A65J.DBB16691-F1A8-40B8-99E7-FB206B3B680C.pdf A65J TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 5 NO YES NO EJ Prostate A LIVING 2012 3be6c54c-f606-4eba-8242-8dff705fa2d0 TCGA-EJ-A65J-01A-11D-A30W-01 TCGA-EJ-A65J-01A-11D-A30Z-05 TCGA-EJ-A65J-01A-11D-A30X-08 3be6c54c-f606-4eba-8242-8dff705fa2d0 TCGA-EJ-A65J-01 TCGA-EJ-A65J-01 28242B19-CD4F-4829-A3AF-2FDB30A11DCC TCGA-EJ-A65J-01A-11D-A30W-01 3be6c54c-f606-4eba-8242-8dff705fa2d0 TCGA-EJ-A65J-01 TCGA-EJ-A65J-01 TCGA-EJ-A65J-01A-11D-A30X-08 TCGA-EJ-A65J-01A-11D-A30X-08 3be6c54c-f606-4eba-8242-8dff705fa2d0 +TCGA-EJ-A65M-01 TCGA-EJ-A65M-01 TCGA-EJ-A65M TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-EJ-A65M-F64721 TCGA-EJ-A65M TCGA-EJ-A65M-01A NO M0 T2c -23767 69 0 230 230 Scheduled Follow-up Submission Complete Remission/Response 2014-9-10 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Transurethral resection (TURBT) 340 NO Bilateral NO YES NO 30 0 true No N0 T2c TCGA-EJ-A65M.E0FB271C-8BC6-43FB-BE90-85A28009D962.pdf A65M TUMOR FREE 3 Complete Remission/Response 0.1 NO Primary Tumor 01 3 NO YES NO EJ Prostate A LIVING 2013 9d16eccb-44fa-4188-9ad2-3a17ed821247 TCGA-EJ-A65M-01A-11D-A323-01 TCGA-EJ-A65M-01A-11D-A29T-05 TCGA-EJ-A65M-01A-11D-A29Q-08 9d16eccb-44fa-4188-9ad2-3a17ed821247 TCGA-EJ-A65M-01 TCGA-EJ-A65M-01 7F4408EE-6B45-4B45-95B9-887D81BE65ED TCGA-EJ-A65M-01A-11D-A323-01 9d16eccb-44fa-4188-9ad2-3a17ed821247 TCGA-EJ-A65M-01 TCGA-EJ-A65M-01 TCGA-EJ-A65M-01A-11D-A29Q-08 9d16eccb-44fa-4188-9ad2-3a17ed821247 +TCGA-EJ-A6RA-01 TCGA-EJ-A6RA-01 TCGA-EJ-A6RA TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 70 TCGA-EJ-A6RA-F64722 TCGA-EJ-A6RA TCGA-EJ-A6RA-01A YES M0 T3b -25679 213 353 0 353 353 Scheduled Follow-up Submission Complete Remission/Response 2014-9-10 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 250 NO Bilateral NO YES NO 18 1 true No N1 T3b TCGA-EJ-A6RA.556DE138-DE44-471D-94ED-CB755E3221C2.pdf A6RA TUMOR FREE 4 Complete Remission/Response 0.652 NO R0 Primary Tumor 01 4 NO YES NO EJ Prostate A LIVING 2012 ae29efe9-4446-4f0a-b765-f04e3935d7a8 TCGA-EJ-A6RA-01A-11D-A33S-01 TCGA-EJ-A6RA-01A-11D-A33U-05 TCGA-EJ-A6RA-01A-11D-A33T-08 ae29efe9-4446-4f0a-b765-f04e3935d7a8 TCGA-EJ-A6RA-01 TCGA-EJ-A6RA-01 F5E509C5-BC34-48C6-8A6C-1FF0E6AB35EB TCGA-EJ-A6RA-01A-11D-A33S-01 ae29efe9-4446-4f0a-b765-f04e3935d7a8 TCGA-EJ-A6RA-01 TCGA-EJ-A6RA-01 TCGA-EJ-A6RA-01A-11D-A33T-08 ae29efe9-4446-4f0a-b765-f04e3935d7a8 +TCGA-EJ-A6RC-01 TCGA-EJ-A6RC-01 TCGA-EJ-A6RC TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 64 TCGA-EJ-A6RC-F64723 TCGA-EJ-A6RC TCGA-EJ-A6RC-01A NO M0 T1c -23598 631 0 873 693 Scheduled Follow-up Submission Complete Remission/Response 2014-9-10 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Transurethral resection (TURBT) 450 NO Bilateral NO YES NO 38 0 true Yes, History of Prior Malignancy N0 TCGA-EJ-A6RC.3DB930C6-0B64-4FBF-8BB8-5FA4EBC122CA.pdf A6RC TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 NO YES NO EJ Prostate A LIVING 2011 ea34e227-a427-42a6-9f42-80069e972764 TCGA-EJ-A6RC-01A-11D-A32A-01 TCGA-EJ-A6RC-01A-11D-A32C-05 TCGA-EJ-A6RC-01A-11D-A32B-08 ea34e227-a427-42a6-9f42-80069e972764 TCGA-EJ-A6RC-01 TCGA-EJ-A6RC-01 6A0937DE-EB47-4357-8115-729EB785BEE9 TCGA-EJ-A6RC-01A-11D-A32A-01 ea34e227-a427-42a6-9f42-80069e972764 TCGA-EJ-A6RC-01 TCGA-EJ-A6RC-01 TCGA-EJ-A6RC-01A-11D-A32B-08 ea34e227-a427-42a6-9f42-80069e972764 +TCGA-EJ-A7NF-01 TCGA-EJ-A7NF-01 TCGA-EJ-A7NF TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 56 TCGA-EJ-A7NF-F64724 TCGA-EJ-A7NF TCGA-EJ-A7NF-01A NO M0 T2c -20587 195 0 250 117 Scheduled Follow-up Submission Complete Remission/Response 2014-9-10 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Transurethral resection (TURBT) 150 NO Bilateral NO YES NO 29 0 true No N0 T2c TCGA-EJ-A7NF.1487F0B2-58BB-41C3-B23F-F51676796AA7.pdf A7NF TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO EJ Prostate A LIVING 2013 d94972a7-535d-4bb8-b221-d3c22a120d01 TCGA-EJ-A7NF-01A-11D-A33S-01 TCGA-EJ-A7NF-01A-11D-A33U-05 TCGA-EJ-A7NF-01A-11D-A33T-08 d94972a7-535d-4bb8-b221-d3c22a120d01 TCGA-EJ-A7NF-01 TCGA-EJ-A7NF-01 23E96E8D-9AD1-457D-A617-0D3DE4600803 TCGA-EJ-A7NF-01A-11D-A33S-01 d94972a7-535d-4bb8-b221-d3c22a120d01 TCGA-EJ-A7NF-01 TCGA-EJ-A7NF-01 TCGA-EJ-A7NF-01A-11D-A33T-08 d94972a7-535d-4bb8-b221-d3c22a120d01 +TCGA-EJ-A7NG-01 TCGA-EJ-A7NG-01 TCGA-EJ-A7NG TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-EJ-A7NG-F64725 TCGA-EJ-A7NG TCGA-EJ-A7NG-01A NO M0 T3a -23458 209 0 432 264 Scheduled Follow-up Submission Complete Remission/Response 2014-9-10 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 300 NO Bilateral NO YES NO 6 0 true No N0 T3a TCGA-EJ-A7NG.05993405-656B-4DB6-98BC-8359E16AC6AB.pdf A7NG TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO EJ Prostate A LIVING 2013 06c95ac2-2f97-4200-9a29-a3ff8cce8697 TCGA-EJ-A7NG-01A-31D-A33S-01 TCGA-EJ-A7NG-01A-31D-A33U-05 TCGA-EJ-A7NG-01A-31D-A33T-08 06c95ac2-2f97-4200-9a29-a3ff8cce8697 TCGA-EJ-A7NG-01 TCGA-EJ-A7NG-01 8BF5A499-EE3C-440E-BDF2-8C9D8C239A49 TCGA-EJ-A7NG-01A-31D-A33S-01 06c95ac2-2f97-4200-9a29-a3ff8cce8697 TCGA-EJ-A7NG-01 TCGA-EJ-A7NG-01 TCGA-EJ-A7NG-01A-31D-A33T-08 06c95ac2-2f97-4200-9a29-a3ff8cce8697 +TCGA-EJ-A7NH-01 TCGA-EJ-A7NH-01 TCGA-EJ-A7NH TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 56 TCGA-EJ-A7NH-F64726 TCGA-EJ-A7NH TCGA-EJ-A7NH-01A NO M0 T2c -20734 230 0 474 105 Scheduled Follow-up Submission Complete Remission/Response 2014-9-10 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 210 NO Bilateral NO YES NO 4 true No N0 T2c TCGA-EJ-A7NH.87E5A9C3-9C6F-4452-9D52-FAD4F7FC66C1.pdf A7NH TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO EJ Prostate A LIVING 2013 a4e4f617-d329-4c8f-8cbd-f6111c427f71 TCGA-EJ-A7NH-01A-12D-A33S-01 TCGA-EJ-A7NH-01A-12D-A33U-05 TCGA-EJ-A7NH-01A-12D-A33T-08 a4e4f617-d329-4c8f-8cbd-f6111c427f71 TCGA-EJ-A7NH-01 TCGA-EJ-A7NH-01 778F2F34-4266-4338-A5B0-F3C745CFCE84 TCGA-EJ-A7NH-01A-12D-A33S-01 a4e4f617-d329-4c8f-8cbd-f6111c427f71 TCGA-EJ-A7NH-01 TCGA-EJ-A7NH-01 TCGA-EJ-A7NH-01A-12D-A33T-08 a4e4f617-d329-4c8f-8cbd-f6111c427f71 +TCGA-EJ-A7NJ-01 TCGA-EJ-A7NJ-01 TCGA-EJ-A7NJ TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-EJ-A7NJ-F64727 TCGA-EJ-A7NJ TCGA-EJ-A7NJ-01A NO M0 T2c -21748 211 0 197 92 Scheduled Follow-up Submission Complete Remission/Response 2014-9-10 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 250 NO Bilateral NO YES NO 16 0 true No N0 T2c TCGA-EJ-A7NJ.B6D55BEF-A9C3-4092-AE17-FB6790EC65AD.pdf A7NJ TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO EJ Prostate A LIVING 2013 1f891baf-2b98-4c2f-8f5f-799018220513 TCGA-EJ-A7NJ-01A-22D-A34T-01 TCGA-EJ-A7NJ-01A-22D-A34V-05 TCGA-EJ-A7NJ-01A-22D-A34U-08 1f891baf-2b98-4c2f-8f5f-799018220513 TCGA-EJ-A7NJ-01 TCGA-EJ-A7NJ-01 825423E3-4CC3-4082-80B6-234E46E852A5 TCGA-EJ-A7NJ-01A-22D-A34T-01 1f891baf-2b98-4c2f-8f5f-799018220513 TCGA-EJ-A7NJ-01 TCGA-EJ-A7NJ-01 TCGA-EJ-A7NJ-01A-22D-A34U-08 1f891baf-2b98-4c2f-8f5f-799018220513 +TCGA-EJ-A7NK-01 TCGA-EJ-A7NK-01 TCGA-EJ-A7NK TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 58 TCGA-EJ-A7NK-F64761 TCGA-EJ-A7NK TCGA-EJ-A7NK-01A NO M0 T3a -21530 254 0 476 295 Scheduled Follow-up Submission Complete Remission/Response 2014-9-10 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Transurethral resection (TURBT) 140 NO Bilateral NO YES NO 48 0 true No N0 T3a TCGA-EJ-A7NK.E1362D2A-6ED3-4BA3-A92D-63C5024946A6.pdf A7NK TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO EJ Prostate A LIVING 2012 107d849f-0497-4daa-bd4e-d82570909838 TCGA-EJ-A7NK-01A-12D-A34T-01 TCGA-EJ-A7NK-01A-12D-A34V-05 TCGA-EJ-A7NK-01A-12D-A34U-08 107d849f-0497-4daa-bd4e-d82570909838 TCGA-EJ-A7NK-01 TCGA-EJ-A7NK-01 6377B90F-C552-45B6-B84D-D757F51A1C00 TCGA-EJ-A7NK-01A-12D-A34T-01 107d849f-0497-4daa-bd4e-d82570909838 TCGA-EJ-A7NK-01 TCGA-EJ-A7NK-01 TCGA-EJ-A7NK-01A-12D-A34U-08 107d849f-0497-4daa-bd4e-d82570909838 +TCGA-EJ-A7NM-01 TCGA-EJ-A7NM-01 TCGA-EJ-A7NM TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-EJ-A7NM-F64762 TCGA-EJ-A7NM TCGA-EJ-A7NM-01A NO M0 T3b -23603 115 0 128 128 Scheduled Follow-up Submission Complete Remission/Response 2014-9-10 MALE 9 Prostate Adenocarcinoma, Other Subtype No C61 8500/3 C61.9 YES Core needle biopsy 410 NO Bilateral NO YES NO 29 3 true No N1 T3b TCGA-EJ-A7NM.D7D49539-80E3-4A37-BEEB-FA75951947F8.pdf A7NM TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 5 NO YES NO EJ Prostate A LIVING 2013 e311b8ad-1c32-4ccc-8e42-f7a8bae8b7d9 TCGA-EJ-A7NM-01A-21D-A33S-01 TCGA-EJ-A7NM-01A-21D-A33U-05 TCGA-EJ-A7NM-01A-21D-A33T-08 e311b8ad-1c32-4ccc-8e42-f7a8bae8b7d9 TCGA-EJ-A7NM-01 TCGA-EJ-A7NM-01 BAEA99A1-A645-4D7C-97F1-137E6CEB9038 TCGA-EJ-A7NM-01A-21D-A33S-01 e311b8ad-1c32-4ccc-8e42-f7a8bae8b7d9 TCGA-EJ-A7NM-01 TCGA-EJ-A7NM-01 TCGA-EJ-A7NM-01A-21D-A33T-08 e311b8ad-1c32-4ccc-8e42-f7a8bae8b7d9 +TCGA-EJ-A7NN-01 TCGA-EJ-A7NN-01 TCGA-EJ-A7NN TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-EJ-A7NN-F64763 TCGA-EJ-A7NN TCGA-EJ-A7NN-01A YES M0 T3b -22499 191 197 0 197 197 Scheduled Follow-up Submission Complete Remission/Response 2014-9-10 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 240 NO Bilateral NO YES NO 25 3 true No N1 T3b TCGA-EJ-A7NN.4027496E-5E84-4502-BD86-980339AD9896.pdf A7NN TUMOR FREE 4 Complete Remission/Response 0.3 NO R1 Primary Tumor 01 3 NO YES NO EJ Prostate A LIVING 2013 f46d3930-be89-420e-b0b7-ffad2c8149e7 TCGA-EJ-A7NN-01A-11D-A33U-05 TCGA-EJ-A7NN-01A-11D-A33T-08 f46d3930-be89-420e-b0b7-ffad2c8149e7 TCGA-EJ-A7NN-01 TCGA-EJ-A7NN-01 7B1E4C11-AF47-425F-909D-E10AC1CBE6FD f46d3930-be89-420e-b0b7-ffad2c8149e7 TCGA-EJ-A7NN-01 f46d3930-be89-420e-b0b7-ffad2c8149e7 +TCGA-EJ-A8FN-01 TCGA-EJ-A8FN-01 TCGA-EJ-A8FN TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 58 TCGA-EJ-A8FN-F64780 TCGA-EJ-A8FN TCGA-EJ-A8FN-01A NO M0 T2c -21506 203 0 329 203 Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 330 NO Bilateral NO YES NO 25 0 true No N0 T2c TCGA-EJ-A8FN.FCAC56D3-5775-4A05-A739-108C8FBC9FD8.pdf A8FN TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO EJ Prostate A LIVING 2013 0984a482-7559-48b4-a09d-d95f78816f23 TCGA-EJ-A8FN-01A-11D-A34T-01 TCGA-EJ-A8FN-01A-11D-A34V-05 TCGA-EJ-A8FN-01A-11D-A34U-08 0984a482-7559-48b4-a09d-d95f78816f23 TCGA-EJ-A8FN-01 TCGA-EJ-A8FN-01 F1611C3D-6100-471B-859C-40E31E3888E3 TCGA-EJ-A8FN-01A-11D-A34T-01 0984a482-7559-48b4-a09d-d95f78816f23 TCGA-EJ-A8FN-01 TCGA-EJ-A8FN-01 TCGA-EJ-A8FN-01A-11D-A34U-08 0984a482-7559-48b4-a09d-d95f78816f23 +TCGA-EJ-A8FO-01 TCGA-EJ-A8FO-01 TCGA-EJ-A8FO TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 51 TCGA-EJ-A8FO-F64781 TCGA-EJ-A8FO TCGA-EJ-A8FO-01A NO M0 T3a -18875 177 0 282 156 Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma, Other Subtype No C61 8500/3 C61.9 YES Core needle biopsy 240 NO Bilateral NO YES NO 37 0 true No N0 T3a TCGA-EJ-A8FO.72728A33-3CFC-43B5-B88C-B2DC34C83207.pdf A8FO TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 NO YES NO EJ Prostate A LIVING 2013 56336ee0-a1f8-4426-adec-b1c92d96891f TCGA-EJ-A8FO-01A-21D-A363-01 TCGA-EJ-A8FO-01A-21D-A365-05 TCGA-EJ-A8FO-01A-21D-A364-08 56336ee0-a1f8-4426-adec-b1c92d96891f TCGA-EJ-A8FO-01 TCGA-EJ-A8FO-01 FDF37A07-FD07-4BA1-AF95-1A9DBCB40159 TCGA-EJ-A8FO-01A-21D-A363-01 56336ee0-a1f8-4426-adec-b1c92d96891f TCGA-EJ-A8FO-01 TCGA-EJ-A8FO-01 56336ee0-a1f8-4426-adec-b1c92d96891f +TCGA-EJ-A8FO-11 TCGA-EJ-A8FO-11 TCGA-EJ-A8FO TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 51 TCGA-EJ-A8FO-F64781 TCGA-EJ-A8FO NO M0 T3a -18875 0 282 156 Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma, Other Subtype No C61 8500/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 37 0 No N0 T3a A8FO TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 3 NO YES NO EJ Prostate LIVING 2013 edeacf74-688e-4996-868e-e78277d17415 edeacf74-688e-4996-868e-e78277d17415 TCGA-EJ-A8FO-11 edeacf74-688e-4996-868e-e78277d17415 TCGA-EJ-A8FO-11 edeacf74-688e-4996-868e-e78277d17415 +TCGA-EJ-A8FP-01 TCGA-EJ-A8FP-01 TCGA-EJ-A8FP TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 59 TCGA-EJ-A8FP-F64784 TCGA-EJ-A8FP YES M0 T2c -21769 117 0 299 117 Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 8 Prostate Adenocarcinoma, Other Subtype No C61 8500/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 40 0 No N0 T2c A8FP TUMOR FREE 3 Complete Remission/Response 0.2 NO R0 Primary Tumor 01 5 NO YES NO EJ Prostate LIVING 2013 b9ec6c3f-9801-4c81-9c80-fabc85306c31 TCGA-EJ-A8FP-01A-21D-A363-01 TCGA-EJ-A8FP-01A-21D-A365-05 TCGA-EJ-A8FP-01A-21D-A364-08 b9ec6c3f-9801-4c81-9c80-fabc85306c31 TCGA-EJ-A8FP-01 TCGA-EJ-A8FP-01 TCGA-EJ-A8FP-01A-21D-A363-01 b9ec6c3f-9801-4c81-9c80-fabc85306c31 TCGA-EJ-A8FP-01 TCGA-EJ-A8FP-01 b9ec6c3f-9801-4c81-9c80-fabc85306c31 +TCGA-EJ-A8FS-01 TCGA-EJ-A8FS-01 TCGA-EJ-A8FS TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-EJ-A8FS-F64787 TCGA-EJ-A8FS TCGA-EJ-A8FS-01A YES M0 T3a -24380 126 216 0 266 216 Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Transurethral resection (TURBT) 130 NO Bilateral NO YES NO 69 0 true No N0 T3a TCGA-EJ-A8FS.18FF4FBA-0D6B-44D5-B5B5-68CD8DADF716.pdf A8FS TUMOR FREE 3 Complete Remission/Response 0.3 NO R0 Primary Tumor 01 4 NO YES NO EJ Prostate A LIVING 2013 b31f1e9a-cc4d-4e17-ab88-d88e234df83d TCGA-EJ-A8FS-01A-11D-A34T-01 TCGA-EJ-A8FS-01A-11D-A34V-05 TCGA-EJ-A8FS-01A-11D-A34U-08 b31f1e9a-cc4d-4e17-ab88-d88e234df83d TCGA-EJ-A8FS-01 TCGA-EJ-A8FS-01 CEEB54AF-A48E-4549-B69A-3A1A8FEC2C37 TCGA-EJ-A8FS-01A-11D-A34T-01 b31f1e9a-cc4d-4e17-ab88-d88e234df83d TCGA-EJ-A8FS-01 TCGA-EJ-A8FS-01 TCGA-EJ-A8FS-01A-11D-A34U-08 b31f1e9a-cc4d-4e17-ab88-d88e234df83d +TCGA-EJ-A8FU-01 TCGA-EJ-A8FU-01 TCGA-EJ-A8FU TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-EJ-A8FU-F64788 TCGA-EJ-A8FU TCGA-EJ-A8FU-01A M0 T3a -23472 89 0 138 Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 210 NO Bilateral NO YES NO 29 0 true No N0 T3a TCGA-EJ-A8FU.613A9A17-E6E6-4A15-A06A-FB3D91D7459A.pdf A8FU TUMOR FREE 5 Complete Remission/Response NO R0 Primary Tumor 01 3 NO YES NO EJ Prostate A LIVING 2013 7adcdf73-3ad3-4da7-ab27-2888f1d4f53a TCGA-EJ-A8FU-01A-11D-A363-01 TCGA-EJ-A8FU-01A-11D-A365-05 TCGA-EJ-A8FU-01A-11D-A364-08 7adcdf73-3ad3-4da7-ab27-2888f1d4f53a TCGA-EJ-A8FU-01 TCGA-EJ-A8FU-01 48A36EB4-79FB-45E7-8BB1-0FA1D5FCDA2C TCGA-EJ-A8FU-01A-11D-A363-01 7adcdf73-3ad3-4da7-ab27-2888f1d4f53a TCGA-EJ-A8FU-01 TCGA-EJ-A8FU-01 TCGA-EJ-A8FU-01A-11D-A364-08 7adcdf73-3ad3-4da7-ab27-2888f1d4f53a +TCGA-EJ-AB20-01 TCGA-EJ-AB20-01 TCGA-EJ-AB20 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-EJ-AB20-F64790 TCGA-EJ-AB20 TCGA-EJ-AB20-01A NO M0 T2c -22626 136 0 131 131 Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 180 NO Bilateral NO YES NO 18 0 true No N0 T2c TCGA-EJ-AB20.C1D97704-7C64-4C39-8812-BD8B95C2299F.pdf AB20 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 NO YES NO EJ Prostate A LIVING 2013 4e640b86-66f7-458c-af5c-b195778aa295 TCGA-EJ-AB20-01A-12D-A41J-01 TCGA-EJ-AB20-01A-12D-A41L-05 TCGA-EJ-AB20-01A-12D-A41K-08 4e640b86-66f7-458c-af5c-b195778aa295 TCGA-EJ-AB20-01 TCGA-EJ-AB20-01 44B3263E-DF68-4D34-A432-90A0A37198BF TCGA-EJ-AB20-01A-12D-A41J-01 4e640b86-66f7-458c-af5c-b195778aa295 TCGA-EJ-AB20-01 TCGA-EJ-AB20-01 4e640b86-66f7-458c-af5c-b195778aa295 +TCGA-EJ-AB27-01 TCGA-EJ-AB27-01 TCGA-EJ-AB27 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 51 TCGA-EJ-AB27-F64798 TCGA-EJ-AB27 TCGA-EJ-AB27-01A NO M0 T1c -18648 130 0 145 145 Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 490 NO Bilateral NO YES NO 15 0 true No N0 T2c TCGA-EJ-AB27.83FBE69E-525B-4833-BD10-AE4360BFF925.pdf AB27 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 NO YES NO EJ Prostate A LIVING 2013 7ea62df0-1cc5-4bd9-ad9e-3d68aa965731 TCGA-EJ-AB27-01A-11D-A41J-01 TCGA-EJ-AB27-01A-11D-A41L-05 TCGA-EJ-AB27-01A-11D-A41K-08 7ea62df0-1cc5-4bd9-ad9e-3d68aa965731 TCGA-EJ-AB27-01 TCGA-EJ-AB27-01 409CD05B-3C7C-47EF-91CD-F3D730230A79 TCGA-EJ-AB27-01A-11D-A41J-01 7ea62df0-1cc5-4bd9-ad9e-3d68aa965731 TCGA-EJ-AB27-01 TCGA-EJ-AB27-01 7ea62df0-1cc5-4bd9-ad9e-3d68aa965731 +TCGA-FC-7708-01 TCGA-FC-7708-01 TCGA-FC-7708 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 52 TCGA-FC-7708-F55508 TCGA-FC-7708 TCGA-FC-7708-01A NO M0 T1c -19144 0 864 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-1-8 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.9 NO Bilateral 1.3 YES YES NO 4 0 No N0 T3a TCGA-FC-7708.da17eddc-be95-4387-9c6a-fa647f33ceb7.pdf 7708 TUMOR FREE 4 Complete Remission/Response NO RX Primary Tumor 01 3 0.2 NO YES NO FC Apex|Middle Prostate A LIVING 2011 Overlapping / Multiple Zones 39239ac6-7757-43ca-928a-4885260ecbc7 TCGA-FC-7708-01A-11D-2112-01 TCGA-FC-7708-01A-11D-2116-05 TCGA-FC-7708-01A-11D-2114-08 39239ac6-7757-43ca-928a-4885260ecbc7 TCGA-FC-7708-01 TCGA-FC-7708-01 AD6852A9-511A-4380-80DD-ACEC1139B9E9 TCGA-FC-7708-01A-11D-2112-01 39239ac6-7757-43ca-928a-4885260ecbc7 TCGA-FC-7708-01 TCGA-FC-7708-01 TCGA-FC-7708-01A-11D-2114-08 TCGA-FC-7708-01A-11D-2114-08 39239ac6-7757-43ca-928a-4885260ecbc7 +TCGA-FC-7961-01 TCGA-FC-7961-01 TCGA-FC-7961 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-FC-7961-F33190 TCGA-FC-7961 TCGA-FC-7961-01A M0 T1c -22888 65 0 469 YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2012-6-22 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Bilateral 1.9 YES YES NO 3 0 No N0 T3a TCGA-FC-7961.38213CCD-4ED4-43B8-BFA0-38300DD35095.pdf 7961 TUMOR FREE 4 Complete Remission/Response NO Primary Tumor 01 5 0.3 NO YES NO FC Apex Prostate A LIVING 2011 Peripheral Zone 038600cd-c0ca-4de4-9539-570f7b960793 TCGA-FC-7961-01A-11D-A323-01 TCGA-FC-7961-01A-11D-A29T-05 TCGA-FC-7961-01A-11D-A29Q-08 038600cd-c0ca-4de4-9539-570f7b960793 TCGA-FC-7961-01 TCGA-FC-7961-01 3B491827-1556-45E0-B647-AB15B3716C84 TCGA-FC-7961-01A-11D-A323-01 038600cd-c0ca-4de4-9539-570f7b960793 TCGA-FC-7961-01 TCGA-FC-7961-01 TCGA-FC-7961-01A-11D-A29Q-08 TCGA-FC-7961-01A-11D-A29Q-08 038600cd-c0ca-4de4-9539-570f7b960793 +TCGA-FC-A4JI-01 TCGA-FC-A4JI-01 TCGA-FC-A4JI TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 70 TCGA-FC-A4JI-F68094 TCGA-FC-A4JI TCGA-FC-A4JI-01A Normal (no evidence of prostate cancer) [cM0] M0 T4 -25931 12 101 16 0 877 YES Extraprostatic Extension Localized (e.g. seminal vesicles) NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-21 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 630 NO Bilateral NO NO NO true No T3a TCGA-FC-A4JI.BEFDDE59-6838-433A-BAFC-82B4D3802349.pdf A4JI TUMOR FREE 5 Complete Remission/Response YES R0 Primary Tumor 01 3 YES YES NO FC Apex|Middle|Base Prostate A LIVING 2012 Central Zone 4351923f-0818-42f3-9869-6963bcd2e98d TCGA-FC-A4JI-01A-11D-A256-01 TCGA-FC-A4JI-01A-11D-A258-05 TCGA-FC-A4JI-01A-11D-A257-08 4351923f-0818-42f3-9869-6963bcd2e98d TCGA-FC-A4JI-01 TCGA-FC-A4JI-01 9ECD6E03-86DE-4395-9BCF-34A4AD7369C8 TCGA-FC-A4JI-01A-11D-A256-01 4351923f-0818-42f3-9869-6963bcd2e98d TCGA-FC-A4JI-01 TCGA-FC-A4JI-01 TCGA-FC-A4JI-01A-11D-A257-08 TCGA-FC-A4JI-01A-11D-A257-08 4351923f-0818-42f3-9869-6963bcd2e98d +TCGA-FC-A5OB-01 TCGA-FC-A5OB-01 TCGA-FC-A5OB TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 53 TCGA-FC-A5OB-F61434 TCGA-FC-A5OB TCGA-FC-A5OB-01A NO Abnormal (not related to prostate cancer) M0 T3a -19413 9 162 9 0 680 110 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission 2014-6-30 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 210 NO Bilateral NO YES NO 9 0 true No N0 T3b TCGA-FC-A5OB.E54208A5-C6DA-450A-AA5D-9A8FE5F6ECD6.pdf A5OB WITH TUMOR 4 5.22 YES R1 Primary Tumor 01 5 YES YES NO FC Middle|Base Prostate A LIVING 2012 Overlapping / Multiple Zones 131d97b1-b0d3-41d1-8fba-aaaa9eabdf9d TCGA-FC-A5OB-01A-11D-A323-01 TCGA-FC-A5OB-01A-11D-A29T-05 TCGA-FC-A5OB-01A-11D-A29Q-08 131d97b1-b0d3-41d1-8fba-aaaa9eabdf9d TCGA-FC-A5OB-01 TCGA-FC-A5OB-01 D10ACA59-D338-42DF-98CF-3700E1685EE7 TCGA-FC-A5OB-01A-11D-A323-01 131d97b1-b0d3-41d1-8fba-aaaa9eabdf9d TCGA-FC-A5OB-01 TCGA-FC-A5OB-01 TCGA-FC-A5OB-01A-11D-A29Q-08 TCGA-FC-A5OB-01A-11D-A29Q-08 131d97b1-b0d3-41d1-8fba-aaaa9eabdf9d +TCGA-FC-A66V-01 TCGA-FC-A66V-01 TCGA-FC-A66V TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 74 TCGA-FC-A66V-F52816 TCGA-FC-A66V TCGA-FC-A66V-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T3b -27282 28 287 27 0 524 -164 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-12-6 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 180 NO Bilateral YES YES NO 2 0 true No N0 T3b TCGA-FC-A66V.3C1BD6CD-0915-4DEA-A013-F2DE554C267F.pdf A66V TUMOR FREE 4 Complete Remission/Response 10.8 NO R0 Primary Tumor 01 3 NO YES NO FC Middle|Base Prostate A LIVING 2012 Overlapping / Multiple Zones 60448472-d440-4608-8fca-b54c41c5cde1 TCGA-FC-A66V-01A-21D-A30D-01 TCGA-FC-A66V-01A-21D-A30F-05 TCGA-FC-A66V-01A-21D-A30E-08 60448472-d440-4608-8fca-b54c41c5cde1 TCGA-FC-A66V-01 TCGA-FC-A66V-01 371030A1-7FA0-4209-9BF5-BADF2AC4F795 TCGA-FC-A66V-01A-21D-A30D-01 60448472-d440-4608-8fca-b54c41c5cde1 TCGA-FC-A66V-01 TCGA-FC-A66V-01 60448472-d440-4608-8fca-b54c41c5cde1 +TCGA-FC-A6HD-01 TCGA-FC-A6HD-01 TCGA-FC-A6HD TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 77 TCGA-FC-A6HD-F71333 TCGA-FC-A6HD TCGA-FC-A6HD-01A Normal (no evidence of prostate cancer) [cM0] M0 T3a -28197 33 140 33 0 789 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-24 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 210 NO Bilateral NO YES NO 10 0 true No N0 T3a TCGA-FC-A6HD.7452FEB1-FFB9-4DD2-8CD7-5BEB2B108208.pdf A6HD TUMOR FREE 4 Complete Remission/Response NO R0 Primary Tumor 01 3 NO YES NO FC Middle Prostate A LIVING 2013 Overlapping / Multiple Zones 6b96fce2-199f-463c-982e-4ed8179ddd90 TCGA-FC-A6HD-01A-11D-A31K-01 TCGA-FC-A6HD-01A-11D-A31M-05 TCGA-FC-A6HD-01A-11D-A31L-08 6b96fce2-199f-463c-982e-4ed8179ddd90 TCGA-FC-A6HD-01 TCGA-FC-A6HD-01 038EF7E4-5CAF-4197-AE7F-DFD662D046C4 TCGA-FC-A6HD-01A-11D-A31K-01 6b96fce2-199f-463c-982e-4ed8179ddd90 TCGA-FC-A6HD-01 TCGA-FC-A6HD-01 TCGA-FC-A6HD-01A-11D-A31L-08 6b96fce2-199f-463c-982e-4ed8179ddd90 +TCGA-FC-A8O0-01 TCGA-FC-A8O0-01 TCGA-FC-A8O0 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-FC-A8O0-F71394 TCGA-FC-A8O0 TCGA-FC-A8O0-01A NO M0 T2c -25115 168 10 -8 0 616 18 YES Extraprostatic Extension Localized (e.g. seminal vesicles) YES Extraprostatic Extension Localized (e.g. seminal vesicles)|Extraprostatic Extension (regional lymphadenopathy) [e.g. cN1] Scheduled Follow-up Submission Complete Remission/Response 2015-3-25 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 430 NO Bilateral NO YES NO 12 0 true No N0 T3a TCGA-FC-A8O0.4DC18F34-9319-45E5-8ECA-D86E9CD81EE6.pdf A8O0 TUMOR FREE 3 Complete Remission/Response 7.82 R0 Primary Tumor 01 3 4 YES NO FC Base Prostate A LIVING 2013 Peripheral Zone e5b8a092-0e86-4003-9ba6-112006161e93 TCGA-FC-A8O0-01A-41D-A376-01 TCGA-FC-A8O0-01A-41D-A378-05 TCGA-FC-A8O0-01A-41D-A377-08 e5b8a092-0e86-4003-9ba6-112006161e93 TCGA-FC-A8O0-01 TCGA-FC-A8O0-01 8CE26D55-72E6-4DBB-A99A-B5CB7594C7A8 TCGA-FC-A8O0-01A-41D-A376-01 e5b8a092-0e86-4003-9ba6-112006161e93 TCGA-FC-A8O0-01 TCGA-FC-A8O0-01 TCGA-FC-A8O0-01A-41D-A377-08 e5b8a092-0e86-4003-9ba6-112006161e93 +TCGA-G9-6329-01 TCGA-G9-6329-01 TCGA-G9-6329 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-G9-6329-F40680 TCGA-G9-6329 TCGA-G9-6329-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -24797 10 10 0 1266 923 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.7 NO Bilateral 1.3 NO NO NO No T2c TCGA-G9-6329.fd7b8f28-b1ee-428e-859c-c888c459a3b0.pdf 6329 TUMOR FREE 3 Complete Remission/Response 0.03 NO R0 Primary Tumor 01 4 0.2 NO NO YES G9 Prostate A LIVING 2009 3b6f54f6-1812-474f-aced-f6790e59611c TCGA-G9-6329-01A-13D-1959-01 TCGA-G9-6329-01A-13D-1963-05 TCGA-G9-6329-01A-13D-1961-08 3b6f54f6-1812-474f-aced-f6790e59611c TCGA-G9-6329-01 TCGA-G9-6329-01 41AF7C4D-6EF8-49D7-9F6A-2A84A4BB23BB TCGA-G9-6329-01A-13D-1959-01 3b6f54f6-1812-474f-aced-f6790e59611c TCGA-G9-6329-01 TCGA-G9-6329-01 TCGA-G9-6329-01A-13D-1961-08 TCGA-G9-6329-01A-13D-1961-08 3b6f54f6-1812-474f-aced-f6790e59611c +TCGA-G9-6332-01 TCGA-G9-6332-01 TCGA-G9-6332 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES YES 55 TCGA-G9-6332-F40976 TCGA-G9-6332 TCGA-G9-6332-01A Normal (no evidence of prostate cancer) [cM0] M0 T2b -20166 11 11 0 2657 1285 2090 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Progressive Disease 2013-3-8 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.2 NO Bilateral 0.4 NO YES New Primary Tumor YES 7 0 No N0 T3a TCGA-G9-6332.18b9fda1-2d69-4c5e-94ba-bfbbcd742bdd.pdf 6332 WITH TUMOR 4 Complete Remission/Response 0.73 NO R0 Primary Tumor 01 3 0.1 NO NO YES G9 Apex|Base Prostate A LIVING 2005 22ec0a34-74ad-48d6-80f4-b88ef082101d TCGA-G9-6332-01A-11D-1785-01 TCGA-G9-6332-01A-11D-1787-05 TCGA-G9-6332-01A-11D-1786-08 TCGA-G9-6332-01A-11D-1786-08 22ec0a34-74ad-48d6-80f4-b88ef082101d TCGA-G9-6332-01 TCGA-G9-6332-01 TCGA-G9-6332-01A-11D-1785-01 22ec0a34-74ad-48d6-80f4-b88ef082101d TCGA-G9-6332-01 TCGA-G9-6332-01 TCGA-G9-6332-01A-11D-1786-08 22ec0a34-74ad-48d6-80f4-b88ef082101d +TCGA-G9-6332-11 TCGA-G9-6332-11 TCGA-G9-6332 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES YES 55 TCGA-G9-6332-F40976 TCGA-G9-6332 TCGA-G9-6332-11A Normal (no evidence of prostate cancer) [cM0] M0 T2b -20166 11 11 0 2657 1285 2090 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Progressive Disease 2013-3-8 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 1 NO YES New Primary Tumor YES 7 0 No N0 T3a 6332 WITH TUMOR 4 Complete Remission/Response 0.73 NO R0 Solid Tissue Normal 11 3 0.5 NO NO YES G9 Apex|Base Prostate A LIVING 2005 TCGA-G9-6332-11A-01D-1787-05 +TCGA-G9-6333-01 TCGA-G9-6333-01 TCGA-G9-6333 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-G9-6333-F42766 TCGA-G9-6333 TCGA-G9-6333-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -24249 1102 1102 0 2465 1920 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-4-30 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 1 NO YES NO 13 0 No N0 T2c TCGA-G9-6333.df50612f-a299-468b-b6bf-226366f4cf42.pdf 6333 TUMOR FREE 4 Complete Remission/Response 0.03 NO R0 Primary Tumor 01 3 0.2 NO NO YES G9 Apex|Base Prostate A LIVING 2006 644e2830-703e-4a1f-86e3-f9cea798c1eb TCGA-G9-6333-01A-12D-1959-01 TCGA-G9-6333-01A-12D-1963-05 TCGA-G9-6333-01A-12D-1961-08 644e2830-703e-4a1f-86e3-f9cea798c1eb TCGA-G9-6333-01 TCGA-G9-6333-01 TCGA-G9-6333-01A-12D-1959-01 644e2830-703e-4a1f-86e3-f9cea798c1eb TCGA-G9-6333-01 TCGA-G9-6333-01 TCGA-G9-6333-01A-12D-1961-08 TCGA-G9-6333-01A-12D-1961-08 644e2830-703e-4a1f-86e3-f9cea798c1eb +TCGA-G9-6333-11 TCGA-G9-6333-11 TCGA-G9-6333 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-G9-6333-F42766 TCGA-G9-6333 TCGA-G9-6333-11A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -24249 1102 1102 0 2465 1920 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-4-30 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.9 NO Bilateral 1.4 NO YES NO 13 0 No N0 T2c 6333 TUMOR FREE 4 Complete Remission/Response 0.03 NO R0 Solid Tissue Normal 11 3 0.4 NO NO YES G9 Apex|Base Prostate A LIVING 2006 7e787a16-e77d-46eb-8666-7489349b5c82 TCGA-G9-6333-11A-01D-1963-05 7e787a16-e77d-46eb-8666-7489349b5c82 TCGA-G9-6333-11 7e787a16-e77d-46eb-8666-7489349b5c82 TCGA-G9-6333-11 7e787a16-e77d-46eb-8666-7489349b5c82 +TCGA-G9-6336-01 TCGA-G9-6336-01 TCGA-G9-6336 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-G9-6336-F40679 TCGA-G9-6336 TCGA-G9-6336-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2c -20851 98 104 0 2068 1669 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.3 NO Bilateral 0.4 NO YES NO 5 0 No N0 TCGA-G9-6336.ceda2ffb-b844-4f89-baba-82a66e6f3f0e.pdf 6336 TUMOR FREE 3 Complete Remission/Response 0.1 NO R1 Primary Tumor 01 4 0.2 NO NO YES G9 Apex|Base Prostate A LIVING 2007 9cbe4eef-89aa-453e-b22b-1c1256bf3c51 TCGA-G9-6336-01A-11D-1785-01 TCGA-G9-6336-01A-11D-1787-05 TCGA-G9-6336-01A-11D-1786-08 TCGA-G9-6336-01A-11D-1786-08 9cbe4eef-89aa-453e-b22b-1c1256bf3c51 TCGA-G9-6336-01 TCGA-G9-6336-01 TCGA-G9-6336-01A-11D-1785-01 9cbe4eef-89aa-453e-b22b-1c1256bf3c51 TCGA-G9-6336-01 TCGA-G9-6336-01 TCGA-G9-6336-01A-11D-1786-08 TCGA-G9-6336-01A-11D-1786-08 9cbe4eef-89aa-453e-b22b-1c1256bf3c51 +TCGA-G9-6338-01 TCGA-G9-6338-01 TCGA-G9-6338 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-G9-6338-F42755 TCGA-G9-6338 TCGA-G9-6338-01A Normal (no evidence of prostate cancer) [cM0] M0 T1c -22360 13 82 0 2028 1634 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-4-30 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1 NO YES NO 2 0 No N0 T3a TCGA-G9-6338.d3962697-f160-4a76-bfbe-81c06c89d5c3.pdf 6338 TUMOR FREE 4 Complete Remission/Response 0.05 NO R1 Primary Tumor 01 3 0.2 NO NO YES G9 Apex Prostate A LIVING 2007 3790dc43-aa3d-4d1b-aa7a-340675c98bd4 TCGA-G9-6338-01A-12D-1959-01 TCGA-G9-6338-01A-12D-1963-05 TCGA-G9-6338-01A-12D-1961-08 3790dc43-aa3d-4d1b-aa7a-340675c98bd4 TCGA-G9-6338-01 TCGA-G9-6338-01 186A0C7B-C4BC-47F6-A2B3-43D06A5E72A1 TCGA-G9-6338-01A-12D-1959-01 3790dc43-aa3d-4d1b-aa7a-340675c98bd4 TCGA-G9-6338-01 TCGA-G9-6338-01 TCGA-G9-6338-01A-12D-1961-08 3790dc43-aa3d-4d1b-aa7a-340675c98bd4 +TCGA-G9-6339-01 TCGA-G9-6339-01 TCGA-G9-6339 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 58 TCGA-G9-6339-F66665 TCGA-G9-6339 TCGA-G9-6339-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T3b -21305 4 1634 0 2551 2110 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-22 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Bilateral 1.3 NO YES NO 6 0 No N0 T3b TCGA-G9-6339.10FA561E-76C7-4F83-BC1C-B858DF9CCC46.pdf 6339 TUMOR FREE 3 Complete Remission/Response 0.03 NO R0 Primary Tumor 01 4 0.3 NO NO YES G9 Apex|Middle|Base Prostate A LIVING 2007 18c4e2fd-5696-4577-bd9d-019a402f7c81 TCGA-G9-6339-01A-12D-A30W-01 TCGA-G9-6339-01A-12D-A30Z-05 TCGA-G9-6339-01A-12D-A30X-08 18c4e2fd-5696-4577-bd9d-019a402f7c81 TCGA-G9-6339-01 TCGA-G9-6339-01 0DEC7849-6BCD-40D9-89E3-4E1C08BEF242 TCGA-G9-6339-01A-12D-A30W-01 18c4e2fd-5696-4577-bd9d-019a402f7c81 TCGA-G9-6339-01 TCGA-G9-6339-01 TCGA-G9-6339-01A-12D-A30X-08 18c4e2fd-5696-4577-bd9d-019a402f7c81 +TCGA-G9-6342-01 TCGA-G9-6342-01 TCGA-G9-6342 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-G9-6342-F40650 TCGA-G9-6342 TCGA-G9-6342-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2c -22472 32 36 0 1696 1338 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 0.8 NO NO NO No T3a TCGA-G9-6342.80379cb8-9fb7-4e01-9e4a-2bf7813dc839.pdf 6342 TUMOR FREE 3 Complete Remission/Response 0.05 NO R0 Primary Tumor 01 3 0.3 NO 4 NO YES G9 Apex|Base Prostate A LIVING 2008 07384291-d5cc-44d8-a025-f10636c91691 TCGA-G9-6342-01A-11D-1959-01 TCGA-G9-6342-01A-11D-1963-05 TCGA-G9-6342-01A-11D-1961-08 07384291-d5cc-44d8-a025-f10636c91691 TCGA-G9-6342-01 TCGA-G9-6342-01 78676530-C980-4B09-984C-A54A0B59899D TCGA-G9-6342-01A-11D-1959-01 07384291-d5cc-44d8-a025-f10636c91691 TCGA-G9-6342-01 TCGA-G9-6342-01 TCGA-G9-6342-01A-11D-1961-08 TCGA-G9-6342-01A-11D-1961-08 07384291-d5cc-44d8-a025-f10636c91691 +TCGA-G9-6342-11 TCGA-G9-6342-11 TCGA-G9-6342 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-G9-6342-F40650 TCGA-G9-6342 TCGA-G9-6342-11A NO Normal (no evidence of prostate cancer) [cM0] M0 T2c -22472 32 36 0 1696 1338 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.2 NO NO NO No T3a 6342 TUMOR FREE 3 Complete Remission/Response 0.05 NO R0 Solid Tissue Normal 11 3 0.5 NO 4 NO YES G9 Apex|Base Prostate A LIVING 2008 35c918eb-2a20-4e32-93d4-ae2c80d6cee7 TCGA-G9-6342-11A-02D-1963-05 35c918eb-2a20-4e32-93d4-ae2c80d6cee7 TCGA-G9-6342-11 35c918eb-2a20-4e32-93d4-ae2c80d6cee7 TCGA-G9-6342-11 35c918eb-2a20-4e32-93d4-ae2c80d6cee7 +TCGA-G9-6343-01 TCGA-G9-6343-01 TCGA-G9-6343 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-G9-6343-F68582 TCGA-G9-6343 TCGA-G9-6343-01A NO M0 T2a -22843 0 2450 554 NO NO Scheduled Follow-up Submission 2014-12-1 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 1.5 NO NO No T2c TCGA-G9-6343.3d7d837b-a09e-4281-93af-a789123a9356.pdf 6343 TUMOR FREE 4 Complete Remission/Response 0.03 NO R0 Primary Tumor 01 3 0.2 NO NO YES G9 Apex|Base Prostate A LIVING 2008 938046b4-330f-49e1-99b3-4cc4a1a1e48d TCGA-G9-6343-01A-21D-1959-01 TCGA-G9-6343-01A-21D-1963-05 TCGA-G9-6343-01A-21D-1961-08 938046b4-330f-49e1-99b3-4cc4a1a1e48d TCGA-G9-6343-01 TCGA-G9-6343-01 16D4166B-4EF0-476D-AD9A-7A2D8CD0E180 TCGA-G9-6343-01A-21D-1959-01 938046b4-330f-49e1-99b3-4cc4a1a1e48d TCGA-G9-6343-01 TCGA-G9-6343-01 TCGA-G9-6343-01A-21D-1961-08 938046b4-330f-49e1-99b3-4cc4a1a1e48d +TCGA-G9-6347-01 TCGA-G9-6347-01 TCGA-G9-6347 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-G9-6347-F61289 TCGA-G9-6347 TCGA-G9-6347-01A NO M0 T1c -21721 0 2089 1718 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-26 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 1 NO NO NO No T2c TCGA-G9-6347.2ED4FCE8-5DCF-4529-95E5-C454529D7971.pdf 6347 TUMOR FREE 3 Complete Remission/Response 00.03 NO R0 Primary Tumor 01 3 0.1 NO NO YES G9 Apex|Middle Prostate A LIVING 2008 Peripheral Zone 817b51f3-fa06-4c82-956e-220b4396d30b TCGA-G9-6347-01A-11D-A31K-01 TCGA-G9-6347-01A-11D-A31M-05 TCGA-G9-6347-01A-11D-A31L-08 817b51f3-fa06-4c82-956e-220b4396d30b TCGA-G9-6347-01 TCGA-G9-6347-01 28F07B17-A295-4C80-814E-1A7FA932D08E TCGA-G9-6347-01A-11D-A31K-01 817b51f3-fa06-4c82-956e-220b4396d30b TCGA-G9-6347-01 TCGA-G9-6347-01 TCGA-G9-6347-01A-11D-A31L-08 817b51f3-fa06-4c82-956e-220b4396d30b +TCGA-G9-6348-01 TCGA-G9-6348-01 TCGA-G9-6348 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-G9-6348-F40648 TCGA-G9-6348 NO Abnormal (not related to prostate cancer) M0 T3a -24936 31 31 0 1515 1136 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO [Discrepancy] NO 15 0 No N0 T2c 6348 TUMOR FREE 3 Complete Remission/Response 0.02 NO R0 Primary Tumor 01 4 NO NO YES G9 Apex|Base Prostate LIVING 2008 f1647dd0-3eda-473f-9902-12d0817ee165 TCGA-G9-6348-01A-11D-1785-01 TCGA-G9-6348-01A-11D-1787-05 TCGA-G9-6348-01A-11D-1786-08 TCGA-G9-6348-01A-11D-1786-08 f1647dd0-3eda-473f-9902-12d0817ee165 TCGA-G9-6348-01 TCGA-G9-6348-01 TCGA-G9-6348-01A-11D-1785-01 f1647dd0-3eda-473f-9902-12d0817ee165 TCGA-G9-6348-01 TCGA-G9-6348-01 TCGA-G9-6348-01A-11D-1786-08 TCGA-G9-6348-01A-11D-1786-08 f1647dd0-3eda-473f-9902-12d0817ee165 +TCGA-G9-6348-11 TCGA-G9-6348-11 TCGA-G9-6348 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-G9-6348-F40648 TCGA-G9-6348 NO Abnormal (not related to prostate cancer) M0 T3a -24936 31 31 0 1515 1136 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO [Discrepancy] NO 15 0 No N0 T2c 6348 TUMOR FREE 3 Complete Remission/Response 0.02 NO R0 Solid Tissue Normal 11 4 NO NO YES G9 Apex|Base Prostate LIVING 2008 f2ad4c22-c476-44af-a8ca-dffcae313ae2 TCGA-G9-6348-11A-01D-1787-05 f2ad4c22-c476-44af-a8ca-dffcae313ae2 TCGA-G9-6348-11 f2ad4c22-c476-44af-a8ca-dffcae313ae2 TCGA-G9-6348-11 f2ad4c22-c476-44af-a8ca-dffcae313ae2 +TCGA-G9-6351-01 TCGA-G9-6351-01 TCGA-G9-6351 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 51 TCGA-G9-6351-F68538 TCGA-G9-6351 TCGA-G9-6351-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -18723 8 11 0 2048 1215 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-25 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.3 NO Bilateral 0.6 NO NO NO No T2c TCGA-G9-6351.7942304b-0a3d-492c-bbb2-65695f1958e4.pdf 6351 TUMOR FREE 3 Complete Remission/Response 0.03 YES R1 Primary Tumor 01 4 0.3 NO NO YES G9 Apex Prostate A LIVING 2008 5b656979-9a9f-4ef2-8948-2979d1db0c68 TCGA-G9-6351-01A-21D-1959-01 TCGA-G9-6351-01A-21D-1963-05 TCGA-G9-6351-01A-21D-1961-08 5b656979-9a9f-4ef2-8948-2979d1db0c68 TCGA-G9-6351-01 TCGA-G9-6351-01 0CC4613B-D3AE-44E1-86B8-BF52A68C44CD TCGA-G9-6351-01A-21D-1959-01 5b656979-9a9f-4ef2-8948-2979d1db0c68 TCGA-G9-6351-01 TCGA-G9-6351-01 TCGA-G9-6351-01A-21D-1961-08 TCGA-G9-6351-01A-21D-1961-08 5b656979-9a9f-4ef2-8948-2979d1db0c68 +TCGA-G9-6351-11 TCGA-G9-6351-11 TCGA-G9-6351 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 51 TCGA-G9-6351-F68538 TCGA-G9-6351 TCGA-G9-6351-11A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -18723 8 11 0 2048 1215 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-25 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 120 1 NO Bilateral 1.4 NO NO NO No T2c 6351 TUMOR FREE 3 Complete Remission/Response 0.03 YES R1 Solid Tissue Normal 11 4 0.3 NO NO YES G9 Apex Prostate A LIVING 2008 6b264e41-b852-4221-8e09-692a6a639ccf TCGA-G9-6351-11A-01D-1963-05 6b264e41-b852-4221-8e09-692a6a639ccf TCGA-G9-6351-11 6b264e41-b852-4221-8e09-692a6a639ccf TCGA-G9-6351-11 6b264e41-b852-4221-8e09-692a6a639ccf +TCGA-G9-6353-01 TCGA-G9-6353-01 TCGA-G9-6353 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 58 TCGA-G9-6353-F42753 TCGA-G9-6353 TCGA-G9-6353-01A NO M0 T1c -21221 0 1542 590 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-4-30 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 1 NO NO NO No T3a TCGA-G9-6353.72b2694f-8b37-402a-a75a-2a50372a789e.pdf 6353 TUMOR FREE 3 Complete Remission/Response 0.1 NO R1 Primary Tumor 01 4 0.5 NO NO YES G9 Apex|Middle Prostate A LIVING 2009 Peripheral Zone f8cdc431-ee4c-4337-975f-eb380faebb8c TCGA-G9-6353-01A-11D-1959-01 TCGA-G9-6353-01A-11D-1963-05 TCGA-G9-6353-01A-11D-1961-08 f8cdc431-ee4c-4337-975f-eb380faebb8c TCGA-G9-6353-01 TCGA-G9-6353-01 0B613135-6859-4DD9-9090-C52376CEA024 TCGA-G9-6353-01A-11D-1959-01 f8cdc431-ee4c-4337-975f-eb380faebb8c TCGA-G9-6353-01 TCGA-G9-6353-01 TCGA-G9-6353-01A-11D-1961-08 TCGA-G9-6353-01A-11D-1961-08 f8cdc431-ee4c-4337-975f-eb380faebb8c +TCGA-G9-6353-11 TCGA-G9-6353-11 TCGA-G9-6353 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 58 TCGA-G9-6353-F42753 TCGA-G9-6353 TCGA-G9-6353-11A NO M0 T1c -21221 0 1542 590 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-4-30 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Bilateral 1.1 NO NO NO No T3a 6353 TUMOR FREE 3 Complete Remission/Response 0.1 NO R1 Solid Tissue Normal 11 4 0.6 NO NO YES G9 Apex|Middle Prostate A LIVING 2009 Peripheral Zone TCGA-G9-6353-11A-02D-1963-05 +TCGA-G9-6354-01 TCGA-G9-6354-01 TCGA-G9-6354 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-G9-6354-F70314 TCGA-G9-6354 TCGA-G9-6354-01A NO M0 T1c -20403 0 2066 525 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-9 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.1 NO Right 0.6 NO NO NO No T2b TCGA-G9-6354.CFFC4C63-D738-41CD-8EE3-25C190A9638C.pdf 6354 TUMOR FREE 3 Complete Remission/Response 00.03 NO R0 Primary Tumor 01 4 0.1 NO NO YES G9 Apex|Base Prostate A LIVING 2009 99b27a89-5e60-4b2f-8d54-2bea08ac897c TCGA-G9-6354-01A-11D-A30W-01 TCGA-G9-6354-01A-11D-A30Z-05 TCGA-G9-6354-01A-11D-A30X-08 99b27a89-5e60-4b2f-8d54-2bea08ac897c TCGA-G9-6354-01 TCGA-G9-6354-01 TCGA-G9-6354-01A-11D-A30W-01 99b27a89-5e60-4b2f-8d54-2bea08ac897c TCGA-G9-6354-01 TCGA-G9-6354-01 TCGA-G9-6354-01A-11D-A30X-08 99b27a89-5e60-4b2f-8d54-2bea08ac897c +TCGA-G9-6356-01 TCGA-G9-6356-01 TCGA-G9-6356 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-G9-6356-F40973 TCGA-G9-6356 TCGA-G9-6356-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -22010 24 21 0 1434 986 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-3-8 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 1.3 NO YES NO 5 0 No N0 T3b TCGA-G9-6356.818a2716-ca81-4534-ba13-a0fe3a18b2e9.pdf 6356 TUMOR FREE 4 Complete Remission/Response 0.13 NO R1 Primary Tumor 01 5 0.6 NO 3 NO YES G9 Apex|Base Prostate A LIVING 2009 9584ae14-c30b-421b-8975-b5b1bb94a465 TCGA-G9-6356-01A-11D-1785-01 TCGA-G9-6356-01A-11D-1787-05 TCGA-G9-6356-01A-11D-1786-08 TCGA-G9-6356-01A-11D-1786-08 9584ae14-c30b-421b-8975-b5b1bb94a465 TCGA-G9-6356-01 TCGA-G9-6356-01 64132E9C-00E9-4F9B-8DBB-63B39E1CFFC9 TCGA-G9-6356-01A-11D-1785-01 9584ae14-c30b-421b-8975-b5b1bb94a465 TCGA-G9-6356-01 TCGA-G9-6356-01 TCGA-G9-6356-01A-11D-1786-08 TCGA-G9-6356-01A-11D-1786-08 9584ae14-c30b-421b-8975-b5b1bb94a465 +TCGA-G9-6356-11 TCGA-G9-6356-11 TCGA-G9-6356 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-G9-6356-F40973 TCGA-G9-6356 NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -22010 24 21 0 1434 986 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-3-8 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 5 0 No N0 T3b 6356 TUMOR FREE 4 Complete Remission/Response 0.13 NO R1 Solid Tissue Normal 11 5 NO 3 NO YES G9 Apex|Base Prostate LIVING 2009 aabc18c1-ba2e-40a8-b564-eb97b2a188f8 TCGA-G9-6356-11A-01D-1787-05 aabc18c1-ba2e-40a8-b564-eb97b2a188f8 TCGA-G9-6356-11 aabc18c1-ba2e-40a8-b564-eb97b2a188f8 TCGA-G9-6356-11 aabc18c1-ba2e-40a8-b564-eb97b2a188f8 +TCGA-G9-6361-01 TCGA-G9-6361-01 TCGA-G9-6361 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-G9-6361-F42767 TCGA-G9-6361 TCGA-G9-6361-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2c -22565 38 31 0 1415 1002 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-4-30 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.7 NO Bilateral 1.3 NO YES NO 12 0 No N0 T3a TCGA-G9-6361.49fe865a-79e8-4ff3-a52e-9888c4514cf2.pdf 6361 TUMOR FREE 3 Complete Remission/Response 0.1 NO R1 Primary Tumor 01 4 0.2 NO NO YES G9 Apex|Base Prostate A LIVING 2009 011453b6-9736-4ea4-8845-bbe4416783d3 TCGA-G9-6361-01A-21D-1959-01 TCGA-G9-6361-01A-21D-1963-05 TCGA-G9-6361-01A-21D-1961-08 011453b6-9736-4ea4-8845-bbe4416783d3 TCGA-G9-6361-01 TCGA-G9-6361-01 E7B28BAE-ED87-4EF9-A0C9-A32D513CE718 TCGA-G9-6361-01A-21D-1959-01 011453b6-9736-4ea4-8845-bbe4416783d3 TCGA-G9-6361-01 TCGA-G9-6361-01 TCGA-G9-6361-01A-21D-1961-08 TCGA-G9-6361-01A-21D-1961-08 011453b6-9736-4ea4-8845-bbe4416783d3 +TCGA-G9-6362-01 TCGA-G9-6362-01 TCGA-G9-6362 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 57 TCGA-G9-6362-F44046 TCGA-G9-6362 TCGA-G9-6362-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -21149 8 1443 0 1443 815 NO NO Scheduled Follow-up Submission Progressive Disease 2013-6-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Bilateral 1.2 NO YES Biochemical evidence of disease YES 2 0 No N0 T3a TCGA-G9-6362.fc8bac85-e3c5-47c1-b4c1-9b8834e01780.pdf 6362 WITH TUMOR 4 Progressive Disease 0.07 NO R1 Primary Tumor 01 3 0.2 NO 5 NO YES G9 Apex|Base Prostate A LIVING 2009 986964bc-b680-4fc1-8f93-20772f0a8949 TCGA-G9-6362-01A-11D-1785-01 TCGA-G9-6362-01A-11D-1787-05 TCGA-G9-6362-01A-11D-1786-08 TCGA-G9-6362-01A-11D-1786-08 986964bc-b680-4fc1-8f93-20772f0a8949 TCGA-G9-6362-01 TCGA-G9-6362-01 3840697C-A557-4C88-BE3D-8FE326DE6C5E TCGA-G9-6362-01A-11D-1785-01 986964bc-b680-4fc1-8f93-20772f0a8949 TCGA-G9-6362-01 TCGA-G9-6362-01 TCGA-G9-6362-01A-11D-1786-08 986964bc-b680-4fc1-8f93-20772f0a8949 +TCGA-G9-6362-11 TCGA-G9-6362-11 TCGA-G9-6362 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 57 TCGA-G9-6362-F44046 TCGA-G9-6362 NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -21149 8 1443 0 1443 815 NO NO Scheduled Follow-up Submission Progressive Disease 2013-6-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES Biochemical evidence of disease YES 2 0 No N0 T3a 6362 WITH TUMOR 4 Progressive Disease 0.07 NO R1 Solid Tissue Normal 11 3 NO 5 NO YES G9 Apex|Base Prostate LIVING 2009 d5a6b5e2-f1af-4b1f-bfbe-2b3c05f3f642 TCGA-G9-6362-11A-01D-1787-05 d5a6b5e2-f1af-4b1f-bfbe-2b3c05f3f642 TCGA-G9-6362-11 d5a6b5e2-f1af-4b1f-bfbe-2b3c05f3f642 TCGA-G9-6362-11 d5a6b5e2-f1af-4b1f-bfbe-2b3c05f3f642 +TCGA-G9-6363-01 TCGA-G9-6363-01 TCGA-G9-6363 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-G9-6363-F44074 TCGA-G9-6363 TCGA-G9-6363-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -23480 58 23 0 1378 993 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-6-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.9 NO Bilateral 1.2 NO YES NO 6 0 No N0 T4 TCGA-G9-6363.bd52ccc2-462d-41df-a5a4-dc45bd78aea4.pdf 6363 TUMOR FREE 4 Complete Remission/Response 0.03 NO R0 Primary Tumor 01 3 0.3 NO NO YES G9 Base Prostate A LIVING 2009 766eb893-3bc9-4a17-9b66-7eed2b1c01c3 TCGA-G9-6363-01A-21D-1785-01 TCGA-G9-6363-01A-21D-1787-05 TCGA-G9-6363-01A-21D-1786-08 TCGA-G9-6363-01A-21D-1786-08 766eb893-3bc9-4a17-9b66-7eed2b1c01c3 TCGA-G9-6363-01 TCGA-G9-6363-01 6E48E2C0-5361-44BC-B94A-EC324A89657D TCGA-G9-6363-01A-21D-1785-01 766eb893-3bc9-4a17-9b66-7eed2b1c01c3 TCGA-G9-6363-01 TCGA-G9-6363-01 TCGA-G9-6363-01A-21D-1786-08 TCGA-G9-6363-01A-21D-1786-08 766eb893-3bc9-4a17-9b66-7eed2b1c01c3 +TCGA-G9-6363-11 TCGA-G9-6363-11 TCGA-G9-6363 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-G9-6363-F44074 TCGA-G9-6363 TCGA-G9-6363-11A NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -23480 58 23 0 1378 993 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-6-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 100 0.7 NO Bilateral 1.8 NO YES NO 6 0 No N0 T4 6363 TUMOR FREE 4 Complete Remission/Response 0.03 NO R0 Solid Tissue Normal 11 3 0.4 NO NO YES G9 Base Prostate A LIVING 2009 1eda4d9f-e9a1-4ee7-8c71-559c8940b751 TCGA-G9-6363-11A-01D-1787-05 1eda4d9f-e9a1-4ee7-8c71-559c8940b751 TCGA-G9-6363-11 1eda4d9f-e9a1-4ee7-8c71-559c8940b751 TCGA-G9-6363-11 1eda4d9f-e9a1-4ee7-8c71-559c8940b751 +TCGA-G9-6364-01 TCGA-G9-6364-01 TCGA-G9-6364 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 72 TCGA-G9-6364-F40643 TCGA-G9-6364 TCGA-G9-6364-01A NO M0 -26603 0 1198 841 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Transurethral resection (TURBT) 0.8 NO Bilateral 1.7 NO YES NO 25 0 Yes N0 T3a TCGA-G9-6364.81deb5a1-4d5d-490a-a956-a64a4e6763f8.pdf 6364 TUMOR FREE 3 Complete Remission/Response 0.03 NO R0 Primary Tumor 01 4 0.4 NO NO YES G9 Prostate A LIVING 2009 e9de50a5-d753-40f8-bb1f-3602ad9627ca TCGA-G9-6364-01A-21D-1785-01 TCGA-G9-6364-01A-21D-1787-05 TCGA-G9-6364-01A-21D-1786-08 TCGA-G9-6364-01A-21D-1786-08 e9de50a5-d753-40f8-bb1f-3602ad9627ca TCGA-G9-6364-01 TCGA-G9-6364-01 9813C17B-FBC4-4064-AA64-7F4C4AAEDD00 TCGA-G9-6364-01A-21D-1785-01 e9de50a5-d753-40f8-bb1f-3602ad9627ca TCGA-G9-6364-01 TCGA-G9-6364-01 TCGA-G9-6364-01A-21D-1786-08 TCGA-G9-6364-01A-21D-1786-08 e9de50a5-d753-40f8-bb1f-3602ad9627ca +TCGA-G9-6364-11 TCGA-G9-6364-11 TCGA-G9-6364 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 72 TCGA-G9-6364-F40643 TCGA-G9-6364 TCGA-G9-6364-11A NO M0 -26603 0 1198 841 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Transurethral resection (TURBT) 1 NO Bilateral 2 NO YES NO 25 0 Yes N0 T3a 6364 TUMOR FREE 3 Complete Remission/Response 0.03 NO R0 Solid Tissue Normal 11 4 0.3 NO NO YES G9 Prostate A LIVING 2009 TCGA-G9-6364-11A-01D-1787-05 +TCGA-G9-6365-01 TCGA-G9-6365-01 TCGA-G9-6365 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 71 TCGA-G9-6365-F42754 TCGA-G9-6365 TCGA-G9-6365-01A NO T2a -26207 0 1363 804 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-4-30 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Bilateral 2 NO YES NO 13 0 No N0 T4 TCGA-G9-6365.0f1f5e1b-4086-4a77-96ba-2108abdde80f.pdf 6365 TUMOR FREE 3 Complete Remission/Response 0.01 NO R1 Primary Tumor 01 4 0.3 NO NO YES G9 Apex|Base Prostate A LIVING 2009 67816085-c038-4c4f-86f0-b03e6da18aee TCGA-G9-6365-01A-11D-1785-01 TCGA-G9-6365-01A-11D-1787-05 TCGA-G9-6365-01A-11D-1786-08 TCGA-G9-6365-01A-11D-1786-08 67816085-c038-4c4f-86f0-b03e6da18aee TCGA-G9-6365-01 TCGA-G9-6365-01 2FD641B9-006D-40FE-8E01-678EEC130C6E TCGA-G9-6365-01A-11D-1785-01 67816085-c038-4c4f-86f0-b03e6da18aee TCGA-G9-6365-01 TCGA-G9-6365-01 TCGA-G9-6365-01A-11D-1786-08 TCGA-G9-6365-01A-11D-1786-08 67816085-c038-4c4f-86f0-b03e6da18aee +TCGA-G9-6365-11 TCGA-G9-6365-11 TCGA-G9-6365 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 71 TCGA-G9-6365-F42754 TCGA-G9-6365 TCGA-G9-6365-11A NO T2a -26207 0 1363 804 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-4-30 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 2.2 NO YES NO 13 0 No N0 T4 6365 TUMOR FREE 3 Complete Remission/Response 0.01 NO R1 Solid Tissue Normal 11 4 0.2 NO NO YES G9 Apex|Base Prostate A LIVING 2009 40c411e7-c0cb-4aff-8418-fd7400562bad TCGA-G9-6365-11A-01D-1787-05 40c411e7-c0cb-4aff-8418-fd7400562bad TCGA-G9-6365-11 40c411e7-c0cb-4aff-8418-fd7400562bad TCGA-G9-6365-11 40c411e7-c0cb-4aff-8418-fd7400562bad +TCGA-G9-6366-01 TCGA-G9-6366-01 TCGA-G9-6366 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-G9-6366-F68583 TCGA-G9-6366 TCGA-G9-6366-01A NO T1c -22428 0 1947 101 NO NO Scheduled Follow-up Submission 2014-12-1 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.2 NO Left 1.8 NO NO No T3b TCGA-G9-6366.6ef07861-a4db-4aa2-ba73-4cd43e10d72f.pdf 6366 4 Complete Remission/Response 0.1 R0 Primary Tumor 01 3 0.2 NO YES G9 Apex|Base Prostate A LIVING 2009 27357b4d-5d44-4c5e-bb80-0d5f68c3db8e TCGA-G9-6366-01A-11D-2112-01 TCGA-G9-6366-01A-11D-2116-05 TCGA-G9-6366-01A-11D-2114-08 27357b4d-5d44-4c5e-bb80-0d5f68c3db8e TCGA-G9-6366-01 TCGA-G9-6366-01 5675FF17-E0DA-44EC-81FE-892D96FF7ECA TCGA-G9-6366-01A-11D-2112-01 27357b4d-5d44-4c5e-bb80-0d5f68c3db8e TCGA-G9-6366-01 TCGA-G9-6366-01 TCGA-G9-6366-01A-11D-2114-08 TCGA-G9-6366-01A-11D-2114-08 27357b4d-5d44-4c5e-bb80-0d5f68c3db8e +TCGA-G9-6367-01 TCGA-G9-6367-01 TCGA-G9-6367 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-G9-6367-F40631 TCGA-G9-6367 TCGA-G9-6367-01A Normal (no evidence of prostate cancer) [cM0] M0 T2b -22176 30 30 0 1222 836 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Progressive Disease 2013-3-8 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 1.6 NO YES NO 5 0 No N0 T3a TCGA-G9-6367.1306f52c-6633-4ca8-8998-c5306e0c34be.pdf 6367 WITH TUMOR 4 Progressive Disease 0.42 NO R1 Primary Tumor 01 5 0.4 NO 3 NO YES G9 Apex|Base Prostate A LIVING 2009 e0881b2c-c095-4742-ba07-71286ed84d93 TCGA-G9-6367-01A-11D-1785-01 TCGA-G9-6367-01A-11D-1787-05 TCGA-G9-6367-01A-11D-1786-08 TCGA-G9-6367-01A-11D-1786-08 e0881b2c-c095-4742-ba07-71286ed84d93 TCGA-G9-6367-01 TCGA-G9-6367-01 236D0F90-0152-4454-ACC2-D0F5316627CE TCGA-G9-6367-01A-11D-1785-01 e0881b2c-c095-4742-ba07-71286ed84d93 TCGA-G9-6367-01 TCGA-G9-6367-01 TCGA-G9-6367-01A-11D-1786-08 TCGA-G9-6367-01A-11D-1786-08 e0881b2c-c095-4742-ba07-71286ed84d93 +TCGA-G9-6367-11 TCGA-G9-6367-11 TCGA-G9-6367 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-G9-6367-F40631 TCGA-G9-6367 TCGA-G9-6367-11A Normal (no evidence of prostate cancer) [cM0] M0 T2b -22176 30 30 0 1222 836 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Progressive Disease 2013-3-8 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.5 NO YES NO 5 0 No N0 T3a 6367 WITH TUMOR 4 Progressive Disease 0.42 NO R1 Solid Tissue Normal 11 5 0.4 NO 3 NO YES G9 Apex|Base Prostate A LIVING 2009 TCGA-G9-6367-11A-01D-1787-05 +TCGA-G9-6369-01 TCGA-G9-6369-01 TCGA-G9-6369 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-G9-6369-F40640 TCGA-G9-6369 TCGA-G9-6369-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -20238 35 23 0 1215 851 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 1 NO YES NO 21 0 No N0 T2c TCGA-G9-6369.8da381e8-6bab-4b75-9ae3-d7b76f90f044.pdf 6369 TUMOR FREE 4 Complete Remission/Response 0.03 NO R0 Primary Tumor 01 3 0.2 NO NO YES G9 Base Prostate A LIVING 2009 3d626bcf-fa11-443c-ac02-b2a099494189 TCGA-G9-6369-01A-21D-1959-01 TCGA-G9-6369-01A-21D-1963-05 TCGA-G9-6369-01A-21D-1961-08 3d626bcf-fa11-443c-ac02-b2a099494189 TCGA-G9-6369-01 TCGA-G9-6369-01 TCGA-G9-6369-01A-21D-1959-01 3d626bcf-fa11-443c-ac02-b2a099494189 TCGA-G9-6369-01 TCGA-G9-6369-01 TCGA-G9-6369-01A-21D-1961-08 3d626bcf-fa11-443c-ac02-b2a099494189 +TCGA-G9-6370-01 TCGA-G9-6370-01 TCGA-G9-6370 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 52 TCGA-G9-6370-F40638 TCGA-G9-6370 TCGA-G9-6370-01A NO M0 T1c -19149 0 1156 806 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 1.2 NO YES NO 1 0 No N0 T3b TCGA-G9-6370.fa0332e6-d535-45c0-8ed9-9b36816f1350.pdf 6370 TUMOR FREE 3 Complete Remission/Response 0.03 NO R0 Primary Tumor 01 4 0.4 NO NO YES G9 Apex|Base Prostate A LIVING 2009 d964a3c5-aa6c-431c-b179-7e0b70e26e2d TCGA-G9-6370-01A-11D-1785-01 TCGA-G9-6370-01A-11D-1787-05 TCGA-G9-6370-01A-11D-1786-08 TCGA-G9-6370-01A-11D-1786-08 d964a3c5-aa6c-431c-b179-7e0b70e26e2d TCGA-G9-6370-01 TCGA-G9-6370-01 661EDA4E-9E63-4FDD-BDB4-9010BA2B499A TCGA-G9-6370-01A-11D-1785-01 d964a3c5-aa6c-431c-b179-7e0b70e26e2d TCGA-G9-6370-01 TCGA-G9-6370-01 TCGA-G9-6370-01A-11D-1786-08 TCGA-G9-6370-01A-11D-1786-08 d964a3c5-aa6c-431c-b179-7e0b70e26e2d +TCGA-G9-6371-01 TCGA-G9-6371-01 TCGA-G9-6371 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 58 TCGA-G9-6371-F40637 TCGA-G9-6371 TCGA-G9-6371-01A NO M0 T1c -21365 0 1226 846 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 1 NO NO NO No T2c TCGA-G9-6371.26034718-f43a-491d-99fb-934d99ba4a6a.pdf 6371 TUMOR FREE 3 Complete Remission/Response 0.03 NO R1 Primary Tumor 01 3 0.3 NO NO YES G9 Apex|Base Prostate A LIVING 2009 f1503f33-421a-4d7b-8e87-d73f5cbcc760 TCGA-G9-6371-01A-11D-1785-01 TCGA-G9-6371-01A-11D-1787-05 TCGA-G9-6371-01A-11D-1786-08 TCGA-G9-6371-01A-11D-1786-08 f1503f33-421a-4d7b-8e87-d73f5cbcc760 TCGA-G9-6371-01 TCGA-G9-6371-01 837A890A-ED54-4C9F-8A65-A3A1E2391267 TCGA-G9-6371-01A-11D-1785-01 f1503f33-421a-4d7b-8e87-d73f5cbcc760 TCGA-G9-6371-01 TCGA-G9-6371-01 TCGA-G9-6371-01A-11D-1786-08 TCGA-G9-6371-01A-11D-1786-08 f1503f33-421a-4d7b-8e87-d73f5cbcc760 +TCGA-G9-6373-01 TCGA-G9-6373-01 TCGA-G9-6373 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-G9-6373-F40635 TCGA-G9-6373 TCGA-G9-6373-01A Normal (no evidence of prostate cancer) [cM0] M0 T2b -24887 29 0 811 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.9 NO Bilateral 1 NO NO NO No T3a TCGA-G9-6373.ed631fb0-95e4-4b30-963f-1ff4cb4f0ece.pdf 6373 TUMOR FREE 4 Complete Remission/Response NO R0 Primary Tumor 01 3 0.1 NO NO YES G9 Apex|Base Prostate A LIVING 2009 5ed0de42-f949-4046-895b-f97853201a8d TCGA-G9-6373-01A-11D-1785-01 TCGA-G9-6373-01A-11D-1787-05 TCGA-G9-6373-01A-11D-1786-08 TCGA-G9-6373-01A-11D-1786-08 5ed0de42-f949-4046-895b-f97853201a8d TCGA-G9-6373-01 TCGA-G9-6373-01 E22A00A4-A324-478F-BCBD-623FED9198EA TCGA-G9-6373-01A-11D-1785-01 5ed0de42-f949-4046-895b-f97853201a8d TCGA-G9-6373-01 TCGA-G9-6373-01 TCGA-G9-6373-01A-11D-1786-08 5ed0de42-f949-4046-895b-f97853201a8d +TCGA-G9-6373-11 TCGA-G9-6373-11 TCGA-G9-6373 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-G9-6373-F40635 TCGA-G9-6373 TCGA-G9-6373-11A Normal (no evidence of prostate cancer) [cM0] M0 T2b -24887 29 0 811 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 2.5 NO NO NO No T3a 6373 TUMOR FREE 4 Complete Remission/Response NO R0 Solid Tissue Normal 11 3 0.2 NO NO YES G9 Apex|Base Prostate A LIVING 2009 TCGA-G9-6373-11A-01D-1787-05 +TCGA-G9-6377-01 TCGA-G9-6377-01 TCGA-G9-6377 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-G9-6377-F40633 TCGA-G9-6377 TCGA-G9-6377-01A NO Abnormal (not related to prostate cancer) M0 T2b -22419 36 11 0 958 518 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 1.4 NO YES NO 6 0 No N0 T2c TCGA-G9-6377.520abbf9-817a-45db-aecc-22c4fc80ddae.pdf 6377 TUMOR FREE 3 Complete Remission/Response 0.03 NO R0 Primary Tumor 01 4 0.2 NO NO YES G9 Apex|Base Prostate A LIVING 2009 47d13480-7771-450a-ab70-07c8ca2eb14f TCGA-G9-6377-01A-11D-1959-01 TCGA-G9-6377-01A-11D-1963-05 TCGA-G9-6377-01A-11D-1961-08 47d13480-7771-450a-ab70-07c8ca2eb14f TCGA-G9-6377-01 TCGA-G9-6377-01 6BA4F223-DC52-474F-87C0-A362EA498FB0 TCGA-G9-6377-01A-11D-1959-01 47d13480-7771-450a-ab70-07c8ca2eb14f TCGA-G9-6377-01 TCGA-G9-6377-01 TCGA-G9-6377-01A-11D-1961-08 TCGA-G9-6377-01A-11D-1961-08 47d13480-7771-450a-ab70-07c8ca2eb14f +TCGA-G9-6378-01 TCGA-G9-6378-01 TCGA-G9-6378 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 54 TCGA-G9-6378-F40630 TCGA-G9-6378 TCGA-G9-6378-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -19879 -176 100 0 1155 223 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.9 NO Bilateral 1.2 NO NO NO No T2c TCGA-G9-6378.425008c5-919c-45b3-beb7-2392d6866ffb.pdf 6378 TUMOR FREE 3 Complete Remission/Response 0.03 NO R1 Primary Tumor 01 4 0.2 NO NO YES G9 Apex|Base Prostate A LIVING 2009 02334a5d-c3a2-4ea6-8e4e-d603a8fbc43c TCGA-G9-6378-01A-11D-1785-01 TCGA-G9-6378-01A-11D-1787-05 TCGA-G9-6378-01A-11D-1786-08 TCGA-G9-6378-01A-11D-1786-08 02334a5d-c3a2-4ea6-8e4e-d603a8fbc43c TCGA-G9-6378-01 TCGA-G9-6378-01 9EE8BD41-956E-4AB2-B578-5C05E9E08578 TCGA-G9-6378-01A-11D-1785-01 02334a5d-c3a2-4ea6-8e4e-d603a8fbc43c TCGA-G9-6378-01 TCGA-G9-6378-01 TCGA-G9-6378-01A-11D-1786-08 TCGA-G9-6378-01A-11D-1786-08 02334a5d-c3a2-4ea6-8e4e-d603a8fbc43c +TCGA-G9-6379-01 TCGA-G9-6379-01 TCGA-G9-6379 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-G9-6379-F66664 TCGA-G9-6379 TCGA-G9-6379-01A NO M0 T1b -25126 0 1778 1393 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-22 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.5 NO YES NO 6 0 No N0 T3b TCGA-G9-6379.A097CB29-5440-45F9-B261-025603C37CEF.pdf 6379 TUMOR FREE 4 Complete Remission/Response 00.03 NO R1 Primary Tumor 01 3 0.4 NO 5 NO YES G9 Apex Prostate A LIVING 2009 edc61caa-7008-45ba-b69b-8998ad510549 TCGA-G9-6379-01A-11D-A31K-01 TCGA-G9-6379-01A-11D-A31M-05 TCGA-G9-6379-01A-11D-A31L-08 edc61caa-7008-45ba-b69b-8998ad510549 TCGA-G9-6379-01 TCGA-G9-6379-01 6C9DE27B-1BA3-4466-8D4C-21875C2A0364 TCGA-G9-6379-01A-11D-A31K-01 edc61caa-7008-45ba-b69b-8998ad510549 TCGA-G9-6379-01 TCGA-G9-6379-01 TCGA-G9-6379-01A-11D-A31L-08 edc61caa-7008-45ba-b69b-8998ad510549 +TCGA-G9-6384-01 TCGA-G9-6384-01 TCGA-G9-6384 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 53 TCGA-G9-6384-F40625 TCGA-G9-6384 TCGA-G9-6384-01A NO M0 T1c -19620 0 765 390 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.7 NO Bilateral 1.2 NO YES NO 14 0 No N0 T3a TCGA-G9-6384.6987c1c1-6e23-44f0-bba8-6bba4a288025.pdf 6384 TUMOR FREE 3 Complete Remission/Response 0.03 NO R0 Primary Tumor 01 4 0.6 NO NO YES G9 Apex|Base Prostate A LIVING 2010 30e19950-9bbe-4952-8308-41689e57430c TCGA-G9-6384-01A-11D-1785-01 TCGA-G9-6384-01A-11D-1787-05 TCGA-G9-6384-01A-11D-1786-08 TCGA-G9-6384-01A-11D-1786-08 30e19950-9bbe-4952-8308-41689e57430c TCGA-G9-6384-01 TCGA-G9-6384-01 7AEAE7AC-64AC-472B-B93E-362036E8C058 TCGA-G9-6384-01A-11D-1785-01 30e19950-9bbe-4952-8308-41689e57430c TCGA-G9-6384-01 TCGA-G9-6384-01 TCGA-G9-6384-01A-11D-1786-08 TCGA-G9-6384-01A-11D-1786-08 30e19950-9bbe-4952-8308-41689e57430c +TCGA-G9-6384-11 TCGA-G9-6384-11 TCGA-G9-6384 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 53 TCGA-G9-6384-F40625 TCGA-G9-6384 TCGA-G9-6384-11A NO M0 T1c -19620 0 765 390 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.7 NO Bilateral 1 NO YES NO 14 0 No N0 T3a 6384 TUMOR FREE 3 Complete Remission/Response 0.03 NO R0 Solid Tissue Normal 11 4 0.3 NO NO YES G9 Apex|Base Prostate A LIVING 2010 36973833-7245-444f-94e9-062e6b83df14 TCGA-G9-6384-11A-01D-1787-05 36973833-7245-444f-94e9-062e6b83df14 TCGA-G9-6384-11 36973833-7245-444f-94e9-062e6b83df14 TCGA-G9-6384-11 36973833-7245-444f-94e9-062e6b83df14 +TCGA-G9-6385-01 TCGA-G9-6385-01 TCGA-G9-6385 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-G9-6385-F40620 TCGA-G9-6385 NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -24399 12 0 830 336 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO NO NO No T2c 6385 TUMOR FREE 3 Complete Remission/Response 0.064 NO R0 Primary Tumor 01 4 NO NO YES G9 Base Prostate LIVING 2010 c72a1f85-6eb7-45ef-ac30-f695d87226ed TCGA-G9-6385-01A-11D-1785-01 TCGA-G9-6385-01A-11D-1787-05 TCGA-G9-6385-01A-11D-1786-08 TCGA-G9-6385-01A-11D-1786-08 c72a1f85-6eb7-45ef-ac30-f695d87226ed TCGA-G9-6385-01 TCGA-G9-6385-01 TCGA-G9-6385-01A-11D-1785-01 c72a1f85-6eb7-45ef-ac30-f695d87226ed TCGA-G9-6385-01 TCGA-G9-6385-01 TCGA-G9-6385-01A-11D-1786-08 TCGA-G9-6385-01A-11D-1786-08 c72a1f85-6eb7-45ef-ac30-f695d87226ed +TCGA-G9-6385-11 TCGA-G9-6385-11 TCGA-G9-6385 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-G9-6385-F40620 TCGA-G9-6385 TCGA-G9-6385-11A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -24399 12 0 830 336 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.3 NO NO NO No T2c 6385 TUMOR FREE 3 Complete Remission/Response 0.064 NO R0 Solid Tissue Normal 11 4 0.3 NO NO YES G9 Base Prostate A LIVING 2010 TCGA-G9-6385-11A-01D-1787-05 +TCGA-G9-6494-01 TCGA-G9-6494-01 TCGA-G9-6494 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-G9-6494-F41058 TCGA-G9-6494 TCGA-G9-6494-01A Normal (no evidence of prostate cancer) [cM0] M0 T1c -24381 -13 -13 0 1771 1423 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Progressive Disease 2013-3-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.7 NO YES NO 2 0 No N0 T4 TCGA-G9-6494.9aad0222-0731-498b-a9c2-400ce0ccfa0d.pdf 6494 WITH TUMOR 4 Progressive Disease 1.13 NO R1 Primary Tumor 01 3 0.4 NO NO YES G9 Base Prostate A LIVING 2008 8a2f149d-34a9-4be2-8bc5-d3d25f1df7e3 TCGA-G9-6494-01A-11D-1785-01 TCGA-G9-6494-01A-11D-1787-05 TCGA-G9-6494-01A-11D-1786-08 TCGA-G9-6494-01A-11D-1786-08 8a2f149d-34a9-4be2-8bc5-d3d25f1df7e3 TCGA-G9-6494-01 TCGA-G9-6494-01 F22871CE-C484-455D-8446-DBE2A62AE7C4 TCGA-G9-6494-01A-11D-1785-01 8a2f149d-34a9-4be2-8bc5-d3d25f1df7e3 TCGA-G9-6494-01 TCGA-G9-6494-01 TCGA-G9-6494-01A-11D-1786-08 TCGA-G9-6494-01A-11D-1786-08 8a2f149d-34a9-4be2-8bc5-d3d25f1df7e3 +TCGA-G9-6494-11 TCGA-G9-6494-11 TCGA-G9-6494 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-G9-6494-F41058 TCGA-G9-6494 TCGA-G9-6494-11A Normal (no evidence of prostate cancer) [cM0] M0 T1c -24381 -13 -13 0 1771 1423 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Progressive Disease 2013-3-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 1.5 NO YES NO 2 0 No N0 T4 6494 WITH TUMOR 4 Progressive Disease 1.13 NO R1 Solid Tissue Normal 11 3 0.5 NO NO YES G9 Base Prostate A LIVING 2008 TCGA-G9-6494-11A-01D-1787-05 +TCGA-G9-6496-01 TCGA-G9-6496-01 TCGA-G9-6496 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-G9-6496-F41001 TCGA-G9-6496 TCGA-G9-6496-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -22602 19 20 0 1726 703 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-3-8 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.2 NO YES NO 15 0 No N0 T2c TCGA-G9-6496.193cca51-2d1f-49aa-afdb-63a55d689c86.pdf 6496 TUMOR FREE 4 Complete Remission/Response 0.03 NO R0 Primary Tumor 01 3 0.5 NO NO YES G9 Apex|Base Prostate A LIVING 2008 6a2c4d22-f7b6-4e0a-bd71-a669786da5b1 TCGA-G9-6496-01A-11D-1785-01 TCGA-G9-6496-01A-11D-1787-05 TCGA-G9-6496-01A-11D-1786-08 TCGA-G9-6496-01A-11D-1786-08 6a2c4d22-f7b6-4e0a-bd71-a669786da5b1 TCGA-G9-6496-01 TCGA-G9-6496-01 E5EBFB91-E2C6-47C1-8719-F596466B36A7 TCGA-G9-6496-01A-11D-1785-01 6a2c4d22-f7b6-4e0a-bd71-a669786da5b1 TCGA-G9-6496-01 TCGA-G9-6496-01 TCGA-G9-6496-01A-11D-1786-08 6a2c4d22-f7b6-4e0a-bd71-a669786da5b1 +TCGA-G9-6496-11 TCGA-G9-6496-11 TCGA-G9-6496 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-G9-6496-F41001 TCGA-G9-6496 TCGA-G9-6496-11A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -22602 19 20 0 1726 703 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-3-8 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1.2 NO Bilateral 1.7 NO YES NO 15 0 No N0 T2c 6496 TUMOR FREE 4 Complete Remission/Response 0.03 NO R0 Solid Tissue Normal 11 3 0.5 NO NO YES G9 Apex|Base Prostate A LIVING 2008 7aa49ecf-9e25-4166-9ed2-487c41f1066c TCGA-G9-6496-11A-01D-1787-05 7aa49ecf-9e25-4166-9ed2-487c41f1066c TCGA-G9-6496-11 7aa49ecf-9e25-4166-9ed2-487c41f1066c TCGA-G9-6496-11 7aa49ecf-9e25-4166-9ed2-487c41f1066c +TCGA-G9-6498-01 TCGA-G9-6498-01 TCGA-G9-6498 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 53 TCGA-G9-6498-F65343 TCGA-G9-6498 TCGA-G9-6498-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -19568 47 1342 0 1952 1608 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-22 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 1.3 NO NO NO No T3a TCGA-G9-6498.0F610D96-54E9-4E40-B3D4-19554C782057.pdf 6498 TUMOR FREE 3 Complete Remission/Response 00.03 NO R1 Primary Tumor 01 4 0.4 NO NO YES G9 Apex Prostate A LIVING 2008 1b8f8f6d-a1c4-43b3-ae29-7fb64e512b83 TCGA-G9-6498-01A-12D-A30W-01 TCGA-G9-6498-01A-12D-A30Z-05 TCGA-G9-6498-01A-12D-A30X-08 1b8f8f6d-a1c4-43b3-ae29-7fb64e512b83 TCGA-G9-6498-01 TCGA-G9-6498-01 E8DBE708-FF85-4793-8778-8DC3EA7542EE TCGA-G9-6498-01A-12D-A30W-01 1b8f8f6d-a1c4-43b3-ae29-7fb64e512b83 TCGA-G9-6498-01 TCGA-G9-6498-01 TCGA-G9-6498-01A-12D-A30X-08 1b8f8f6d-a1c4-43b3-ae29-7fb64e512b83 +TCGA-G9-6499-01 TCGA-G9-6499-01 TCGA-G9-6499 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-G9-6499-F41000 TCGA-G9-6499 TCGA-G9-6499-01A NO Equivocal M0 T3a -24388 56 421 0 1543 1109 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-3-8 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.4 NO YES NO 13 0 No N0 T3a TCGA-G9-6499.8e1d4212-b252-4019-b188-3cdd60be733d.pdf 6499 TUMOR FREE 4 Complete Remission/Response 0.11 NO R0 Primary Tumor 01 5 0.3 NO NO YES G9 Apex|Base Prostate A LIVING 2008 a597168e-2c74-4e79-b863-45c94ac8efa1 TCGA-G9-6499-01A-12D-1959-01 TCGA-G9-6499-01A-12D-1963-05 TCGA-G9-6499-01A-12D-1961-08 a597168e-2c74-4e79-b863-45c94ac8efa1 TCGA-G9-6499-01 TCGA-G9-6499-01 8452B7C0-AB4D-402F-A9FF-513FABC3E7ED TCGA-G9-6499-01A-12D-1959-01 a597168e-2c74-4e79-b863-45c94ac8efa1 TCGA-G9-6499-01 TCGA-G9-6499-01 TCGA-G9-6499-01A-12D-1961-08 TCGA-G9-6499-01A-12D-1961-08 a597168e-2c74-4e79-b863-45c94ac8efa1 +TCGA-G9-6499-11 TCGA-G9-6499-11 TCGA-G9-6499 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-G9-6499-F41000 TCGA-G9-6499 TCGA-G9-6499-11A NO Equivocal M0 T3a -24388 56 421 0 1543 1109 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-3-8 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 60 1 NO Bilateral 1.5 NO YES NO 13 0 No N0 T3a 6499 TUMOR FREE 4 Complete Remission/Response 0.11 NO R0 Solid Tissue Normal 11 5 0.5 NO NO YES G9 Apex|Base Prostate A LIVING 2008 0cb961d7-87be-40c2-b703-3e424b8c8e78 TCGA-G9-6499-11A-02D-1963-05 0cb961d7-87be-40c2-b703-3e424b8c8e78 TCGA-G9-6499-11 0cb961d7-87be-40c2-b703-3e424b8c8e78 TCGA-G9-6499-11 0cb961d7-87be-40c2-b703-3e424b8c8e78 +TCGA-G9-7509-01 TCGA-G9-7509-01 TCGA-G9-7509 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 48 TCGA-G9-7509-F65350 TCGA-G9-7509 NO M0 T1c -17538 0 1610 352 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-22 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO NO NO No T2c 7509 TUMOR FREE 3 Complete Remission/Response 0.03 NO R0 Primary Tumor 01 3 NO 4 NO YES G9 Apex|Middle|Base Prostate LIVING 2009 b5d317d7-382e-4695-9f30-bb6664b3189f TCGA-G9-7509-01A-11D-A41J-01 TCGA-G9-7509-01A-11D-A41L-05 TCGA-G9-7509-01A-11D-A41K-08 b5d317d7-382e-4695-9f30-bb6664b3189f TCGA-G9-7509-01 TCGA-G9-7509-01 TCGA-G9-7509-01A-11D-A41J-01 b5d317d7-382e-4695-9f30-bb6664b3189f TCGA-G9-7509-01 TCGA-G9-7509-01 b5d317d7-382e-4695-9f30-bb6664b3189f +TCGA-G9-7510-01 TCGA-G9-7510-01 TCGA-G9-7510 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-G9-7510-F48752 TCGA-G9-7510 TCGA-G9-7510-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -24187 22 22 0 1185 674 YES Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1] NO Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.9 NO Bilateral 1.6 NO YES NO 10 0 No N0 T3a TCGA-G9-7510.11c8711a-57c0-41fe-82fa-2e9592fef570.pdf 7510 TUMOR FREE 4 Complete Remission/Response 0.03 NO R1 Primary Tumor 01 4 0.5 NO 5 NO YES G9 Apex Prostate A LIVING 2010 c969c5c7-c72e-4e8f-9213-8ab2f192c845 TCGA-G9-7510-01A-11D-2259-01 TCGA-G9-7510-01A-11D-2261-05 TCGA-G9-7510-01A-11D-2260-08 c969c5c7-c72e-4e8f-9213-8ab2f192c845 TCGA-G9-7510-01 TCGA-G9-7510-01 075BD106-9C0B-424C-90D1-BDECE264407C TCGA-G9-7510-01A-11D-2259-01 c969c5c7-c72e-4e8f-9213-8ab2f192c845 TCGA-G9-7510-01 TCGA-G9-7510-01 TCGA-G9-7510-01A-11D-2260-08 TCGA-G9-7510-01A-11D-2260-08 c969c5c7-c72e-4e8f-9213-8ab2f192c845 +TCGA-G9-7519-01 TCGA-G9-7519-01 TCGA-G9-7519 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 58 TCGA-G9-7519-F48751 TCGA-G9-7519 TCGA-G9-7519-01A NO Abnormal (not related to prostate cancer) M0 T1c -21276 7 7 0 849 457 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Bilateral 1.1 NO NO NO No T2c TCGA-G9-7519.07227b7d-9285-4d1b-9484-ccdb20841905.pdf 7519 TUMOR FREE 3 Complete Remission/Response 0.03 NO R0 Primary Tumor 01 4 0.7 NO NO YES G9 Apex|Base Prostate A LIVING 2010 104e14d3-f1d5-443f-88fd-6d67c98b1eff TCGA-G9-7519-01A-11D-2259-01 TCGA-G9-7519-01A-11D-2261-05 TCGA-G9-7519-01A-11D-2260-08 104e14d3-f1d5-443f-88fd-6d67c98b1eff TCGA-G9-7519-01 TCGA-G9-7519-01 TCGA-G9-7519-01A-11D-2259-01 104e14d3-f1d5-443f-88fd-6d67c98b1eff TCGA-G9-7519-01 TCGA-G9-7519-01 TCGA-G9-7519-01A-11D-2260-08 TCGA-G9-7519-01A-11D-2260-08 104e14d3-f1d5-443f-88fd-6d67c98b1eff +TCGA-G9-7521-01 TCGA-G9-7521-01 TCGA-G9-7521 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 52 TCGA-G9-7521-F48747 TCGA-G9-7521 TCGA-G9-7521-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T3a -19216 13 12 45 0 942 487 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Progressive Disease 2013-9-20 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Bilateral 0.9 NO YES NO 9 1 No N1 T3a TCGA-G9-7521.b0a188e3-c084-4e2d-93dd-31de3a3f47e6.pdf 7521 TUMOR FREE 4 [Discrepancy] 0.06 NO R0 Primary Tumor 01 4 0.2 YES 5 NO YES G9 Apex|Base Prostate A LIVING 2010 c3841b03-197a-4cd1-9331-02fde85bcb55 TCGA-G9-7521-01A-11D-2259-01 TCGA-G9-7521-01A-11D-2261-05 TCGA-G9-7521-01A-11D-2260-08 c3841b03-197a-4cd1-9331-02fde85bcb55 TCGA-G9-7521-01 TCGA-G9-7521-01 28F62670-5FB9-4BCC-9E9F-AF8119B2A924 TCGA-G9-7521-01A-11D-2259-01 c3841b03-197a-4cd1-9331-02fde85bcb55 TCGA-G9-7521-01 TCGA-G9-7521-01 TCGA-G9-7521-01A-11D-2260-08 TCGA-G9-7521-01A-11D-2260-08 c3841b03-197a-4cd1-9331-02fde85bcb55 +TCGA-G9-7522-01 TCGA-G9-7522-01 TCGA-G9-7522 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 49 TCGA-G9-7522-F61288 TCGA-G9-7522 TCGA-G9-7522-01A NO M0 T1c -18033 0 1078 452 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-26 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.9 NO Bilateral 1.1 NO YES NO 9 0 No N0 T2c TCGA-G9-7522.8d3c4720-f528-4a73-b2f0-95b2aac093f2.pdf 7522 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.4 NO NO YES G9 Apex Prostate A LIVING 2011 79ff57d5-3224-4195-aa64-32ccd6d23e27 TCGA-G9-7522-01A-11D-2259-01 TCGA-G9-7522-01A-11D-2261-05 TCGA-G9-7522-01A-11D-2260-08 79ff57d5-3224-4195-aa64-32ccd6d23e27 TCGA-G9-7522-01 TCGA-G9-7522-01 D7FFB71D-C1DE-4BE4-8BDC-68CF02134A65 TCGA-G9-7522-01A-11D-2259-01 79ff57d5-3224-4195-aa64-32ccd6d23e27 TCGA-G9-7522-01 TCGA-G9-7522-01 TCGA-G9-7522-01A-11D-2260-08 TCGA-G9-7522-01A-11D-2260-08 79ff57d5-3224-4195-aa64-32ccd6d23e27 +TCGA-G9-7523-01 TCGA-G9-7523-01 TCGA-G9-7523 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 44 TCGA-G9-7523-F48753 TCGA-G9-7523 TCGA-G9-7523-01A NO Abnormal (not related to prostate cancer) M0 T1c -16269 20 20 0 857 324 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 MALE 10 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Bilateral 1.4 NO YES NO 10 0 No N0 T3a TCGA-G9-7523.8a16d779-bcf3-4371-87ec-3cd68330b1d6.pdf 7523 TUMOR FREE 5 Complete Remission/Response 0.03 NO R1 Primary Tumor 01 5 0.3 NO NO YES G9 Apex|Base Prostate A LIVING 2011 5f4f5adc-cebd-473a-94c7-b93426be2b95 TCGA-G9-7523-01A-11D-2259-01 TCGA-G9-7523-01A-11D-2261-05 TCGA-G9-7523-01A-11D-2260-08 5f4f5adc-cebd-473a-94c7-b93426be2b95 TCGA-G9-7523-01 TCGA-G9-7523-01 75D8D91C-63A8-46D0-A807-6E9866561892 TCGA-G9-7523-01A-11D-2259-01 5f4f5adc-cebd-473a-94c7-b93426be2b95 TCGA-G9-7523-01 TCGA-G9-7523-01 TCGA-G9-7523-01A-11D-2260-08 TCGA-G9-7523-01A-11D-2260-08 5f4f5adc-cebd-473a-94c7-b93426be2b95 +TCGA-G9-7525-01 TCGA-G9-7525-01 TCGA-G9-7525 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-G9-7525-F48745 TCGA-G9-7525 TCGA-G9-7525-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -23481 12 12 0 994 512 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.9 NO Bilateral 1.8 NO YES NO 6 0 No N0 T2c TCGA-G9-7525.837a5284-61ec-4a13-9743-010fc6a8df6a.pdf 7525 TUMOR FREE 4 Complete Remission/Response 0.03 NO R0 Primary Tumor 01 3 0.4 NO NO YES G9 Base Prostate A LIVING 2010 e0888e7a-a0d3-4016-8ed2-8818c332aeea TCGA-G9-7525-01A-31D-2259-01 TCGA-G9-7525-01A-31D-2261-05 TCGA-G9-7525-01A-31D-2260-08 e0888e7a-a0d3-4016-8ed2-8818c332aeea TCGA-G9-7525-01 TCGA-G9-7525-01 05FBCA7E-B3A1-4E9D-8B97-9B99184A6FE9 TCGA-G9-7525-01A-31D-2259-01 e0888e7a-a0d3-4016-8ed2-8818c332aeea TCGA-G9-7525-01 TCGA-G9-7525-01 TCGA-G9-7525-01A-31D-2260-08 e0888e7a-a0d3-4016-8ed2-8818c332aeea +TCGA-G9-A9S0-01 TCGA-G9-A9S0-01 TCGA-G9-A9S0 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 53 TCGA-G9-A9S0-F60806 TCGA-G9-A9S0 TCGA-G9-A9S0-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T2a -19530 73 840 791 73 429 0 650 759 YES No Evidence of Extraprostatic Extension NO Additional New Tumor Event Progressive Disease 2014-6-17 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Transurethral resection (TURBT) 130 NO Bilateral NO YES Other, specify Distant Metastasis Lung and Liver YES 13 5 true No N1 T3b TCGA-G9-A9S0.2E6B54C4-BC0A-46E3-A3F9-B55CEB1B1ECD.pdf Prostate Cancer A9S0 WITH TUMOR 4 Complete Remission/Response 10.87 YES R1 Primary Tumor 01 4 Medical Record YES 5 NO YES G9 Apex|Middle|Base YES Prostate Distant Metastasis A DECEASED 2011 Overlapping / Multiple Zones 22cc7838-fc6a-431b-b25a-07ca943a6f48 TCGA-G9-A9S0-01A-11D-A41J-01 TCGA-G9-A9S0-01A-11D-A41L-05 TCGA-G9-A9S0-01A-11D-A41K-08 22cc7838-fc6a-431b-b25a-07ca943a6f48 TCGA-G9-A9S0-01 TCGA-G9-A9S0-01 D14CE3A5-6656-4629-83C6-1E3F97F5975E TCGA-G9-A9S0-01A-11D-A41J-01 22cc7838-fc6a-431b-b25a-07ca943a6f48 TCGA-G9-A9S0-01 TCGA-G9-A9S0-01 22cc7838-fc6a-431b-b25a-07ca943a6f48 +TCGA-G9-A9S4-01 TCGA-G9-A9S4-01 TCGA-G9-A9S4 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-G9-A9S4-F66995 TCGA-G9-A9S4 TCGA-G9-A9S4-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2a -22684 14 610 14 0 906 753 YES Extraprostatic Extension Localized (e.g. seminal vesicles) NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-29 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 180 NO Bilateral NO YES NO 10 4 true No N1 T3b TCGA-G9-A9S4.0507DFC9-971C-46F3-BC03-AACA10A49202.pdf A9S4 TUMOR FREE 4 Complete Remission/Response 0.03 NO R1 Primary Tumor 01 4 YES 5 NO YES G9 Apex|Middle|Base Prostate A LIVING 2012 Overlapping / Multiple Zones e41ecd5a-af8e-4852-991a-026efa65e442 TCGA-G9-A9S4-01A-11D-A41L-05 TCGA-G9-A9S4-01A-11D-A41K-08 e41ecd5a-af8e-4852-991a-026efa65e442 TCGA-G9-A9S4-01 TCGA-G9-A9S4-01 DABBFE73-E93A-4139-806C-0CB24B428F09 e41ecd5a-af8e-4852-991a-026efa65e442 TCGA-G9-A9S4-01 e41ecd5a-af8e-4852-991a-026efa65e442 +TCGA-G9-A9S7-01 TCGA-G9-A9S7-01 TCGA-G9-A9S7 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-G9-A9S7-F66989 TCGA-G9-A9S7 TCGA-G9-A9S7-01A NO Abnormal (not related to prostate cancer) M0 T2a -20213 32 452 32 0 728 643 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Partial Remission/Response 2014-10-29 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 170 NO Bilateral NO YES NO 8 0 true No N0 T3a TCGA-G9-A9S7.32AD969B-10BB-4FA2-872B-D789382CD3CC.pdf A9S7 WITH TUMOR 4 Partial Remission/Response 0.13 YES R0 Primary Tumor 01 4 NO NO YES G9 Apex|Middle Prostate A LIVING 2012 Overlapping / Multiple Zones d04b0992-91fb-4af2-92cd-dbb361a1b83f TCGA-G9-A9S7-01A-11D-A41J-01 TCGA-G9-A9S7-01A-11D-A41L-05 TCGA-G9-A9S7-01A-11D-A41K-08 d04b0992-91fb-4af2-92cd-dbb361a1b83f TCGA-G9-A9S7-01 TCGA-G9-A9S7-01 C8A9A75B-19E8-413E-BB04-CCD62A432551 TCGA-G9-A9S7-01A-11D-A41J-01 d04b0992-91fb-4af2-92cd-dbb361a1b83f TCGA-G9-A9S7-01 TCGA-G9-A9S7-01 d04b0992-91fb-4af2-92cd-dbb361a1b83f +TCGA-H9-7775-01 TCGA-H9-7775-01 TCGA-H9-7775 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-H9-7775-F37932 TCGA-H9-7775 TCGA-H9-7775-01A NO -24898 0 185 73 Scheduled Follow-up Submission Complete Remission/Response 2012-12-6 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Right 1 YES NO NO No T2c TCGA-H9-7775.2a752788-15f1-4879-96a7-eaf5dfa6921d.pdf 7775 TUMOR FREE 3 Complete Remission/Response 0.04 NO Primary Tumor 01 4 0.4 NO 0 YES NO H9 Prostate A LIVING 2011 8c9b95d4-ee46-4312-ba8c-8000c9988ee8 TCGA-H9-7775-01A-11D-2112-01 TCGA-H9-7775-01A-11D-2116-05 TCGA-H9-7775-01A-11D-2114-08 8c9b95d4-ee46-4312-ba8c-8000c9988ee8 TCGA-H9-7775-01 TCGA-H9-7775-01 49F8D1FD-0D46-4BCD-9EDA-5B65E8D44702 TCGA-H9-7775-01A-11D-2112-01 8c9b95d4-ee46-4312-ba8c-8000c9988ee8 TCGA-H9-7775-01 TCGA-H9-7775-01 TCGA-H9-7775-01A-11D-2114-08 TCGA-H9-7775-01A-11D-2114-08 8c9b95d4-ee46-4312-ba8c-8000c9988ee8 +TCGA-H9-A6BX-01 TCGA-H9-A6BX-01 TCGA-H9-A6BX TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-H9-A6BX-F63936 TCGA-H9-A6BX TCGA-H9-A6BX-01A NO -22039 479 0 941 570 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-8-21 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES 190 NO Bilateral NO NO NO false No T2c TCGA-H9-A6BX.5AEA61BF-A79E-4A8A-B3F1-45982DAF288E.pdf A6BX TUMOR FREE 3 Complete Remission/Response 0.04 NO R0 Primary Tumor 01 3 NO YES NO H9 Prostate A LIVING 2012 ba7eb097-85ab-40fd-86dc-1e5aeb388843 TCGA-H9-A6BX-01A-31D-A30W-01 TCGA-H9-A6BX-01A-31D-A30Z-05 TCGA-H9-A6BX-01A-31D-A30X-08 ba7eb097-85ab-40fd-86dc-1e5aeb388843 TCGA-H9-A6BX-01 TCGA-H9-A6BX-01 8FFDCA02-C4DE-4D31-8543-7A991F96C0F3 TCGA-H9-A6BX-01A-31D-A30W-01 ba7eb097-85ab-40fd-86dc-1e5aeb388843 TCGA-H9-A6BX-01 TCGA-H9-A6BX-01 TCGA-H9-A6BX-01A-31D-A30X-08 ba7eb097-85ab-40fd-86dc-1e5aeb388843 +TCGA-H9-A6BY-01 TCGA-H9-A6BY-01 TCGA-H9-A6BY TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-H9-A6BY-F58346 TCGA-H9-A6BY TCGA-H9-A6BY-01A T1c -23297 303 0 112 Scheduled Follow-up Submission 2014-4-7 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 120 NO Bilateral YES YES NO 19 0 false No N0 T3a TCGA-H9-A6BY.87EDA3C6-8BAC-49FD-8592-1D38812660E6.pdf A6BY 3 RX Primary Tumor 01 4 YES NO H9 Prostate A LIVING 2012 Overlapping / Multiple Zones d6c9e56e-c040-40ff-a71b-74bd4a2d431c TCGA-H9-A6BY-01A-11D-A30D-01 TCGA-H9-A6BY-01A-11D-A30F-05 TCGA-H9-A6BY-01A-11D-A30E-08 d6c9e56e-c040-40ff-a71b-74bd4a2d431c TCGA-H9-A6BY-01 TCGA-H9-A6BY-01 983C6816-B0C5-431C-9ACE-5287D0F35D5B TCGA-H9-A6BY-01A-11D-A30D-01 d6c9e56e-c040-40ff-a71b-74bd4a2d431c TCGA-H9-A6BY-01 TCGA-H9-A6BY-01 TCGA-H9-A6BY-01A-11D-A30E-08 d6c9e56e-c040-40ff-a71b-74bd4a2d431c +TCGA-HC-7075-01 TCGA-HC-7075-01 TCGA-HC-7075 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-HC-7075-F45566 TCGA-HC-7075 M0 T1c 0 601 96 Scheduled Follow-up Submission Complete Remission/Response 2013-7-17 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Right NO NO NO No T2a 7075 TUMOR FREE 3 Complete Remission/Response .01 NO R0 Primary Tumor 01 3 NO NO YES HC Prostate LIVING 2010 ee8dbce4-8e78-42dd-b090-8de64629f92f TCGA-HC-7075-01A-11D-1959-01 TCGA-HC-7075-01A-11D-1963-05 TCGA-HC-7075-01A-11D-1961-08 ee8dbce4-8e78-42dd-b090-8de64629f92f TCGA-HC-7075-01 TCGA-HC-7075-01 TCGA-HC-7075-01A-11D-1959-01 ee8dbce4-8e78-42dd-b090-8de64629f92f TCGA-HC-7075-01 TCGA-HC-7075-01 TCGA-HC-7075-01A-11D-1961-08 TCGA-HC-7075-01A-11D-1961-08 ee8dbce4-8e78-42dd-b090-8de64629f92f +TCGA-HC-7077-01 TCGA-HC-7077-01 TCGA-HC-7077 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-HC-7077-F47784 TCGA-HC-7077 TCGA-HC-7077-01A Normal (no evidence of prostate cancer) [cM0] M0 T1c -23636 -14 0 2115 1749 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Transurethral resection (TURBT) 0.5 NO Bilateral 1.1 NO NO NO No T3a TCGA-HC-7077.67940700-dcd0-4e3c-9cca-4f6daeacf34c.pdf 7077 TUMOR FREE 3 Complete Remission/Response .83 NO R0 Primary Tumor 01 3 0.1 NO NO YES HC Prostate A LIVING 2006 5330437a-0b3d-4249-9c70-a5f967f989de TCGA-HC-7077-01A-11D-1959-01 TCGA-HC-7077-01A-11D-1963-05 TCGA-HC-7077-01A-11D-1961-08 5330437a-0b3d-4249-9c70-a5f967f989de TCGA-HC-7077-01 TCGA-HC-7077-01 9DBBA55C-BD0C-47E4-A1DF-E4F80130BF60 TCGA-HC-7077-01A-11D-1959-01 5330437a-0b3d-4249-9c70-a5f967f989de TCGA-HC-7077-01 TCGA-HC-7077-01 TCGA-HC-7077-01A-11D-1961-08 TCGA-HC-7077-01A-11D-1961-08 5330437a-0b3d-4249-9c70-a5f967f989de +TCGA-HC-7078-01 TCGA-HC-7078-01 TCGA-HC-7078 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 69 TCGA-HC-7078-F47785 TCGA-HC-7078 Normal (no evidence of prostate cancer) [cM0] M0 T1c -25402 0 1985 1409 NO No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 3 0 No N0 T3a 7078 TUMOR FREE 3 Complete Remission/Response .01 NO R0 Primary Tumor 01 4 NO NO YES HC Prostate LIVING 2007 c1188eb0-1e8b-4451-b9bc-312f33bb9fd3 TCGA-HC-7078-01A-11D-2112-01 TCGA-HC-7078-01A-11D-2116-05 TCGA-HC-7078-01A-11D-2114-08 c1188eb0-1e8b-4451-b9bc-312f33bb9fd3 TCGA-HC-7078-01 TCGA-HC-7078-01 TCGA-HC-7078-01A-11D-2112-01 c1188eb0-1e8b-4451-b9bc-312f33bb9fd3 TCGA-HC-7078-01 TCGA-HC-7078-01 TCGA-HC-7078-01A-11D-2114-08 TCGA-HC-7078-01A-11D-2114-08 c1188eb0-1e8b-4451-b9bc-312f33bb9fd3 +TCGA-HC-7079-01 TCGA-HC-7079-01 TCGA-HC-7079 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO YES 51 TCGA-HC-7079-F64395 TCGA-HC-7079 TCGA-HC-7079-01A M0 T3a -18734 380 0 1184 380 126 929 NO NO Scheduled Follow-up Submission Stable Disease 2014-8-29 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 0.9 NO YES Biochemical evidence of disease YES 4 0 No N0 T3a TCGA-HC-7079.8e42fce1-33e7-45e1-b8e9-2faf5a02766d.pdf 7079 WITH TUMOR 3 Partial Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.3 NO NO YES HC Apex|Middle|Base Prostate A LIVING 2010 0a67e3de-1840-44f1-ae19-14f3c2df230c TCGA-HC-7079-01A-11D-1959-01 TCGA-HC-7079-01A-11D-1963-05 TCGA-HC-7079-01A-11D-1961-08 0a67e3de-1840-44f1-ae19-14f3c2df230c TCGA-HC-7079-01 TCGA-HC-7079-01 7E67A6D7-6D0A-44A0-BCB0-0EDF56685FD2 TCGA-HC-7079-01A-11D-1959-01 0a67e3de-1840-44f1-ae19-14f3c2df230c TCGA-HC-7079-01 TCGA-HC-7079-01 TCGA-HC-7079-01A-11D-1961-08 TCGA-HC-7079-01A-11D-1961-08 0a67e3de-1840-44f1-ae19-14f3c2df230c +TCGA-HC-7080-01 TCGA-HC-7080-01 TCGA-HC-7080 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 66 TCGA-HC-7080-F64334 TCGA-HC-7080 TCGA-HC-7080-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2a -24243 19 19 0 1106 894 104 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-8-28 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Right 0.5 NO YES New Primary Tumor YES 2 0 No N0 T2a TCGA-HC-7080.f2bf590a-9473-47fe-89a9-69c480b6c42b.pdf 7080 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.2 NO NO YES HC Apex|Middle Prostate A LIVING 2010 8d250084-d374-4ec4-994b-6c5f9c0f1a14 TCGA-HC-7080-01A-11D-1959-01 TCGA-HC-7080-01A-11D-1963-05 TCGA-HC-7080-01A-11D-1961-08 8d250084-d374-4ec4-994b-6c5f9c0f1a14 TCGA-HC-7080-01 TCGA-HC-7080-01 TCGA-HC-7080-01A-11D-1959-01 8d250084-d374-4ec4-994b-6c5f9c0f1a14 TCGA-HC-7080-01 TCGA-HC-7080-01 TCGA-HC-7080-01A-11D-1961-08 TCGA-HC-7080-01A-11D-1961-08 8d250084-d374-4ec4-994b-6c5f9c0f1a14 +TCGA-HC-7081-01 TCGA-HC-7081-01 TCGA-HC-7081 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-HC-7081-F64330 TCGA-HC-7081 TCGA-HC-7081-01A 0 1136 Scheduled Follow-up Submission Stable Disease 2014-8-28 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Bilateral 0.8 NO NO NO No T3b TCGA-HC-7081.75d1573a-cbf6-4b3c-93c4-2d410586884c.pdf 7081 WITH TUMOR 4 Partial Remission/Response YES R2 Primary Tumor 01 5 0.3 NO YES NO HC Prostate A LIVING 2010 9dcee6b2-ff25-4db1-be9a-9ac5e6e49c90 TCGA-HC-7081-01A-11D-1959-01 TCGA-HC-7081-01A-11D-1963-05 TCGA-HC-7081-01A-11D-1961-08 9dcee6b2-ff25-4db1-be9a-9ac5e6e49c90 TCGA-HC-7081-01 TCGA-HC-7081-01 C39E6101-EF90-4969-9F01-AA137D5370D2 TCGA-HC-7081-01A-11D-1959-01 9dcee6b2-ff25-4db1-be9a-9ac5e6e49c90 TCGA-HC-7081-01 TCGA-HC-7081-01 TCGA-HC-7081-01A-11D-1961-08 TCGA-HC-7081-01A-11D-1961-08 9dcee6b2-ff25-4db1-be9a-9ac5e6e49c90 +TCGA-HC-7209-01 TCGA-HC-7209-01 TCGA-HC-7209 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-HC-7209-F66045 TCGA-HC-7209 TCGA-HC-7209-01A T2b -22129 0 440 108 Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO Bilateral 0.6 YES YES NO 2 0 No N0 T2c TCGA-HC-7209.87f8ff1b-d58b-470e-9156-144cbe34b71c.pdf 7209 TUMOR FREE 3 Complete Remission/Response 0.05 NO R0 Primary Tumor 01 3 0.1 NO YES NO HC Apex|Middle|Base Prostate A LIVING 2011 9675123f-6606-4e75-be55-3ef938c72178 TCGA-HC-7209-01A-11D-2112-01 TCGA-HC-7209-01A-11D-2116-05 TCGA-HC-7209-01A-11D-2114-08 9675123f-6606-4e75-be55-3ef938c72178 TCGA-HC-7209-01 TCGA-HC-7209-01 TCGA-HC-7209-01A-11D-2112-01 9675123f-6606-4e75-be55-3ef938c72178 TCGA-HC-7209-01 TCGA-HC-7209-01 TCGA-HC-7209-01A-11D-2114-08 TCGA-HC-7209-01A-11D-2114-08 9675123f-6606-4e75-be55-3ef938c72178 +TCGA-HC-7210-01 TCGA-HC-7210-01 TCGA-HC-7210 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 74 TCGA-HC-7210-F64378 TCGA-HC-7210 TCGA-HC-7210-01A -27343 0 868 149 Scheduled Follow-up Submission Complete Remission/Response 2014-8-29 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.9 NO Right 1.1 NO YES NO 7 0 No N0 T2a TCGA-HC-7210.8398444a-bfad-41d6-94a6-ab85ddf159aa.pdf 7210 TUMOR FREE 3 Complete Remission/Response .1 NO R0 Primary Tumor 01 4 0.4 NO YES NO HC Prostate A LIVING 2011 a83b2830-20b3-4773-b929-733f772252ec TCGA-HC-7210-01A-11D-2112-01 TCGA-HC-7210-01A-11D-2116-05 TCGA-HC-7210-01A-11D-2114-08 a83b2830-20b3-4773-b929-733f772252ec TCGA-HC-7210-01 TCGA-HC-7210-01 B7EB854F-8169-4DD4-86E5-139AE6F39CB2 TCGA-HC-7210-01A-11D-2112-01 a83b2830-20b3-4773-b929-733f772252ec TCGA-HC-7210-01 TCGA-HC-7210-01 TCGA-HC-7210-01A-11D-2114-08 TCGA-HC-7210-01A-11D-2114-08 a83b2830-20b3-4773-b929-733f772252ec +TCGA-HC-7211-01 TCGA-HC-7211-01 TCGA-HC-7211 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-HC-7211-F64373 TCGA-HC-7211 TCGA-HC-7211-01A Normal (no evidence of prostate cancer) [cM0] M0 T2a -22768 14 14 0 1221 -17 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-8-29 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 0.7 NO YES NO 10 0 No N0 T2c TCGA-HC-7211.47e4122a-96e7-43d6-9242-ad7bff977ba8.pdf 7211 TUMOR FREE 3 Complete Remission/Response 10.9 NO R0 Primary Tumor 01 4 0.4 NO NO YES HC Apex|Middle|Base Prostate A LIVING 2010 3b524c3b-40b6-43bd-8108-5243463ce4a0 TCGA-HC-7211-01A-11D-2112-01 TCGA-HC-7211-01A-11D-2116-05 TCGA-HC-7211-01A-11D-2114-08 3b524c3b-40b6-43bd-8108-5243463ce4a0 TCGA-HC-7211-01 TCGA-HC-7211-01 071088A3-B9EB-44CF-A3DB-ED777A2263C4 TCGA-HC-7211-01A-11D-2112-01 3b524c3b-40b6-43bd-8108-5243463ce4a0 TCGA-HC-7211-01 TCGA-HC-7211-01 TCGA-HC-7211-01A-11D-2114-08 TCGA-HC-7211-01A-11D-2114-08 3b524c3b-40b6-43bd-8108-5243463ce4a0 +TCGA-HC-7211-11 TCGA-HC-7211-11 TCGA-HC-7211 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-HC-7211-F64373 TCGA-HC-7211 TCGA-HC-7211-11A Normal (no evidence of prostate cancer) [cM0] M0 T2a -22768 14 14 0 1221 -17 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-8-29 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 0.5 NO YES NO 10 0 No N0 T2c 7211 TUMOR FREE 3 Complete Remission/Response 10.9 NO R0 Solid Tissue Normal 11 4 0.4 NO NO YES HC Apex|Middle|Base Prostate A LIVING 2010 7dc99228-873b-44e1-a2cb-9bd2fe9d217f TCGA-HC-7211-11A-01D-2116-05 7dc99228-873b-44e1-a2cb-9bd2fe9d217f TCGA-HC-7211-11 7dc99228-873b-44e1-a2cb-9bd2fe9d217f TCGA-HC-7211-11 7dc99228-873b-44e1-a2cb-9bd2fe9d217f +TCGA-HC-7212-01 TCGA-HC-7212-01 TCGA-HC-7212 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 56 TCGA-HC-7212-F45569 TCGA-HC-7212 TCGA-HC-7212-01A M0 -20576 396 0 870 424 Scheduled Follow-up Submission Complete Remission/Response 2013-7-17 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Right 1 NO YES Biochemical evidence of disease YES 4 0 No N0 T2a TCGA-HC-7212.b401d78b-78c2-4e6e-86db-c93997da85a4.pdf 7212 TUMOR FREE 3 Complete Remission/Response .28 Primary Tumor 01 4 0.3 YES NO HC Prostate A LIVING 2011 23e9edc6-a5ab-4dca-9243-a40e69d65615 TCGA-HC-7212-01A-11D-2112-01 TCGA-HC-7212-01A-11D-2116-05 TCGA-HC-7212-01A-11D-2114-08 23e9edc6-a5ab-4dca-9243-a40e69d65615 TCGA-HC-7212-01 TCGA-HC-7212-01 56489764-D94A-4346-B9E1-5BBD98590625 TCGA-HC-7212-01A-11D-2112-01 23e9edc6-a5ab-4dca-9243-a40e69d65615 TCGA-HC-7212-01 TCGA-HC-7212-01 TCGA-HC-7212-01A-11D-2114-08 TCGA-HC-7212-01A-11D-2114-08 23e9edc6-a5ab-4dca-9243-a40e69d65615 +TCGA-HC-7213-01 TCGA-HC-7213-01 TCGA-HC-7213 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES YES 53 TCGA-HC-7213-F66041 TCGA-HC-7213 TCGA-HC-7213-01A YES M0 T3b -19699 22 34 170 0 1219 170 170 YES No Evidence of Extraprostatic Extension YES Extraprostatic Extension Localized (e.g. seminal vesicles) Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.1 NO YES Biochemical evidence of disease YES 4 0 No N0 T3b TCGA-HC-7213.8b2f0b23-7a12-432a-b209-37e57a2f112b.pdf 7213 TUMOR FREE 4 Partial Remission/Response 4.09 NO R0 Primary Tumor 01 5 0.3 NO YES NO HC Apex|Middle|Base Prostate A LIVING 2010 cf7a71f6-8d7d-4833-b9b2-c40abc1654e6 TCGA-HC-7213-01A-11D-2112-01 TCGA-HC-7213-01A-11D-2116-05 TCGA-HC-7213-01A-11D-2114-08 cf7a71f6-8d7d-4833-b9b2-c40abc1654e6 TCGA-HC-7213-01 TCGA-HC-7213-01 423C67EC-ACA2-4723-8E0C-689CBD6709DA TCGA-HC-7213-01A-11D-2112-01 cf7a71f6-8d7d-4833-b9b2-c40abc1654e6 TCGA-HC-7213-01 TCGA-HC-7213-01 TCGA-HC-7213-01A-11D-2114-08 TCGA-HC-7213-01A-11D-2114-08 cf7a71f6-8d7d-4833-b9b2-c40abc1654e6 +TCGA-HC-7230-01 TCGA-HC-7230-01 TCGA-HC-7230 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 50 TCGA-HC-7230-F64379 TCGA-HC-7230 TCGA-HC-7230-01A -18577 0 1001 Scheduled Follow-up Submission Complete Remission/Response 2014-8-29 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.4 NO 0.5 NO YES NO 3 0 No N0 T2c TCGA-HC-7230.0c078733-c8ed-4d5c-9da0-979f4af4fc4f.pdf 7230 TUMOR FREE 3 Complete Remission/Response 3 NO R0 Primary Tumor 01 4 0.1 NO YES NO HC Prostate A LIVING 2011 2ff3af27-d43b-4707-a337-0ff988ac2763 TCGA-HC-7230-01A-11D-2112-01 TCGA-HC-7230-01A-11D-2116-05 TCGA-HC-7230-01A-11D-2114-08 2ff3af27-d43b-4707-a337-0ff988ac2763 TCGA-HC-7230-01 TCGA-HC-7230-01 TCGA-HC-7230-01A-11D-2112-01 2ff3af27-d43b-4707-a337-0ff988ac2763 TCGA-HC-7230-01 TCGA-HC-7230-01 TCGA-HC-7230-01A-11D-2114-08 TCGA-HC-7230-01A-11D-2114-08 2ff3af27-d43b-4707-a337-0ff988ac2763 +TCGA-HC-7231-01 TCGA-HC-7231-01 TCGA-HC-7231 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-HC-7231-F63153 TCGA-HC-7231 M0 T1c -24278 0 939 Scheduled Follow-up Submission Complete Remission/Response 2014-7-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO NO NO No T2c 7231 TUMOR FREE 3 Complete Remission/Response NO R0 Primary Tumor 01 4 NO YES NO HC Prostate LIVING 2011 f7d253d6-fce6-42d3-8926-563e8e7eff7f TCGA-HC-7231-01A-11D-2112-01 TCGA-HC-7231-01A-11D-2116-05 TCGA-HC-7231-01A-11D-2114-08 f7d253d6-fce6-42d3-8926-563e8e7eff7f TCGA-HC-7231-01 TCGA-HC-7231-01 TCGA-HC-7231-01A-11D-2112-01 f7d253d6-fce6-42d3-8926-563e8e7eff7f TCGA-HC-7231-01 TCGA-HC-7231-01 TCGA-HC-7231-01A-11D-2114-08 TCGA-HC-7231-01A-11D-2114-08 f7d253d6-fce6-42d3-8926-563e8e7eff7f +TCGA-HC-7232-01 TCGA-HC-7232-01 TCGA-HC-7232 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO YES 66 TCGA-HC-7232-F64391 TCGA-HC-7232 TCGA-HC-7232-01A -24324 766 0 1161 766 Scheduled Follow-up Submission Stable Disease 2014-8-29 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 1 NO NO Biochemical evidence of disease YES No T3b TCGA-HC-7232.d5b6e727-43d6-4d27-a7ae-d89c046ef4eb.pdf 7232 WITH TUMOR 4 Complete Remission/Response NO R0 Primary Tumor 01 5 0.4 NO YES NO HC Prostate A LIVING 2011 499d25b2-e516-4aea-b732-5c8096dc968a TCGA-HC-7232-01A-11D-2112-01 TCGA-HC-7232-01A-11D-2116-05 TCGA-HC-7232-01A-11D-2114-08 499d25b2-e516-4aea-b732-5c8096dc968a TCGA-HC-7232-01 TCGA-HC-7232-01 7B5B1C42-36DB-4D44-96DD-6E8769289C80 TCGA-HC-7232-01A-11D-2112-01 499d25b2-e516-4aea-b732-5c8096dc968a TCGA-HC-7232-01 TCGA-HC-7232-01 TCGA-HC-7232-01A-11D-2114-08 TCGA-HC-7232-01A-11D-2114-08 499d25b2-e516-4aea-b732-5c8096dc968a +TCGA-HC-7233-01 TCGA-HC-7233-01 TCGA-HC-7233 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 73 TCGA-HC-7233-F63155 TCGA-HC-7233 TCGA-HC-7233-01A 0 1355 Scheduled Follow-up Submission Complete Remission/Response 2014-7-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.9 NO Left 1 NO YES NO 2 0 Yes N0 T2a TCGA-HC-7233.3531e095-4042-4fc8-aa69-522b16e4e1fc.pdf 7233 TUMOR FREE 4 Complete Remission/Response NO R1 Primary Tumor 01 3 0.6 NO NO YES HC Apex Prostate A LIVING 2010 81388e39-1fc8-47bd-b49b-946bc979996d TCGA-HC-7233-01A-11D-2112-01 TCGA-HC-7233-01A-11D-2116-05 TCGA-HC-7233-01A-11D-2114-08 81388e39-1fc8-47bd-b49b-946bc979996d TCGA-HC-7233-01 TCGA-HC-7233-01 A195D5BC-E277-436D-B0F6-1BF27D835B89 TCGA-HC-7233-01A-11D-2112-01 81388e39-1fc8-47bd-b49b-946bc979996d TCGA-HC-7233-01 TCGA-HC-7233-01 TCGA-HC-7233-01A-11D-2114-08 TCGA-HC-7233-01A-11D-2114-08 81388e39-1fc8-47bd-b49b-946bc979996d +TCGA-HC-7736-01 TCGA-HC-7736-01 TCGA-HC-7736 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-HC-7736-F60206 TCGA-HC-7736 TCGA-HC-7736-01A M0 T2b -21703 -21 0 1103 102 YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2014-5-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1 NO YES NO 13 0 No N0 T2c TCGA-HC-7736.d5cb57cb-ff9a-4c83-b019-7b5ed2cd7494.pdf 7736 TUMOR FREE 3 Complete Remission/Response .02 NO R0 Primary Tumor 01 4 0.4 NO NO YES HC Middle|Base Prostate A LIVING 2010 28ebf50e-d63f-439e-8e16-4a815eccb465 TCGA-HC-7736-01A-11D-2112-01 TCGA-HC-7736-01A-11D-2116-05 TCGA-HC-7736-01A-11D-2114-08 28ebf50e-d63f-439e-8e16-4a815eccb465 TCGA-HC-7736-01 TCGA-HC-7736-01 11886AD8-EAB8-4749-A880-4AF10F7EDFC1 TCGA-HC-7736-01A-11D-2112-01 28ebf50e-d63f-439e-8e16-4a815eccb465 TCGA-HC-7736-01 TCGA-HC-7736-01 TCGA-HC-7736-01A-11D-2114-08 TCGA-HC-7736-01A-11D-2114-08 28ebf50e-d63f-439e-8e16-4a815eccb465 +TCGA-HC-7737-01 TCGA-HC-7737-01 TCGA-HC-7737 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-HC-7737-F60207 TCGA-HC-7737 Normal (no evidence of prostate cancer) [cM0] M0 T1c -20122 9 9 0 1090 147 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-5-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 8 1 No N1 T2c 7737 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO NO YES HC Prostate LIVING 2010 bdb4a761-71cf-4465-a48f-4f938493ffcb TCGA-HC-7737-01A-11D-2112-01 TCGA-HC-7737-01A-11D-2116-05 TCGA-HC-7737-01A-11D-2114-08 bdb4a761-71cf-4465-a48f-4f938493ffcb TCGA-HC-7737-01 TCGA-HC-7737-01 TCGA-HC-7737-01A-11D-2112-01 bdb4a761-71cf-4465-a48f-4f938493ffcb TCGA-HC-7737-01 TCGA-HC-7737-01 TCGA-HC-7737-01A-11D-2114-08 TCGA-HC-7737-01A-11D-2114-08 bdb4a761-71cf-4465-a48f-4f938493ffcb +TCGA-HC-7737-11 TCGA-HC-7737-11 TCGA-HC-7737 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-HC-7737-F60207 TCGA-HC-7737 TCGA-HC-7737-11A Normal (no evidence of prostate cancer) [cM0] M0 T1c -20122 9 9 0 1090 147 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-5-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.7 NO Bilateral 0.8 NO YES NO 8 1 No N1 T2c 7737 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 4 0.4 NO NO YES HC Prostate A LIVING 2010 801b06ab-6ef3-46ba-af12-3b2230aabf51 TCGA-HC-7737-11A-02D-2116-05 801b06ab-6ef3-46ba-af12-3b2230aabf51 TCGA-HC-7737-11 801b06ab-6ef3-46ba-af12-3b2230aabf51 TCGA-HC-7737-11 801b06ab-6ef3-46ba-af12-3b2230aabf51 +TCGA-HC-7738-01 TCGA-HC-7738-01 TCGA-HC-7738 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 58 TCGA-HC-7738-F63151 TCGA-HC-7738 M0 -21195 420 0 964 420 Scheduled Follow-up Submission Stable Disease 2014-7-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO NO Other, specify Biochemical evidence of disease biochemical recurrence only YES No T2c 7738 WITH TUMOR 3 Partial Remission/Response NO R0 Primary Tumor 01 4 NO YES NO HC Apex NO Prostate LIVING 2011 b02ac966-c160-4310-a80d-98fdc6134074 TCGA-HC-7738-01A-11D-2112-01 TCGA-HC-7738-01A-11D-2116-05 TCGA-HC-7738-01A-11D-2114-08 b02ac966-c160-4310-a80d-98fdc6134074 TCGA-HC-7738-01 TCGA-HC-7738-01 TCGA-HC-7738-01A-11D-2112-01 b02ac966-c160-4310-a80d-98fdc6134074 TCGA-HC-7738-01 TCGA-HC-7738-01 TCGA-HC-7738-01A-11D-2114-08 b02ac966-c160-4310-a80d-98fdc6134074 +TCGA-HC-7738-11 TCGA-HC-7738-11 TCGA-HC-7738 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 58 TCGA-HC-7738-F63151 TCGA-HC-7738 TCGA-HC-7738-11A M0 -21195 420 0 964 420 Scheduled Follow-up Submission Stable Disease 2014-7-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.1 NO NO Other, specify Biochemical evidence of disease biochemical recurrence only YES No T2c 7738 WITH TUMOR 3 Partial Remission/Response NO R0 Solid Tissue Normal 11 4 0.5 NO YES NO HC Apex NO Prostate A LIVING 2011 65592ca4-9afc-462c-86ee-a5f352aeb1f0 65592ca4-9afc-462c-86ee-a5f352aeb1f0 TCGA-HC-7738-11 65592ca4-9afc-462c-86ee-a5f352aeb1f0 TCGA-HC-7738-11 65592ca4-9afc-462c-86ee-a5f352aeb1f0 +TCGA-HC-7740-01 TCGA-HC-7740-01 TCGA-HC-7740 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-HC-7740-F48772 TCGA-HC-7740 TCGA-HC-7740-01A M0 T2a -21883 0 717 154 Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.7 NO Bilateral 1.2 NO YES NO 4 0 No N0 T2c TCGA-HC-7740.d2b80346-3a50-4fc3-99c2-0e15225cc433.pdf 7740 TUMOR FREE 3 Complete Remission/Response 0 NO R0 Primary Tumor 01 4 0.3 NO YES NO HC Apex|Middle|Base Prostate A LIVING 2011 095f3c80-890e-4529-816c-306daf614ec2 TCGA-HC-7740-01A-11D-2112-01 TCGA-HC-7740-01B-04D-2299-05,TCGA-HC-7740-01A-11D-2116-05 TCGA-HC-7740-01A-11D-2114-08 095f3c80-890e-4529-816c-306daf614ec2 TCGA-HC-7740-01 TCGA-HC-7740-01 23F340A8-0AC4-4218-A18E-4CFDED8782FA TCGA-HC-7740-01A-11D-2112-01 095f3c80-890e-4529-816c-306daf614ec2 TCGA-HC-7740-01 TCGA-HC-7740-01 TCGA-HC-7740-01A-11D-2114-08,TCGA-HC-7740-01B-04D-2298-08 TCGA-HC-7740-01A-11D-2114-08 095f3c80-890e-4529-816c-306daf614ec2 +TCGA-HC-7740-11 TCGA-HC-7740-11 TCGA-HC-7740 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-HC-7740-F48772 TCGA-HC-7740 TCGA-HC-7740-11A M0 T2a -21883 0 717 154 Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 0.6 NO YES NO 4 0 No N0 T2c 7740 TUMOR FREE 3 Complete Remission/Response 0 NO R0 Solid Tissue Normal 11 4 0.4 NO YES NO HC Apex|Middle|Base Prostate A LIVING 2011 0120b5b1-d204-429a-aa21-704fd98624ea 0120b5b1-d204-429a-aa21-704fd98624ea TCGA-HC-7740-11 0120b5b1-d204-429a-aa21-704fd98624ea TCGA-HC-7740-11 0120b5b1-d204-429a-aa21-704fd98624ea +TCGA-HC-7742-01 TCGA-HC-7742-01 TCGA-HC-7742 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES NO 58 TCGA-HC-7742-F66039 TCGA-HC-7742 NO M0 -21323 210 0 938 113 651 Scheduled Follow-up Submission Stable Disease 2014-10-1 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy NO YES Biochemical evidence of disease YES 2 0 No N0 T3a 7742 WITH TUMOR 3 Partial Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO HC Prostate LIVING 2011 d8765abc-befa-49b5-893e-04de2ddb2ee1 TCGA-HC-7742-01A-11D-2112-01 TCGA-HC-7742-01A-11D-2116-05 TCGA-HC-7742-01A-11D-2114-08 d8765abc-befa-49b5-893e-04de2ddb2ee1 TCGA-HC-7742-01 TCGA-HC-7742-01 TCGA-HC-7742-01A-11D-2112-01 d8765abc-befa-49b5-893e-04de2ddb2ee1 TCGA-HC-7742-01 TCGA-HC-7742-01 TCGA-HC-7742-01A-11D-2114-08 TCGA-HC-7742-01A-11D-2114-08 d8765abc-befa-49b5-893e-04de2ddb2ee1 +TCGA-HC-7742-11 TCGA-HC-7742-11 TCGA-HC-7742 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES NO 58 TCGA-HC-7742-F66039 TCGA-HC-7742 TCGA-HC-7742-11A NO M0 -21323 210 0 938 113 651 Scheduled Follow-up Submission Stable Disease 2014-10-1 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 0.6 NO 0.7 NO YES Biochemical evidence of disease YES 2 0 No N0 T3a 7742 WITH TUMOR 3 Partial Remission/Response 0.1 NO R0 Solid Tissue Normal 11 4 0.3 NO YES NO HC Prostate A LIVING 2011 12358445-06b8-4055-8454-69b8544774fc TCGA-HC-7742-11A-01D-2116-05 12358445-06b8-4055-8454-69b8544774fc TCGA-HC-7742-11 12358445-06b8-4055-8454-69b8544774fc TCGA-HC-7742-11 12358445-06b8-4055-8454-69b8544774fc +TCGA-HC-7744-01 TCGA-HC-7744-01 TCGA-HC-7744 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 46 TCGA-HC-7744-F46991 TCGA-HC-7744 TCGA-HC-7744-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -17065 10 40 42 0 531 282 YES YES Extraprostatic Extension Localized (e.g. seminal vesicles) Scheduled Follow-up Submission Complete Remission/Response 2013-8-21 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 1 NO YES NO 8 0 No N0 T3b TCGA-HC-7744.01b8c2af-bdf8-4627-bf6e-c7a41d929b94.pdf 7744 TUMOR FREE 4 Complete Remission/Response 0.04 YES R1 Primary Tumor 01 3 0.3 NO YES NO HC Apex|Middle|Base Prostate A LIVING 2011 82b1d50a-9ed4-4d42-80d4-59d06b43df3e TCGA-HC-7744-01A-11D-2112-01 TCGA-HC-7744-01A-11D-2116-05 TCGA-HC-7744-01A-11D-2114-08 82b1d50a-9ed4-4d42-80d4-59d06b43df3e TCGA-HC-7744-01 TCGA-HC-7744-01 607F5599-9CEB-49A9-8D9D-8EAA0C9ED792 TCGA-HC-7744-01A-11D-2112-01 82b1d50a-9ed4-4d42-80d4-59d06b43df3e TCGA-HC-7744-01 TCGA-HC-7744-01 TCGA-HC-7744-01A-11D-2114-08 TCGA-HC-7744-01A-11D-2114-08 82b1d50a-9ed4-4d42-80d4-59d06b43df3e +TCGA-HC-7745-01 TCGA-HC-7745-01 TCGA-HC-7745 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-HC-7745-F66044 TCGA-HC-7745 -24078 0 721 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 3 0 No N0 T3b 7745 TUMOR FREE 4 Complete Remission/Response NO R0 Primary Tumor 01 3 YES YES NO HC Middle Prostate LIVING 2011 d26a0c98-2768-48df-ab84-dcce5e18537a TCGA-HC-7745-01A-11D-2112-01 TCGA-HC-7745-01A-11D-2116-05 TCGA-HC-7745-01A-11D-2114-08 d26a0c98-2768-48df-ab84-dcce5e18537a TCGA-HC-7745-01 TCGA-HC-7745-01 TCGA-HC-7745-01A-11D-2112-01 d26a0c98-2768-48df-ab84-dcce5e18537a TCGA-HC-7745-01 TCGA-HC-7745-01 TCGA-HC-7745-01A-11D-2114-08 d26a0c98-2768-48df-ab84-dcce5e18537a +TCGA-HC-7745-11 TCGA-HC-7745-11 TCGA-HC-7745 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-HC-7745-F66044 TCGA-HC-7745 TCGA-HC-7745-11A -24078 0 721 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.8 NO Bilateral 1.1 NO YES NO 3 0 No N0 T3b 7745 TUMOR FREE 4 Complete Remission/Response NO R0 Solid Tissue Normal 11 3 0.3 YES YES NO HC Middle Prostate A LIVING 2011 3e2b99bc-6a05-4de8-b135-923d443cd4fa TCGA-HC-7745-11A-01D-2116-05 3e2b99bc-6a05-4de8-b135-923d443cd4fa TCGA-HC-7745-11 3e2b99bc-6a05-4de8-b135-923d443cd4fa TCGA-HC-7745-11 3e2b99bc-6a05-4de8-b135-923d443cd4fa +TCGA-HC-7747-01 TCGA-HC-7747-01 TCGA-HC-7747 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 52 TCGA-HC-7747-F60208 TCGA-HC-7747 NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -19188 25 25 0 748 392 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-5-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 4 0 No N0 T2c 7747 TUMOR FREE 3 Complete Remission/Response 0.19 YES Primary Tumor 01 4 NO YES NO HC Apex|Middle|Base Prostate LIVING 2011 a88b498e-6e56-4d49-b11d-827ad2b29b5d TCGA-HC-7747-01A-11D-2112-01 TCGA-HC-7747-01A-11D-2116-05 TCGA-HC-7747-01A-11D-2114-08 a88b498e-6e56-4d49-b11d-827ad2b29b5d TCGA-HC-7747-01 TCGA-HC-7747-01 TCGA-HC-7747-01A-11D-2112-01 a88b498e-6e56-4d49-b11d-827ad2b29b5d TCGA-HC-7747-01 TCGA-HC-7747-01 TCGA-HC-7747-01A-11D-2114-08 TCGA-HC-7747-01A-11D-2114-08 a88b498e-6e56-4d49-b11d-827ad2b29b5d +TCGA-HC-7747-11 TCGA-HC-7747-11 TCGA-HC-7747 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 52 TCGA-HC-7747-F60208 TCGA-HC-7747 TCGA-HC-7747-11A NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -19188 25 25 0 748 392 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-5-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 1.1 NO YES NO 4 0 No N0 T2c 7747 TUMOR FREE 3 Complete Remission/Response 0.19 YES Solid Tissue Normal 11 4 0.4 NO YES NO HC Apex|Middle|Base Prostate A LIVING 2011 8f9b3818-5334-4aa0-9ad1-22bca0afb925 8f9b3818-5334-4aa0-9ad1-22bca0afb925 TCGA-HC-7747-11 8f9b3818-5334-4aa0-9ad1-22bca0afb925 TCGA-HC-7747-11 8f9b3818-5334-4aa0-9ad1-22bca0afb925 +TCGA-HC-7748-01 TCGA-HC-7748-01 TCGA-HC-7748 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-HC-7748-F48774 TCGA-HC-7748 TCGA-HC-7748-01A -22072 0 792 99 Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.7 NO Right 0.8 NO YES NO 10 0 Yes N0 T2a TCGA-HC-7748.6516e000-dc8c-4715-a561-ee47a114ad23.pdf 7748 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 0.4 NO YES NO HC Prostate A LIVING 2011 eb9c4bc2-f85e-4ec1-bd7f-ba2eff32ff1b TCGA-HC-7748-01A-11D-2112-01 TCGA-HC-7748-01A-11D-2116-05 TCGA-HC-7748-01A-11D-2114-08 eb9c4bc2-f85e-4ec1-bd7f-ba2eff32ff1b TCGA-HC-7748-01 TCGA-HC-7748-01 09D67575-C709-4A9C-BB42-85F697F4ECAC TCGA-HC-7748-01A-11D-2112-01 eb9c4bc2-f85e-4ec1-bd7f-ba2eff32ff1b TCGA-HC-7748-01 TCGA-HC-7748-01 TCGA-HC-7748-01A-11D-2114-08 TCGA-HC-7748-01A-11D-2114-08 eb9c4bc2-f85e-4ec1-bd7f-ba2eff32ff1b +TCGA-HC-7749-01 TCGA-HC-7749-01 TCGA-HC-7749 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 70 TCGA-HC-7749-F48773 TCGA-HC-7749 TCGA-HC-7749-01A M0 -25688 0 724 102 Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.3 NO Right 0.3 NO YES NO 10 0 No N0 T3a TCGA-HC-7749.35e33cb7-77a7-4d02-b4ec-9374423027c0.pdf 7749 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 0.2 NO 5 YES NO HC Middle|Base Prostate A LIVING 2011 6551bbb1-297f-41db-969b-17bb3c432426 TCGA-HC-7749-01A-11D-2112-01 TCGA-HC-7749-01A-11D-2116-05 TCGA-HC-7749-01A-11D-2114-08 6551bbb1-297f-41db-969b-17bb3c432426 TCGA-HC-7749-01 TCGA-HC-7749-01 TCGA-HC-7749-01A-11D-2112-01 6551bbb1-297f-41db-969b-17bb3c432426 TCGA-HC-7749-01 TCGA-HC-7749-01 TCGA-HC-7749-01A-11D-2114-08 TCGA-HC-7749-01A-11D-2114-08 6551bbb1-297f-41db-969b-17bb3c432426 +TCGA-HC-7750-01 TCGA-HC-7750-01 TCGA-HC-7750 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 50 TCGA-HC-7750-F46692 TCGA-HC-7750 TCGA-HC-7750-01A M0 T2b -18580 0 522 83 Scheduled Follow-up Submission Complete Remission/Response 2013-8-13 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.3 NO Left 0.4 NO NO NO No T2c TCGA-HC-7750.f05d95fd-391d-49ab-8a2f-039110a654bd.pdf 7750 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.2 NO YES NO HC Apex|Middle|Base Prostate A LIVING 2011 54ad372c-0c62-42b9-86c4-91cd0e148af2 TCGA-HC-7750-01A-11D-2112-01 TCGA-HC-7750-01A-11D-2116-05 TCGA-HC-7750-01A-11D-2114-08 54ad372c-0c62-42b9-86c4-91cd0e148af2 TCGA-HC-7750-01 TCGA-HC-7750-01 TCGA-HC-7750-01A-11D-2112-01 54ad372c-0c62-42b9-86c4-91cd0e148af2 TCGA-HC-7750-01 TCGA-HC-7750-01 TCGA-HC-7750-01A-11D-2114-08 TCGA-HC-7750-01A-11D-2114-08 54ad372c-0c62-42b9-86c4-91cd0e148af2 +TCGA-HC-7752-01 TCGA-HC-7752-01 TCGA-HC-7752 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-HC-7752-F64386 TCGA-HC-7752 M0 -22366 0 782 138 Scheduled Follow-up Submission Complete Remission/Response 2014-8-29 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 6 0 No N0 T2c 7752 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO HC Base Prostate LIVING 2011 f57a7df0-0aaf-4181-b8c1-f50133964823 TCGA-HC-7752-01A-11D-2112-01 TCGA-HC-7752-01A-11D-2116-05 TCGA-HC-7752-01A-11D-2114-08 f57a7df0-0aaf-4181-b8c1-f50133964823 TCGA-HC-7752-01 TCGA-HC-7752-01 TCGA-HC-7752-01A-11D-2112-01 f57a7df0-0aaf-4181-b8c1-f50133964823 TCGA-HC-7752-01 TCGA-HC-7752-01 TCGA-HC-7752-01A-11D-2114-08 f57a7df0-0aaf-4181-b8c1-f50133964823 +TCGA-HC-7752-11 TCGA-HC-7752-11 TCGA-HC-7752 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-HC-7752-F64386 TCGA-HC-7752 M0 -22366 0 782 138 Scheduled Follow-up Submission Complete Remission/Response 2014-8-29 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 6 0 No N0 T2c 7752 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 4 NO YES NO HC Base Prostate LIVING 2011 c08293b3-507d-4c7c-8b14-9a328e1d15fe TCGA-HC-7752-11A-01D-2116-05 c08293b3-507d-4c7c-8b14-9a328e1d15fe TCGA-HC-7752-11 c08293b3-507d-4c7c-8b14-9a328e1d15fe TCGA-HC-7752-11 c08293b3-507d-4c7c-8b14-9a328e1d15fe +TCGA-HC-7817-01 TCGA-HC-7817-01 TCGA-HC-7817 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 52 TCGA-HC-7817-F60204 TCGA-HC-7817 TCGA-HC-7817-01B NO Normal (no evidence of prostate cancer) [cM0] M0 -19207 0 928 171 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2014-5-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 0.8 NO Bilateral 1.1 NO NO NO No T3b TCGA-HC-7817.A1E3EC71-D7D2-4286-A12F-78ADFD27E53C.pdf 7817 TUMOR FREE 4 Complete Remission/Response 0.1 YES Primary Tumor 01 3 0.5 NO YES NO HC Apex|Middle|Base Prostate B LIVING 2011 c995e591-f2b7-4c3e-ae81-9e72b9548b57 TCGA-HC-7817-01B-11D-A323-01 TCGA-HC-7817-01B-11D-A29T-05 TCGA-HC-7817-01B-11D-A29Q-08 c995e591-f2b7-4c3e-ae81-9e72b9548b57 TCGA-HC-7817-01 TCGA-HC-7817-01 1B96882F-EE27-453F-84A4-83C09511A492 TCGA-HC-7817-01B-11D-A323-01 c995e591-f2b7-4c3e-ae81-9e72b9548b57 TCGA-HC-7817-01 TCGA-HC-7817-01 TCGA-HC-7817-01B-11D-A29Q-08 c995e591-f2b7-4c3e-ae81-9e72b9548b57 +TCGA-HC-7818-01 TCGA-HC-7818-01 TCGA-HC-7818 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-HC-7818-F64380 TCGA-HC-7818 TCGA-HC-7818-01A M0 T2b -24391 0 938 99 Scheduled Follow-up Submission Complete Remission/Response 2014-8-29 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.2 NO Bilateral 0.4 NO YES NO 6 0 No N0 T2c TCGA-HC-7818.e6f3745f-31bf-4475-85f8-956811ce6cb6.pdf 7818 TUMOR FREE 3 Complete Remission/Response 0.01 NO R0 Primary Tumor 01 4 0.2 NO YES NO HC Apex|Middle|Base Prostate A LIVING 2011 776e6a2e-e939-4c92-b8dc-000c91bf5f64 TCGA-HC-7818-01A-11D-2112-01 TCGA-HC-7818-01A-11D-2116-05 TCGA-HC-7818-01A-11D-2114-08 776e6a2e-e939-4c92-b8dc-000c91bf5f64 TCGA-HC-7818-01 TCGA-HC-7818-01 TCGA-HC-7818-01A-11D-2112-01 776e6a2e-e939-4c92-b8dc-000c91bf5f64 TCGA-HC-7818-01 TCGA-HC-7818-01 TCGA-HC-7818-01A-11D-2114-08 TCGA-HC-7818-01A-11D-2114-08 776e6a2e-e939-4c92-b8dc-000c91bf5f64 +TCGA-HC-7819-01 TCGA-HC-7819-01 TCGA-HC-7819 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 53 TCGA-HC-7819-F56150 TCGA-HC-7819 TCGA-HC-7819-01A M0 T2c -19663 -73 0 543 172 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.3 NO Bilateral 0.3 NO YES NO 3 0 No N0 T2c TCGA-HC-7819.ab62f75e-d1f0-47f7-8a78-4151af81d409.pdf 7819 TUMOR FREE 4 Complete Remission/Response .01 NO R2 Primary Tumor 01 4 0.3 NO 4 YES NO HC Prostate A LIVING 2011 Central Zone 285a1a43-5494-49f4-95bb-671ebc1a953a TCGA-HC-7819-01A-11D-2112-01 TCGA-HC-7819-01A-11D-2116-05 TCGA-HC-7819-01A-11D-2114-08 285a1a43-5494-49f4-95bb-671ebc1a953a TCGA-HC-7819-01 TCGA-HC-7819-01 TCGA-HC-7819-01A-11D-2112-01 285a1a43-5494-49f4-95bb-671ebc1a953a TCGA-HC-7819-01 TCGA-HC-7819-01 TCGA-HC-7819-01A-11D-2114-08 285a1a43-5494-49f4-95bb-671ebc1a953a +TCGA-HC-7819-11 TCGA-HC-7819-11 TCGA-HC-7819 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 53 TCGA-HC-7819-F56150 TCGA-HC-7819 M0 T2c -19663 -73 0 543 172 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 3 0 No N0 T2c 7819 TUMOR FREE 4 Complete Remission/Response .01 NO R2 Solid Tissue Normal 11 4 NO 4 YES NO HC Prostate LIVING 2011 Central Zone e95f79a8-15ea-4b95-9f8e-b63ada04c51e TCGA-HC-7819-11A-01D-2116-05 e95f79a8-15ea-4b95-9f8e-b63ada04c51e TCGA-HC-7819-11 e95f79a8-15ea-4b95-9f8e-b63ada04c51e TCGA-HC-7819-11 e95f79a8-15ea-4b95-9f8e-b63ada04c51e +TCGA-HC-7820-01 TCGA-HC-7820-01 TCGA-HC-7820 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 72 TCGA-HC-7820-F57012 TCGA-HC-7820 TCGA-HC-7820-01A -26576 0 747 Scheduled Follow-up Submission Complete Remission/Response 2014-2-28 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.3 NO Bilateral 0.4 NO NO NO No T2c TCGA-HC-7820.750c91eb-1732-4ca3-8c71-f1309a90e4f5.pdf 7820 TUMOR FREE 3 Complete Remission/Response NO R0 Primary Tumor 01 4 0.1 NO YES NO HC Prostate A LIVING 2011 297e88ae-4a8d-4021-825a-8a7d7e2f71d1 TCGA-HC-7820-01A-11D-2112-01 TCGA-HC-7820-01A-11D-2116-05 TCGA-HC-7820-01A-11D-2114-08 297e88ae-4a8d-4021-825a-8a7d7e2f71d1 TCGA-HC-7820-01 TCGA-HC-7820-01 TCGA-HC-7820-01A-11D-2112-01 297e88ae-4a8d-4021-825a-8a7d7e2f71d1 TCGA-HC-7820-01 TCGA-HC-7820-01 TCGA-HC-7820-01A-11D-2114-08 TCGA-HC-7820-01A-11D-2114-08 297e88ae-4a8d-4021-825a-8a7d7e2f71d1 +TCGA-HC-7820-11 TCGA-HC-7820-11 TCGA-HC-7820 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 72 TCGA-HC-7820-F57012 TCGA-HC-7820 TCGA-HC-7820-11A -26576 0 747 Scheduled Follow-up Submission Complete Remission/Response 2014-2-28 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 0.9 NO NO NO No T2c 7820 TUMOR FREE 3 Complete Remission/Response NO R0 Solid Tissue Normal 11 4 0.4 NO YES NO HC Prostate A LIVING 2011 TCGA-HC-7820-11A-01D-2116-05 +TCGA-HC-7821-01 TCGA-HC-7821-01 TCGA-HC-7821 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 54 TCGA-HC-7821-F66038 TCGA-HC-7821 NO M0 -19894 950 0 956 236 Scheduled Follow-up Submission Progressive Disease 2014-10-1 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES Biochemical evidence of disease YES 7 2 Yes N1 T3b 7821 WITH TUMOR 4 Complete Remission/Response 0.01 YES Primary Tumor 01 4 YES YES NO HC Apex|Middle|Base Prostate LIVING 2011 df9ee925-86bc-4ccc-b308-0c7d6d1d4fd7 TCGA-HC-7821-01A-12D-2112-01 TCGA-HC-7821-01A-12D-2116-05 TCGA-HC-7821-01A-12D-2114-08 df9ee925-86bc-4ccc-b308-0c7d6d1d4fd7 TCGA-HC-7821-01 TCGA-HC-7821-01 TCGA-HC-7821-01A-12D-2112-01 df9ee925-86bc-4ccc-b308-0c7d6d1d4fd7 TCGA-HC-7821-01 TCGA-HC-7821-01 TCGA-HC-7821-01A-12D-2114-08 TCGA-HC-7821-01A-12D-2114-08 df9ee925-86bc-4ccc-b308-0c7d6d1d4fd7 +TCGA-HC-8213-01 TCGA-HC-8213-01 TCGA-HC-8213 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 48 TCGA-HC-8213-F45567 TCGA-HC-8213 TCGA-HC-8213-01A -17673 0 589 Scheduled Follow-up Submission Complete Remission/Response 2013-7-17 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES 0.5 NO Bilateral 0.7 NO NO NO No T2c TCGA-HC-8213.E6CE4E34-DE42-455C-AD93-CCE42FCFE049.pdf 8213 TUMOR FREE 3 Complete Remission/Response NO R0 Primary Tumor 01 3 0.3 NO YES NO HC Prostate A LIVING 2011 61843a22-9a35-4370-a301-881d5c967d29 TCGA-HC-8213-01A-11D-A323-01 TCGA-HC-8213-01A-11D-A29T-05 TCGA-HC-8213-01A-11D-A29Q-08 61843a22-9a35-4370-a301-881d5c967d29 TCGA-HC-8213-01 TCGA-HC-8213-01 TCGA-HC-8213-01A-11D-A323-01 61843a22-9a35-4370-a301-881d5c967d29 TCGA-HC-8213-01 TCGA-HC-8213-01 TCGA-HC-8213-01A-11D-A29Q-08 TCGA-HC-8213-01A-11D-A29Q-08 61843a22-9a35-4370-a301-881d5c967d29 +TCGA-HC-8216-01 TCGA-HC-8216-01 TCGA-HC-8216 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 58 TCGA-HC-8216-F48769 TCGA-HC-8216 TCGA-HC-8216-01A Normal (no evidence of prostate cancer) [cM0] M0 T2a -21428 10 10 0 682 137 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.3 NO Right 0.4 NO YES NO 3 0 No N0 T3a TCGA-HC-8216.CD881D57-9CCB-4984-8C37-B3DDE9189814.pdf 8216 TUMOR FREE 4 Complete Remission/Response .19 NO R0 Primary Tumor 01 3 0.3 NO 5 YES NO HC Middle|Base Prostate A LIVING 2011 98021887-fb82-4cb4-a5f4-c4316901da21 TCGA-HC-8216-01A-11D-A323-01 TCGA-HC-8216-01A-11D-A29T-05 TCGA-HC-8216-01A-11D-A29Q-08 98021887-fb82-4cb4-a5f4-c4316901da21 TCGA-HC-8216-01 TCGA-HC-8216-01 TCGA-HC-8216-01A-11D-A323-01 98021887-fb82-4cb4-a5f4-c4316901da21 TCGA-HC-8216-01 TCGA-HC-8216-01 TCGA-HC-8216-01A-11D-A29Q-08 TCGA-HC-8216-01A-11D-A29Q-08 98021887-fb82-4cb4-a5f4-c4316901da21 +TCGA-HC-8256-01 TCGA-HC-8256-01 TCGA-HC-8256 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 53 TCGA-HC-8256-F64369 TCGA-HC-8256 M0 -19598 0 860 Scheduled Follow-up Submission Complete Remission/Response 2014-8-29 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO NO NO No T2c 8256 TUMOR FREE 3 Complete Remission/Response NO R0 Primary Tumor 01 4 NO YES NO HC Prostate LIVING 2011 c7ab83e0-85c1-4224-8f47-746221f66d1e TCGA-HC-8256-01A-11D-2259-01 TCGA-HC-8256-01A-11D-2261-05 TCGA-HC-8256-01A-11D-2260-08 c7ab83e0-85c1-4224-8f47-746221f66d1e TCGA-HC-8256-01 TCGA-HC-8256-01 TCGA-HC-8256-01A-11D-2259-01 c7ab83e0-85c1-4224-8f47-746221f66d1e TCGA-HC-8256-01 TCGA-HC-8256-01 TCGA-HC-8256-01A-11D-2260-08 TCGA-HC-8256-01A-11D-2260-08 c7ab83e0-85c1-4224-8f47-746221f66d1e +TCGA-HC-8257-01 TCGA-HC-8257-01 TCGA-HC-8257 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 70 TCGA-HC-8257-F57852 TCGA-HC-8257 TCGA-HC-8257-01A NO -25629 0 726 726 Scheduled Follow-up Submission Complete Remission/Response 2014-3-27 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES 0.3 NO Bilateral 1.1 NO YES NO 8 1 No N1 T3b TCGA-HC-8257.ff35baf5-f38f-4458-8c20-c61d61c61c19.pdf 8257 TUMOR FREE 3 Complete Remission/Response 0.1 NO R1 Primary Tumor 01 4 0.1 YES YES NO HC Prostate A LIVING 2011 940cfbb0-1808-41e0-8b13-4447b0d3c8cc TCGA-HC-8257-01A-11D-2259-01 TCGA-HC-8257-01A-11D-2261-05 TCGA-HC-8257-01A-11D-2260-08 940cfbb0-1808-41e0-8b13-4447b0d3c8cc TCGA-HC-8257-01 TCGA-HC-8257-01 TCGA-HC-8257-01A-11D-2259-01 940cfbb0-1808-41e0-8b13-4447b0d3c8cc TCGA-HC-8257-01 TCGA-HC-8257-01 TCGA-HC-8257-01A-11D-2260-08 TCGA-HC-8257-01A-11D-2260-08 940cfbb0-1808-41e0-8b13-4447b0d3c8cc +TCGA-HC-8258-01 TCGA-HC-8258-01 TCGA-HC-8258 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 56 TCGA-HC-8258-F48771 TCGA-HC-8258 NO -20703 0 847 162 Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 2 0 No N0 T2c 8258 TUMOR FREE 3 Complete Remission/Response .01 NO Primary Tumor 01 3 NO YES NO HC Prostate LIVING 2011 b353ec8f-70d1-40a6-bf94-12662bd11146 TCGA-HC-8258-01A-11D-2259-01 TCGA-HC-8258-01B-05D-2299-05,TCGA-HC-8258-01A-11D-2261-05 TCGA-HC-8258-01A-11D-2260-08 b353ec8f-70d1-40a6-bf94-12662bd11146 TCGA-HC-8258-01 TCGA-HC-8258-01 TCGA-HC-8258-01A-11D-2259-01 b353ec8f-70d1-40a6-bf94-12662bd11146 TCGA-HC-8258-01 TCGA-HC-8258-01 TCGA-HC-8258-01B-05D-2298-08,TCGA-HC-8258-01A-11D-2260-08 TCGA-HC-8258-01A-11D-2260-08 b353ec8f-70d1-40a6-bf94-12662bd11146 +TCGA-HC-8258-11 TCGA-HC-8258-11 TCGA-HC-8258 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 56 TCGA-HC-8258-F48771 TCGA-HC-8258 TCGA-HC-8258-11A NO -20703 0 847 162 Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 0.6 NO YES NO 2 0 No N0 T2c 8258 TUMOR FREE 3 Complete Remission/Response .01 NO Solid Tissue Normal 11 3 0.3 NO YES NO HC Prostate A LIVING 2011 575740a1-6467-4f58-b462-6fd1a4f63c51 575740a1-6467-4f58-b462-6fd1a4f63c51 TCGA-HC-8258-11 575740a1-6467-4f58-b462-6fd1a4f63c51 TCGA-HC-8258-11 575740a1-6467-4f58-b462-6fd1a4f63c51 +TCGA-HC-8259-01 TCGA-HC-8259-01 TCGA-HC-8259 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 50 TCGA-HC-8259-F66035 TCGA-HC-8259 NO M0 T1c -18309 0 924 123 Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Left NO NO NO No T2a 8259 TUMOR FREE 3 Complete Remission/Response 0.01 NO R0 Primary Tumor 01 3 NO YES NO HC Prostate LIVING 2011 add784d0-7733-448c-a8b9-53442128d8ac TCGA-HC-8259-01A-11D-2259-01 TCGA-HC-8259-01A-11D-2261-05 TCGA-HC-8259-01A-11D-2260-08 add784d0-7733-448c-a8b9-53442128d8ac TCGA-HC-8259-01 TCGA-HC-8259-01 TCGA-HC-8259-01A-11D-2259-01 add784d0-7733-448c-a8b9-53442128d8ac TCGA-HC-8259-01 TCGA-HC-8259-01 TCGA-HC-8259-01A-11D-2260-08 add784d0-7733-448c-a8b9-53442128d8ac +TCGA-HC-8259-11 TCGA-HC-8259-11 TCGA-HC-8259 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 50 TCGA-HC-8259-F66035 TCGA-HC-8259 NO M0 T1c -18309 0 924 123 Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Left NO NO NO No T2a 8259 TUMOR FREE 3 Complete Remission/Response 0.01 NO R0 Solid Tissue Normal 11 3 NO YES NO HC Prostate LIVING 2011 b805e5e4-4d99-46c8-b308-11cac572ac42 b805e5e4-4d99-46c8-b308-11cac572ac42 TCGA-HC-8259-11 b805e5e4-4d99-46c8-b308-11cac572ac42 TCGA-HC-8259-11 b805e5e4-4d99-46c8-b308-11cac572ac42 +TCGA-HC-8260-01 TCGA-HC-8260-01 TCGA-HC-8260 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 43 TCGA-HC-8260-F64387 TCGA-HC-8260 TCGA-HC-8260-01A NO M0 -15884 0 686 106 Scheduled Follow-up Submission Complete Remission/Response 2014-8-29 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.7 NO Bilateral 1 NO YES NO 9 0 No N0 T2c TCGA-HC-8260.12d41624-f0a9-4ba1-aa55-18fea0b733af.pdf 8260 TUMOR FREE 3 Complete Remission/Response 0.01 NO R1 Primary Tumor 01 4 0.1 NO YES NO HC Apex Prostate A LIVING 2011 Peripheral Zone 59a3d245-6921-4799-9eb7-1bff6021680f TCGA-HC-8260-01A-11D-2259-01 TCGA-HC-8260-01A-11D-2261-05 TCGA-HC-8260-01A-11D-2260-08 59a3d245-6921-4799-9eb7-1bff6021680f TCGA-HC-8260-01 TCGA-HC-8260-01 TCGA-HC-8260-01A-11D-2259-01 59a3d245-6921-4799-9eb7-1bff6021680f TCGA-HC-8260-01 TCGA-HC-8260-01 TCGA-HC-8260-01A-11D-2260-08 TCGA-HC-8260-01A-11D-2260-08 59a3d245-6921-4799-9eb7-1bff6021680f +TCGA-HC-8260-11 TCGA-HC-8260-11 TCGA-HC-8260 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 43 TCGA-HC-8260-F64387 TCGA-HC-8260 TCGA-HC-8260-11A NO M0 -15884 0 686 106 Scheduled Follow-up Submission Complete Remission/Response 2014-8-29 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.6 NO Bilateral 0.9 NO YES NO 9 0 No N0 T2c 8260 TUMOR FREE 3 Complete Remission/Response 0.01 NO R1 Solid Tissue Normal 11 4 0.3 NO YES NO HC Apex Prostate A LIVING 2011 Peripheral Zone 094a8a62-d69a-4054-a9d8-120cf7920c39 094a8a62-d69a-4054-a9d8-120cf7920c39 TCGA-HC-8260-11 094a8a62-d69a-4054-a9d8-120cf7920c39 TCGA-HC-8260-11 094a8a62-d69a-4054-a9d8-120cf7920c39 +TCGA-HC-8261-01 TCGA-HC-8261-01 TCGA-HC-8261 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 48 TCGA-HC-8261-F57017 TCGA-HC-8261 TCGA-HC-8261-01A -17874 0 546 Scheduled Follow-up Submission Complete Remission/Response 2014-2-28 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.3 NO Bilateral 0.4 NO NO NO No T2c TCGA-HC-8261.66690c59-06ae-4d5e-b862-3be6a11d67fb.pdf 8261 TUMOR FREE 3 Complete Remission/Response NO R0 Primary Tumor 01 4 0.2 NO YES NO HC Prostate A LIVING 2011 4a54f172-9435-4e46-8396-405634425db2 TCGA-HC-8261-01A-11D-2259-01 TCGA-HC-8261-01A-11D-2261-05,TCGA-HC-8261-01B-05D-2299-05 TCGA-HC-8261-01A-11D-2260-08 4a54f172-9435-4e46-8396-405634425db2 TCGA-HC-8261-01 TCGA-HC-8261-01 TCGA-HC-8261-01A-11D-2259-01 4a54f172-9435-4e46-8396-405634425db2 TCGA-HC-8261-01 TCGA-HC-8261-01 TCGA-HC-8261-01A-11D-2260-08,TCGA-HC-8261-01B-05D-2298-08 TCGA-HC-8261-01A-11D-2260-08 4a54f172-9435-4e46-8396-405634425db2 +TCGA-HC-8262-01 TCGA-HC-8262-01 TCGA-HC-8262 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-HC-8262-F48770 TCGA-HC-8262 NO -20946 0 679 112 Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 8 0 No N0 T2c 8262 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO HC Prostate LIVING 2011 b081b1a5-2ab9-401b-a892-83e1d51ade54 TCGA-HC-8262-01A-11D-2259-01 TCGA-HC-8262-01A-11D-2261-05 TCGA-HC-8262-01A-11D-2260-08 b081b1a5-2ab9-401b-a892-83e1d51ade54 TCGA-HC-8262-01 TCGA-HC-8262-01 TCGA-HC-8262-01A-11D-2259-01 b081b1a5-2ab9-401b-a892-83e1d51ade54 TCGA-HC-8262-01 TCGA-HC-8262-01 TCGA-HC-8262-01A-11D-2260-08 TCGA-HC-8262-01A-11D-2260-08 b081b1a5-2ab9-401b-a892-83e1d51ade54 +TCGA-HC-8262-11 TCGA-HC-8262-11 TCGA-HC-8262 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-HC-8262-F48770 TCGA-HC-8262 TCGA-HC-8262-11A NO -20946 0 679 112 Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 0.7 NO YES NO 8 0 No N0 T2c 8262 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Solid Tissue Normal 11 4 0.3 NO YES NO HC Prostate A LIVING 2011 4979a47e-0078-40c7-abad-849dfd54263c 4979a47e-0078-40c7-abad-849dfd54263c TCGA-HC-8262-11 4979a47e-0078-40c7-abad-849dfd54263c TCGA-HC-8262-11 4979a47e-0078-40c7-abad-849dfd54263c +TCGA-HC-8264-01 TCGA-HC-8264-01 TCGA-HC-8264 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-HC-8264 TCGA-HC-8264-01B -22177 0 48 2013-1-25 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.7 NO Bilateral 1.2 YES NO 2 1 No N1 T3b TCGA-HC-8264.147b5116-ae7b-4c43-8e6d-3a0064f28902.pdf 8264 WITH TUMOR 4 R1 Primary Tumor 01 5 0.5 YES NO HC Prostate B LIVING 2011 9adad1de-52dd-48a2-b025-bc9081af4ac9 TCGA-HC-8264-01B-11D-2391-01 TCGA-HC-8264-01B-11D-2399-05 TCGA-HC-8264-01B-11D-2395-08 9adad1de-52dd-48a2-b025-bc9081af4ac9 TCGA-HC-8264-01 TCGA-HC-8264-01 3BDBE78B-8F80-44DC-91F0-9763A0A36F29 TCGA-HC-8264-01B-11D-2391-01 9adad1de-52dd-48a2-b025-bc9081af4ac9 TCGA-HC-8264-01 TCGA-HC-8264-01 TCGA-HC-8264-01B-11D-2395-08 TCGA-HC-8264-01B-11D-2395-08 9adad1de-52dd-48a2-b025-bc9081af4ac9 +TCGA-HC-8265-01 TCGA-HC-8265-01 TCGA-HC-8265 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-HC-8265-F48767 TCGA-HC-8265 NO -24382 0 483 119 Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 8 0 No N0 T3a 8265 TUMOR FREE 3 Complete Remission/Response 0.1 YES R1 Primary Tumor 01 5 NO YES NO HC Prostate LIVING 2011 cefe4277-778b-42b3-8e05-5df8327f50be TCGA-HC-8265-01A-11D-2259-01 TCGA-HC-8265-01A-11D-2261-05,TCGA-HC-8265-01B-04D-2299-05 TCGA-HC-8265-01A-11D-2260-08 cefe4277-778b-42b3-8e05-5df8327f50be TCGA-HC-8265-01 TCGA-HC-8265-01 TCGA-HC-8265-01A-11D-2259-01 cefe4277-778b-42b3-8e05-5df8327f50be TCGA-HC-8265-01 TCGA-HC-8265-01 TCGA-HC-8265-01B-04D-2298-08,TCGA-HC-8265-01A-11D-2260-08 TCGA-HC-8265-01A-11D-2260-08 cefe4277-778b-42b3-8e05-5df8327f50be +TCGA-HC-8266-01 TCGA-HC-8266-01 TCGA-HC-8266 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-HC-8266-F66043 TCGA-HC-8266 TCGA-HC-8266-01A M0 -20280 0 473 Scheduled Follow-up Submission 2014-10-1 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES 0.5 NO Bilateral 0.8 NO YES NO 5 0 No N0 T3b TCGA-HC-8266.cb8abdbd-c61d-4ad4-bd8b-a7e9dbc20d2d.pdf 8266 WITH TUMOR 4 NO R1 Primary Tumor 01 4 0.2 NO YES NO HC Prostate A LIVING 2012 32798ff7-089c-46dc-afc3-1c3f3995ecf9 TCGA-HC-8266-01A-11D-2259-01 TCGA-HC-8266-01A-11D-2261-05 TCGA-HC-8266-01A-11D-2260-08 32798ff7-089c-46dc-afc3-1c3f3995ecf9 TCGA-HC-8266-01 TCGA-HC-8266-01 TCGA-HC-8266-01A-11D-2259-01 32798ff7-089c-46dc-afc3-1c3f3995ecf9 TCGA-HC-8266-01 TCGA-HC-8266-01 TCGA-HC-8266-01A-11D-2260-08 TCGA-HC-8266-01A-11D-2260-08 32798ff7-089c-46dc-afc3-1c3f3995ecf9 +TCGA-HC-A48F-01 TCGA-HC-A48F-01 TCGA-HC-A48F TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 47 TCGA-HC-A48F-F64404 TCGA-HC-A48F Normal (no evidence of prostate cancer) [cM0] M0 T1c -17434 29 30 0 680 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-8-29 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 10 1 No N1 T2c A48F TUMOR FREE 4 Complete Remission/Response YES R1 Primary Tumor 01 4 YES YES NO HC Prostate LIVING 2012 Overlapping / Multiple Zones bc2bbaca-4bd5-4a3d-a93a-ebc1bc9f4d5f TCGA-HC-A48F-01A-11D-A256-01 TCGA-HC-A48F-01A-11D-A258-05 TCGA-HC-A48F-01A-11D-A257-08 bc2bbaca-4bd5-4a3d-a93a-ebc1bc9f4d5f TCGA-HC-A48F-01 TCGA-HC-A48F-01 TCGA-HC-A48F-01A-11D-A256-01 bc2bbaca-4bd5-4a3d-a93a-ebc1bc9f4d5f TCGA-HC-A48F-01 TCGA-HC-A48F-01 TCGA-HC-A48F-01A-11D-A257-08 TCGA-HC-A48F-01A-11D-A257-08 bc2bbaca-4bd5-4a3d-a93a-ebc1bc9f4d5f +TCGA-HC-A4ZV-01 TCGA-HC-A4ZV-01 TCGA-HC-A4ZV TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 56 TCGA-HC-A4ZV TCGA-HC-A4ZV-01A T2c -20634 79 0 23 2013-3-15 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 80 NO Bilateral YES NO 13 0 false No N0 T3b TCGA-HC-A4ZV.424EBA82-F32C-4387-B919-F7C8F1212232.pdf A4ZV WITH TUMOR 5 R1 Primary Tumor 01 4 YES NO HC Prostate A LIVING 2012 Overlapping / Multiple Zones 2728c0e3-f8fe-4da4-96ec-885334df4e0f TCGA-HC-A4ZV-01A-11D-A26L-01 TCGA-HC-A4ZV-01A-11D-A26N-05 TCGA-HC-A4ZV-01A-11D-A26M-08 2728c0e3-f8fe-4da4-96ec-885334df4e0f TCGA-HC-A4ZV-01 TCGA-HC-A4ZV-01 TCGA-HC-A4ZV-01A-11D-A26L-01 2728c0e3-f8fe-4da4-96ec-885334df4e0f TCGA-HC-A4ZV-01 TCGA-HC-A4ZV-01 TCGA-HC-A4ZV-01A-11D-A26M-08 TCGA-HC-A4ZV-01A-11D-A26M-08 2728c0e3-f8fe-4da4-96ec-885334df4e0f +TCGA-HC-A631-01 TCGA-HC-A631-01 TCGA-HC-A631 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-HC-A631 TCGA-HC-A631-01A Normal (no evidence of prostate cancer) [cM0] M0 T2 -24749 25 101 21 0 54 YES No Evidence of Extraprostatic Extension 2014-4-22 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 40 NO Bilateral YES NO 2 0 false No N0 T2c TCGA-HC-A631.70585F33-CB9E-4365-9CA2-E384BED102DD.pdf A631 WITH TUMOR 4 R1 Primary Tumor 01 5 3 YES NO HC Prostate A LIVING 2012 95086d05-3789-400a-b663-5d9d3a346325 TCGA-HC-A631-01A-11D-A323-01 TCGA-HC-A631-01A-11D-A29T-05 TCGA-HC-A631-01A-11D-A29Q-08 95086d05-3789-400a-b663-5d9d3a346325 TCGA-HC-A631-01 TCGA-HC-A631-01 TCGA-HC-A631-01A-11D-A323-01 95086d05-3789-400a-b663-5d9d3a346325 TCGA-HC-A631-01 TCGA-HC-A631-01 TCGA-HC-A631-01A-11D-A29Q-08 TCGA-HC-A631-01A-11D-A29Q-08 95086d05-3789-400a-b663-5d9d3a346325 +TCGA-HC-A632-01 TCGA-HC-A632-01 TCGA-HC-A632 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-HC-A632 NO M0 T1c -24916 0 61 2013-10-15 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral YES NO 5 0 No N0 T3a A632 TUMOR FREE 4 R0 Primary Tumor 01 5 YES NO HC Prostate LIVING 2013 e766089b-b399-4231-ad1a-139c4283a5bd TCGA-HC-A632-01A-11D-A323-01 TCGA-HC-A632-01A-11D-A29T-05 TCGA-HC-A632-01A-11D-A29Q-08 e766089b-b399-4231-ad1a-139c4283a5bd TCGA-HC-A632-01 TCGA-HC-A632-01 TCGA-HC-A632-01A-11D-A323-01 e766089b-b399-4231-ad1a-139c4283a5bd TCGA-HC-A632-01 TCGA-HC-A632-01 TCGA-HC-A632-01A-11D-A29Q-08 TCGA-HC-A632-01A-11D-A29Q-08 e766089b-b399-4231-ad1a-139c4283a5bd +TCGA-HC-A6AL-01 TCGA-HC-A6AL-01 TCGA-HC-A6AL TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-HC-A6AL TCGA-HC-A6AL-01A M0 T1c -23618 224 21 0 67 YES No Evidence of Extraprostatic Extension NO 2013-9-19 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 50 NO Bilateral YES NO 3 0 false No N0 T2c TCGA-HC-A6AL.2A2BA0EA-C67A-4AA6-948C-019AA6475C06.pdf A6AL TUMOR FREE 3 R0 Primary Tumor 01 4 YES NO HC Prostate A LIVING 2012 97ce2468-dfb0-41c5-903c-577728feff95 TCGA-HC-A6AL-01A-11D-A30D-01 TCGA-HC-A6AL-01A-11D-A30F-05 TCGA-HC-A6AL-01A-11D-A30E-08 97ce2468-dfb0-41c5-903c-577728feff95 TCGA-HC-A6AL-01 TCGA-HC-A6AL-01 TCGA-HC-A6AL-01A-11D-A30D-01 97ce2468-dfb0-41c5-903c-577728feff95 TCGA-HC-A6AL-01 TCGA-HC-A6AL-01 TCGA-HC-A6AL-01A-11D-A30E-08 97ce2468-dfb0-41c5-903c-577728feff95 +TCGA-HC-A6AN-01 TCGA-HC-A6AN-01 TCGA-HC-A6AN TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-HC-A6AN TCGA-HC-A6AN-01A M0 T1c -24697 209 0 49 2014-4-22 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 20 NO Bilateral YES NO 1 0 false No N0 T3a TCGA-HC-A6AN.D5C8CC7E-BADE-457C-AC31-CC138C8C794C.pdf A6AN WITH TUMOR 4 R1 Primary Tumor 01 3 YES NO HC Prostate A LIVING 2012 6af0bf8a-6243-493b-92f5-4ea2604d35cd TCGA-HC-A6AN-01A-11D-A30D-01 TCGA-HC-A6AN-01A-11D-A30F-05 TCGA-HC-A6AN-01A-11D-A30E-08 6af0bf8a-6243-493b-92f5-4ea2604d35cd TCGA-HC-A6AN-01 TCGA-HC-A6AN-01 TCGA-HC-A6AN-01A-11D-A30D-01 6af0bf8a-6243-493b-92f5-4ea2604d35cd TCGA-HC-A6AN-01 TCGA-HC-A6AN-01 TCGA-HC-A6AN-01A-11D-A30E-08 6af0bf8a-6243-493b-92f5-4ea2604d35cd +TCGA-HC-A6AO-01 TCGA-HC-A6AO-01 TCGA-HC-A6AO TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 52 TCGA-HC-A6AO-F66036 TCGA-HC-A6AO TCGA-HC-A6AO-01A M0 T1c -19298 301 0 530 NO YES Extraprostatic Extension Localized (e.g. seminal vesicles) Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 30 NO Bilateral NO NO NO false No T2c TCGA-HC-A6AO.37F41695-9D8D-4CA1-9728-6A04AAD76274.pdf A6AO TUMOR FREE 4 Complete Remission/Response NO R0 Primary Tumor 01 3 NO YES NO HC Prostate A LIVING 2012 9ff2bdcd-1c48-4f81-8644-c302132b2400 TCGA-HC-A6AO-01A-11D-A30D-01 TCGA-HC-A6AO-01A-11D-A30F-05 TCGA-HC-A6AO-01A-11D-A30E-08 9ff2bdcd-1c48-4f81-8644-c302132b2400 TCGA-HC-A6AO-01 TCGA-HC-A6AO-01 TCGA-HC-A6AO-01A-11D-A30D-01 9ff2bdcd-1c48-4f81-8644-c302132b2400 TCGA-HC-A6AO-01 TCGA-HC-A6AO-01 TCGA-HC-A6AO-01A-11D-A30E-08 9ff2bdcd-1c48-4f81-8644-c302132b2400 +TCGA-HC-A6AP-01 TCGA-HC-A6AP-01 TCGA-HC-A6AP TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-HC-A6AP TCGA-HC-A6AP-01A M0 T1c -22318 182 15 0 71 YES No Evidence of Extraprostatic Extension NO 2013-9-19 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 40 NO Bilateral NO NO false No T2c TCGA-HC-A6AP.7271E139-D1C7-4FB1-B148-54DE4A1DF42B.pdf A6AP 3 RX Primary Tumor 01 4 YES NO HC Prostate A LIVING 2012 Overlapping / Multiple Zones 14b3c94a-781d-4df9-9ee6-a3236d099dc6 TCGA-HC-A6AP-01A-11D-A30D-01 TCGA-HC-A6AP-01A-11D-A30F-05 TCGA-HC-A6AP-01A-11D-A30E-08 14b3c94a-781d-4df9-9ee6-a3236d099dc6 TCGA-HC-A6AP-01 TCGA-HC-A6AP-01 TCGA-HC-A6AP-01A-11D-A30D-01 14b3c94a-781d-4df9-9ee6-a3236d099dc6 TCGA-HC-A6AP-01 TCGA-HC-A6AP-01 TCGA-HC-A6AP-01A-11D-A30E-08 14b3c94a-781d-4df9-9ee6-a3236d099dc6 +TCGA-HC-A6AQ-01 TCGA-HC-A6AQ-01 TCGA-HC-A6AQ TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-HC-A6AQ Normal (no evidence of prostate cancer) [cM0] M0 T1c -22208 15 0 106 NO NO 2013-9-19 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO NO Yes, History of Prior Malignancy T2c A6AQ TUMOR FREE 3 R0 Primary Tumor 01 4 YES NO HC Prostate LIVING 2012 deeaffd6-c733-4fc1-857e-693a49b73423 TCGA-HC-A6AQ-01A-11D-A30D-01 TCGA-HC-A6AQ-01A-11D-A30F-05 TCGA-HC-A6AQ-01A-11D-A30E-08 deeaffd6-c733-4fc1-857e-693a49b73423 TCGA-HC-A6AQ-01 TCGA-HC-A6AQ-01 TCGA-HC-A6AQ-01A-11D-A30D-01 deeaffd6-c733-4fc1-857e-693a49b73423 TCGA-HC-A6AQ-01 TCGA-HC-A6AQ-01 TCGA-HC-A6AQ-01A-11D-A30E-08 deeaffd6-c733-4fc1-857e-693a49b73423 +TCGA-HC-A6AS-01 TCGA-HC-A6AS-01 TCGA-HC-A6AS TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 70 TCGA-HC-A6AS TCGA-HC-A6AS-01A Normal (no evidence of prostate cancer) [cM0] M0 T1c -25661 27 127 27 0 44 YES No Evidence of Extraprostatic Extension NO 2013-9-19 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 30 NO Right YES NO 5 0 false No N0 T2a TCGA-HC-A6AS.89891821-AF8C-4105-8270-D6FCF714697F.pdf A6AS TUMOR FREE 3 R0 Primary Tumor 01 4 YES NO HC Prostate A LIVING 2012 9605aa9b-2739-4d98-864d-fcfdb59b9ef5 TCGA-HC-A6AS-01A-11D-A30D-01 TCGA-HC-A6AS-01A-11D-A30F-05 TCGA-HC-A6AS-01A-11D-A30E-08 9605aa9b-2739-4d98-864d-fcfdb59b9ef5 TCGA-HC-A6AS-01 TCGA-HC-A6AS-01 TCGA-HC-A6AS-01A-11D-A30D-01 9605aa9b-2739-4d98-864d-fcfdb59b9ef5 TCGA-HC-A6AS-01 TCGA-HC-A6AS-01 TCGA-HC-A6AS-01A-11D-A30E-08 9605aa9b-2739-4d98-864d-fcfdb59b9ef5 +TCGA-HC-A6HX-01 TCGA-HC-A6HX-01 TCGA-HC-A6HX TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-HC-A6HX TCGA-HC-A6HX-01A M0 T1c -20263 112 0 38 2013-9-19 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 30 NO Bilateral YES NO 4 0 false No N0 T2c TCGA-HC-A6HX.0E22E3BE-B28B-40CC-83F9-9B59593B7187.pdf A6HX TUMOR FREE 4 R0 Primary Tumor 01 3 5 YES NO HC Prostate A LIVING 2013 95fd9476-083d-41d5-a7dc-a605673b82d3 TCGA-HC-A6HX-01A-11D-A31K-01 TCGA-HC-A6HX-01A-11D-A31M-05 TCGA-HC-A6HX-01A-11D-A31L-08 95fd9476-083d-41d5-a7dc-a605673b82d3 TCGA-HC-A6HX-01 TCGA-HC-A6HX-01 TCGA-HC-A6HX-01A-11D-A31K-01 95fd9476-083d-41d5-a7dc-a605673b82d3 TCGA-HC-A6HX-01 TCGA-HC-A6HX-01 TCGA-HC-A6HX-01A-11D-A31L-08 95fd9476-083d-41d5-a7dc-a605673b82d3 +TCGA-HC-A6HY-01 TCGA-HC-A6HY-01 TCGA-HC-A6HY TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 51 TCGA-HC-A6HY TCGA-HC-A6HY-01A M0 T1c -18779 179 92 0 134 YES No Evidence of Extraprostatic Extension 2013-9-19 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 50 NO Bilateral NO NO false No T2c TCGA-HC-A6HY.91DC18E8-EF04-47C0-A77F-632A9DE2BA55.pdf A6HY TUMOR FREE 3 R0 Primary Tumor 01 4 YES NO HC Prostate A LIVING 2012 027f330a-6206-4fd4-8790-8bb5e0207bc1 TCGA-HC-A6HY-01A-11D-A31K-01 TCGA-HC-A6HY-01A-11D-A31M-05 TCGA-HC-A6HY-01A-11D-A31L-08 027f330a-6206-4fd4-8790-8bb5e0207bc1 TCGA-HC-A6HY-01 TCGA-HC-A6HY-01 TCGA-HC-A6HY-01A-11D-A31K-01 027f330a-6206-4fd4-8790-8bb5e0207bc1 TCGA-HC-A6HY-01 TCGA-HC-A6HY-01 TCGA-HC-A6HY-01A-11D-A31L-08 027f330a-6206-4fd4-8790-8bb5e0207bc1 +TCGA-HC-A76W-01 TCGA-HC-A76W-01 TCGA-HC-A76W TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 73 TCGA-HC-A76W TCGA-HC-A76W-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2 -26755 62 260 0 213 213 NO NO 2014-3-28 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 50 NO Bilateral YES NO 4 0 true Yes, History of Synchronous/Bilateral Malignancy N0 T3b TCGA-HC-A76W.C59C0C25-B1FC-45C5-AD7E-0FBA9574656C.pdf A76W WITH TUMOR 3 0.01 R1 Primary Tumor 01 4 YES NO HC Apex|Middle|Base Prostate A LIVING 2012 94399af6-33b3-4622-a5b1-d2e446061980 TCGA-HC-A76W-01A-11D-A33S-01 TCGA-HC-A76W-01A-11D-A33U-05 TCGA-HC-A76W-01A-11D-A33T-08 94399af6-33b3-4622-a5b1-d2e446061980 TCGA-HC-A76W-01 TCGA-HC-A76W-01 TCGA-HC-A76W-01A-11D-A33S-01 94399af6-33b3-4622-a5b1-d2e446061980 TCGA-HC-A76W-01 TCGA-HC-A76W-01 TCGA-HC-A76W-01A-11D-A33T-08 94399af6-33b3-4622-a5b1-d2e446061980 +TCGA-HC-A76X-01 TCGA-HC-A76X-01 TCGA-HC-A76X TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-HC-A76X TCGA-HC-A76X-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -22756 10 149 0 150 150 2014-3-28 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 60 NO Bilateral YES NO 1 0 true No N0 T2c TCGA-HC-A76X.DA72A108-04AA-424B-83EE-714036869E87.pdf A76X TUMOR FREE 3 0.01 R0 Primary Tumor 01 4 YES NO HC Apex|Middle|Base Prostate A LIVING 2013 99dd7197-d956-4e4f-aee1-e0362eef2e20 TCGA-HC-A76X-01A-11D-A33S-01 TCGA-HC-A76X-01A-11D-A33U-05 TCGA-HC-A76X-01A-11D-A33T-08 99dd7197-d956-4e4f-aee1-e0362eef2e20 TCGA-HC-A76X-01 TCGA-HC-A76X-01 43111791-46EE-45BD-813B-EF2A5619C40C TCGA-HC-A76X-01A-11D-A33S-01 99dd7197-d956-4e4f-aee1-e0362eef2e20 TCGA-HC-A76X-01 TCGA-HC-A76X-01 TCGA-HC-A76X-01A-11D-A33T-08 99dd7197-d956-4e4f-aee1-e0362eef2e20 +TCGA-HC-A8CY-01 TCGA-HC-A8CY-01 TCGA-HC-A8CY TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-HC-A8CY Abnormal (not related to prostate cancer) M0 T1c -23154 41 41 0 290 290 YES No Evidence of Extraprostatic Extension NO 2014-3-28 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral YES 3 1 No N1 T3a A8CY WITH TUMOR 5 0.9 R1 Primary Tumor 01 4 YES NO HC Prostate LIVING 2013 Overlapping / Multiple Zones d6c16450-87c1-4b18-bab5-8cb782fdb99c TCGA-HC-A8CY-01A-11D-A363-01 TCGA-HC-A8CY-01A-11D-A365-05 TCGA-HC-A8CY-01A-11D-A364-08 d6c16450-87c1-4b18-bab5-8cb782fdb99c TCGA-HC-A8CY-01 TCGA-HC-A8CY-01 TCGA-HC-A8CY-01A-11D-A363-01 d6c16450-87c1-4b18-bab5-8cb782fdb99c TCGA-HC-A8CY-01 TCGA-HC-A8CY-01 TCGA-HC-A8CY-01A-11D-A364-08 d6c16450-87c1-4b18-bab5-8cb782fdb99c +TCGA-HC-A8D0-01 TCGA-HC-A8D0-01 TCGA-HC-A8D0 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-HC-A8D0-F68682 TCGA-HC-A8D0 TCGA-HC-A8D0-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -22465 11 517 11 14 0 775 110 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2014-12-10 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 60 NO Left NO YES NO 10 0 false No N0 T2a TCGA-HC-A8D0.E29BD9A6-B0F0-42D8-B952-85B71C3D5BC9.pdf A8D0 TUMOR FREE 3 Complete Remission/Response 0.01 NO R0 Primary Tumor 01 4 NO YES NO HC Apex|Middle Prostate A LIVING 2012 Overlapping / Multiple Zones 1dd9dd18-3137-4515-9346-909e772b6ca8 TCGA-HC-A8D0-01A-11D-A363-01 TCGA-HC-A8D0-01A-11D-A365-05 TCGA-HC-A8D0-01A-11D-A364-08 1dd9dd18-3137-4515-9346-909e772b6ca8 TCGA-HC-A8D0-01 TCGA-HC-A8D0-01 TCGA-HC-A8D0-01A-11D-A363-01 1dd9dd18-3137-4515-9346-909e772b6ca8 TCGA-HC-A8D0-01 TCGA-HC-A8D0-01 TCGA-HC-A8D0-01A-11D-A364-08 1dd9dd18-3137-4515-9346-909e772b6ca8 +TCGA-HC-A8D1-01 TCGA-HC-A8D1-01 TCGA-HC-A8D1 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-HC-A8D1-F68683 TCGA-HC-A8D1 NO Normal (no evidence of prostate cancer) [cM0] M0 T2 -25137 14 0 573 168 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-12-10 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 6 0 No N0 T2c A8D1 TUMOR FREE 3 Complete Remission/Response 0.01 NO R0 Primary Tumor 01 4 NO YES NO HC Prostate LIVING 2012 f0c1b588-ebe6-4f6c-a013-c36091c8e29c TCGA-HC-A8D1-01A-11D-A363-01 TCGA-HC-A8D1-01A-11D-A365-05 TCGA-HC-A8D1-01A-11D-A364-08 f0c1b588-ebe6-4f6c-a013-c36091c8e29c TCGA-HC-A8D1-01 TCGA-HC-A8D1-01 TCGA-HC-A8D1-01A-11D-A363-01 f0c1b588-ebe6-4f6c-a013-c36091c8e29c TCGA-HC-A8D1-01 TCGA-HC-A8D1-01 TCGA-HC-A8D1-01A-11D-A364-08 f0c1b588-ebe6-4f6c-a013-c36091c8e29c +TCGA-HC-A9TE-01 TCGA-HC-A9TE-01 TCGA-HC-A9TE TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES YES 64 TCGA-HC-A9TE-F72404 TCGA-HC-A9TE TCGA-HC-A9TE-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2c -23543 13 159 16 216 0 587 216 134 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Stable Disease 2015-6-10 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Transurethral resection (TURBT) 50 NO Bilateral NO YES Other, specify Biochemical evidence of disease Biochemical YES 7 1 false No N0 T3b TCGA-HC-A9TE.BC2B6EED-5BD7-407D-AFAD-47A611F3C62C.pdf A9TE WITH TUMOR 5 Partial Remission/Response 0.064 NO R1 Primary Tumor 01 4 NO 3 YES NO HC Apex|Middle|Base NO Prostate A LIVING 2013 Overlapping / Multiple Zones 212f9e63-ba39-4765-8522-86833312f8db TCGA-HC-A9TE-01A-11D-A41J-01 TCGA-HC-A9TE-01A-11D-A41L-05 TCGA-HC-A9TE-01A-11D-A41K-08 212f9e63-ba39-4765-8522-86833312f8db TCGA-HC-A9TE-01 TCGA-HC-A9TE-01 TCGA-HC-A9TE-01A-11D-A41J-01 212f9e63-ba39-4765-8522-86833312f8db TCGA-HC-A9TE-01 TCGA-HC-A9TE-01 212f9e63-ba39-4765-8522-86833312f8db +TCGA-HC-A9TH-01 TCGA-HC-A9TH-01 TCGA-HC-A9TH TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES NO 58 TCGA-HC-A9TH-F72401 TCGA-HC-A9TH TCGA-HC-A9TH-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1b -21460 155 320 351 0 844 351 295 Scheduled Follow-up Submission Progressive Disease 2015-6-10 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Transurethral resection (TURBT) 60 NO Bilateral NO YES Other, specify Biochemical evidence of disease Biochemical YES 2 0 false No N0 T3b TCGA-HC-A9TH.C2755FC2-E4BD-4997-B2F9-1F1C3A9C28AE.pdf A9TH WITH TUMOR 5 Partial Remission/Response 0.38 NO R1 Primary Tumor 01 4 NO 5 YES NO HC Apex|Middle|Base NO Prostate A LIVING 2013 3d8c5a1e-618c-4a68-b9d7-d01a86ccf88b TCGA-HC-A9TH-01A-11D-A41J-01 TCGA-HC-A9TH-01A-11D-A41L-05 TCGA-HC-A9TH-01A-11D-A41K-08 3d8c5a1e-618c-4a68-b9d7-d01a86ccf88b TCGA-HC-A9TH-01 TCGA-HC-A9TH-01 TCGA-HC-A9TH-01A-11D-A41J-01 3d8c5a1e-618c-4a68-b9d7-d01a86ccf88b TCGA-HC-A9TH-01 TCGA-HC-A9TH-01 3d8c5a1e-618c-4a68-b9d7-d01a86ccf88b +TCGA-HI-7168-01 TCGA-HI-7168-01 TCGA-HI-7168 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES NO 62 TCGA-HI-7168-F66322 TCGA-HI-7168 TCGA-HI-7168-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T1c -22881 19 19 308 0 3323 2505 2289 1523 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Progressive Disease 2014-10-10 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.3 NO YES Bone Biochemical evidence of disease YES 9 0 No N0 T3b TCGA-HI-7168.d29af7d7-996d-44a9-a571-878ea0f95403.pdf 7168 WITH TUMOR 4 Progressive Disease 0.3 R0 Primary Tumor 01 5 0.4 NO YES HI YES Prostate Distant Metastasis A LIVING 2005 5ce29b9f-3b54-45a6-96e1-ddc3494e6141 TCGA-HI-7168-01A-11D-2112-01 TCGA-HI-7168-01A-11D-2116-05 TCGA-HI-7168-01A-11D-2114-08 5ce29b9f-3b54-45a6-96e1-ddc3494e6141 TCGA-HI-7168-01 TCGA-HI-7168-01 3B50FC1B-3EE6-455E-A5ED-DF54202C08F6 TCGA-HI-7168-01A-11D-2112-01 5ce29b9f-3b54-45a6-96e1-ddc3494e6141 TCGA-HI-7168-01 TCGA-HI-7168-01 TCGA-HI-7168-01A-11D-2114-08 TCGA-HI-7168-01A-11D-2114-08 5ce29b9f-3b54-45a6-96e1-ddc3494e6141 +TCGA-HI-7169-01 TCGA-HI-7169-01 TCGA-HI-7169 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-HI-7169-F29015 TCGA-HI-7169 TCGA-HI-7169-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -20133 33 0 2684 1941 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-2-21 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 1.3 YES NO 4 0 No N0 T3a TCGA-HI-7169.ed386bc1-82a8-489e-81e0-53a93325a48e.pdf 7169 TUMOR FREE 3 Complete Remission/Response 0.1 NO R1 Primary Tumor 01 4 0.3 NO NO YES HI Apex Prostate A LIVING 2006 70a93713-e154-46c8-9360-b873c63f0f05 TCGA-HI-7169-01A-11D-2112-01 TCGA-HI-7169-01A-11D-2116-05 TCGA-HI-7169-01A-11D-2114-08 70a93713-e154-46c8-9360-b873c63f0f05 TCGA-HI-7169-01 TCGA-HI-7169-01 32D75427-C6A9-41CD-BF22-B0866C862AFB TCGA-HI-7169-01A-11D-2112-01 70a93713-e154-46c8-9360-b873c63f0f05 TCGA-HI-7169-01 TCGA-HI-7169-01 TCGA-HI-7169-01A-11D-2114-08 70a93713-e154-46c8-9360-b873c63f0f05 +TCGA-HI-7170-01 TCGA-HI-7170-01 TCGA-HI-7170 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 58 TCGA-HI-7170-F29013 TCGA-HI-7170 TCGA-HI-7170-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -21199 -96 -92 -78 0 2522 1746 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2012-2-21 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Transurethral resection (TURBT) 0.8 NO Bilateral 1.3 YES NO 6 0 No N0 T2c TCGA-HI-7170.96f2ece8-246a-43fe-8963-217613c84f0b.pdf 7170 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 0.4 NO NO YES HI Apex Prostate A LIVING 2006 f7ab806e-12d3-4dfc-90bf-cc49851cc34b TCGA-HI-7170-01A-11D-2112-01 TCGA-HI-7170-01A-11D-2116-05 TCGA-HI-7170-01A-11D-2114-08 f7ab806e-12d3-4dfc-90bf-cc49851cc34b TCGA-HI-7170-01 TCGA-HI-7170-01 9AEB253A-A8C4-449F-979B-74FB466A931E TCGA-HI-7170-01A-11D-2112-01 f7ab806e-12d3-4dfc-90bf-cc49851cc34b TCGA-HI-7170-01 TCGA-HI-7170-01 TCGA-HI-7170-01A-11D-2114-08 TCGA-HI-7170-01A-11D-2114-08 f7ab806e-12d3-4dfc-90bf-cc49851cc34b +TCGA-HI-7171-01 TCGA-HI-7171-01 TCGA-HI-7171 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES YES 56 TCGA-HI-7171-F29021 TCGA-HI-7171 TCGA-HI-7171-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T3a -20776 1329 218 0 631 543 631 NO YES No Evidence of Extraprostatic Extension Additional New Tumor Event Progressive Disease 2012-2-22 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 1 NO Bilateral 1.6 YES Biochemical evidence of disease YES 7 0 No N0 T3b TCGA-HI-7171.0bdd67bb-5cf4-4972-9ab6-9878c351857f.pdf 7171 WITH TUMOR 5 Stable Disease 0.7 NO R1 Primary Tumor 01 4 0.3 NO NO YES HI Apex|Middle|Base Prostate Biochemical Recurrence A DECEASED 2008 2fbbb35f-15ae-43a1-bf6b-d3da0bbd38d4 TCGA-HI-7171-01A-12D-2112-01 TCGA-HI-7171-01A-12D-2116-05 TCGA-HI-7171-01A-12D-2114-08 2fbbb35f-15ae-43a1-bf6b-d3da0bbd38d4 TCGA-HI-7171-01 TCGA-HI-7171-01 D29A9541-89D3-46EF-A1C7-C01830B931CB TCGA-HI-7171-01A-12D-2112-01 2fbbb35f-15ae-43a1-bf6b-d3da0bbd38d4 TCGA-HI-7171-01 TCGA-HI-7171-01 TCGA-HI-7171-01A-12D-2114-08 TCGA-HI-7171-01A-12D-2114-08 2fbbb35f-15ae-43a1-bf6b-d3da0bbd38d4 +TCGA-J4-8198-01 TCGA-J4-8198-01 TCGA-J4-8198 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 49 TCGA-J4-8198-F55294 TCGA-J4-8198 TCGA-J4-8198-01A NO M0 T1c -17935 0 614 76 Scheduled Follow-up Submission Complete Remission/Response 2014-1-3 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.7 NO Bilateral 0.8 NO NO NO No T3b TCGA-J4-8198.c61b1da1-f0d2-48c9-ac71-5967799def29.pdf 8198 TUMOR FREE 4 Complete Remission/Response 0.1 NO Primary Tumor 01 3 0.4 NO 5 YES NO J4 Apex|Middle|Base Prostate A LIVING 2011 2cb1479d-b88e-42a6-a576-e519c98689ca TCGA-J4-8198-01A-11D-2259-01 TCGA-J4-8198-01A-11D-2261-05 TCGA-J4-8198-01A-11D-2260-08 2cb1479d-b88e-42a6-a576-e519c98689ca TCGA-J4-8198-01 TCGA-J4-8198-01 4872992E-43CD-4454-AEFE-31A3339F6687 TCGA-J4-8198-01A-11D-2259-01 2cb1479d-b88e-42a6-a576-e519c98689ca TCGA-J4-8198-01 TCGA-J4-8198-01 TCGA-J4-8198-01A-11D-2260-08 TCGA-J4-8198-01A-11D-2260-08 2cb1479d-b88e-42a6-a576-e519c98689ca +TCGA-J4-8200-01 TCGA-J4-8200-01 TCGA-J4-8200 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 47 TCGA-J4-8200-F70849 TCGA-J4-8200 TCGA-J4-8200-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2 -17167 41 41 0 1218 196 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-10 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 0.5 NO Bilateral 0.7 NO YES NO 4 0 No N0 T2c TCGA-J4-8200.5E18C318-D20B-4837-850D-34FD96C87EEC.pdf 8200 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 0.4 NO YES NO J4 Prostate A LIVING 2011 Overlapping / Multiple Zones bcc096bf-c300-4e3d-b616-daee079938e6 TCGA-J4-8200-01A-11D-A323-01 TCGA-J4-8200-01A-11D-A29T-05 TCGA-J4-8200-01A-11D-A29Q-08 bcc096bf-c300-4e3d-b616-daee079938e6 TCGA-J4-8200-01 TCGA-J4-8200-01 1F9E72E0-4F30-43E7-9F49-71B40798BA3C TCGA-J4-8200-01A-11D-A323-01 bcc096bf-c300-4e3d-b616-daee079938e6 TCGA-J4-8200-01 TCGA-J4-8200-01 TCGA-J4-8200-01A-11D-A29Q-08 TCGA-J4-8200-01A-11D-A29Q-08 bcc096bf-c300-4e3d-b616-daee079938e6 +TCGA-J4-A67K-01 TCGA-J4-A67K-01 TCGA-J4-A67K TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-J4-A67K-F63849 TCGA-J4-A67K TCGA-J4-A67K-01A NO M0 T2b -24908 580 0 1004 557 Scheduled Follow-up Submission 2014-8-20 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 190 NO Bilateral NO NO NO true No T2c TCGA-J4-A67K.F8FF8077-8922-4CC8-95DD-4AF68CCC7EEC.pdf A67K TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 NO YES NO J4 Prostate A LIVING 2011 Peripheral Zone 631b5e57-557b-48d1-a263-5c1b456e73b2 TCGA-J4-A67K-01A-21D-A30D-01 TCGA-J4-A67K-01A-21D-A30F-05 TCGA-J4-A67K-01A-21D-A30E-08 631b5e57-557b-48d1-a263-5c1b456e73b2 TCGA-J4-A67K-01 TCGA-J4-A67K-01 602816C4-4D5A-479F-B8A2-B77FCA6993DF TCGA-J4-A67K-01A-21D-A30D-01 631b5e57-557b-48d1-a263-5c1b456e73b2 TCGA-J4-A67K-01 TCGA-J4-A67K-01 TCGA-J4-A67K-01A-21D-A30E-08 631b5e57-557b-48d1-a263-5c1b456e73b2 +TCGA-J4-A67L-01 TCGA-J4-A67L-01 TCGA-J4-A67L TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 54 TCGA-J4-A67L-F63850 TCGA-J4-A67L TCGA-J4-A67L-01A NO M0 T2a -20034 485 0 770 518 Scheduled Follow-up Submission Complete Remission/Response 2014-8-20 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 70 NO Left NO YES NO 1 0 true No N0 T3a TCGA-J4-A67L.91F854F5-D488-4B25-B59A-6CB59C6357BB.pdf A67L TUMOR FREE 3 Complete Remission/Response .01 NO R0 Primary Tumor 01 4 NO YES NO J4 Apex|Middle|Base Prostate A LIVING 2011 Peripheral Zone 1636e620-09c8-46c7-bf33-9efeceae7cd4 TCGA-J4-A67L-01A-11D-A30D-01 TCGA-J4-A67L-01A-11D-A30F-05 TCGA-J4-A67L-01A-11D-A30E-08 1636e620-09c8-46c7-bf33-9efeceae7cd4 TCGA-J4-A67L-01 TCGA-J4-A67L-01 TCGA-J4-A67L-01A-11D-A30D-01 1636e620-09c8-46c7-bf33-9efeceae7cd4 TCGA-J4-A67L-01 TCGA-J4-A67L-01 TCGA-J4-A67L-01A-11D-A30E-08 1636e620-09c8-46c7-bf33-9efeceae7cd4 +TCGA-J4-A67M-01 TCGA-J4-A67M-01 TCGA-J4-A67M TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-J4-A67M-F63853 TCGA-J4-A67M TCGA-J4-A67M-01A NO M0 T2a -20211 482 0 941 482 Scheduled Follow-up Submission Complete Remission/Response 2014-8-20 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 320 NO Bilateral NO YES NO 6 0 true No N0 T3a TCGA-J4-A67M.590FEE5C-E5FF-4DB2-8A7E-6502E5B9A56B.pdf A67M TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 NO YES NO J4 Apex|Middle|Base Prostate A LIVING 2011 Peripheral Zone 2ccc0221-155e-47b1-ace4-6c78bfc5d4a4 TCGA-J4-A67M-01A-11D-A30D-01 TCGA-J4-A67M-01A-11D-A30F-05 TCGA-J4-A67M-01A-11D-A30E-08 2ccc0221-155e-47b1-ace4-6c78bfc5d4a4 TCGA-J4-A67M-01 TCGA-J4-A67M-01 D29C229D-DE77-4076-A5FB-47C4829740BB TCGA-J4-A67M-01A-11D-A30D-01 2ccc0221-155e-47b1-ace4-6c78bfc5d4a4 TCGA-J4-A67M-01 TCGA-J4-A67M-01 TCGA-J4-A67M-01A-11D-A30E-08 2ccc0221-155e-47b1-ace4-6c78bfc5d4a4 +TCGA-J4-A67N-01 TCGA-J4-A67N-01 TCGA-J4-A67N TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 61 TCGA-J4-A67N-F59131 TCGA-J4-A67N TCGA-J4-A67N-01A YES M0 T2a -22420 504 442 0 937 442 503 503 Scheduled Follow-up Submission 2014-8-20 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 420 NO Bilateral NO YES Biochemical evidence of disease YES 8 0 true No N0 T3a TCGA-J4-A67N.70E5E77E-6B59-40A7-8E87-456EF28AED98.pdf A67N WITH TUMOR 3 Complete Remission/Response 0.7 NO R0 Primary Tumor 01 4 NO YES NO J4 Apex|Middle|Base Prostate A LIVING 2011 Peripheral Zone 0c925aa2-8118-498b-8b5f-17740005df68 TCGA-J4-A67N-01A-11D-A30D-01 TCGA-J4-A67N-01A-11D-A30F-05 TCGA-J4-A67N-01A-11D-A30E-08 0c925aa2-8118-498b-8b5f-17740005df68 TCGA-J4-A67N-01 TCGA-J4-A67N-01 74C0C27D-709E-4C30-88C9-F2B79F1338C3 TCGA-J4-A67N-01A-11D-A30D-01 0c925aa2-8118-498b-8b5f-17740005df68 TCGA-J4-A67N-01 TCGA-J4-A67N-01 TCGA-J4-A67N-01A-11D-A30E-08 0c925aa2-8118-498b-8b5f-17740005df68 +TCGA-J4-A67O-01 TCGA-J4-A67O-01 TCGA-J4-A67O TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-J4-A67O-F63884 TCGA-J4-A67O TCGA-J4-A67O-01A NO M0 T2a -21714 392 0 839 490 Scheduled Follow-up Submission Complete Remission/Response 2014-8-20 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 250 NO Bilateral NO YES NO 2 0 true No N0 T2c TCGA-J4-A67O.BF98B941-3DEB-46EB-803D-4A4AF49F529E.pdf A67O TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO J4 Apex Prostate A LIVING 2012 Peripheral Zone e1fd847f-23c7-4baa-a7ff-d0954d855d1a TCGA-J4-A67O-01A-11D-A30D-01 TCGA-J4-A67O-01A-11D-A30F-05 TCGA-J4-A67O-01A-11D-A30E-08 e1fd847f-23c7-4baa-a7ff-d0954d855d1a TCGA-J4-A67O-01 TCGA-J4-A67O-01 4BBFB22E-7BBB-404D-9610-C34F9AD3073D TCGA-J4-A67O-01A-11D-A30D-01 e1fd847f-23c7-4baa-a7ff-d0954d855d1a TCGA-J4-A67O-01 TCGA-J4-A67O-01 TCGA-J4-A67O-01A-11D-A30E-08 e1fd847f-23c7-4baa-a7ff-d0954d855d1a +TCGA-J4-A67Q-01 TCGA-J4-A67Q-01 TCGA-J4-A67Q TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 77 TCGA-J4-A67Q-F63912 TCGA-J4-A67Q TCGA-J4-A67Q-01A NO M0 T2b -28447 584 0 975 616 Scheduled Follow-up Submission Complete Remission/Response 2014-8-21 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 140 NO Bilateral NO NO NO true No T2c TCGA-J4-A67Q.E7702E20-7616-4A88-862B-E860045E9C81.pdf A67Q TUMOR FREE 3 Complete Remission/Response 0.1 NO Primary Tumor 01 3 NO YES NO J4 Apex|Middle Prostate A LIVING 2011 Peripheral Zone 1b57a251-d1ee-4635-b3f8-8109ddbabf7d TCGA-J4-A67Q-01A-21D-A30D-01 TCGA-J4-A67Q-01A-21D-A30F-05 TCGA-J4-A67Q-01A-21D-A30E-08 1b57a251-d1ee-4635-b3f8-8109ddbabf7d TCGA-J4-A67Q-01 TCGA-J4-A67Q-01 0A2BE409-A60C-48FA-BD03-84E82385B1E8 TCGA-J4-A67Q-01A-21D-A30D-01 1b57a251-d1ee-4635-b3f8-8109ddbabf7d TCGA-J4-A67Q-01 TCGA-J4-A67Q-01 TCGA-J4-A67Q-01A-21D-A30E-08 1b57a251-d1ee-4635-b3f8-8109ddbabf7d +TCGA-J4-A67R-01 TCGA-J4-A67R-01 TCGA-J4-A67R TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-J4-A67R-F63916 TCGA-J4-A67R TCGA-J4-A67R-01A NO M0 T1c -23807 440 0 910 454 Scheduled Follow-up Submission Complete Remission/Response 2014-8-21 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 80 NO Bilateral NO YES NO 4 0 true No N0 T2c TCGA-J4-A67R.EAFE4CB1-BB7F-4D26-851D-49ECE5A73750.pdf A67R TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 NO YES NO J4 Middle|Base Prostate A LIVING 2012 Peripheral Zone 5a96d821-45e8-4d06-89c3-1f951c04375d TCGA-J4-A67R-01A-21D-A30D-01 TCGA-J4-A67R-01A-21D-A30F-05 TCGA-J4-A67R-01A-21D-A30E-08 5a96d821-45e8-4d06-89c3-1f951c04375d TCGA-J4-A67R-01 TCGA-J4-A67R-01 040D0D07-1872-426D-AB68-3D598B46AC86 TCGA-J4-A67R-01A-21D-A30D-01 5a96d821-45e8-4d06-89c3-1f951c04375d TCGA-J4-A67R-01 TCGA-J4-A67R-01 TCGA-J4-A67R-01A-21D-A30E-08 5a96d821-45e8-4d06-89c3-1f951c04375d +TCGA-J4-A67S-01 TCGA-J4-A67S-01 TCGA-J4-A67S TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 63 TCGA-J4-A67S-F63921 TCGA-J4-A67S TCGA-J4-A67S-01A NO M0 T2b -23332 427 708 0 833 708 522 Scheduled Follow-up Submission Progressive Disease 2014-8-21 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 50 NO Bilateral NO YES Biochemical evidence of disease YES 3 0 true No N0 T3a TCGA-J4-A67S.D5BC3AA7-D957-4291-8A6B-D148AA7CA909.pdf A67S WITH TUMOR 3 Complete Remission/Response 0.1 NO R1 Primary Tumor 01 4 NO YES NO J4 Apex|Middle|Base Prostate A LIVING 2012 Peripheral Zone 0eb9fc91-e56d-496b-9ecf-683a4d4d6fa1 TCGA-J4-A67S-01A-11D-A30D-01 TCGA-J4-A67S-01A-11D-A30F-05 TCGA-J4-A67S-01A-11D-A30E-08 0eb9fc91-e56d-496b-9ecf-683a4d4d6fa1 TCGA-J4-A67S-01 TCGA-J4-A67S-01 TCGA-J4-A67S-01A-11D-A30D-01 0eb9fc91-e56d-496b-9ecf-683a4d4d6fa1 TCGA-J4-A67S-01 TCGA-J4-A67S-01 TCGA-J4-A67S-01A-11D-A30E-08 0eb9fc91-e56d-496b-9ecf-683a4d4d6fa1 +TCGA-J4-A67T-01 TCGA-J4-A67T-01 TCGA-J4-A67T TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-J4-A67T-F63922 TCGA-J4-A67T TCGA-J4-A67T-01A NO M0 T1c -23211 409 0 183 154 Scheduled Follow-up Submission 2014-8-21 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 490 NO Bilateral YES NO NO true No T2c TCGA-J4-A67T.8E3BAF97-3B7F-4B3A-BC88-BACB5A716DFD.pdf A67T TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO J4 Apex|Middle Prostate A LIVING 2012 Peripheral Zone d268f4e1-937a-40a8-b058-a87949bedd8b TCGA-J4-A67T-01A-11D-A30W-01 TCGA-J4-A67T-01A-11D-A30Z-05 TCGA-J4-A67T-01A-11D-A30X-08 d268f4e1-937a-40a8-b058-a87949bedd8b TCGA-J4-A67T-01 TCGA-J4-A67T-01 0BD80A62-B5B5-40B4-8FC1-DB735D692B75 TCGA-J4-A67T-01A-11D-A30W-01 d268f4e1-937a-40a8-b058-a87949bedd8b TCGA-J4-A67T-01 TCGA-J4-A67T-01 TCGA-J4-A67T-01A-11D-A30X-08 TCGA-J4-A67T-01A-11D-A30X-08 d268f4e1-937a-40a8-b058-a87949bedd8b +TCGA-J4-A6G1-01 TCGA-J4-A6G1-01 TCGA-J4-A6G1 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-J4-A6G1-F63926 TCGA-J4-A6G1 NO M0 T2b -24945 34 0 769 178 YES Extraprostatic Extension Localized (e.g. seminal vesicles) Scheduled Follow-up Submission Complete Remission/Response 2014-8-21 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 2 0 No N0 T3a A6G1 TUMOR FREE 4 Complete Remission/Response 0.1 YES R0 Primary Tumor 01 4 NO 3 YES NO J4 Prostate LIVING 2012 Peripheral Zone a9444bb5-5136-4a9a-b734-167ce00dd040 TCGA-J4-A6G1-01A-11D-A30W-01 TCGA-J4-A6G1-01A-11D-A30Z-05 TCGA-J4-A6G1-01A-11D-A30X-08 a9444bb5-5136-4a9a-b734-167ce00dd040 TCGA-J4-A6G1-01 TCGA-J4-A6G1-01 TCGA-J4-A6G1-01A-11D-A30W-01 a9444bb5-5136-4a9a-b734-167ce00dd040 TCGA-J4-A6G1-01 TCGA-J4-A6G1-01 TCGA-J4-A6G1-01A-11D-A30X-08 TCGA-J4-A6G1-01A-11D-A30X-08 a9444bb5-5136-4a9a-b734-167ce00dd040 +TCGA-J4-A6G3-01 TCGA-J4-A6G3-01 TCGA-J4-A6G3 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES NO 57 TCGA-J4-A6G3-F63927 TCGA-J4-A6G3 TCGA-J4-A6G3-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2 -20836 17 479 15 618 0 849 618 528 NO YES Extraprostatic Extension Localized (e.g. seminal vesicles)|Extraprostatic Extension (regional lymphadenopathy) [e.g. cN1] Scheduled Follow-up Submission 2014-8-21 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 80 NO Bilateral NO YES Biochemical evidence of disease YES 5 0 true No N0 T3b TCGA-J4-A6G3.63F0D5A2-CCAB-48C7-9BD9-F75A699DE1AD.pdf A6G3 WITH TUMOR 4 Partial Remission/Response 0.4 YES R1 Primary Tumor 01 4 NO YES NO J4 Prostate A LIVING 2012 Peripheral Zone 613b606c-0d1e-49ff-bd2b-30fa17b14fb6 TCGA-J4-A6G3-01A-11D-A30W-01 TCGA-J4-A6G3-01A-11D-A30Z-05 TCGA-J4-A6G3-01A-11D-A30X-08 613b606c-0d1e-49ff-bd2b-30fa17b14fb6 TCGA-J4-A6G3-01 TCGA-J4-A6G3-01 TCGA-J4-A6G3-01A-11D-A30W-01 613b606c-0d1e-49ff-bd2b-30fa17b14fb6 TCGA-J4-A6G3-01 TCGA-J4-A6G3-01 TCGA-J4-A6G3-01A-11D-A30X-08 TCGA-J4-A6G3-01A-11D-A30X-08 613b606c-0d1e-49ff-bd2b-30fa17b14fb6 +TCGA-J4-A6M7-01 TCGA-J4-A6M7-01 TCGA-J4-A6M7 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 53 TCGA-J4-A6M7-F63950 TCGA-J4-A6M7 TCGA-J4-A6M7-01A NO M0 T2 -19640 309 0 512 279 Scheduled Follow-up Submission Complete Remission/Response 2014-8-21 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 220 NO Bilateral NO NO NO true No T2c TCGA-J4-A6M7.F717DD9D-074A-4252-9125-C00A3DE587B0.pdf A6M7 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO J4 Apex|Middle Prostate A LIVING 2012 Peripheral Zone b6d9a928-0ecb-43c7-b88a-0179e524a7c2 TCGA-J4-A6M7-01A-11D-A31K-01 TCGA-J4-A6M7-01A-11D-A31M-05 TCGA-J4-A6M7-01A-11D-A31L-08 b6d9a928-0ecb-43c7-b88a-0179e524a7c2 TCGA-J4-A6M7-01 TCGA-J4-A6M7-01 883FCEB6-E39B-4FDB-853F-4C2B8CD97044 TCGA-J4-A6M7-01A-11D-A31K-01 b6d9a928-0ecb-43c7-b88a-0179e524a7c2 TCGA-J4-A6M7-01 TCGA-J4-A6M7-01 TCGA-J4-A6M7-01A-11D-A31L-08 TCGA-J4-A6M7-01A-11D-A31L-08 b6d9a928-0ecb-43c7-b88a-0179e524a7c2 +TCGA-J4-A83I-01 TCGA-J4-A83I-01 TCGA-J4-A83I TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-J4-A83I-F70492 TCGA-J4-A83I TCGA-J4-A83I-01A NO M0 T1c -23240 183 0 685 257 Scheduled Follow-up Submission Complete Remission/Response 2015-2-25 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 100 NO Bilateral NO YES NO 2 0 true No N0 T3a TCGA-J4-A83I.E3AFE230-AE22-4120-BC42-7FE78FCB06A2.pdf A83I TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 NO YES NO J4 Apex|Middle|Base Prostate A LIVING 2013 Peripheral Zone 4dc2d981-d303-4dd8-8ef5-1d1bcd0e8250 TCGA-J4-A83I-01A-11D-A363-01 TCGA-J4-A83I-01A-11D-A365-05 TCGA-J4-A83I-01A-11D-A364-08 4dc2d981-d303-4dd8-8ef5-1d1bcd0e8250 TCGA-J4-A83I-01 TCGA-J4-A83I-01 026361DD-0522-4172-8613-D328607F914A TCGA-J4-A83I-01A-11D-A363-01 4dc2d981-d303-4dd8-8ef5-1d1bcd0e8250 TCGA-J4-A83I-01 TCGA-J4-A83I-01 TCGA-J4-A83I-01A-11D-A364-08 4dc2d981-d303-4dd8-8ef5-1d1bcd0e8250 +TCGA-J4-A83J-01 TCGA-J4-A83J-01 TCGA-J4-A83J TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-J4-A83J-F70133 TCGA-J4-A83J TCGA-J4-A83J-01A NO M0 T1c -24960 272 0 696 235 Scheduled Follow-up Submission Complete Remission/Response 2015-1-28 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 210 NO Bilateral NO YES NO 1 0 true No N0 T2c TCGA-J4-A83J.D3FF2CCF-E6D0-4C8A-9159-F78176E7EE59.pdf A83J TUMOR FREE 3 Complete Remission/Response 0.04 NO R1 Primary Tumor 01 4 NO YES NO J4 Apex|Middle|Base Prostate A LIVING 2013 Peripheral Zone 2bbec916-3c74-45b7-9eab-76022899fe7d TCGA-J4-A83J-01A-11D-A363-01 TCGA-J4-A83J-01A-11D-A365-05 TCGA-J4-A83J-01A-11D-A364-08 2bbec916-3c74-45b7-9eab-76022899fe7d TCGA-J4-A83J-01 TCGA-J4-A83J-01 B2AFB3F8-2683-4C92-8227-4A61741F72F0 TCGA-J4-A83J-01A-11D-A363-01 2bbec916-3c74-45b7-9eab-76022899fe7d TCGA-J4-A83J-01 TCGA-J4-A83J-01 2bbec916-3c74-45b7-9eab-76022899fe7d +TCGA-J4-A83J-11 TCGA-J4-A83J-11 TCGA-J4-A83J TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-J4-A83J-F70133 TCGA-J4-A83J TCGA-J4-A83J-11A NO M0 T1c -24960 272 0 696 235 Scheduled Follow-up Submission Complete Remission/Response 2015-1-28 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 220 NO Bilateral NO YES NO 1 0 true No N0 T2c A83J TUMOR FREE 3 Complete Remission/Response 0.04 NO R1 Solid Tissue Normal 11 4 NO YES NO J4 Apex|Middle|Base Prostate A LIVING 2013 Peripheral Zone 6c5a212a-4dab-45a5-854d-296f0a6ee7c3 6c5a212a-4dab-45a5-854d-296f0a6ee7c3 TCGA-J4-A83J-11 6c5a212a-4dab-45a5-854d-296f0a6ee7c3 TCGA-J4-A83J-11 6c5a212a-4dab-45a5-854d-296f0a6ee7c3 +TCGA-J4-A83K-01 TCGA-J4-A83K-01 TCGA-J4-A83K TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 52 TCGA-J4-A83K-F63953 TCGA-J4-A83K NO M0 T1c -19299 0 328 205 Scheduled Follow-up Submission Complete Remission/Response 2014-8-21 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO NO NO No T2c A83K TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 NO YES NO J4 Apex|Middle|Base Prostate LIVING 2013 Peripheral Zone c16ddaf4-4bfe-4917-a208-aa5a89beb17e TCGA-J4-A83K-01A-11D-A34T-01 TCGA-J4-A83K-01A-11D-A34V-05 TCGA-J4-A83K-01A-11D-A34U-08 c16ddaf4-4bfe-4917-a208-aa5a89beb17e TCGA-J4-A83K-01 TCGA-J4-A83K-01 TCGA-J4-A83K-01A-11D-A34T-01 c16ddaf4-4bfe-4917-a208-aa5a89beb17e TCGA-J4-A83K-01 TCGA-J4-A83K-01 TCGA-J4-A83K-01A-11D-A34U-08 c16ddaf4-4bfe-4917-a208-aa5a89beb17e +TCGA-J4-A83L-01 TCGA-J4-A83L-01 TCGA-J4-A83L TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-J4-A83L-F70493 TCGA-J4-A83L TCGA-J4-A83L-01A NO M0 T1c -22338 218 0 720 316 Scheduled Follow-up Submission Complete Remission/Response 2015-2-18 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 50 NO Bilateral NO YES NO 5 0 true No N0 T2c TCGA-J4-A83L.837A4811-0DAF-46F6-9C84-D2BBFFC56AF0.pdf A83L TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO J4 Apex|Middle|Base Prostate A LIVING 2013 Central Zone 2345f76d-8250-4586-a15a-633ac5abc070 TCGA-J4-A83L-01A-11D-A34T-01 TCGA-J4-A83L-01A-11D-A34V-05 TCGA-J4-A83L-01A-11D-A34U-08 2345f76d-8250-4586-a15a-633ac5abc070 TCGA-J4-A83L-01 TCGA-J4-A83L-01 TCGA-J4-A83L-01A-11D-A34T-01 2345f76d-8250-4586-a15a-633ac5abc070 TCGA-J4-A83L-01 TCGA-J4-A83L-01 2345f76d-8250-4586-a15a-633ac5abc070 +TCGA-J4-A83M-01 TCGA-J4-A83M-01 TCGA-J4-A83M TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO YES 64 TCGA-J4-A83M-F70485 TCGA-J4-A83M TCGA-J4-A83M-01A NO M0 T2c -23624 412 521 0 543 521 437 Scheduled Follow-up Submission Partial Remission/Response 2015-2-18 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 40 NO Bilateral NO YES Biochemical evidence of disease YES 4 0 true No N0 T2c TCGA-J4-A83M.8AA3EBE4-49E8-4D0A-A3A4-B51E41B3AA4F.pdf A83M 4 Complete Remission/Response 0.2 YES R1 Primary Tumor 01 3 NO YES NO J4 Apex|Middle Prostate A LIVING 2012 Peripheral Zone 8ab941c0-6e1c-403c-901d-03ac81bbb81f TCGA-J4-A83M-01A-11D-A34T-01 TCGA-J4-A83M-01A-11D-A34V-05 TCGA-J4-A83M-01A-11D-A34U-08 8ab941c0-6e1c-403c-901d-03ac81bbb81f TCGA-J4-A83M-01 TCGA-J4-A83M-01 TCGA-J4-A83M-01A-11D-A34T-01 8ab941c0-6e1c-403c-901d-03ac81bbb81f TCGA-J4-A83M-01 TCGA-J4-A83M-01 TCGA-J4-A83M-01A-11D-A34U-08 8ab941c0-6e1c-403c-901d-03ac81bbb81f +TCGA-J4-A83N-01 TCGA-J4-A83N-01 TCGA-J4-A83N TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES YES 57 TCGA-J4-A83N-F70169 TCGA-J4-A83N TCGA-J4-A83N-01A NO M0 T1c -20841 519 0 992 433 530 Scheduled Follow-up Submission Progressive Disease 2015-1-29 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 240 NO Bilateral NO NO New Primary Tumor YES true No T2c TCGA-J4-A83N.C40A9D7F-BFEC-4C07-A1C3-A34706E39713.pdf A83N TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO YES NO J4 Apex|Middle|Base Prostate A LIVING 2012 Overlapping / Multiple Zones f01339fa-0c8b-440f-98d2-9f7365e0cc9b TCGA-J4-A83N-01A-11D-A34T-01 TCGA-J4-A83N-01A-11D-A34V-05 TCGA-J4-A83N-01A-11D-A34U-08 f01339fa-0c8b-440f-98d2-9f7365e0cc9b TCGA-J4-A83N-01 TCGA-J4-A83N-01 E949D28E-5B2A-4987-8845-B17F5F98BAD5 TCGA-J4-A83N-01A-11D-A34T-01 f01339fa-0c8b-440f-98d2-9f7365e0cc9b TCGA-J4-A83N-01 TCGA-J4-A83N-01 TCGA-J4-A83N-01A-11D-A34U-08 f01339fa-0c8b-440f-98d2-9f7365e0cc9b +TCGA-J4-AATV-01 TCGA-J4-AATV-01 TCGA-J4-AATV TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 71 TCGA-J4-AATV-F70902 TCGA-J4-AATV TCGA-J4-AATV-01A NO M0 -25943 151 0 553 358 Scheduled Follow-up Submission Partial Remission/Response 2015-3-10 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 50 NO Bilateral NO YES NO 4 true No N0 T2c TCGA-J4-AATV.860F2174-869F-47E4-ABC1-14E4F608669A.pdf AATV WITH TUMOR 3 Partial Remission/Response 0 NO R1 Primary Tumor 01 3 NO YES NO J4 Prostate A LIVING 2013 692c9e12-4ebc-43e2-a520-6e22b6b4e8ed TCGA-J4-AATV-01A-11D-A41J-01 TCGA-J4-AATV-01A-11D-A41L-05 TCGA-J4-AATV-01A-11D-A41K-08 692c9e12-4ebc-43e2-a520-6e22b6b4e8ed TCGA-J4-AATV-01 TCGA-J4-AATV-01 TCGA-J4-AATV-01A-11D-A41J-01 692c9e12-4ebc-43e2-a520-6e22b6b4e8ed TCGA-J4-AATV-01 TCGA-J4-AATV-01 692c9e12-4ebc-43e2-a520-6e22b6b4e8ed +TCGA-J4-AATZ-01 TCGA-J4-AATZ-01 TCGA-J4-AATZ TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-J4-AATZ TCGA-J4-AATZ-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -24226 33 170 23 23 79 0 412 386 No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension 2014-8-14 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 80 NO Bilateral YES YES 4 0 true No N0 T3a TCGA-J4-AATZ.369F71EC-186A-41DA-91F7-B0FD209BEC8F.pdf AATZ WITH TUMOR 4 Complete Remission/Response 0 YES R1 Primary Tumor 01 5 YES YES NO J4 Apex Prostate A LIVING 2013 Peripheral Zone 0f83b483-2bfe-431a-a958-cadf9a19efea TCGA-J4-AATZ-01A-11D-A41J-01 TCGA-J4-AATZ-01A-11D-A41L-05 TCGA-J4-AATZ-01A-11D-A41K-08 0f83b483-2bfe-431a-a958-cadf9a19efea TCGA-J4-AATZ-01 TCGA-J4-AATZ-01 TCGA-J4-AATZ-01A-11D-A41J-01 0f83b483-2bfe-431a-a958-cadf9a19efea TCGA-J4-AATZ-01 TCGA-J4-AATZ-01 0f83b483-2bfe-431a-a958-cadf9a19efea +TCGA-J4-AAU2-01 TCGA-J4-AAU2-01 TCGA-J4-AAU2 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-J4-AAU2-F70142 TCGA-J4-AAU2 TCGA-J4-AAU2-01A NO M0 -21656 430 0 825 224 Scheduled Follow-up Submission Complete Remission/Response 2015-1-28 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 70 NO Bilateral NO YES NO 1 0 true No N0 T2c TCGA-J4-AAU2.D4358B1C-AB27-4B36-ABF9-B4EE2E504493.pdf AAU2 TUMOR FREE 3 Complete Remission/Response 0 NO R0 Primary Tumor 01 3 NO YES NO J4 Prostate A LIVING 2012 3e70c3e7-e946-46c8-b703-bc531bd1edce TCGA-J4-AAU2-01A-11D-A41J-01 TCGA-J4-AAU2-01A-11D-A41L-05 TCGA-J4-AAU2-01A-11D-A41K-08 3e70c3e7-e946-46c8-b703-bc531bd1edce TCGA-J4-AAU2-01 TCGA-J4-AAU2-01 TCGA-J4-AAU2-01A-11D-A41J-01 3e70c3e7-e946-46c8-b703-bc531bd1edce TCGA-J4-AAU2-01 TCGA-J4-AAU2-01 3e70c3e7-e946-46c8-b703-bc531bd1edce +TCGA-J9-A52B-01 TCGA-J9-A52B-01 TCGA-J9-A52B TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-J9-A52B NO Normal (no evidence of prostate cancer) [cM0] T3b -22849 11 11 85 0 422 414 YES No Evidence of Extraprostatic Extension NO 2013-3-14 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy Bilateral YES YES 7 0 No N0 T3b A52B 5 Complete Remission/Response 0.010 NO R1 Primary Tumor 01 4 NO NO YES J9 Apex|Middle|Base Prostate LIVING 2012 Overlapping / Multiple Zones b3c06bf7-49a3-48cb-9418-c25f8559b04c TCGA-J9-A52B-01A-11D-A26L-01 TCGA-J9-A52B-01A-11D-A26N-05 TCGA-J9-A52B-01A-11D-A26M-08 b3c06bf7-49a3-48cb-9418-c25f8559b04c TCGA-J9-A52B-01 TCGA-J9-A52B-01 TCGA-J9-A52B-01A-11D-A26L-01 b3c06bf7-49a3-48cb-9418-c25f8559b04c TCGA-J9-A52B-01 TCGA-J9-A52B-01 TCGA-J9-A52B-01A-11D-A26M-08 TCGA-J9-A52B-01A-11D-A26M-08 b3c06bf7-49a3-48cb-9418-c25f8559b04c +TCGA-J9-A52C-01 TCGA-J9-A52C-01 TCGA-J9-A52C TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-J9-A52C TCGA-J9-A52C-01A NO Normal (no evidence of prostate cancer) [cM0] T1c -20966 38 156 62 0 178 178 YES No Evidence of Extraprostatic Extension NO 2013-3-14 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 90 NO Bilateral NO NO false No T3b TCGA-J9-A52C.CAAC3743-CE39-4A47-8D46-3C4917D469C1.pdf A52C 4 0.03 NO R0 Primary Tumor 01 5 NO 3 YES NO J9 Apex|Middle|Base Prostate A LIVING 2012 Overlapping / Multiple Zones 77d1e365-4ccc-4b1a-aa0d-cda00b246ba4 TCGA-J9-A52C-01A-11D-A26L-01 TCGA-J9-A52C-01A-11D-A26N-05 TCGA-J9-A52C-01A-11D-A26M-08 77d1e365-4ccc-4b1a-aa0d-cda00b246ba4 TCGA-J9-A52C-01 TCGA-J9-A52C-01 F15C57F1-CD77-4883-8DB4-26885DAF5151 TCGA-J9-A52C-01A-11D-A26L-01 77d1e365-4ccc-4b1a-aa0d-cda00b246ba4 TCGA-J9-A52C-01 TCGA-J9-A52C-01 TCGA-J9-A52C-01A-11D-A26M-08 77d1e365-4ccc-4b1a-aa0d-cda00b246ba4 +TCGA-J9-A52D-01 TCGA-J9-A52D-01 TCGA-J9-A52D TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 71 TCGA-J9-A52D NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -26023 -6 21 0 212 146 YES No Evidence of Extraprostatic Extension NO 2014-4-9 MALE 9 Prostate Adenocarcinoma, Other Subtype No C61 8500/3 C61.9 YES Core needle biopsy Bilateral NO NO No T3a A52D TUMOR FREE 4 0.059 NO R0 Primary Tumor 01 5 NO 3 NO YES J9 Apex|Middle Prostate LIVING 2012 Transition Zone f73e06ac-aa61-45be-b666-83279a7fb908 TCGA-J9-A52D-01A-11D-A29T-05 TCGA-J9-A52D-01A-11D-A29Q-08 f73e06ac-aa61-45be-b666-83279a7fb908 TCGA-J9-A52D-01 TCGA-J9-A52D-01 f73e06ac-aa61-45be-b666-83279a7fb908 TCGA-J9-A52D-01 TCGA-J9-A52D-01A-11D-A29Q-08 f73e06ac-aa61-45be-b666-83279a7fb908 +TCGA-J9-A52E-01 TCGA-J9-A52E-01 TCGA-J9-A52E TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-J9-A52E TCGA-J9-A52E-01A NO Normal (no evidence of prostate cancer) [cM0] T2c -23741 15 299 12 89 0 323 393 YES No Evidence of Extraprostatic Extension NO 2013-3-15 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8550/3 C61.9 YES Core needle biopsy 100 NO Bilateral YES YES 8 0 false No N0 T3b TCGA-J9-A52E.5154D45B-244F-45B1-BE2F-9C02716B1CB4.pdf A52E TUMOR FREE 4 Partial Remission/Response 0.01 NO R1 Primary Tumor 01 5 NO 3 NO YES J9 Apex|Middle|Base Prostate A LIVING 2012 Overlapping / Multiple Zones fc25b041-1fcb-456b-8e55-28b74a32ab91 TCGA-J9-A52E-01A-11D-A26L-01 TCGA-J9-A52E-01A-11D-A26N-05 TCGA-J9-A52E-01A-11D-A26M-08 fc25b041-1fcb-456b-8e55-28b74a32ab91 TCGA-J9-A52E-01 TCGA-J9-A52E-01 5E28457A-C9A5-47D7-A83A-3797436403BF TCGA-J9-A52E-01A-11D-A26L-01 fc25b041-1fcb-456b-8e55-28b74a32ab91 TCGA-J9-A52E-01 TCGA-J9-A52E-01 TCGA-J9-A52E-01A-11D-A26M-08 fc25b041-1fcb-456b-8e55-28b74a32ab91 +TCGA-J9-A8CK-01 TCGA-J9-A8CK-01 TCGA-J9-A8CK TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-J9-A8CK TCGA-J9-A8CK-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T3a -24285 8 365 8 0 321 321 YES No Evidence of Extraprostatic Extension NO 2015-2-6 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 90 NO Bilateral NO NO true No T3a TCGA-J9-A8CK.D47D0C55-D871-44F3-A851-BD610FD7BA30.pdf A8CK TUMOR FREE 4 0.010 NO R1 Primary Tumor 01 5 NO 3 YES NO J9 Apex|Middle|Base Prostate A LIVING 2012 Overlapping / Multiple Zones ecb89f0a-31a4-428f-b2be-f882d55a146c TCGA-J9-A8CK-01A-11D-A34T-01 TCGA-J9-A8CK-01A-11D-A34V-05 TCGA-J9-A8CK-01A-11D-A34U-08 ecb89f0a-31a4-428f-b2be-f882d55a146c TCGA-J9-A8CK-01 TCGA-J9-A8CK-01 F5A95D97-F758-48BA-91DD-121B9D7433C4 TCGA-J9-A8CK-01A-11D-A34T-01 ecb89f0a-31a4-428f-b2be-f882d55a146c TCGA-J9-A8CK-01 TCGA-J9-A8CK-01 TCGA-J9-A8CK-01A-11D-A34U-08 ecb89f0a-31a4-428f-b2be-f882d55a146c +TCGA-J9-A8CL-01 TCGA-J9-A8CL-01 TCGA-J9-A8CL TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-J9-A8CL TCGA-J9-A8CL-01A YES Equivocal M0 T3a -24145 6 278 11 132 0 405 405 YES No Evidence of Extraprostatic Extension NO 2015-1-27 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 80 NO Bilateral NO YES true No T3b TCGA-J9-A8CL.062E0E86-B3E0-4CC0-9BE5-0EBDB81DCB5B.pdf A8CL WITH TUMOR 4 12.01 R1 Primary Tumor 01 5 3 YES NO J9 Apex|Middle|Base Prostate A LIVING 2013 Overlapping / Multiple Zones 166b8cda-180b-4095-a991-69e79efec904 TCGA-J9-A8CL-01A-11D-A34T-01 TCGA-J9-A8CL-01A-11D-A34V-05 TCGA-J9-A8CL-01A-11D-A34U-08 166b8cda-180b-4095-a991-69e79efec904 TCGA-J9-A8CL-01 TCGA-J9-A8CL-01 TCGA-J9-A8CL-01A-11D-A34T-01 166b8cda-180b-4095-a991-69e79efec904 TCGA-J9-A8CL-01 TCGA-J9-A8CL-01 TCGA-J9-A8CL-01A-11D-A34U-08 166b8cda-180b-4095-a991-69e79efec904 +TCGA-J9-A8CM-01 TCGA-J9-A8CM-01 TCGA-J9-A8CM TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-J9-A8CM TCGA-J9-A8CM-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T2c -24118 14 238 344 0 463 463 NO NO 2015-2-1 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 230 NO Bilateral YES YES 14 1 true No N1 T3b TCGA-J9-A8CM.7B7CB375-6046-437F-8513-9F713EA6407A.pdf A8CM WITH TUMOR 5 Partial Remission/Response 0.55 NO R1 Primary Tumor 01 4 NO 3 YES NO J9 Apex|Middle|Base Prostate A LIVING 2013 Peripheral Zone 304a95c1-2180-4a81-a85a-880427e97d67 TCGA-J9-A8CM-01A-11D-A34T-01 TCGA-J9-A8CM-01A-11D-A34V-05 TCGA-J9-A8CM-01A-11D-A34U-08 304a95c1-2180-4a81-a85a-880427e97d67 TCGA-J9-A8CM-01 TCGA-J9-A8CM-01 2246A3A6-98DE-4B85-903D-54CF8B93BF07 TCGA-J9-A8CM-01A-11D-A34T-01 304a95c1-2180-4a81-a85a-880427e97d67 TCGA-J9-A8CM-01 TCGA-J9-A8CM-01 TCGA-J9-A8CM-01A-11D-A34U-08 304a95c1-2180-4a81-a85a-880427e97d67 +TCGA-J9-A8CN-01 TCGA-J9-A8CN-01 TCGA-J9-A8CN TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 53 TCGA-J9-A8CN TCGA-J9-A8CN-01A NO M0 T1c -19662 971 0 1237 963 NO NO 2015-2-1 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 100 NO Bilateral NO NO true Yes, History of Prior Malignancy T3a TCGA-J9-A8CN.3D3F5AFD-4DA0-43EC-B6B9-D2F16B6206E8.pdf A8CN TUMOR FREE 3 Complete Remission/Response 0.03 NO R1 Primary Tumor 01 3 NO 4 YES NO J9 Apex|Middle Prostate A LIVING 2011 Transition Zone 2de65e78-be71-4f41-be55-d9ef61b277c3 TCGA-J9-A8CN-01A-11D-A34T-01 TCGA-J9-A8CN-01A-11D-A34V-05 TCGA-J9-A8CN-01A-11D-A34U-08 2de65e78-be71-4f41-be55-d9ef61b277c3 TCGA-J9-A8CN-01 TCGA-J9-A8CN-01 81362E50-EAA0-46FB-99F3-47F19B774B68 TCGA-J9-A8CN-01A-11D-A34T-01 2de65e78-be71-4f41-be55-d9ef61b277c3 TCGA-J9-A8CN-01 TCGA-J9-A8CN-01 TCGA-J9-A8CN-01A-11D-A34U-08 2de65e78-be71-4f41-be55-d9ef61b277c3 +TCGA-J9-A8CP-01 TCGA-J9-A8CP-01 TCGA-J9-A8CP TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-J9-A8CP TCGA-J9-A8CP-01A NO M0 T2a -24299 113 0 386 298 NO NO 2015-2-1 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 90 NO Bilateral NO NO true No T3a TCGA-J9-A8CP.526E96AC-D8A9-4FED-8D31-05E2427DE513.pdf A8CP TUMOR FREE 4 Complete Remission/Response 0.010 NO R0 Primary Tumor 01 3 NO YES NO J9 Apex|Middle Prostate A LIVING 2013 Overlapping / Multiple Zones 4558d242-2bd6-4272-913f-59c6b8f05d64 TCGA-J9-A8CP-01A-11D-A34T-01 TCGA-J9-A8CP-01A-11D-A34V-05 TCGA-J9-A8CP-01A-11D-A34U-08 4558d242-2bd6-4272-913f-59c6b8f05d64 TCGA-J9-A8CP-01 TCGA-J9-A8CP-01 1111DDF5-715A-4D8E-91CC-403BADF8CE57 TCGA-J9-A8CP-01A-11D-A34T-01 4558d242-2bd6-4272-913f-59c6b8f05d64 TCGA-J9-A8CP-01 TCGA-J9-A8CP-01 TCGA-J9-A8CP-01A-11D-A34U-08 4558d242-2bd6-4272-913f-59c6b8f05d64 +TCGA-KC-A4BL-01 TCGA-KC-A4BL-01 TCGA-KC-A4BL TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-KC-A4BL TCGA-KC-A4BL-01A YES Abnormal (not related to prostate cancer) M0 T1c -24081 38 2101 38 66 193 0 934 206 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension 2015-1-23 MALE 7 Prostate Adenocarcinoma Acinar Type Yes, Pharmaceutical Treatment Prior to Resection C61 8140/3 C61.9 YES Core needle biopsy 160 NO Bilateral YES YES 4 0 true No N0 T2c TCGA-KC-A4BL.EEF5303A-D63A-4D2F-A8B6-A78437A583FF.pdf A4BL WITH TUMOR 3 Partial Remission/Response 3.15 R0 Primary Tumor 01 4 5 NO YES KC Middle|Base Prostate A LIVING 2006 Peripheral Zone 71160876-7965-4899-a8b2-c549cc25260b TCGA-KC-A4BL-01A-31D-A256-01 TCGA-KC-A4BL-01A-31D-A258-05 TCGA-KC-A4BL-01A-31D-A257-08 71160876-7965-4899-a8b2-c549cc25260b TCGA-KC-A4BL-01 TCGA-KC-A4BL-01 B926A73F-7CD8-4B97-8E6C-D24AE1EA5431 TCGA-KC-A4BL-01A-31D-A256-01 71160876-7965-4899-a8b2-c549cc25260b TCGA-KC-A4BL-01 TCGA-KC-A4BL-01 TCGA-KC-A4BL-01A-31D-A257-08 TCGA-KC-A4BL-01A-31D-A257-08 71160876-7965-4899-a8b2-c549cc25260b +TCGA-KC-A4BN-01 TCGA-KC-A4BN-01 TCGA-KC-A4BN TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-KC-A4BN TCGA-KC-A4BN-01A NO M0 T1c -20392 1246 44 0 1815 529 NO YES No Evidence of Extraprostatic Extension 2014-7-22 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 570 NO Right YES 6 0 true No N0 T2a TCGA-KC-A4BN.A929648E-54E0-4215-9148-4E1498961697.pdf A4BN TUMOR FREE 3 Complete Remission/Response 0 NO R0 Primary Tumor 01 4 NO NO YES KC Middle Prostate A LIVING 2009 887b3624-2609-4928-9b17-d6e82cc4baa5 TCGA-KC-A4BN-01A-61D-A256-01 TCGA-KC-A4BN-01A-61D-A258-05 TCGA-KC-A4BN-01A-61D-A257-08 887b3624-2609-4928-9b17-d6e82cc4baa5 TCGA-KC-A4BN-01 TCGA-KC-A4BN-01 16E39B12-7B32-4D64-AFA8-5D55E25536DD TCGA-KC-A4BN-01A-61D-A256-01 887b3624-2609-4928-9b17-d6e82cc4baa5 TCGA-KC-A4BN-01 TCGA-KC-A4BN-01 TCGA-KC-A4BN-01A-61D-A257-08 TCGA-KC-A4BN-01A-61D-A257-08 887b3624-2609-4928-9b17-d6e82cc4baa5 +TCGA-KC-A4BO-01 TCGA-KC-A4BO-01 TCGA-KC-A4BO TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-KC-A4BO TCGA-KC-A4BO-01A NO Abnormal (not related to prostate cancer) M0 T1c -20368 21 742 21 98 0 607 478 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension 2015-1-23 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 590 NO Bilateral YES NO 13 0 true No N0 T2c TCGA-KC-A4BO.C601C012-0EC4-4386-9A9A-3485FD4968E1.pdf A4BO TUMOR FREE 3 Complete Remission/Response 0.04 NO R0 Primary Tumor 01 4 NO 5 NO YES KC Apex|Middle Prostate A LIVING 2010 Peripheral Zone TCGA-KC-A4BO-01A-61D-A256-01 TCGA-KC-A4BO-01A-61D-A258-05 TCGA-KC-A4BO-01A-61D-A257-08 TCGA-KC-A4BO-01 8DEB3822-4FED-44E2-9D11-4A43EC0C1CA0 TCGA-KC-A4BO-01A-61D-A256-01 TCGA-KC-A4BO-01 +TCGA-KC-A4BR-01 TCGA-KC-A4BR-01 TCGA-KC-A4BR TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 75 TCGA-KC-A4BR TCGA-KC-A4BR-01A NO Abnormal (not related to prostate cancer) M0 T2 -27741 15 1161 -8 90 1022 0 1349 1258 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension 2015-1-23 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 600 NO Bilateral YES YES 11 1 true No N1 T3b TCGA-KC-A4BR.E44796E6-0446-4706-8B8F-A21D417EAB43.pdf A4BR WITH TUMOR 4 Complete Remission/Response 0.00 NO R0 Primary Tumor 01 5 NO NO YES KC Apex|Middle|Base Prostate A LIVING 2009 Peripheral Zone 47c88c6e-4f26-46bc-8198-06c211f64e00 TCGA-KC-A4BR-01A-32D-A256-01 TCGA-KC-A4BR-01A-32D-A258-05 TCGA-KC-A4BR-01A-32D-A257-08 47c88c6e-4f26-46bc-8198-06c211f64e00 TCGA-KC-A4BR-01 TCGA-KC-A4BR-01 A7B9F799-6958-4860-B828-AE1F4BBB2F24 TCGA-KC-A4BR-01A-32D-A256-01 47c88c6e-4f26-46bc-8198-06c211f64e00 TCGA-KC-A4BR-01 TCGA-KC-A4BR-01 TCGA-KC-A4BR-01A-32D-A257-08 TCGA-KC-A4BR-01A-32D-A257-08 47c88c6e-4f26-46bc-8198-06c211f64e00 +TCGA-KC-A4BV-01 TCGA-KC-A4BV-01 TCGA-KC-A4BV TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-KC-A4BV TCGA-KC-A4BV-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T2 -24138 16 943 18 81 1328 0 1328 1328 YES No Evidence of Extraprostatic Extension YES Extraprostatic Extension Localized (e.g. seminal vesicles) 2014-7-22 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 420 NO Bilateral YES YES 10 0 true No N0 T3a TCGA-KC-A4BV.CC0244A3-48CF-4448-A7F1-5DB9EC3B823A.pdf A4BV WITH TUMOR 4 Complete Remission/Response .530 NO R0 Primary Tumor 01 5 NO 3 NO YES KC Apex|Middle|Base Prostate A LIVING 2010 Overlapping / Multiple Zones 450b68b9-573f-4921-93b6-8a57ff9a7263 TCGA-KC-A4BV-01A-31D-A26L-01 TCGA-KC-A4BV-01A-31D-A26N-05 TCGA-KC-A4BV-01A-31D-A26M-08 450b68b9-573f-4921-93b6-8a57ff9a7263 TCGA-KC-A4BV-01 TCGA-KC-A4BV-01 539AAD8D-FEAE-4C77-9255-512A7274E7B2 TCGA-KC-A4BV-01A-31D-A26L-01 450b68b9-573f-4921-93b6-8a57ff9a7263 TCGA-KC-A4BV-01 TCGA-KC-A4BV-01 TCGA-KC-A4BV-01A-31D-A26M-08 TCGA-KC-A4BV-01A-31D-A26M-08 450b68b9-573f-4921-93b6-8a57ff9a7263 +TCGA-KC-A7F3-01 TCGA-KC-A7F3-01 TCGA-KC-A7F3 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-KC-A7F3 TCGA-KC-A7F3-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -24676 32 195 32 43 0 665 664 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension 2015-1-23 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 270 NO Bilateral YES NO 19 0 true No N0 T2c TCGA-KC-A7F3.8878BDE3-634E-497C-AC4A-219E2F0B7153.pdf A7F3 TUMOR FREE 3 Complete Remission/Response 0.00 NO R0 Primary Tumor 01 4 NO NO YES KC Apex Prostate A LIVING 2013 Peripheral Zone 689a544a-c116-46f9-ae3c-769e793f21c7 TCGA-KC-A7F3-01A-21D-A33S-01 TCGA-KC-A7F3-01A-21D-A33U-05 TCGA-KC-A7F3-01A-21D-A33T-08 689a544a-c116-46f9-ae3c-769e793f21c7 TCGA-KC-A7F3-01 TCGA-KC-A7F3-01 AB99F4D9-FAEF-486D-B47B-2A3F2B08D25D TCGA-KC-A7F3-01A-21D-A33S-01 689a544a-c116-46f9-ae3c-769e793f21c7 TCGA-KC-A7F3-01 TCGA-KC-A7F3-01 TCGA-KC-A7F3-01A-21D-A33T-08 689a544a-c116-46f9-ae3c-769e793f21c7 +TCGA-KC-A7F5-01 TCGA-KC-A7F5-01 TCGA-KC-A7F5 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 54 TCGA-KC-A7F5 TCGA-KC-A7F5-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2c -20015 5 138 5 -56 0 91 91 YES No Evidence of Extraprostatic Extension YES Extraprostatic Extension Localized (e.g. seminal vesicles) 2015-1-25 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 250 NO Right YES NO 16 0 true No N0 T2c TCGA-KC-A7F5.3899F8DA-A4C2-40C3-AE27-227F7992B5EE.pdf A7F5 TUMOR FREE 4 Complete Remission/Response 0.00 NO R0 Primary Tumor 01 3 NO 5 NO YES KC Apex|Middle|Base Prostate A LIVING 2013 Peripheral Zone 9e0d5361-7994-48b6-a865-18d430b72239 TCGA-KC-A7F5-01A-11D-A33U-05 TCGA-KC-A7F5-01A-11D-A33T-08 9e0d5361-7994-48b6-a865-18d430b72239 TCGA-KC-A7F5-01 TCGA-KC-A7F5-01 0E20B975-A3A5-4C07-8351-48E6FFB5F18E 9e0d5361-7994-48b6-a865-18d430b72239 TCGA-KC-A7F5-01 9e0d5361-7994-48b6-a865-18d430b72239 +TCGA-KC-A7F6-01 TCGA-KC-A7F6-01 TCGA-KC-A7F6 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-KC-A7F6 TCGA-KC-A7F6-01A NO Abnormal (not related to prostate cancer) M0 T1c -23367 44 171 44 -121 0 263 193 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension 2015-1-25 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 130 NO Bilateral YES NO 23 0 true No N0 T2c TCGA-KC-A7F6.357EC50A-622F-4757-A044-7E38A12421FE.pdf A7F6 TUMOR FREE 3 Complete Remission/Response 0.00 NO R0 Primary Tumor 01 4 NO NO YES KC Apex|Middle Prostate A LIVING 2013 Peripheral Zone cea23bbc-1a4a-4498-987b-67728912ae40 TCGA-KC-A7F6-01A-11D-A33S-01 TCGA-KC-A7F6-01A-11D-A33U-05 TCGA-KC-A7F6-01A-11D-A33T-08 cea23bbc-1a4a-4498-987b-67728912ae40 TCGA-KC-A7F6-01 TCGA-KC-A7F6-01 24410A14-5036-4D2E-9C9E-5750E1BBA5D9 TCGA-KC-A7F6-01A-11D-A33S-01 cea23bbc-1a4a-4498-987b-67728912ae40 TCGA-KC-A7F6-01 TCGA-KC-A7F6-01 TCGA-KC-A7F6-01A-11D-A33T-08 cea23bbc-1a4a-4498-987b-67728912ae40 +TCGA-KC-A7FA-01 TCGA-KC-A7FA-01 TCGA-KC-A7FA TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-KC-A7FA TCGA-KC-A7FA-01A NO Abnormal (not related to prostate cancer) M0 T2c -23208 70 146 62 40 0 598 161 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension 2015-1-25 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 120 NO Bilateral YES NO 24 0 true Yes, History of Prior Malignancy N0 T3a TCGA-KC-A7FA.CF60F3B8-9AF5-4D51-8E17-BC7940235E96.pdf A7FA TUMOR FREE 3 Complete Remission/Response 0.00 NO R0 Primary Tumor 01 4 NO NO YES KC Apex|Middle|Base Prostate A LIVING 2013 Peripheral Zone 81ee8dcb-89dd-462e-b5de-2394bc6d522b TCGA-KC-A7FA-01A-21D-A33S-01 TCGA-KC-A7FA-01A-21D-A33U-05 TCGA-KC-A7FA-01A-21D-A33T-08 81ee8dcb-89dd-462e-b5de-2394bc6d522b TCGA-KC-A7FA-01 TCGA-KC-A7FA-01 A15A3A98-2810-4154-A9EF-E5B43349BF39 TCGA-KC-A7FA-01A-21D-A33S-01 81ee8dcb-89dd-462e-b5de-2394bc6d522b TCGA-KC-A7FA-01 TCGA-KC-A7FA-01 TCGA-KC-A7FA-01A-21D-A33T-08 81ee8dcb-89dd-462e-b5de-2394bc6d522b +TCGA-KC-A7FD-01 TCGA-KC-A7FD-01 TCGA-KC-A7FD TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-KC-A7FD TCGA-KC-A7FD-01A NO M0 T1c -22745 157 29 45 0 270 144 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension 2015-1-25 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 130 NO Bilateral YES NO 16 0 true No N0 T3a TCGA-KC-A7FD.15E27E53-1EF7-495A-A000-F10108E653C2.pdf A7FD TUMOR FREE 3 Complete Remission/Response 0.00 NO R0 Primary Tumor 01 4 NO NO YES KC Apex|Middle|Base Prostate A LIVING 2013 Peripheral Zone 1d913abe-aadd-498f-9b1d-7d3746ae315c TCGA-KC-A7FD-01A-11D-A33S-01 TCGA-KC-A7FD-01A-11D-A33U-05 TCGA-KC-A7FD-01A-11D-A33T-08 1d913abe-aadd-498f-9b1d-7d3746ae315c TCGA-KC-A7FD-01 TCGA-KC-A7FD-01 9C753A44-DC06-4AC0-B7C1-39B987B0428A TCGA-KC-A7FD-01A-11D-A33S-01 1d913abe-aadd-498f-9b1d-7d3746ae315c TCGA-KC-A7FD-01 TCGA-KC-A7FD-01 TCGA-KC-A7FD-01A-11D-A33T-08 1d913abe-aadd-498f-9b1d-7d3746ae315c +TCGA-KC-A7FE-01 TCGA-KC-A7FE-01 TCGA-KC-A7FE TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-KC-A7FE TCGA-KC-A7FE-01A NO Abnormal (not related to prostate cancer) M0 T1c -22718 76 212 76 53 0 352 185 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension 2015-1-25 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 120 NO Bilateral YES NO 2 0 true No N0 T2c TCGA-KC-A7FE.715B093C-7832-46EA-AC95-01406A90D529.pdf A7FE TUMOR FREE 3 Complete Remission/Response 0.00 NO R1 Primary Tumor 01 4 NO NO YES KC Apex|Middle Prostate A LIVING 2013 Peripheral Zone 17607f39-23c6-4eee-8aa4-ed705284ff4e TCGA-KC-A7FE-01A-12D-A33S-01 TCGA-KC-A7FE-01A-12D-A33U-05 TCGA-KC-A7FE-01A-12D-A33T-08 17607f39-23c6-4eee-8aa4-ed705284ff4e TCGA-KC-A7FE-01 TCGA-KC-A7FE-01 E470C35A-7E13-42A7-9225-78A56D6B1D94 TCGA-KC-A7FE-01A-12D-A33S-01 17607f39-23c6-4eee-8aa4-ed705284ff4e TCGA-KC-A7FE-01 TCGA-KC-A7FE-01 TCGA-KC-A7FE-01A-12D-A33T-08 17607f39-23c6-4eee-8aa4-ed705284ff4e +TCGA-KK-A59V-01 TCGA-KK-A59V-01 TCGA-KK-A59V TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-KK-A59V-F70432 TCGA-KK-A59V TCGA-KK-A59V-01A NO M0 T3a -23483 2742 0 3440 2500 NO NO Scheduled Follow-up Submission 2015-2-13 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 190 NO Bilateral NO YES NO 9 0 true No N0 T3b TCGA-KK-A59V.0A977EFF-C276-46CB-9187-92F504C7B535.pdf A59V TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 5 NO NO YES KK Apex|Middle|Base Prostate A LIVING 2005 Peripheral Zone d8012229-3666-4380-9d2a-2beaca772242 TCGA-KK-A59V-01A-11D-A323-01 TCGA-KK-A59V-01A-11D-A29T-05 TCGA-KK-A59V-01A-11D-A29Q-08 d8012229-3666-4380-9d2a-2beaca772242 TCGA-KK-A59V-01 TCGA-KK-A59V-01 9591CEAE-DBE0-4E1F-BEB7-22EA6579225C TCGA-KK-A59V-01A-11D-A323-01 d8012229-3666-4380-9d2a-2beaca772242 TCGA-KK-A59V-01 TCGA-KK-A59V-01 TCGA-KK-A59V-01A-11D-A29Q-08 d8012229-3666-4380-9d2a-2beaca772242 +TCGA-KK-A59X-01 TCGA-KK-A59X-01 TCGA-KK-A59X TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES NO 55 TCGA-KK-A59X-F70433 TCGA-KK-A59X TCGA-KK-A59X-01A Normal (no evidence of prostate cancer) [cM0] M0 T3a -20416 12 1731 12 0 2535 2233 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission 2015-2-23 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 170 NO Bilateral NO YES Other, specify Locoregional Recurrence Bladder YES 14 2 true No N1 T3b TCGA-KK-A59X.64BB13A6-1071-4C2A-937C-17ACC07ADF75.pdf A59X WITH TUMOR 5 YES R1 Primary Tumor 01 4 NO NO YES KK Apex|Middle|Base YES Prostate Distant Metastasis A LIVING 2008 Peripheral Zone efbbd41e-6911-49d5-9d54-cc95e0c81415 TCGA-KK-A59X-01A-11D-A323-01 TCGA-KK-A59X-01A-11D-A29T-05 TCGA-KK-A59X-01A-11D-A29Q-08 efbbd41e-6911-49d5-9d54-cc95e0c81415 TCGA-KK-A59X-01 TCGA-KK-A59X-01 B8B5E05A-7239-4D32-A975-0409DF415833 TCGA-KK-A59X-01A-11D-A323-01 efbbd41e-6911-49d5-9d54-cc95e0c81415 TCGA-KK-A59X-01 TCGA-KK-A59X-01 TCGA-KK-A59X-01A-11D-A29Q-08 TCGA-KK-A59X-01A-11D-A29Q-08 efbbd41e-6911-49d5-9d54-cc95e0c81415 +TCGA-KK-A59Y-01 TCGA-KK-A59Y-01 TCGA-KK-A59Y TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 56 TCGA-KK-A59Y-F70436 TCGA-KK-A59Y TCGA-KK-A59Y-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T3a -20768 13 1158 13 0 1968 1359 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-16 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 110 NO Bilateral NO YES NO 4 2 true No N1 T3a TCGA-KK-A59Y.324E4C8E-1F95-4DA6-9D1F-97E6087BA2C7.pdf A59Y TUMOR FREE 4 Complete Remission/Response 0.1 YES RX Primary Tumor 01 5 YES NO YES KK Apex|Middle|Base Prostate A LIVING 2009 Peripheral Zone 08a5e204-0002-4148-8b87-bbb9b490e825 TCGA-KK-A59Y-01A-11D-A26L-01 TCGA-KK-A59Y-01A-11D-A26N-05 TCGA-KK-A59Y-01A-11D-A26M-08 08a5e204-0002-4148-8b87-bbb9b490e825 TCGA-KK-A59Y-01 TCGA-KK-A59Y-01 70D842F6-C7CA-4E6A-BB98-0FDC991785D7 TCGA-KK-A59Y-01A-11D-A26L-01 08a5e204-0002-4148-8b87-bbb9b490e825 TCGA-KK-A59Y-01 TCGA-KK-A59Y-01 TCGA-KK-A59Y-01A-11D-A26M-08 TCGA-KK-A59Y-01A-11D-A26M-08 08a5e204-0002-4148-8b87-bbb9b490e825 +TCGA-KK-A59Z-01 TCGA-KK-A59Z-01 TCGA-KK-A59Z TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-KK-A59Z-F70443 TCGA-KK-A59Z TCGA-KK-A59Z-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -24306 24 1985 20 0 2628 849 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission 2015-2-16 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 260 NO Bilateral NO YES NO 2 0 true No N0 T2c TCGA-KK-A59Z.DDF6F24F-4406-49EE-9EE0-7129D8544677.pdf A59Z TUMOR FREE 4 0.1 NO R0 Primary Tumor 01 3 NO NO YES KK Apex|Middle|Base Prostate A LIVING 2007 Peripheral Zone bbc5dea9-50e1-44b7-9d43-82896b9229b5 TCGA-KK-A59Z-01A-12D-A26L-01 TCGA-KK-A59Z-01A-12D-A26N-05 TCGA-KK-A59Z-01A-12D-A26M-08 bbc5dea9-50e1-44b7-9d43-82896b9229b5 TCGA-KK-A59Z-01 TCGA-KK-A59Z-01 8FA1DEF1-8C24-4B15-8875-30538F7E9E91 TCGA-KK-A59Z-01A-12D-A26L-01 bbc5dea9-50e1-44b7-9d43-82896b9229b5 TCGA-KK-A59Z-01 TCGA-KK-A59Z-01 TCGA-KK-A59Z-01A-12D-A26M-08 TCGA-KK-A59Z-01A-12D-A26M-08 bbc5dea9-50e1-44b7-9d43-82896b9229b5 +TCGA-KK-A5A1-01 TCGA-KK-A5A1-01 TCGA-KK-A5A1 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 72 TCGA-KK-A5A1-F70560 TCGA-KK-A5A1 TCGA-KK-A5A1-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T3a -26415 57 3586 2469 14 0 2364 420 YES NO Scheduled Follow-up Submission 2015-2-25 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 90 NO Bilateral NO YES YES 3 0 true No N0 T3b TCGA-KK-A5A1.DF56D103-963E-4C23-9DB8-1333AFF418CE.pdf A5A1 4 Partial Remission/Response 0.1 NO R1 Primary Tumor 01 5 Medical Record NO NO YES KK Apex|Middle|Base Prostate A DECEASED 2003 Overlapping / Multiple Zones acd9261f-37cf-44ca-86c4-e42d88d86b6c TCGA-KK-A5A1-01A-11D-A29T-05 TCGA-KK-A5A1-01A-11D-A29Q-08 acd9261f-37cf-44ca-86c4-e42d88d86b6c TCGA-KK-A5A1-01 TCGA-KK-A5A1-01 B87F9B41-6DAF-42E6-A00F-92DCE6D801F7 acd9261f-37cf-44ca-86c4-e42d88d86b6c TCGA-KK-A5A1-01 TCGA-KK-A5A1-01A-11D-A29Q-08 acd9261f-37cf-44ca-86c4-e42d88d86b6c +TCGA-KK-A6DY-01 TCGA-KK-A6DY-01 TCGA-KK-A6DY TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 50 TCGA-KK-A6DY-F70446 TCGA-KK-A6DY NO M0 T1c -18420 0 4295 903 NO NO Scheduled Follow-up Submission 2015-2-16 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 12 0 No N0 T2c A6DY WITH TUMOR 3 0.1 NO R1 Primary Tumor 01 4 NO NO YES KK Apex|Middle|Base Prostate LIVING 2002 Peripheral Zone bf46c30c-14fa-4e2a-a013-4e84f24eb63b TCGA-KK-A6DY-01A-12D-A30W-01 TCGA-KK-A6DY-01A-12D-A30Z-05 TCGA-KK-A6DY-01A-12D-A30X-08 bf46c30c-14fa-4e2a-a013-4e84f24eb63b TCGA-KK-A6DY-01 TCGA-KK-A6DY-01 TCGA-KK-A6DY-01A-12D-A30W-01 bf46c30c-14fa-4e2a-a013-4e84f24eb63b TCGA-KK-A6DY-01 TCGA-KK-A6DY-01 TCGA-KK-A6DY-01A-12D-A30X-08 TCGA-KK-A6DY-01A-12D-A30X-08 bf46c30c-14fa-4e2a-a013-4e84f24eb63b +TCGA-KK-A6E0-01 TCGA-KK-A6E0-01 TCGA-KK-A6E0 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-KK-A6E0-F70468 TCGA-KK-A6E0 TCGA-KK-A6E0-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T2b -21700 11 859 941 0 1483 941 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-17 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 140 NO Right NO YES NO 9 0 true No N0 T3a TCGA-KK-A6E0.41BD5E57-29AE-41C8-96D7-2832C726E83B.pdf A6E0 TUMOR FREE 4 Complete Remission/Response 0.3 YES R0 Primary Tumor 01 5 YES NO YES KK Apex|Middle|Base Prostate A LIVING 2011 Peripheral Zone 12c2e11c-8ba3-4cce-8c28-c005edc4e4cc TCGA-KK-A6E0-01A-11D-A30W-01 TCGA-KK-A6E0-01A-11D-A30Z-05 TCGA-KK-A6E0-01A-11D-A30X-08 12c2e11c-8ba3-4cce-8c28-c005edc4e4cc TCGA-KK-A6E0-01 TCGA-KK-A6E0-01 A94B48BB-03D7-46D8-9969-4B9000A3B779 TCGA-KK-A6E0-01A-11D-A30W-01 12c2e11c-8ba3-4cce-8c28-c005edc4e4cc TCGA-KK-A6E0-01 TCGA-KK-A6E0-01 TCGA-KK-A6E0-01A-11D-A30X-08 TCGA-KK-A6E0-01A-11D-A30X-08 12c2e11c-8ba3-4cce-8c28-c005edc4e4cc +TCGA-KK-A6E1-01 TCGA-KK-A6E1-01 TCGA-KK-A6E1 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-KK-A6E1-F70479 TCGA-KK-A6E1 TCGA-KK-A6E1-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2c -21063 -24 1598 -24 0 2198 356 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission 2015-2-18 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 250 NO Bilateral NO YES NO 24 5 true No N1 T3b TCGA-KK-A6E1.E8264E2D-E4BB-40BB-9305-18DDD777D664.pdf A6E1 TUMOR FREE 4 Complete Remission/Response 0.1 YES RX Primary Tumor 01 5 YES NO YES KK Apex|Middle|Base Prostate A LIVING 2008 Overlapping / Multiple Zones b38350db-b102-4a38-9edb-0089ca95840b TCGA-KK-A6E1-01A-11D-A30W-01 TCGA-KK-A6E1-01A-11D-A30Z-05 TCGA-KK-A6E1-01A-11D-A30X-08 b38350db-b102-4a38-9edb-0089ca95840b TCGA-KK-A6E1-01 TCGA-KK-A6E1-01 C09F01D2-47DA-4F3F-BC19-D8582CC49A19 TCGA-KK-A6E1-01A-11D-A30W-01 b38350db-b102-4a38-9edb-0089ca95840b TCGA-KK-A6E1-01 TCGA-KK-A6E1-01 TCGA-KK-A6E1-01A-11D-A30X-08 TCGA-KK-A6E1-01A-11D-A30X-08 b38350db-b102-4a38-9edb-0089ca95840b +TCGA-KK-A6E2-01 TCGA-KK-A6E2-01 TCGA-KK-A6E2 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 54 TCGA-KK-A6E2-F70481 TCGA-KK-A6E2 TCGA-KK-A6E2-01A NO M0 T2a -19974 4724 0 5024 438 NO NO Scheduled Follow-up Submission 2015-2-24 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 290 NO Bilateral NO YES NO 5 0 true No N0 T2c TCGA-KK-A6E2.84DBE486-DFA5-4FBC-BA8F-E10CC0247645.pdf A6E2 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO NO YES KK Apex|Middle|Base Prostate A LIVING 2000 Transition Zone 79d5f928-67b2-4db0-b018-a52889200dd3 TCGA-KK-A6E2-01A-11D-A30W-01 TCGA-KK-A6E2-01A-11D-A30Z-05 TCGA-KK-A6E2-01A-11D-A30X-08 79d5f928-67b2-4db0-b018-a52889200dd3 TCGA-KK-A6E2-01 TCGA-KK-A6E2-01 25BF06AA-FAB2-4F89-82C0-02F34E3A37B0 TCGA-KK-A6E2-01A-11D-A30W-01 79d5f928-67b2-4db0-b018-a52889200dd3 TCGA-KK-A6E2-01 TCGA-KK-A6E2-01 TCGA-KK-A6E2-01A-11D-A30X-08 TCGA-KK-A6E2-01A-11D-A30X-08 79d5f928-67b2-4db0-b018-a52889200dd3 +TCGA-KK-A6E3-01 TCGA-KK-A6E3-01 TCGA-KK-A6E3 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 56 TCGA-KK-A6E3 TCGA-KK-A6E3-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -20547 10 3355 0 2056 1065 NO NO 2014-3-27 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 140 NO Bilateral YES NO 3 0 true No N0 T2c TCGA-KK-A6E3.4796F9C1-49BD-411E-9D9B-D95001D76F53.pdf A6E3 TUMOR FREE 3 0.1 NO R0 Primary Tumor 01 4 NO NO YES KK Apex|Middle|Base Prostate A LIVING 2004 Transition Zone 40126675-87b4-4f49-8e55-2cf42bb536eb TCGA-KK-A6E3-01A-21D-A30D-01 TCGA-KK-A6E3-01A-21D-A30F-05 TCGA-KK-A6E3-01A-21D-A30E-08 40126675-87b4-4f49-8e55-2cf42bb536eb TCGA-KK-A6E3-01 TCGA-KK-A6E3-01 E9D6E375-6D3B-411F-899B-F37954C61755 TCGA-KK-A6E3-01A-21D-A30D-01 40126675-87b4-4f49-8e55-2cf42bb536eb TCGA-KK-A6E3-01 TCGA-KK-A6E3-01 TCGA-KK-A6E3-01A-21D-A30E-08 40126675-87b4-4f49-8e55-2cf42bb536eb +TCGA-KK-A6E4-01 TCGA-KK-A6E4-01 TCGA-KK-A6E4 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 69 TCGA-KK-A6E4-F70483 TCGA-KK-A6E4 TCGA-KK-A6E4-01A NO M0 T1c -25338 3094 3502 0 2753 890 NO NO Scheduled Follow-up Submission 2015-2-24 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 190 NO Right NO YES NO 4 0 true No N0 T2b TCGA-KK-A6E4.D4A30E0D-4829-4B4E-863A-DF2ACED85BE8.pdf A6E4 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 Medical Record NO NO YES KK Apex|Middle|Base Prostate A DECEASED 2004 Peripheral Zone 5793ef8d-17da-49a6-a606-9ce76c0a7a2a TCGA-KK-A6E4-01A-11D-A30D-01 TCGA-KK-A6E4-01A-11D-A30F-05 TCGA-KK-A6E4-01A-11D-A30E-08 5793ef8d-17da-49a6-a606-9ce76c0a7a2a TCGA-KK-A6E4-01 TCGA-KK-A6E4-01 BAAC61A0-2FB1-49F5-BA68-C00EFDA0A519 TCGA-KK-A6E4-01A-11D-A30D-01 5793ef8d-17da-49a6-a606-9ce76c0a7a2a TCGA-KK-A6E4-01 TCGA-KK-A6E4-01 TCGA-KK-A6E4-01A-11D-A30E-08 5793ef8d-17da-49a6-a606-9ce76c0a7a2a +TCGA-KK-A6E5-01 TCGA-KK-A6E5-01 TCGA-KK-A6E5 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-KK-A6E5-F70484 TCGA-KK-A6E5 NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -23144 -19 -19 0 2073 1496 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-24 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 27 0 No N0 T3b A6E5 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 NO NO YES KK Apex|Middle|Base Prostate LIVING 2009 Peripheral Zone a9e18d77-7074-49d6-b686-fa7d3463d156 TCGA-KK-A6E5-01A-11D-A30W-01 TCGA-KK-A6E5-01A-11D-A30Z-05 TCGA-KK-A6E5-01A-11D-A30X-08 a9e18d77-7074-49d6-b686-fa7d3463d156 TCGA-KK-A6E5-01 TCGA-KK-A6E5-01 TCGA-KK-A6E5-01A-11D-A30W-01 a9e18d77-7074-49d6-b686-fa7d3463d156 TCGA-KK-A6E5-01 TCGA-KK-A6E5-01 TCGA-KK-A6E5-01A-11D-A30X-08 TCGA-KK-A6E5-01A-11D-A30X-08 a9e18d77-7074-49d6-b686-fa7d3463d156 +TCGA-KK-A6E6-01 TCGA-KK-A6E6-01 TCGA-KK-A6E6 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 69 TCGA-KK-A6E6 TCGA-KK-A6E6-01A NO M0 T2b -25320 3813 0 3447 3447 NO NO 2014-3-27 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 50 NO Bilateral YES NO 5 0 true No N0 T3a TCGA-KK-A6E6.C67B882A-02B1-4511-B55C-87A33FC3E73E.pdf A6E6 TUMOR FREE 4 0.1 NO R0 Primary Tumor 01 5 NO NO YES KK Apex|Middle|Base Prostate A LIVING 2002 Peripheral Zone 79922276-6e00-4f17-851f-554f52f71520 TCGA-KK-A6E6-01A-11D-A30W-01 TCGA-KK-A6E6-01A-11D-A30Z-05 TCGA-KK-A6E6-01A-11D-A30X-08 79922276-6e00-4f17-851f-554f52f71520 TCGA-KK-A6E6-01 TCGA-KK-A6E6-01A-11D-A30W-01 79922276-6e00-4f17-851f-554f52f71520 TCGA-KK-A6E6-01 TCGA-KK-A6E6-01A-11D-A30X-08 TCGA-KK-A6E6-01A-11D-A30X-08 79922276-6e00-4f17-851f-554f52f71520 +TCGA-KK-A6E7-01 TCGA-KK-A6E7-01 TCGA-KK-A6E7 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 46 TCGA-KK-A6E7-F70486 TCGA-KK-A6E7 TCGA-KK-A6E7-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -17074 -46 2151 -45 8 925 0 2760 925 1847 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension|Equivocal Scheduled Follow-up Submission 2015-2-24 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 40 NO Bilateral NO YES Biochemical evidence of disease YES 11 1 true No N1 T3a TCGA-KK-A6E7.8173D1A9-5564-4824-AFD6-2097B90F4008.pdf A6E7 WITH TUMOR 5 Partial Remission/Response 0.1 NO R1 Primary Tumor 01 4 NO NO YES KK Apex|Middle Prostate A LIVING 2007 Transition Zone 025caa8f-3290-488b-b7d0-aacf769a53e4 TCGA-KK-A6E7-01A-11D-A31K-01 TCGA-KK-A6E7-01A-11D-A31M-05 TCGA-KK-A6E7-01A-11D-A31L-08 025caa8f-3290-488b-b7d0-aacf769a53e4 TCGA-KK-A6E7-01 TCGA-KK-A6E7-01 TCGA-KK-A6E7-01A-11D-A31K-01 025caa8f-3290-488b-b7d0-aacf769a53e4 TCGA-KK-A6E7-01 TCGA-KK-A6E7-01 TCGA-KK-A6E7-01A-11D-A31L-08 025caa8f-3290-488b-b7d0-aacf769a53e4 +TCGA-KK-A6E8-01 TCGA-KK-A6E8-01 TCGA-KK-A6E8 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-KK-A6E8 TCGA-KK-A6E8-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -25026 97 2128 104 0 1770 1769 NO YES No Evidence of Extraprostatic Extension 2014-3-27 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 120 NO Bilateral YES NO 14 0 true No N0 T2c TCGA-KK-A6E8.3716A52E-E0B7-4FE0-AC2B-07F2F3A0D6AD.pdf A6E8 TUMOR FREE 4 0.1 NO RX Primary Tumor 01 5 NO NO YES KK Apex|Middle|Base Prostate A LIVING 2007 Transition Zone 246b4ac3-ceec-41c2-bab9-ed88baf668ae TCGA-KK-A6E8-01A-11D-A31K-01 TCGA-KK-A6E8-01A-11D-A31M-05 TCGA-KK-A6E8-01A-11D-A31L-08 246b4ac3-ceec-41c2-bab9-ed88baf668ae TCGA-KK-A6E8-01 TCGA-KK-A6E8-01 97219DA1-B3A3-4DD9-99AC-2C016445BA33 TCGA-KK-A6E8-01A-11D-A31K-01 246b4ac3-ceec-41c2-bab9-ed88baf668ae TCGA-KK-A6E8-01 TCGA-KK-A6E8-01 TCGA-KK-A6E8-01A-11D-A31L-08 246b4ac3-ceec-41c2-bab9-ed88baf668ae +TCGA-KK-A7AP-01 TCGA-KK-A7AP-01 TCGA-KK-A7AP TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-KK-A7AP TCGA-KK-A7AP-01A Normal (no evidence of prostate cancer) [cM0] M0 T2b -20403 175 1130 0 196 NO NO 2014-6-6 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 160 NO Right YES 15 2 true Yes, History of Prior Malignancy N1 T3b TCGA-KK-A7AP.5B2E970F-CF58-4A8E-90FD-A1AA16C95142.pdf A7AP 4 R1 Primary Tumor 01 5 NO YES KK Apex|Middle|Base Prostate A LIVING 2010 Overlapping / Multiple Zones 9a4b7216-886c-4247-bcf3-22abc9d10835 TCGA-KK-A7AP-01A-12D-A33S-01 TCGA-KK-A7AP-01A-12D-A33U-05 TCGA-KK-A7AP-01A-12D-A33T-08 9a4b7216-886c-4247-bcf3-22abc9d10835 TCGA-KK-A7AP-01 TCGA-KK-A7AP-01 B3C464FD-9E3F-4667-A0E9-E0DC47D65764 TCGA-KK-A7AP-01A-12D-A33S-01 9a4b7216-886c-4247-bcf3-22abc9d10835 TCGA-KK-A7AP-01 TCGA-KK-A7AP-01 TCGA-KK-A7AP-01A-12D-A33T-08 9a4b7216-886c-4247-bcf3-22abc9d10835 +TCGA-KK-A7AQ-01 TCGA-KK-A7AQ-01 TCGA-KK-A7AQ TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-KK-A7AQ-F70490 TCGA-KK-A7AQ NO M0 T2a -22731 38 1217 0 1610 1385 YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2015-2-24 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 11 0 No N0 T2c A7AQ TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 NO 5 NO YES KK Apex|Middle Prostate LIVING 2010 Peripheral Zone b87af222-7056-4704-80c6-6766b8826767 TCGA-KK-A7AQ-01A-11D-A33S-01 TCGA-KK-A7AQ-01A-11D-A33U-05 TCGA-KK-A7AQ-01A-11D-A33T-08 b87af222-7056-4704-80c6-6766b8826767 TCGA-KK-A7AQ-01 TCGA-KK-A7AQ-01 TCGA-KK-A7AQ-01A-11D-A33S-01 b87af222-7056-4704-80c6-6766b8826767 TCGA-KK-A7AQ-01 TCGA-KK-A7AQ-01 b87af222-7056-4704-80c6-6766b8826767 +TCGA-KK-A7AU-01 TCGA-KK-A7AU-01 TCGA-KK-A7AU TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-KK-A7AU-F70505 TCGA-KK-A7AU TCGA-KK-A7AU-01A NO M0 T2b -23118 1266 123 207 0 1775 1621 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2015-2-24 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 120 NO Bilateral NO YES NO 11 3 true No N1 T3b TCGA-KK-A7AU.4BA7AC63-6B00-44E3-9545-6A4836912B1E.pdf A7AU TUMOR FREE 4 Progressive Disease 0.0 NO R1 Primary Tumor 01 5 NO NO YES KK Apex|Middle|Base Prostate A LIVING 2010 Peripheral Zone eb344d08-f396-47b1-b832-dc0eb5d4abfb TCGA-KK-A7AU-01A-11D-A32A-01 TCGA-KK-A7AU-01A-11D-A32C-05 TCGA-KK-A7AU-01A-11D-A32B-08 eb344d08-f396-47b1-b832-dc0eb5d4abfb TCGA-KK-A7AU-01 TCGA-KK-A7AU-01 294C495A-6213-4318-9EF8-8F5D005BE309 TCGA-KK-A7AU-01A-11D-A32A-01 eb344d08-f396-47b1-b832-dc0eb5d4abfb TCGA-KK-A7AU-01 TCGA-KK-A7AU-01 TCGA-KK-A7AU-01A-11D-A32B-08 eb344d08-f396-47b1-b832-dc0eb5d4abfb +TCGA-KK-A7AV-01 TCGA-KK-A7AV-01 TCGA-KK-A7AV TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 58 TCGA-KK-A7AV-F70507 TCGA-KK-A7AV TCGA-KK-A7AV-01A NO M0 T1c -21192 587 48 0 822 822 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2015-2-24 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 60 NO Bilateral NO YES NO 23 0 true No N0 T2c TCGA-KK-A7AV.7C653DC8-83CE-42D9-A3D5-FA06CAFFF8EE.pdf A7AV TUMOR FREE 3 Complete Remission/Response 0.1 NO RX Primary Tumor 01 4 NO NO YES KK Apex|Middle|Base Prostate A LIVING 2012 Peripheral Zone 2b18be96-7a63-4bd7-b937-db23d45dd36c TCGA-KK-A7AV-01A-11D-A32A-01 TCGA-KK-A7AV-01A-11D-A32C-05 TCGA-KK-A7AV-01A-11D-A32B-08 2b18be96-7a63-4bd7-b937-db23d45dd36c TCGA-KK-A7AV-01 TCGA-KK-A7AV-01 TCGA-KK-A7AV-01A-11D-A32A-01 2b18be96-7a63-4bd7-b937-db23d45dd36c TCGA-KK-A7AV-01 TCGA-KK-A7AV-01 TCGA-KK-A7AV-01A-11D-A32B-08 2b18be96-7a63-4bd7-b937-db23d45dd36c +TCGA-KK-A7AW-01 TCGA-KK-A7AW-01 TCGA-KK-A7AW TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-KK-A7AW TCGA-KK-A7AW-01A YES M0 T2a -20869 983 11 204 0 1054 204 YES NO 2014-8-19 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 60 NO Right YES 9 1 true No N1 T3a TCGA-KK-A7AW.B5E8DF63-7C54-4D45-93ED-5C80075C63A5.pdf A7AW TUMOR FREE 4 0.8 R0 Primary Tumor 01 3 NO YES KK Apex|Middle|Base Prostate A LIVING 2010 Peripheral Zone 4f9b77fa-f087-44c3-a8f2-aeec410bfc9c TCGA-KK-A7AW-01A-11D-A32A-01 TCGA-KK-A7AW-01A-11D-A32C-05 TCGA-KK-A7AW-01A-11D-A32B-08 4f9b77fa-f087-44c3-a8f2-aeec410bfc9c TCGA-KK-A7AW-01 TCGA-KK-A7AW-01 TCGA-KK-A7AW-01A-11D-A32A-01 4f9b77fa-f087-44c3-a8f2-aeec410bfc9c TCGA-KK-A7AW-01 TCGA-KK-A7AW-01 4f9b77fa-f087-44c3-a8f2-aeec410bfc9c +TCGA-KK-A7AY-01 TCGA-KK-A7AY-01 TCGA-KK-A7AY TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-KK-A7AY-F70514 TCGA-KK-A7AY TCGA-KK-A7AY-01A NO M0 T2a -22220 1246 1124 0 1754 1572 NO NO Scheduled Follow-up Submission Stable Disease 2015-2-24 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 110 NO Bilateral NO YES NO 8 0 true No N0 T2c TCGA-KK-A7AY.BA64AA42-00AD-4DAD-ABE7-BDDC253B9B45.pdf A7AY TUMOR FREE 4 Complete Remission/Response 0.2 NO R0 Primary Tumor 01 3 NO NO YES KK Apex|Middle|Base Prostate A LIVING 2010 Peripheral Zone 0fecf92d-9c02-4da8-aadd-c8105b99698b TCGA-KK-A7AY-01A-11D-A33S-01 TCGA-KK-A7AY-01A-11D-A33U-05 TCGA-KK-A7AY-01A-11D-A33T-08 0fecf92d-9c02-4da8-aadd-c8105b99698b TCGA-KK-A7AY-01 TCGA-KK-A7AY-01 TCGA-KK-A7AY-01A-11D-A33S-01 0fecf92d-9c02-4da8-aadd-c8105b99698b TCGA-KK-A7AY-01 TCGA-KK-A7AY-01 0fecf92d-9c02-4da8-aadd-c8105b99698b +TCGA-KK-A7AZ-01 TCGA-KK-A7AZ-01 TCGA-KK-A7AZ TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 56 TCGA-KK-A7AZ-F70515 TCGA-KK-A7AZ TCGA-KK-A7AZ-01A T2b -20507 1045 141 0 1519 NO YES Equivocal Scheduled Follow-up Submission 2015-2-24 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 200 NO Right NO YES 14 0 true No N0 T3a TCGA-KK-A7AZ.5DEA3530-6618-4A73-94C7-F23DA06DA52C.pdf A7AZ 4 R0 Primary Tumor 01 3 NO YES KK Apex|Middle|Base Prostate A LIVING 2010 Peripheral Zone 4d8fe8a9-7bf2-4c95-8aae-f43baeab5826 TCGA-KK-A7AZ-01A-12D-A32A-01 TCGA-KK-A7AZ-01A-12D-A32C-05 TCGA-KK-A7AZ-01A-12D-A32B-08 4d8fe8a9-7bf2-4c95-8aae-f43baeab5826 TCGA-KK-A7AZ-01 10053A5A-9749-41FA-BD4F-3EA396C1F1D5 TCGA-KK-A7AZ-01A-12D-A32A-01 4d8fe8a9-7bf2-4c95-8aae-f43baeab5826 TCGA-KK-A7AZ-01 4d8fe8a9-7bf2-4c95-8aae-f43baeab5826 +TCGA-KK-A7B0-01 TCGA-KK-A7B0-01 TCGA-KK-A7B0 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-KK-A7B0-F70516 TCGA-KK-A7B0 TCGA-KK-A7B0-01A NO M0 T2b -24756 783 606 0 1329 999 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-24 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 150 NO Bilateral NO YES NO 17 0 true No N0 T3b TCGA-KK-A7B0.A6F717F0-66D2-4AEB-88F6-1A95D26489BC.pdf A7B0 TUMOR FREE 4 Stable Disease 0.1 NO R0 Primary Tumor 01 5 NO NO YES KK Apex|Middle|Base Prostate A LIVING 2011 Overlapping / Multiple Zones 13d2199f-d552-4ea3-9d7c-c2d1fb01d7a7 TCGA-KK-A7B0-01A-11D-A32A-01 TCGA-KK-A7B0-01A-11D-A32C-05 TCGA-KK-A7B0-01A-11D-A32B-08 13d2199f-d552-4ea3-9d7c-c2d1fb01d7a7 TCGA-KK-A7B0-01 TCGA-KK-A7B0-01 021977C3-C439-419A-B3DF-AAE39EAC4CA2 TCGA-KK-A7B0-01A-11D-A32A-01 13d2199f-d552-4ea3-9d7c-c2d1fb01d7a7 TCGA-KK-A7B0-01 TCGA-KK-A7B0-01 13d2199f-d552-4ea3-9d7c-c2d1fb01d7a7 +TCGA-KK-A7B1-01 TCGA-KK-A7B1-01 TCGA-KK-A7B1 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-KK-A7B1-F70517 TCGA-KK-A7B1 TCGA-KK-A7B1-01A NO M0 T1c -23803 839 52 0 1063 179 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission 2015-2-24 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 110 NO Bilateral NO YES 21 0 true No N0 T3a TCGA-KK-A7B1.F7802347-53BA-44B9-ACFE-7A10A014822B.pdf A7B1 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 NO NO YES KK Apex|Middle|Base Prostate A LIVING 2011 Peripheral Zone 9bf3daf6-37b4-4dea-92e9-6ed6e54f69f6 TCGA-KK-A7B1-01A-11D-A32A-01 TCGA-KK-A7B1-01A-11D-A32C-05 TCGA-KK-A7B1-01A-11D-A32B-08 9bf3daf6-37b4-4dea-92e9-6ed6e54f69f6 TCGA-KK-A7B1-01 TCGA-KK-A7B1-01 5F2ABD6D-5C1F-480B-A75B-4748C9E42AE7 TCGA-KK-A7B1-01A-11D-A32A-01 9bf3daf6-37b4-4dea-92e9-6ed6e54f69f6 TCGA-KK-A7B1-01 TCGA-KK-A7B1-01 TCGA-KK-A7B1-01A-11D-A32B-08 9bf3daf6-37b4-4dea-92e9-6ed6e54f69f6 +TCGA-KK-A7B2-01 TCGA-KK-A7B2-01 TCGA-KK-A7B2 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 68 TCGA-KK-A7B2-F70518 TCGA-KK-A7B2 TCGA-KK-A7B2-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -24845 58 554 58 692 0 1099 692 845 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Stable Disease 2015-2-24 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 130 NO Left NO YES Biochemical evidence of disease YES 13 1 true No N1 T3a TCGA-KK-A7B2.9A37DFF6-CDD7-40DD-A6A6-3966BC4E275A.pdf A7B2 WITH TUMOR 4 Stable Disease 0.3 NO R0 Primary Tumor 01 5 NO NO YES KK Apex|Middle|Base Prostate A LIVING 2012 Overlapping / Multiple Zones 9d5f0b9f-ff36-4a80-8472-412d0ec803c5 TCGA-KK-A7B2-01A-12D-A32A-01 TCGA-KK-A7B2-01A-12D-A32C-05 TCGA-KK-A7B2-01A-12D-A32B-08 9d5f0b9f-ff36-4a80-8472-412d0ec803c5 TCGA-KK-A7B2-01 TCGA-KK-A7B2-01 EAFA78AE-262F-4BCC-BDFA-051C9DDA0F8E TCGA-KK-A7B2-01A-12D-A32A-01 9d5f0b9f-ff36-4a80-8472-412d0ec803c5 TCGA-KK-A7B2-01 TCGA-KK-A7B2-01 9d5f0b9f-ff36-4a80-8472-412d0ec803c5 +TCGA-KK-A7B3-01 TCGA-KK-A7B3-01 TCGA-KK-A7B3 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO 62 TCGA-KK-A7B3-F70519 TCGA-KK-A7B3 TCGA-KK-A7B3-01A NO M0 T3a -22830 486 112 294 0 899 294 637 NO YES Extraprostatic Extension Localized (e.g. seminal vesicles) Scheduled Follow-up Submission Complete Remission/Response 2015-2-24 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 220 NO Bilateral NO YES Biochemical evidence of disease YES 17 0 true Yes, History of Prior Malignancy N0 T3b TCGA-KK-A7B3.45C687C3-52B9-4035-B916-777128B9AAE0.pdf A7B3 TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 5 NO NO YES KK Apex|Middle|Base Prostate A LIVING 2012 Peripheral Zone f3b04f74-8565-45f4-8a14-c0400c954ac4 TCGA-KK-A7B3-01A-11D-A33S-01 TCGA-KK-A7B3-01A-11D-A33U-05 TCGA-KK-A7B3-01A-11D-A33T-08 f3b04f74-8565-45f4-8a14-c0400c954ac4 TCGA-KK-A7B3-01 TCGA-KK-A7B3-01 E8F9ABEF-B961-4190-A287-607F24C58972 TCGA-KK-A7B3-01A-11D-A33S-01 f3b04f74-8565-45f4-8a14-c0400c954ac4 TCGA-KK-A7B3-01 TCGA-KK-A7B3-01 TCGA-KK-A7B3-01A-11D-A33T-08 f3b04f74-8565-45f4-8a14-c0400c954ac4 +TCGA-KK-A7B4-01 TCGA-KK-A7B4-01 TCGA-KK-A7B4 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 64 TCGA-KK-A7B4-F70523 TCGA-KK-A7B4 TCGA-KK-A7B4-01A YES Equivocal M0 T3b -23644 29 434 29 637 0 987 963 637 NO YES Equivocal Scheduled Follow-up Submission Progressive Disease 2015-2-24 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 160 NO Bilateral NO YES Bone Locoregional Recurrence YES 20 8 true Yes, History of Prior Malignancy N1 T3b TCGA-KK-A7B4.19CE314A-B253-4F6F-9D77-37B33CFC6F2E.pdf A7B4 WITH TUMOR 4 Stable Disease 0.6 NO R1 Primary Tumor 01 5 YES NO YES KK Apex|Middle|Base YES Prostate Distant Metastasis A LIVING 2012 Overlapping / Multiple Zones dce52b98-298c-4980-ba8b-3791b6528d4c TCGA-KK-A7B4-01A-11D-A32A-01 TCGA-KK-A7B4-01A-11D-A32C-05 TCGA-KK-A7B4-01A-11D-A32B-08 dce52b98-298c-4980-ba8b-3791b6528d4c TCGA-KK-A7B4-01 TCGA-KK-A7B4-01 5F026779-6B16-48A6-B59A-8478CCD3ED24 TCGA-KK-A7B4-01A-11D-A32A-01 dce52b98-298c-4980-ba8b-3791b6528d4c TCGA-KK-A7B4-01 TCGA-KK-A7B4-01 TCGA-KK-A7B4-01A-11D-A32B-08 dce52b98-298c-4980-ba8b-3791b6528d4c +TCGA-KK-A8I4-01 TCGA-KK-A8I4-01 TCGA-KK-A8I4 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES NO 64 TCGA-KK-A8I4-F70491 TCGA-KK-A8I4 TCGA-KK-A8I4-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2c -23706 70 1798 70 2162 0 2259 2162 1964 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission 2015-2-24 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 120 NO Left NO YES Biochemical evidence of disease YES 15 1 true No N1 T3b TCGA-KK-A8I4.633E280A-24F4-49FF-95B8-DDA5F447480E.pdf A8I4 WITH TUMOR 4 Progressive Disease 0.2 NO R0 Primary Tumor 01 3 NO 5 NO YES KK Apex|Middle|Base Prostate A LIVING 2008 Peripheral Zone b4d87462-1fc4-4ee4-b905-c2919ebceb33 TCGA-KK-A8I4-01A-11D-A363-01 TCGA-KK-A8I4-01A-11D-A365-05 TCGA-KK-A8I4-01A-11D-A364-08 b4d87462-1fc4-4ee4-b905-c2919ebceb33 TCGA-KK-A8I4-01 TCGA-KK-A8I4-01 07EC66DD-ACFD-471B-B7D2-C15742CB2D03 TCGA-KK-A8I4-01A-11D-A363-01 b4d87462-1fc4-4ee4-b905-c2919ebceb33 TCGA-KK-A8I4-01 TCGA-KK-A8I4-01 TCGA-KK-A8I4-01A-11D-A364-08 b4d87462-1fc4-4ee4-b905-c2919ebceb33 +TCGA-KK-A8I5-01 TCGA-KK-A8I5-01 TCGA-KK-A8I5 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-KK-A8I5-F70513 TCGA-KK-A8I5 TCGA-KK-A8I5-01A NO M0 T2a -20337 2717 0 3096 1979 NO NO Scheduled Follow-up Submission 2015-2-24 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 130 NO Right NO YES NO 6 true No N0 T2b TCGA-KK-A8I5.CF19D931-B8BE-4978-8C08-081744230305.pdf A8I5 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO NO YES KK Apex|Middle|Base Prostate A LIVING 2006 Peripheral Zone 1afe5497-bd6d-45b9-816d-52e7fb20ea4e TCGA-KK-A8I5-01A-11D-A363-01 TCGA-KK-A8I5-01A-11D-A365-05 TCGA-KK-A8I5-01A-11D-A364-08 1afe5497-bd6d-45b9-816d-52e7fb20ea4e TCGA-KK-A8I5-01 TCGA-KK-A8I5-01 5EEB5789-0D53-4ECE-9924-918EDE7B89D5 TCGA-KK-A8I5-01A-11D-A363-01 1afe5497-bd6d-45b9-816d-52e7fb20ea4e TCGA-KK-A8I5-01 TCGA-KK-A8I5-01 TCGA-KK-A8I5-01A-11D-A364-08 1afe5497-bd6d-45b9-816d-52e7fb20ea4e +TCGA-KK-A8I6-01 TCGA-KK-A8I6-01 TCGA-KK-A8I6 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 58 TCGA-KK-A8I6 TCGA-KK-A8I6-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -21499 -14 808 -13 17 0 668 668 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension 2014-8-18 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 170 NO Bilateral YES NO 23 0 true No N0 T3a TCGA-KK-A8I6.11107580-AAF3-4CE8-AC75-8636CE8C515E.pdf A8I6 TUMOR FREE 4 Complete Remission/Response 0.2 NO R0 Primary Tumor 01 3 NO NO YES KK Apex|Middle|Base Prostate A LIVING 2011 Peripheral Zone 0b02de77-8d04-4be6-87db-0f0506ee5e54 TCGA-KK-A8I6-01A-11D-A363-01 TCGA-KK-A8I6-01A-11D-A365-05 TCGA-KK-A8I6-01A-11D-A364-08 0b02de77-8d04-4be6-87db-0f0506ee5e54 TCGA-KK-A8I6-01 TCGA-KK-A8I6-01 EA1C6B94-A29F-478B-8416-BB5106EDCB57 TCGA-KK-A8I6-01A-11D-A363-01 0b02de77-8d04-4be6-87db-0f0506ee5e54 TCGA-KK-A8I6-01 TCGA-KK-A8I6-01 TCGA-KK-A8I6-01A-11D-A364-08 0b02de77-8d04-4be6-87db-0f0506ee5e54 +TCGA-KK-A8I7-01 TCGA-KK-A8I7-01 TCGA-KK-A8I7 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES NO 55 TCGA-KK-A8I7-F70524 TCGA-KK-A8I7 TCGA-KK-A8I7-01A NO M0 T2c -20256 1634 24 1088 0 2002 1756 1877 1756 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-24 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 150 NO Bilateral NO YES Biochemical evidence of disease YES 9 0 true No N0 T3b TCGA-KK-A8I7.70BA9BA3-05E5-4B40-9D6A-BBECCAAADD81.pdf A8I7 TUMOR FREE 4 Progressive Disease 0.1 NO R1 Primary Tumor 01 5 NO NO YES KK Apex|Middle|Base YES Prostate Biochemical Recurrence A LIVING 2009 Peripheral Zone 6086c6f1-e184-4a3e-935d-3addef5ecc2c TCGA-KK-A8I7-01A-21D-A363-01 TCGA-KK-A8I7-01A-21D-A365-05 TCGA-KK-A8I7-01A-21D-A364-08 6086c6f1-e184-4a3e-935d-3addef5ecc2c TCGA-KK-A8I7-01 TCGA-KK-A8I7-01 9FBC8B7D-6DEA-40F3-860E-97AD2E34A9D8 TCGA-KK-A8I7-01A-21D-A363-01 6086c6f1-e184-4a3e-935d-3addef5ecc2c TCGA-KK-A8I7-01 TCGA-KK-A8I7-01 6086c6f1-e184-4a3e-935d-3addef5ecc2c +TCGA-KK-A8I8-01 TCGA-KK-A8I8-01 TCGA-KK-A8I8 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 69 TCGA-KK-A8I8-F70526 TCGA-KK-A8I8 TCGA-KK-A8I8-01A NO M0 T2a -25546 535 31 0 967 757 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2015-2-24 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 110 NO Bilateral NO YES NO 27 true No N0 T3b TCGA-KK-A8I8.EA62695C-65BD-4E4A-BB9D-0D1CC5B90636.pdf A8I8 TUMOR FREE 4 Complete Remission/Response 0.1 YES R1 Primary Tumor 01 5 NO NO YES KK Apex|Middle|Base Prostate A LIVING 2012 Peripheral Zone 532e3276-07d4-4e86-a955-4f474bc8ae36 TCGA-KK-A8I8-01A-11D-A363-01 TCGA-KK-A8I8-01A-11D-A365-05 TCGA-KK-A8I8-01A-11D-A364-08 532e3276-07d4-4e86-a955-4f474bc8ae36 TCGA-KK-A8I8-01 TCGA-KK-A8I8-01 0EECAF91-E4FB-4BA9-B556-C995CE9DD3E3 TCGA-KK-A8I8-01A-11D-A363-01 532e3276-07d4-4e86-a955-4f474bc8ae36 TCGA-KK-A8I8-01 TCGA-KK-A8I8-01 TCGA-KK-A8I8-01A-11D-A364-08 532e3276-07d4-4e86-a955-4f474bc8ae36 +TCGA-KK-A8I9-01 TCGA-KK-A8I9-01 TCGA-KK-A8I9 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 61 TCGA-KK-A8I9-F70527 TCGA-KK-A8I9 TCGA-KK-A8I9-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -22295 0 528 -3 0 940 0 1001 940 721 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Stable Disease 2015-2-24 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 50 NO Bilateral NO YES Biochemical evidence of disease YES 14 true No N0 T3a TCGA-KK-A8I9.D086A0A1-E06A-4B7E-B158-A5D04BCE06E1.pdf A8I9 WITH TUMOR 4 Complete Remission/Response 0.1 YES RX Primary Tumor 01 4 YES NO YES KK Apex|Middle|Base Prostate A LIVING 2012 Peripheral Zone 239d5e7e-5fb5-4df3-ae6b-a5a06ee296ae TCGA-KK-A8I9-01A-11D-A363-01 TCGA-KK-A8I9-01A-11D-A365-05 TCGA-KK-A8I9-01A-11D-A364-08 239d5e7e-5fb5-4df3-ae6b-a5a06ee296ae TCGA-KK-A8I9-01 TCGA-KK-A8I9-01 TCGA-KK-A8I9-01A-11D-A363-01 239d5e7e-5fb5-4df3-ae6b-a5a06ee296ae TCGA-KK-A8I9-01 TCGA-KK-A8I9-01 TCGA-KK-A8I9-01A-11D-A364-08 239d5e7e-5fb5-4df3-ae6b-a5a06ee296ae +TCGA-KK-A8IA-01 TCGA-KK-A8IA-01 TCGA-KK-A8IA TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 69 TCGA-KK-A8IA-F70528 TCGA-KK-A8IA TCGA-KK-A8IA-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T3b -25284 26 1665 26 0 1931 1383 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission 2015-2-24 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 230 NO Bilateral NO YES NO 19 3 true No N1 T3b TCGA-KK-A8IA.641BD2CD-8B57-49BB-A2E1-9EB78097B4D6.pdf A8IA 4 0.1 NO RX Primary Tumor 01 5 YES NO YES KK Apex|Middle|Base Prostate A LIVING 2009 Peripheral Zone fbf9c35e-9b03-4c5e-a065-0265ae35a409 TCGA-KK-A8IA-01A-11D-A363-01 TCGA-KK-A8IA-01A-11D-A365-05 TCGA-KK-A8IA-01A-11D-A364-08 fbf9c35e-9b03-4c5e-a065-0265ae35a409 TCGA-KK-A8IA-01 TCGA-KK-A8IA-01 C8238611-9006-49FE-ADFB-D1167916A28B TCGA-KK-A8IA-01A-11D-A363-01 fbf9c35e-9b03-4c5e-a065-0265ae35a409 TCGA-KK-A8IA-01 TCGA-KK-A8IA-01 TCGA-KK-A8IA-01A-11D-A364-08 fbf9c35e-9b03-4c5e-a065-0265ae35a409 +TCGA-KK-A8IB-01 TCGA-KK-A8IB-01 TCGA-KK-A8IB TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-KK-A8IB TCGA-KK-A8IB-01A M0 T2a -24041 338 0 83 NO NO 2014-8-19 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 360 NO Bilateral YES 21 true Yes, History of Prior Malignancy N0 T3a TCGA-KK-A8IB.B9FBCA1B-CAEB-48A1-87B8-C873AC07FD8B.pdf A8IB 4 R0 Primary Tumor 01 5 NO YES KK Apex|Middle|Base Prostate A LIVING 2012 Peripheral Zone 02fea7d7-d604-41c2-9506-a62824140df4 TCGA-KK-A8IB-01A-11D-A363-01 TCGA-KK-A8IB-01A-11D-A365-05 TCGA-KK-A8IB-01A-11D-A364-08 02fea7d7-d604-41c2-9506-a62824140df4 TCGA-KK-A8IB-01 TCGA-KK-A8IB-01 A8E140A3-8006-48CA-9C0F-E202F9AE1B4D TCGA-KK-A8IB-01A-11D-A363-01 02fea7d7-d604-41c2-9506-a62824140df4 TCGA-KK-A8IB-01 TCGA-KK-A8IB-01 TCGA-KK-A8IB-01A-11D-A364-08 02fea7d7-d604-41c2-9506-a62824140df4 +TCGA-KK-A8IC-01 TCGA-KK-A8IC-01 TCGA-KK-A8IC TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES NO 54 TCGA-KK-A8IC-F64008 TCGA-KK-A8IC TCGA-KK-A8IC-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T1c -19902 7 1784 6 1060 0 2051 1060 2047 2019 YES No Evidence of Extraprostatic Extension NO Additional New Tumor Event Stable Disease 2014-8-25 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 140 NO Bilateral NO YES Biochemical evidence of disease YES 38 true No N0 T3b TCGA-KK-A8IC.D11CB264-3D9E-49ED-85AA-57E4A26A5ED1.pdf A8IC WITH TUMOR 4 Progressive Disease 0.9 NO R0 Primary Tumor 01 5 NO NO YES KK Apex|Middle|Base Prostate A LIVING 2008 Peripheral Zone 8ae687ed-f9b2-41fc-88d7-e977fef25582 TCGA-KK-A8IC-01A-11D-A363-01 TCGA-KK-A8IC-01A-11D-A365-05 TCGA-KK-A8IC-01A-11D-A364-08 8ae687ed-f9b2-41fc-88d7-e977fef25582 TCGA-KK-A8IC-01 TCGA-KK-A8IC-01 6718AED6-8EDA-4AEC-8C7D-07BC69E6B132 TCGA-KK-A8IC-01A-11D-A363-01 8ae687ed-f9b2-41fc-88d7-e977fef25582 TCGA-KK-A8IC-01 TCGA-KK-A8IC-01 TCGA-KK-A8IC-01A-11D-A364-08 8ae687ed-f9b2-41fc-88d7-e977fef25582 +TCGA-KK-A8ID-01 TCGA-KK-A8ID-01 TCGA-KK-A8ID TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 70 TCGA-KK-A8ID-F70529 TCGA-KK-A8ID TCGA-KK-A8ID-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -25851 43 1717 -5 0 2107 1924 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-24 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 160 NO Bilateral NO YES NO 19 2 true No N1 T3b TCGA-KK-A8ID.51303D5A-8963-4A4E-8A30-8EB0CA6D9437.pdf A8ID TUMOR FREE 5 Complete Remission/Response 0.1 NO R1 Primary Tumor 01 4 YES NO YES KK Apex|Middle|Base Prostate A LIVING 2009 Overlapping / Multiple Zones dc0bcf42-993d-4119-b91e-399a639c1480 TCGA-KK-A8ID-01A-11D-A363-01 TCGA-KK-A8ID-01A-11D-A365-05 TCGA-KK-A8ID-01A-11D-A364-08 dc0bcf42-993d-4119-b91e-399a639c1480 TCGA-KK-A8ID-01 TCGA-KK-A8ID-01 6E2ED8C2-EA96-47D4-9F6E-125D5D6686D0 TCGA-KK-A8ID-01A-11D-A363-01 dc0bcf42-993d-4119-b91e-399a639c1480 TCGA-KK-A8ID-01 TCGA-KK-A8ID-01 TCGA-KK-A8ID-01A-11D-A364-08 dc0bcf42-993d-4119-b91e-399a639c1480 +TCGA-KK-A8IF-01 TCGA-KK-A8IF-01 TCGA-KK-A8IF TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-KK-A8IF TCGA-KK-A8IF-01A YES M0 T2a -20888 2351 522 648 0 804 788 NO YES No Evidence of Extraprostatic Extension 2014-8-18 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 160 NO Bilateral YES YES 33 true No N0 T3a TCGA-KK-A8IF.BF56F683-5D52-4154-B9D4-1B6D2608C5AA.pdf A8IF WITH TUMOR 4 0.7 R0 Primary Tumor 01 3 NO YES KK Apex|Middle|Base Prostate A LIVING 2007 Transition Zone 8744dea9-5e21-47b0-9327-8177526d9d31 TCGA-KK-A8IF-01A-11D-A363-01 TCGA-KK-A8IF-01A-11D-A365-05 TCGA-KK-A8IF-01A-11D-A364-08 8744dea9-5e21-47b0-9327-8177526d9d31 TCGA-KK-A8IF-01 TCGA-KK-A8IF-01 0FF387D4-AB6A-425A-8256-1237F7FC0F2F TCGA-KK-A8IF-01A-11D-A363-01 8744dea9-5e21-47b0-9327-8177526d9d31 TCGA-KK-A8IF-01 TCGA-KK-A8IF-01 TCGA-KK-A8IF-01A-11D-A364-08 8744dea9-5e21-47b0-9327-8177526d9d31 +TCGA-KK-A8IG-01 TCGA-KK-A8IG-01 TCGA-KK-A8IG TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-KK-A8IG-F70530 TCGA-KK-A8IG TCGA-KK-A8IG-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2a -20266 63 2057 63 0 2505 2211 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-24 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 60 NO Bilateral NO YES NO 19 true No N0 T3a TCGA-KK-A8IG.D1F786EC-03F5-458B-99AC-3B89EFFF2297.pdf A8IG TUMOR FREE 4 Complete Remission/Response 0.1 NO R1 Primary Tumor 01 3 NO NO YES KK Apex|Middle Prostate A LIVING 2008 Transition Zone 95c350df-1871-430a-9c08-f3d88e2edcaf TCGA-KK-A8IG-01A-11D-A363-01 TCGA-KK-A8IG-01A-11D-A365-05 TCGA-KK-A8IG-01A-11D-A364-08 95c350df-1871-430a-9c08-f3d88e2edcaf TCGA-KK-A8IG-01 TCGA-KK-A8IG-01 TCGA-KK-A8IG-01A-11D-A363-01 95c350df-1871-430a-9c08-f3d88e2edcaf TCGA-KK-A8IG-01 TCGA-KK-A8IG-01 TCGA-KK-A8IG-01A-11D-A364-08 95c350df-1871-430a-9c08-f3d88e2edcaf +TCGA-KK-A8IH-01 TCGA-KK-A8IH-01 TCGA-KK-A8IH TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 50 TCGA-KK-A8IH-F70531 TCGA-KK-A8IH TCGA-KK-A8IH-01A NO M0 T2b -18560 1631 0 2013 1634 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-24 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 170 NO Bilateral NO YES NO 10 true No N0 T3a TCGA-KK-A8IH.E2FC2177-CB74-4E23-B24D-68F4ECEA57C2.pdf A8IH TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 NO 5 NO YES KK Apex|Middle|Base Prostate A LIVING 2009 Peripheral Zone 994566a7-664e-4b9b-9320-126940c14b6b TCGA-KK-A8IH-01A-11D-A363-01 TCGA-KK-A8IH-01A-11D-A365-05 TCGA-KK-A8IH-01A-11D-A364-08 994566a7-664e-4b9b-9320-126940c14b6b TCGA-KK-A8IH-01 TCGA-KK-A8IH-01 9755CEAB-EF49-4F43-9710-C1BC7820B893 TCGA-KK-A8IH-01A-11D-A363-01 994566a7-664e-4b9b-9320-126940c14b6b TCGA-KK-A8IH-01 TCGA-KK-A8IH-01 TCGA-KK-A8IH-01A-11D-A364-08 994566a7-664e-4b9b-9320-126940c14b6b +TCGA-KK-A8II-01 TCGA-KK-A8II-01 TCGA-KK-A8II TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES NO 61 TCGA-KK-A8II-F68762 TCGA-KK-A8II TCGA-KK-A8II-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T2c -22460 -28 3293 3467 11 626 0 1854 2891 YES No Evidence of Extraprostatic Extension NO Additional New Tumor Event Progressive Disease 2014-12-16 MALE 9 Prostate Adenocarcinoma, Other Subtype No C61 8500/3 C61.9 YES Core needle biopsy 240 NO Bilateral NO YES Bone Biochemical evidence of disease YES 19 true No N0 T3a TCGA-KK-A8II.0C940BA1-22F7-412D-AD58-84B950157601.pdf A8II WITH TUMOR 4 Complete Remission/Response 39.8 NO R0 Primary Tumor 01 5 Medical Record NO NO YES KK Apex|Middle|Base YES Prostate Distant Metastasis A DECEASED 2004 Peripheral Zone d5cb344a-fec2-4370-88ef-4837ae8573dc TCGA-KK-A8II-01A-11D-A363-01 TCGA-KK-A8II-01A-11D-A365-05 TCGA-KK-A8II-01A-11D-A364-08 d5cb344a-fec2-4370-88ef-4837ae8573dc TCGA-KK-A8II-01 TCGA-KK-A8II-01 7DE10C16-6E56-4BE0-BB42-B651B2DF2C24 TCGA-KK-A8II-01A-11D-A363-01 d5cb344a-fec2-4370-88ef-4837ae8573dc TCGA-KK-A8II-01 TCGA-KK-A8II-01 TCGA-KK-A8II-01A-11D-A364-08 d5cb344a-fec2-4370-88ef-4837ae8573dc +TCGA-KK-A8IJ-01 TCGA-KK-A8IJ-01 TCGA-KK-A8IJ TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-KK-A8IJ TCGA-KK-A8IJ-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T3a -21793 42 1749 42 0 1559 167 YES No Evidence of Extraprostatic Extension NO 2014-8-19 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 240 NO Bilateral YES YES 34 1 true No N1 T3b TCGA-KK-A8IJ.F224443D-410F-4F1E-9CA0-04A652985616.pdf A8IJ 4 0.1 R0 Primary Tumor 01 3 5 NO YES KK Apex|Middle|Base Prostate A LIVING 2009 Peripheral Zone a8f619f1-c92e-4e7b-99f9-d25984935cde TCGA-KK-A8IJ-01A-11D-A34T-01 TCGA-KK-A8IJ-01A-11D-A34V-05 TCGA-KK-A8IJ-01A-11D-A34U-08 a8f619f1-c92e-4e7b-99f9-d25984935cde TCGA-KK-A8IJ-01 TCGA-KK-A8IJ-01 8D73AAEA-C409-4438-8682-99786DF345D5 TCGA-KK-A8IJ-01A-11D-A34T-01 a8f619f1-c92e-4e7b-99f9-d25984935cde TCGA-KK-A8IJ-01 TCGA-KK-A8IJ-01 TCGA-KK-A8IJ-01A-11D-A34U-08 a8f619f1-c92e-4e7b-99f9-d25984935cde +TCGA-KK-A8IK-01 TCGA-KK-A8IK-01 TCGA-KK-A8IK TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 56 TCGA-KK-A8IK-F70532 TCGA-KK-A8IK TCGA-KK-A8IK-01A NO Abnormal (not related to prostate cancer) M0 T1c -20594 -69 1759 -69 0 2052 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission 2015-2-24 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 80 NO Bilateral NO YES NO 6 true No N0 T2c TCGA-KK-A8IK.CBFE7CBE-890E-4749-9566-0CE41A93D69D.pdf A8IK TUMOR FREE 4 Complete Remission/Response 0.0 NO R0 Primary Tumor 01 5 NO NO YES KK Apex|Middle|Base Prostate A LIVING 2008 Peripheral Zone 2d669bc4-fb4b-4db9-b6a3-f54dde950056 TCGA-KK-A8IK-01A-11D-A363-01 TCGA-KK-A8IK-01A-11D-A365-05 TCGA-KK-A8IK-01A-11D-A364-08 2d669bc4-fb4b-4db9-b6a3-f54dde950056 TCGA-KK-A8IK-01 TCGA-KK-A8IK-01 TCGA-KK-A8IK-01A-11D-A363-01 2d669bc4-fb4b-4db9-b6a3-f54dde950056 TCGA-KK-A8IK-01 TCGA-KK-A8IK-01 TCGA-KK-A8IK-01A-11D-A364-08 2d669bc4-fb4b-4db9-b6a3-f54dde950056 +TCGA-KK-A8IL-01 TCGA-KK-A8IL-01 TCGA-KK-A8IL TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-KK-A8IL TCGA-KK-A8IL-01A NO M0 T1c -23849 1420 628 7 87 0 144 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension 2014-8-19 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 60 NO Bilateral YES 08 01 true No N1 T3b TCGA-KK-A8IL.9F54DC02-35C0-4D0E-A1D8-63F820CF72C4.pdf A8IL 4 0.1 R1 Primary Tumor 01 5 Medical Record NO YES KK Apex|Middle|Base Prostate A DECEASED 2009 Peripheral Zone 0e2cfe4b-18fe-47f6-b357-a43f97a9b531 TCGA-KK-A8IL-01A-11D-A363-01 TCGA-KK-A8IL-01A-11D-A365-05 TCGA-KK-A8IL-01A-11D-A364-08 0e2cfe4b-18fe-47f6-b357-a43f97a9b531 TCGA-KK-A8IL-01 TCGA-KK-A8IL-01 TCGA-KK-A8IL-01A-11D-A363-01 0e2cfe4b-18fe-47f6-b357-a43f97a9b531 TCGA-KK-A8IL-01 TCGA-KK-A8IL-01 TCGA-KK-A8IL-01A-11D-A364-08 0e2cfe4b-18fe-47f6-b357-a43f97a9b531 +TCGA-KK-A8IM-01 TCGA-KK-A8IM-01 TCGA-KK-A8IM TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-KK-A8IM-F70533 TCGA-KK-A8IM TCGA-KK-A8IM-01A NO M0 T2a -20425 1466 0 1915 1438 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-24 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 60 NO Bilateral NO YES NO 5 true No N0 T2c TCGA-KK-A8IM.C0D3148F-A371-4983-9E62-DA5446385173.pdf A8IM TUMOR FREE 4 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 3 NO NO YES KK Apex|Middle|Base Prostate A LIVING 2009 Peripheral Zone 6d249571-1535-4db3-9860-a56a02941200 TCGA-KK-A8IM-01A-11D-A363-01 TCGA-KK-A8IM-01A-11D-A365-05 TCGA-KK-A8IM-01A-11D-A364-08 6d249571-1535-4db3-9860-a56a02941200 TCGA-KK-A8IM-01 TCGA-KK-A8IM-01 TCGA-KK-A8IM-01A-11D-A363-01 6d249571-1535-4db3-9860-a56a02941200 TCGA-KK-A8IM-01 TCGA-KK-A8IM-01 6d249571-1535-4db3-9860-a56a02941200 +TCGA-M7-A71Y-01 TCGA-M7-A71Y-01 TCGA-M7-A71Y TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-M7-A71Y-F61811 TCGA-M7-A71Y TCGA-M7-A71Y-01A NO T1c -20357 183 0 493 158 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-7-7 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 140 NO Bilateral NO NO NO false No T2c TCGA-M7-A71Y.569825C5-98D3-4A52-AD1D-2859F8F54A34.pdf A71Y TUMOR FREE 3 Complete Remission/Response NO R0 Primary Tumor 01 4 NO YES NO M7 Apex|Middle|Base Prostate A LIVING 2013 Overlapping / Multiple Zones a3f81069-d0a9-49af-bd22-24c6142241b6 TCGA-M7-A71Y-01A-22D-A32A-01 TCGA-M7-A71Y-01A-22D-A32C-05 TCGA-M7-A71Y-01A-22D-A32B-08 a3f81069-d0a9-49af-bd22-24c6142241b6 TCGA-M7-A71Y-01 693F8FB0-76DB-4A04-A20A-0C73077ED9A6 TCGA-M7-A71Y-01A-22D-A32A-01 a3f81069-d0a9-49af-bd22-24c6142241b6 TCGA-M7-A71Y-01 TCGA-M7-A71Y-01A-22D-A32B-08 a3f81069-d0a9-49af-bd22-24c6142241b6 +TCGA-M7-A71Z-01 TCGA-M7-A71Z-01 TCGA-M7-A71Z TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-M7-A71Z-F68775 TCGA-M7-A71Z TCGA-M7-A71Z-01A NO T2a -22785 136 0 643 209 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-12-15 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 160 NO Right NO YES NO 9 0 false No N0 T3a TCGA-M7-A71Z.5F9BC119-B8E9-4C05-8A34-AA8E79C490B6.pdf A71Z TUMOR FREE 4 Complete Remission/Response NO R0 Primary Tumor 01 3 NO YES NO M7 Apex|Base Prostate A LIVING 2013 Overlapping / Multiple Zones f64c8677-da87-4543-b53c-4de28d86fff1 TCGA-M7-A71Z-01A-12D-A32A-01 TCGA-M7-A71Z-01A-12D-A32C-05 TCGA-M7-A71Z-01A-12D-A32B-08 f64c8677-da87-4543-b53c-4de28d86fff1 TCGA-M7-A71Z-01 TCGA-M7-A71Z-01 C3F52FA3-A05B-48C0-B7A0-82B463A0CCEB TCGA-M7-A71Z-01A-12D-A32A-01 f64c8677-da87-4543-b53c-4de28d86fff1 TCGA-M7-A71Z-01 TCGA-M7-A71Z-01 f64c8677-da87-4543-b53c-4de28d86fff1 +TCGA-M7-A720-01 TCGA-M7-A720-01 TCGA-M7-A720 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 53 TCGA-M7-A720-F70038 TCGA-M7-A720 TCGA-M7-A720-01A NO T1c -19642 190 0 384 302 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-26 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 130 NO Bilateral YES NO NO false No T2c TCGA-M7-A720.65D5D425-D41A-4E98-AA86-119F3BE1D3CE.pdf A720 TUMOR FREE 3 Complete Remission/Response NO R0 Primary Tumor 01 3 NO YES NO M7 Middle|Base Prostate A LIVING 2013 Peripheral Zone 0c18423b-7a7e-440d-96a7-ec3815aa411c TCGA-M7-A720-01A-12D-A32A-01 TCGA-M7-A720-01A-12D-A32C-05 TCGA-M7-A720-01A-12D-A32B-08 0c18423b-7a7e-440d-96a7-ec3815aa411c TCGA-M7-A720-01 TCGA-M7-A720-01 EBE5ED85-FD4C-431A-9BE7-B88BF2582708 TCGA-M7-A720-01A-12D-A32A-01 0c18423b-7a7e-440d-96a7-ec3815aa411c TCGA-M7-A720-01 TCGA-M7-A720-01 TCGA-M7-A720-01A-12D-A32B-08 0c18423b-7a7e-440d-96a7-ec3815aa411c +TCGA-M7-A721-01 TCGA-M7-A721-01 TCGA-M7-A721 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 70 TCGA-M7-A721-F61812 TCGA-M7-A721 TCGA-M7-A721-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -25585 -8 276 -8 0 400 162 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission 2014-7-7 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 120 NO Bilateral YES NO NO false No T2c TCGA-M7-A721.357FE07A-B561-44BF-B59B-811F77C1F634.pdf A721 TUMOR FREE 3 Complete Remission/Response NO R1 Primary Tumor 01 4 NO YES NO M7 Apex|Middle|Base Prostate A LIVING 2012 Overlapping / Multiple Zones b490a174-95fa-4681-be76-e1690fb17131 TCGA-M7-A721-01A-12D-A32A-01 TCGA-M7-A721-01A-12D-A32C-05 TCGA-M7-A721-01A-12D-A32B-08 b490a174-95fa-4681-be76-e1690fb17131 TCGA-M7-A721-01 TCGA-M7-A721-01 7416D676-6F14-4971-A20B-EB2C5E1FFF69 TCGA-M7-A721-01A-12D-A32A-01 b490a174-95fa-4681-be76-e1690fb17131 TCGA-M7-A721-01 TCGA-M7-A721-01 TCGA-M7-A721-01A-12D-A32B-08 b490a174-95fa-4681-be76-e1690fb17131 +TCGA-M7-A722-01 TCGA-M7-A722-01 TCGA-M7-A722 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-M7-A722-F71084 TCGA-M7-A722 TCGA-M7-A722-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T2a -23880 3 577 3 559 0 1060 559 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-17 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 190 NO Bilateral NO YES YES 4 0 false No N0 T3a TCGA-M7-A722.4D0EE4BC-69EC-45D2-8739-24E1FE1A526A.pdf A722 TUMOR FREE 4 Partial Remission/Response NO R1 Primary Tumor 01 4 NO 3 YES NO M7 Prostate A LIVING 2011 Overlapping / Multiple Zones ed257c43-c4be-42c9-8968-82bb9c0b8ce2 TCGA-M7-A722-01A-12D-A363-01 TCGA-M7-A722-01A-12D-A365-05 TCGA-M7-A722-01A-12D-A364-08 ed257c43-c4be-42c9-8968-82bb9c0b8ce2 TCGA-M7-A722-01 TCGA-M7-A722-01 51538E59-F215-414E-B126-F5AC77501A97 TCGA-M7-A722-01A-12D-A363-01 ed257c43-c4be-42c9-8968-82bb9c0b8ce2 TCGA-M7-A722-01 TCGA-M7-A722-01 ed257c43-c4be-42c9-8968-82bb9c0b8ce2 +TCGA-M7-A723-01 TCGA-M7-A723-01 TCGA-M7-A723 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 54 TCGA-M7-A723-F61813 TCGA-M7-A723 TCGA-M7-A723-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -20064 8 442 11 0 763 62 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-7-7 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 150 NO Bilateral NO YES NO 17 1 false No N1 T3b TCGA-M7-A723.8F42420C-A513-4A6A-A89F-B5C9303FBF59.pdf A723 TUMOR FREE 4 Complete Remission/Response 0.1 YES R1 Primary Tumor 01 3 YES 5 YES NO M7 Apex|Middle|Base Prostate A LIVING 2012 Overlapping / Multiple Zones d139f13a-72aa-4bd8-bee2-c60c6bb016f2 TCGA-M7-A723-01A-12D-A32A-01 TCGA-M7-A723-01A-12D-A32C-05 TCGA-M7-A723-01A-12D-A32B-08 d139f13a-72aa-4bd8-bee2-c60c6bb016f2 TCGA-M7-A723-01 TCGA-M7-A723-01 6368E005-1260-485C-B019-1F2C82B5715E TCGA-M7-A723-01A-12D-A32A-01 d139f13a-72aa-4bd8-bee2-c60c6bb016f2 TCGA-M7-A723-01 TCGA-M7-A723-01 d139f13a-72aa-4bd8-bee2-c60c6bb016f2 +TCGA-M7-A724-01 TCGA-M7-A724-01 TCGA-M7-A724 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-M7-A724-F70042 TCGA-M7-A724 TCGA-M7-A724-01A NO Abnormal (not related to prostate cancer) M0 T1c -23595 11 351 35 0 889 483 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-26 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 160 NO Right NO YES YES 7 0 false No N0 T3a TCGA-M7-A724.AF3AE21A-2D5F-4769-B438-C42415A47330.pdf A724 WITH TUMOR 4 Progressive Disease NO R1 Primary Tumor 01 4 NO YES NO M7 Apex|Base Prostate A LIVING 2012 Peripheral Zone 8a3c4f20-3714-4dfd-9fb2-e7bae0c73432 TCGA-M7-A724-01A-12D-A32A-01 TCGA-M7-A724-01A-12D-A32C-05 TCGA-M7-A724-01A-12D-A32B-08 8a3c4f20-3714-4dfd-9fb2-e7bae0c73432 TCGA-M7-A724-01 TCGA-M7-A724-01 10D64418-9272-47C7-B03F-A58D2AB83E6A TCGA-M7-A724-01A-12D-A32A-01 8a3c4f20-3714-4dfd-9fb2-e7bae0c73432 TCGA-M7-A724-01 TCGA-M7-A724-01 8a3c4f20-3714-4dfd-9fb2-e7bae0c73432 +TCGA-M7-A725-01 TCGA-M7-A725-01 TCGA-M7-A725 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 56 TCGA-M7-A725-F61814 TCGA-M7-A725 TCGA-M7-A725-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T3a -20474 16 240 16 0 573 96 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission 2014-7-10 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 110 NO Bilateral NO YES NO 11 0 false No N0 T3b TCGA-M7-A725.5885079D-F3C7-44DB-9BA1-60DCA1C9919C.pdf A725 TUMOR FREE 4 Complete Remission/Response NO R1 Primary Tumor 01 3 NO 5 YES NO M7 Apex|Base Prostate A LIVING 2012 Overlapping / Multiple Zones 2faac3f0-67e2-433a-ad56-c43e794c7fee TCGA-M7-A725-01A-12D-A32A-01 TCGA-M7-A725-01A-12D-A32C-05 TCGA-M7-A725-01A-12D-A32B-08 2faac3f0-67e2-433a-ad56-c43e794c7fee TCGA-M7-A725-01 TCGA-M7-A725-01 6911F17B-F9E6-45FC-8BB3-9ED3C8BEA353 TCGA-M7-A725-01A-12D-A32A-01 2faac3f0-67e2-433a-ad56-c43e794c7fee TCGA-M7-A725-01 TCGA-M7-A725-01 TCGA-M7-A725-01A-12D-A32B-08 2faac3f0-67e2-433a-ad56-c43e794c7fee +TCGA-MG-AAMC-01 TCGA-MG-AAMC-01 TCGA-MG-AAMC TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-MG-AAMC-F68686 TCGA-MG-AAMC TCGA-MG-AAMC-01A NO M0 T1c -21846 278 0 173 54 Scheduled Follow-up Submission 2015-1-9 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 40 NO YES NO true No N0 T3a TCGA-MG-AAMC.CBC765C1-9191-4A40-979F-CF2434B10CAB.pdf AAMC TUMOR FREE 4 Complete Remission/Response .01 NO R0 Primary Tumor 01 5 NO 3 NO YES MG Prostate A LIVING 2013 1747f562-8e96-47e6-96ab-26f34d54b4bd TCGA-MG-AAMC-01A-11D-A41J-01 TCGA-MG-AAMC-01A-11D-A41L-05 TCGA-MG-AAMC-01A-11D-A41K-08 1747f562-8e96-47e6-96ab-26f34d54b4bd TCGA-MG-AAMC-01 TCGA-MG-AAMC-01 TCGA-MG-AAMC-01A-11D-A41J-01 1747f562-8e96-47e6-96ab-26f34d54b4bd TCGA-MG-AAMC-01 TCGA-MG-AAMC-01 1747f562-8e96-47e6-96ab-26f34d54b4bd +TCGA-QU-A6IL-01 TCGA-QU-A6IL-01 TCGA-QU-A6IL TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-QU-A6IL-F66982 TCGA-QU-A6IL TCGA-QU-A6IL-01A NO M0 T2a -23710 4048 0 97 91 Complete Remission/Response 2014-10-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy NO Bilateral YES YES NO 4 0 true No N0 T2c TCGA-QU-A6IL.EF13AC98-FA7C-442C-A6A4-A5E7ECB2596D.pdf A6IL TUMOR FREE 3 Complete Remission/Response 0.2 NO R0 Primary Tumor 01 4 NO NO YES QU Apex|Middle|Base Prostate A LIVING 2002 788e9097-8705-44e4-a7c7-7fbb75f7f9e2 TCGA-QU-A6IL-01A-11D-A31K-01 TCGA-QU-A6IL-01A-11D-A31M-05 TCGA-QU-A6IL-01A-11D-A31L-08 788e9097-8705-44e4-a7c7-7fbb75f7f9e2 TCGA-QU-A6IL-01 TCGA-QU-A6IL-01 TCGA-QU-A6IL-01A-11D-A31K-01 788e9097-8705-44e4-a7c7-7fbb75f7f9e2 TCGA-QU-A6IL-01 TCGA-QU-A6IL-01 TCGA-QU-A6IL-01A-11D-A31L-08 788e9097-8705-44e4-a7c7-7fbb75f7f9e2 +TCGA-QU-A6IM-01 TCGA-QU-A6IM-01 TCGA-QU-A6IM TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-QU-A6IM-F66983 TCGA-QU-A6IM TCGA-QU-A6IM-01A NO Equivocal M0 T2b -21792 35 3796 50 35 0 1247 896 YES Equivocal YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2014-10-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 40 NO Left YES YES NO 2 0 true Yes, History of Prior Malignancy N0 T2a TCGA-QU-A6IM.6999B5F3-AC5C-4447-9590-548F103039C3.pdf A6IM TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO NO YES QU Apex|Middle Prostate A LIVING 2003 9fe289f4-0f5f-4d72-935c-4fb3f44fa91a TCGA-QU-A6IM-01A-11D-A31K-01 TCGA-QU-A6IM-01A-11D-A31M-05 TCGA-QU-A6IM-01A-11D-A31L-08 9fe289f4-0f5f-4d72-935c-4fb3f44fa91a TCGA-QU-A6IM-01 TCGA-QU-A6IM-01 TCGA-QU-A6IM-01A-11D-A31K-01 9fe289f4-0f5f-4d72-935c-4fb3f44fa91a TCGA-QU-A6IM-01 TCGA-QU-A6IM-01 TCGA-QU-A6IM-01A-11D-A31L-08 9fe289f4-0f5f-4d72-935c-4fb3f44fa91a +TCGA-QU-A6IN-01 TCGA-QU-A6IN-01 TCGA-QU-A6IN TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-QU-A6IN-F66984 TCGA-QU-A6IN TCGA-QU-A6IN-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -22286 21 3789 43 0 4264 3428 NO YES Scheduled Follow-up Submission Complete Remission/Response 2014-10-31 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 110 NO Bilateral NO YES NO 15 0 true No N0 T2c TCGA-QU-A6IN.11063611-DCFF-427E-89A9-25961C79DF07.pdf A6IN TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 4 NO 5 NO YES QU Apex|Middle|Base Prostate A LIVING 2003 3447e7c9-5d79-4cc0-9e00-6c8552565597 TCGA-QU-A6IN-01A-11D-A31K-01 TCGA-QU-A6IN-01A-11D-A31M-05 TCGA-QU-A6IN-01A-11D-A31L-08 3447e7c9-5d79-4cc0-9e00-6c8552565597 TCGA-QU-A6IN-01 TCGA-QU-A6IN-01 9964CB21-71EF-4A39-AEC3-EE674BA4372A TCGA-QU-A6IN-01A-11D-A31K-01 3447e7c9-5d79-4cc0-9e00-6c8552565597 TCGA-QU-A6IN-01 TCGA-QU-A6IN-01 TCGA-QU-A6IN-01A-11D-A31L-08 3447e7c9-5d79-4cc0-9e00-6c8552565597 +TCGA-QU-A6IO-01 TCGA-QU-A6IO-01 TCGA-QU-A6IO TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 53 TCGA-QU-A6IO-F66985 TCGA-QU-A6IO NO M0 T1c -19564 0 3716 1436 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-31 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 2 0 No N0 T2c A6IO TUMOR FREE 3 Complete Remission/Response 0.1 NO R1 Primary Tumor 01 3 NO NO YES QU Apex|Middle|Base Prostate LIVING 2003 f974f0e8-cbca-4d1f-a435-937f945ea3dc TCGA-QU-A6IO-01A-11D-A31K-01 TCGA-QU-A6IO-01A-11D-A31M-05 TCGA-QU-A6IO-01A-11D-A31L-08 f974f0e8-cbca-4d1f-a435-937f945ea3dc TCGA-QU-A6IO-01 TCGA-QU-A6IO-01 TCGA-QU-A6IO-01A-11D-A31K-01 f974f0e8-cbca-4d1f-a435-937f945ea3dc TCGA-QU-A6IO-01 TCGA-QU-A6IO-01 TCGA-QU-A6IO-01A-11D-A31L-08 f974f0e8-cbca-4d1f-a435-937f945ea3dc +TCGA-QU-A6IP-01 TCGA-QU-A6IP-01 TCGA-QU-A6IP TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-QU-A6IP-F66986 TCGA-QU-A6IP TCGA-QU-A6IP-01A NO M0 T2a -24212 3118 0 2620 2620 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-31 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 140 NO Right YES YES NO 2 0 true No N0 T2a TCGA-QU-A6IP.D1E73097-6F07-4B1E-8914-074FA037CB85.pdf A6IP TUMOR FREE 3 Complete Remission/Response 0 NO R0 Primary Tumor 01 3 NO NO YES QU Middle|Base Prostate A LIVING 2004 8adec7c9-1c95-419b-9876-a3f9d068d392 TCGA-QU-A6IP-01A-11D-A31K-01 TCGA-QU-A6IP-01A-11D-A31M-05 TCGA-QU-A6IP-01A-11D-A31L-08 8adec7c9-1c95-419b-9876-a3f9d068d392 TCGA-QU-A6IP-01 TCGA-QU-A6IP-01 EB984C4C-CF89-438A-81FC-096B5871D2AC TCGA-QU-A6IP-01A-11D-A31K-01 8adec7c9-1c95-419b-9876-a3f9d068d392 TCGA-QU-A6IP-01 TCGA-QU-A6IP-01 TCGA-QU-A6IP-01A-11D-A31L-08 TCGA-QU-A6IP-01A-11D-A31L-08 8adec7c9-1c95-419b-9876-a3f9d068d392 +TCGA-SU-A7E7-01 TCGA-SU-A7E7-01 TCGA-SU-A7E7 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 60 TCGA-SU-A7E7-F64938 TCGA-SU-A7E7 TCGA-SU-A7E7-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -22185 6 165 -10 0 551 426 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-16 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 300 NO Right NO YES NO 9 0 true No N0 T2b TCGA-SU-A7E7.120AA6E7-735D-442E-99AA-4EFE93C365F6.pdf A7E7 TUMOR FREE 5 Complete Remission/Response 0.01 NO R0 Primary Tumor 01 3 NO YES NO SU Base Prostate A LIVING 2013 Peripheral Zone 041bbea8-d1fe-4f96-be85-67a95e651044 TCGA-SU-A7E7-01A-22D-A33S-01 TCGA-SU-A7E7-01A-22D-A33U-05 TCGA-SU-A7E7-01A-22D-A33T-08 041bbea8-d1fe-4f96-be85-67a95e651044 TCGA-SU-A7E7-01 TCGA-SU-A7E7-01 BDF1C6D7-456C-4997-916C-9B23F232A664 TCGA-SU-A7E7-01A-22D-A33S-01 041bbea8-d1fe-4f96-be85-67a95e651044 TCGA-SU-A7E7-01 TCGA-SU-A7E7-01 TCGA-SU-A7E7-01A-22D-A33T-08 041bbea8-d1fe-4f96-be85-67a95e651044 +TCGA-TK-A8OK-01 TCGA-TK-A8OK-01 TCGA-TK-A8OK TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 73 TCGA-TK-A8OK-F58472 TCGA-TK-A8OK TCGA-TK-A8OK-01A M0 -26976 202 0 27 Scheduled Follow-up Submission 2014-11-11 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 620 NO Right YES NO false No TCGA-TK-A8OK.887947BA-A888-40C4-8582-EE89E678EC04.pdf A8OK TUMOR FREE 3 NO Primary Tumor 01 4 NO YES NO TK Prostate A LIVING 2013 Overlapping / Multiple Zones 244e1006-d5b9-46cb-8478-8a4591fdb6be TCGA-TK-A8OK-01A-22D-A363-01 TCGA-TK-A8OK-01A-22D-A365-05 TCGA-TK-A8OK-01A-22D-A364-08 244e1006-d5b9-46cb-8478-8a4591fdb6be TCGA-TK-A8OK-01 TCGA-TK-A8OK-01 48E215F9-D144-4253-9EF0-103F29FFC37A TCGA-TK-A8OK-01A-22D-A363-01 244e1006-d5b9-46cb-8478-8a4591fdb6be TCGA-TK-A8OK-01 TCGA-TK-A8OK-01 TCGA-TK-A8OK-01A-22D-A364-08 244e1006-d5b9-46cb-8478-8a4591fdb6be +TCGA-TP-A8TT-01 TCGA-TP-A8TT-01 TCGA-TP-A8TT TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES 64 TCGA-TP-A8TT-F60866 TCGA-TP-A8TT TCGA-TP-A8TT-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -23476 23 265 15 0 526 237 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-15 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 440 NO Left NO YES NO 11 0 true No N0 T3a TCGA-TP-A8TT.35E5E09D-8872-4BCC-99DC-876A3CCF9761.pdf A8TT 4 Partial Remission/Response 0.024 YES R0 Primary Tumor 01 3 NO YES NO TP Apex|Middle|Base Prostate A LIVING 2013 Peripheral Zone f5204ae5-1d85-41ec-b9c2-c48c310c5710 TCGA-TP-A8TT-01A-12D-A41J-01 TCGA-TP-A8TT-01A-12D-A41L-05 TCGA-TP-A8TT-01A-12D-A41K-08 f5204ae5-1d85-41ec-b9c2-c48c310c5710 TCGA-TP-A8TT-01 TCGA-TP-A8TT-01 91676E09-874E-4641-A572-E0C8CCDEA92B TCGA-TP-A8TT-01A-12D-A41J-01 f5204ae5-1d85-41ec-b9c2-c48c310c5710 TCGA-TP-A8TT-01 TCGA-TP-A8TT-01 f5204ae5-1d85-41ec-b9c2-c48c310c5710 +TCGA-TP-A8TV-01 TCGA-TP-A8TV-01 TCGA-TP-A8TV TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-TP-A8TV-F70511 TCGA-TP-A8TV TCGA-TP-A8TV-01A NO M0 T1c -22872 194 0 610 249 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-19 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 300 NO Bilateral NO YES NO 4 0 true No N0 T2c TCGA-TP-A8TV.5B38DF20-A6AF-4CD7-9322-36D4823C7A3E.pdf A8TV TUMOR FREE 4 Complete Remission/Response 0.019 YES R1 Primary Tumor 01 3 NO 5 YES NO TP Apex|Middle|Base Prostate A LIVING 2013 Overlapping / Multiple Zones ae3426f1-be88-4bf6-8ff4-3c7b7d6a804f TCGA-TP-A8TV-01A-11D-A41J-01 TCGA-TP-A8TV-01A-11D-A41L-05 TCGA-TP-A8TV-01A-11D-A41K-08 ae3426f1-be88-4bf6-8ff4-3c7b7d6a804f TCGA-TP-A8TV-01 TCGA-TP-A8TV-01 5180CC69-E884-45CD-BAFB-4E64897AD807 TCGA-TP-A8TV-01A-11D-A41J-01 ae3426f1-be88-4bf6-8ff4-3c7b7d6a804f TCGA-TP-A8TV-01 TCGA-TP-A8TV-01 ae3426f1-be88-4bf6-8ff4-3c7b7d6a804f +TCGA-V1-A8MF-01 TCGA-V1-A8MF-01 TCGA-V1-A8MF TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-V1-A8MF-F69431 TCGA-V1-A8MF TCGA-V1-A8MF-01A NO M0 T2c -24090 1449 1218 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-9 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 130 NO Bilateral NO YES NO 8 0 true No N0 T3a TCGA-V1-A8MF.C2A32E46-BB93-43E6-BF3A-995745161434.pdf A8MF 3 Complete Remission/Response 0.14 NO R1 Primary Tumor 01 3 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone c84acacb-d7ab-481e-8462-94693fdf5980 TCGA-V1-A8MF-01A-11D-A363-01 TCGA-V1-A8MF-01A-11D-A365-05 TCGA-V1-A8MF-01A-11D-A364-08 c84acacb-d7ab-481e-8462-94693fdf5980 TCGA-V1-A8MF-01 TCGA-V1-A8MF-01 78954B24-3805-4FCB-8F89-11BA10F942BA TCGA-V1-A8MF-01A-11D-A363-01 c84acacb-d7ab-481e-8462-94693fdf5980 TCGA-V1-A8MF-01 TCGA-V1-A8MF-01 TCGA-V1-A8MF-01A-11D-A364-08 c84acacb-d7ab-481e-8462-94693fdf5980 +TCGA-V1-A8MG-01 TCGA-V1-A8MG-01 TCGA-V1-A8MG TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 53 TCGA-V1-A8MG-F69432 TCGA-V1-A8MG NO M0 T2c -19710 857 583 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-9 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO NO NO No T3b A8MG 3 Complete Remission/Response 0.03 NO R1 Primary Tumor 01 4 NO NO YES V1 Apex Prostate LIVING Peripheral Zone b1c64c55-b558-44b3-b617-a84d6b493d82 TCGA-V1-A8MG-01A-11D-A363-01 TCGA-V1-A8MG-01A-11D-A365-05 TCGA-V1-A8MG-01A-11D-A364-08 b1c64c55-b558-44b3-b617-a84d6b493d82 TCGA-V1-A8MG-01 TCGA-V1-A8MG-01 TCGA-V1-A8MG-01A-11D-A363-01 b1c64c55-b558-44b3-b617-a84d6b493d82 TCGA-V1-A8MG-01 TCGA-V1-A8MG-01 TCGA-V1-A8MG-01A-11D-A364-08 b1c64c55-b558-44b3-b617-a84d6b493d82 +TCGA-V1-A8MJ-01 TCGA-V1-A8MJ-01 TCGA-V1-A8MJ TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES YES 58 TCGA-V1-A8MJ-F69461 TCGA-V1-A8MJ TCGA-V1-A8MJ-01A NO M0 T2a -21535 428 1791 1230 NO NO Scheduled Follow-up Submission Partial Remission/Response 2015-1-9 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 70 NO Bilateral NO YES Biochemical evidence of disease YES 16 1 true No N1 T3a TCGA-V1-A8MJ.5BF9CF4D-B724-4FFD-A336-ECE60FC80E0D.pdf A8MJ 3 Progressive Disease 0.015 NO R0 Primary Tumor 01 4 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone 98662e95-24f7-41c7-a3f4-50ce203fa9a4 TCGA-V1-A8MJ-01A-11D-A363-01 TCGA-V1-A8MJ-01A-11D-A365-05 TCGA-V1-A8MJ-01A-11D-A364-08 98662e95-24f7-41c7-a3f4-50ce203fa9a4 TCGA-V1-A8MJ-01 TCGA-V1-A8MJ-01 F9FA02A5-1B22-4CD3-A3E3-C41BA3BCC61C TCGA-V1-A8MJ-01A-11D-A363-01 98662e95-24f7-41c7-a3f4-50ce203fa9a4 TCGA-V1-A8MJ-01 TCGA-V1-A8MJ-01 TCGA-V1-A8MJ-01A-11D-A364-08 98662e95-24f7-41c7-a3f4-50ce203fa9a4 +TCGA-V1-A8MK-01 TCGA-V1-A8MK-01 TCGA-V1-A8MK TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 41 TCGA-V1-A8MK-F69460 TCGA-V1-A8MK YES M0 T2a -15330 508 -1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-9 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO NO NO No N0 T2c A8MK 3 Complete Remission/Response 0.83 NO R0 Primary Tumor 01 3 NO NO YES V1 Apex Prostate LIVING Peripheral Zone c7a98315-43bb-4917-90c9-93f9caf47fdc TCGA-V1-A8MK-01A-11D-A363-01 TCGA-V1-A8MK-01A-11D-A365-05 TCGA-V1-A8MK-01A-11D-A364-08 c7a98315-43bb-4917-90c9-93f9caf47fdc TCGA-V1-A8MK-01 TCGA-V1-A8MK-01 TCGA-V1-A8MK-01A-11D-A363-01 c7a98315-43bb-4917-90c9-93f9caf47fdc TCGA-V1-A8MK-01 TCGA-V1-A8MK-01 c7a98315-43bb-4917-90c9-93f9caf47fdc +TCGA-V1-A8ML-01 TCGA-V1-A8ML-01 TCGA-V1-A8ML TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-V1-A8ML-F69415 TCGA-V1-A8ML TCGA-V1-A8ML-01A NO M0 T2b -23360 448 448 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-9 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 10 NO Bilateral NO YES NO 12 0 true No N0 T2c TCGA-V1-A8ML.4C4405A3-FC07-4155-8C5A-2693E34F347B.pdf A8ML 3 Complete Remission/Response 0.01 NO R0 Primary Tumor 01 4 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone 4866c074-094a-4432-8d23-825fd698eeda TCGA-V1-A8ML-01A-11D-A376-01 TCGA-V1-A8ML-01A-11D-A378-05 TCGA-V1-A8ML-01A-11D-A377-08 4866c074-094a-4432-8d23-825fd698eeda TCGA-V1-A8ML-01 TCGA-V1-A8ML-01 TCGA-V1-A8ML-01A-11D-A376-01 4866c074-094a-4432-8d23-825fd698eeda TCGA-V1-A8ML-01 TCGA-V1-A8ML-01 TCGA-V1-A8ML-01A-11D-A377-08 4866c074-094a-4432-8d23-825fd698eeda +TCGA-V1-A8MM-01 TCGA-V1-A8MM-01 TCGA-V1-A8MM TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO YES 60 TCGA-V1-A8MM-F69416 TCGA-V1-A8MM TCGA-V1-A8MM-01A YES M0 T2b -22265 990 1195 990 NO NO Scheduled Follow-up Submission Partial Remission/Response 2015-1-9 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 90 NO Bilateral NO YES Biochemical evidence of disease YES 10 0 true No N0 T3a TCGA-V1-A8MM.2FBA596B-858D-4043-BDCF-CCE582A74D67.pdf A8MM 4 Progressive Disease 0.37 NO R0 Primary Tumor 01 3 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone 0386cc4d-0318-4293-a22e-869c3b34fa63 TCGA-V1-A8MM-01A-11D-A376-01 TCGA-V1-A8MM-01A-11D-A378-05 TCGA-V1-A8MM-01A-11D-A377-08 0386cc4d-0318-4293-a22e-869c3b34fa63 TCGA-V1-A8MM-01 TCGA-V1-A8MM-01 TCGA-V1-A8MM-01A-11D-A376-01 0386cc4d-0318-4293-a22e-869c3b34fa63 TCGA-V1-A8MM-01 TCGA-V1-A8MM-01 0386cc4d-0318-4293-a22e-869c3b34fa63 +TCGA-V1-A8MU-01 TCGA-V1-A8MU-01 TCGA-V1-A8MU TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES YES 56 TCGA-V1-A8MU-F69444 TCGA-V1-A8MU TCGA-V1-A8MU-01A NO M0 T2b -20805 87 192 1876 1384 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Partial Remission/Response 2015-1-9 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 160 NO Bilateral NO YES Biochemical evidence of disease YES 15 1 true No N1 T3a TCGA-V1-A8MU.8E072738-2D8E-4254-B1DE-A8008C614B7F.pdf A8MU 3 Progressive Disease 0.015 NO R1 Primary Tumor 01 4 YES NO YES V1 Apex Prostate A LIVING Peripheral Zone 823142ae-3165-44fd-bdd8-b54acef6897f TCGA-V1-A8MU-01A-11D-A376-01 TCGA-V1-A8MU-01A-11D-A378-05 TCGA-V1-A8MU-01A-11D-A377-08 823142ae-3165-44fd-bdd8-b54acef6897f TCGA-V1-A8MU-01 TCGA-V1-A8MU-01 F8BA1C00-8A41-4A7D-86EF-1A96CE49DD97 TCGA-V1-A8MU-01A-11D-A376-01 823142ae-3165-44fd-bdd8-b54acef6897f TCGA-V1-A8MU-01 TCGA-V1-A8MU-01 TCGA-V1-A8MU-01A-11D-A377-08 823142ae-3165-44fd-bdd8-b54acef6897f +TCGA-V1-A8WL-01 TCGA-V1-A8WL-01 TCGA-V1-A8WL TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-V1-A8WL-F69417 TCGA-V1-A8WL TCGA-V1-A8WL-01A NO M0 T1c -23725 1948 1175 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-9 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 90 NO Bilateral NO YES NO 4 0 true No N0 T3a TCGA-V1-A8WL.6E301400-1200-40F7-8249-AD310C44A212.pdf A8WL 3 Complete Remission/Response 0.015 NO R0 Primary Tumor 01 4 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone bd8e46c1-5b67-407e-a6fb-67017488a923 TCGA-V1-A8WL-01A-11D-A376-01 TCGA-V1-A8WL-01A-11D-A378-05 TCGA-V1-A8WL-01A-11D-A377-08 bd8e46c1-5b67-407e-a6fb-67017488a923 TCGA-V1-A8WL-01 TCGA-V1-A8WL-01 5ABADB84-AB1D-46E4-9878-16013D54EF24 TCGA-V1-A8WL-01A-11D-A376-01 bd8e46c1-5b67-407e-a6fb-67017488a923 TCGA-V1-A8WL-01 TCGA-V1-A8WL-01 TCGA-V1-A8WL-01A-11D-A377-08 bd8e46c1-5b67-407e-a6fb-67017488a923 +TCGA-V1-A8WN-01 TCGA-V1-A8WN-01 TCGA-V1-A8WN TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 47 TCGA-V1-A8WN-F69450 TCGA-V1-A8WN TCGA-V1-A8WN-01A NO M0 T2a -17520 924 463 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-9 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 30 NO Bilateral NO NO NO true No T2c TCGA-V1-A8WN.F25C1C00-CDFE-4ABD-A920-857AFEA691A5.pdf A8WN 3 Complete Remission/Response 0.02 NO R0 Primary Tumor 01 3 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone 15b039c0-f334-4221-b438-c859bb46cc26 TCGA-V1-A8WN-01A-11D-A376-01 TCGA-V1-A8WN-01A-11D-A378-05 TCGA-V1-A8WN-01A-11D-A377-08 15b039c0-f334-4221-b438-c859bb46cc26 TCGA-V1-A8WN-01 TCGA-V1-A8WN-01 TCGA-V1-A8WN-01A-11D-A376-01 15b039c0-f334-4221-b438-c859bb46cc26 TCGA-V1-A8WN-01 TCGA-V1-A8WN-01 TCGA-V1-A8WN-01A-11D-A377-08 15b039c0-f334-4221-b438-c859bb46cc26 +TCGA-V1-A8WS-01 TCGA-V1-A8WS-01 TCGA-V1-A8WS TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO YES 56 TCGA-V1-A8WS-F69434 TCGA-V1-A8WS TCGA-V1-A8WS-01A NO M0 T1c -20805 474 474 NO NO Scheduled Follow-up Submission Partial Remission/Response 2015-1-9 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 30 NO Bilateral NO NO Biochemical evidence of disease YES true No T3b TCGA-V1-A8WS.0BD9565E-DBBB-428D-BF6D-2B31F0E5DDC5.pdf A8WS 3 Progressive Disease 0.09 NO R0 Primary Tumor 01 3 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone 0514988e-85d3-4ce1-a860-39bd5ac19660 TCGA-V1-A8WS-01A-11D-A376-01 TCGA-V1-A8WS-01A-11D-A378-05 TCGA-V1-A8WS-01A-11D-A377-08 0514988e-85d3-4ce1-a860-39bd5ac19660 TCGA-V1-A8WS-01 TCGA-V1-A8WS-01 TCGA-V1-A8WS-01A-11D-A376-01 0514988e-85d3-4ce1-a860-39bd5ac19660 TCGA-V1-A8WS-01 TCGA-V1-A8WS-01 TCGA-V1-A8WS-01A-11D-A377-08 0514988e-85d3-4ce1-a860-39bd5ac19660 +TCGA-V1-A8WV-01 TCGA-V1-A8WV-01 TCGA-V1-A8WV TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 52 TCGA-V1-A8WV-F69419 TCGA-V1-A8WV NO M0 T2a -19345 95 686 686 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-9 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 10 1 No N1 T3b A8WV 4 Complete Remission/Response 0.01 NO R0 Primary Tumor 01 5 YES NO YES V1 Middle Prostate LIVING Peripheral Zone bfb7a272-3b86-4d5d-a3df-6aea8fd3b66b TCGA-V1-A8WV-01A-11D-A376-01 TCGA-V1-A8WV-01A-11D-A378-05 TCGA-V1-A8WV-01A-11D-A377-08 bfb7a272-3b86-4d5d-a3df-6aea8fd3b66b TCGA-V1-A8WV-01 TCGA-V1-A8WV-01 TCGA-V1-A8WV-01A-11D-A376-01 bfb7a272-3b86-4d5d-a3df-6aea8fd3b66b TCGA-V1-A8WV-01 TCGA-V1-A8WV-01 TCGA-V1-A8WV-01A-11D-A377-08 bfb7a272-3b86-4d5d-a3df-6aea8fd3b66b +TCGA-V1-A8WW-01 TCGA-V1-A8WW-01 TCGA-V1-A8WW TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO YES 59 TCGA-V1-A8WW-F69466 TCGA-V1-A8WW TCGA-V1-A8WW-01A NO M0 T2b -21900 709 58 1078 695 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Partial Remission/Response 2015-1-9 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 50 NO Bilateral NO YES Biochemical evidence of disease YES 20 1 true No N1 T3b TCGA-V1-A8WW.36FBC30B-6566-4C5F-BE51-D267B4F856B3.pdf A8WW 4 Progressive Disease 0.015 NO R0 Primary Tumor 01 5 YES NO YES V1 Apex Prostate A LIVING Peripheral Zone 213f0f94-d682-462b-bbb3-bd8ce9f0ffff TCGA-V1-A8WW-01A-11D-A376-01 TCGA-V1-A8WW-01A-11D-A378-05 TCGA-V1-A8WW-01A-11D-A377-08 213f0f94-d682-462b-bbb3-bd8ce9f0ffff TCGA-V1-A8WW-01 TCGA-V1-A8WW-01 TCGA-V1-A8WW-01A-11D-A376-01 213f0f94-d682-462b-bbb3-bd8ce9f0ffff TCGA-V1-A8WW-01 TCGA-V1-A8WW-01 TCGA-V1-A8WW-01A-11D-A377-08 213f0f94-d682-462b-bbb3-bd8ce9f0ffff +TCGA-V1-A8X3-01 TCGA-V1-A8X3-01 TCGA-V1-A8X3 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 51 TCGA-V1-A8X3-F69469 TCGA-V1-A8X3 TCGA-V1-A8X3-01A NO M0 T1c -18980 202 202 NO NO Scheduled Follow-up Submission 2015-1-9 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 170 NO Bilateral NO YES NO 18 0 true No N0 T2c TCGA-V1-A8X3.267C0EAB-ECC4-44BC-89C9-8C54F3B22A6E.pdf A8X3 3 Complete Remission/Response 0.03 NO R1 Primary Tumor 01 4 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone 560a04b3-0738-4a27-ad0f-c6a5a091c869 TCGA-V1-A8X3-01A-11D-A376-01 TCGA-V1-A8X3-01A-11D-A378-05 TCGA-V1-A8X3-01A-11D-A377-08 560a04b3-0738-4a27-ad0f-c6a5a091c869 TCGA-V1-A8X3-01 TCGA-V1-A8X3-01 3540A732-C76A-4951-AA6D-EFC400F6A272 TCGA-V1-A8X3-01A-11D-A376-01 560a04b3-0738-4a27-ad0f-c6a5a091c869 TCGA-V1-A8X3-01 TCGA-V1-A8X3-01 TCGA-V1-A8X3-01A-11D-A377-08 560a04b3-0738-4a27-ad0f-c6a5a091c869 +TCGA-V1-A9O5-01 TCGA-V1-A9O5-01 TCGA-V1-A9O5 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 64 TCGA-V1-A9O5-F69449 TCGA-V1-A9O5 TCGA-V1-A9O5-01A YES M0 T2b -23725 25 124 1932 1776 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-9 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 230 NO Bilateral NO YES Biochemical evidence of disease YES 20 6 true No N1 T4 TCGA-V1-A9O5.4C94E826-144A-4879-99A3-E3B1655D4066.pdf A9O5 5 Complete Remission/Response 3.26 YES R1 Primary Tumor 01 4 YES NO YES V1 Apex Prostate A LIVING Peripheral Zone ac245ce7-dd49-4b6e-8692-6cf440e99b89 TCGA-V1-A9O5-01A-11D-A41J-01 TCGA-V1-A9O5-01A-11D-A41L-05 TCGA-V1-A9O5-01A-11D-A41K-08 ac245ce7-dd49-4b6e-8692-6cf440e99b89 TCGA-V1-A9O5-01 TCGA-V1-A9O5-01 1DB43799-AB1A-4C07-8E9B-D04B154FEAC6 TCGA-V1-A9O5-01A-11D-A41J-01 ac245ce7-dd49-4b6e-8692-6cf440e99b89 TCGA-V1-A9O5-01 TCGA-V1-A9O5-01 ac245ce7-dd49-4b6e-8692-6cf440e99b89 +TCGA-V1-A9O5-06 TCGA-V1-A9O5-06 TCGA-V1-A9O5 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 64 TCGA-V1-A9O5-F69449 TCGA-V1-A9O5 YES M0 T2b -23725 25 124 1932 1776 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-9 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO YES Biochemical evidence of disease YES 20 6 No N1 T4 A9O5 5 Complete Remission/Response 3.26 YES R1 Metastatic 06 4 YES NO YES V1 Apex Prostate LIVING Peripheral Zone b23ad2ad-d6d2-4e5a-96d7-424cd506a180 TCGA-V1-A9O5-06A-11D-A41L-05 TCGA-V1-A9O5-06A-11D-A41K-08 b23ad2ad-d6d2-4e5a-96d7-424cd506a180 TCGA-V1-A9O5-06 b23ad2ad-d6d2-4e5a-96d7-424cd506a180 TCGA-V1-A9O5-06 b23ad2ad-d6d2-4e5a-96d7-424cd506a180 +TCGA-V1-A9O7-01 TCGA-V1-A9O7-01 TCGA-V1-A9O7 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES NO 60 TCGA-V1-A9O7-F69451 TCGA-V1-A9O7 TCGA-V1-A9O7-01A YES M0 T2b -22265 45 819 2499 2425 NO YES Scheduled Follow-up Submission Partial Remission/Response 2015-1-9 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 710 NO Bilateral NO YES Biochemical evidence of disease YES 15 0 true No N0 T3a TCGA-V1-A9O7.0D2327CA-DE0A-4B74-BD53-6370ED222B96.pdf A9O7 5 Progressive Disease 9.69 YES R1 Primary Tumor 01 4 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone 66e392a4-c4fb-43a7-bba1-6a940967158f TCGA-V1-A9O7-01A-21D-A41J-01 TCGA-V1-A9O7-01A-21D-A41L-05 TCGA-V1-A9O7-01A-21D-A41K-08 66e392a4-c4fb-43a7-bba1-6a940967158f TCGA-V1-A9O7-01 TCGA-V1-A9O7-01 TCGA-V1-A9O7-01A-21D-A41J-01 66e392a4-c4fb-43a7-bba1-6a940967158f TCGA-V1-A9O7-01 TCGA-V1-A9O7-01 66e392a4-c4fb-43a7-bba1-6a940967158f +TCGA-V1-A9O9-01 TCGA-V1-A9O9-01 TCGA-V1-A9O9 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 56 TCGA-V1-A9O9-F69445 TCGA-V1-A9O9 YES M0 -20805 2870 -53 NO NO Scheduled Follow-up Submission 2015-1-9 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 12 0 No N0 T3b A9O9 3 Complete Remission/Response 5.04 NO R0 Primary Tumor 01 5 NO NO YES V1 Apex Prostate LIVING Peripheral Zone dda7df91-6e67-46d3-bfdc-d5bde725f44c TCGA-V1-A9O9-01A-11D-A41J-01 TCGA-V1-A9O9-01A-11D-A41L-05 TCGA-V1-A9O9-01A-11D-A41K-08 dda7df91-6e67-46d3-bfdc-d5bde725f44c TCGA-V1-A9O9-01 TCGA-V1-A9O9-01 TCGA-V1-A9O9-01A-11D-A41J-01 dda7df91-6e67-46d3-bfdc-d5bde725f44c TCGA-V1-A9O9-01 TCGA-V1-A9O9-01 dda7df91-6e67-46d3-bfdc-d5bde725f44c +TCGA-V1-A9OA-01 TCGA-V1-A9OA-01 TCGA-V1-A9OA TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-V1-A9OA-F69441 TCGA-V1-A9OA TCGA-V1-A9OA-01A NO M0 T2c -22630 27 636 510 NO YES Scheduled Follow-up Submission Complete Remission/Response 2015-1-9 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 10 NO Bilateral NO YES NO 8 1 true No N1 T3b TCGA-V1-A9OA.F8BC91E0-7D98-40B2-B99E-570564C3ECD2.pdf A9OA 4 Complete Remission/Response 0.01 YES R0 Primary Tumor 01 5 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone 434c7cb8-d131-46e0-a068-5345b5a77fff TCGA-V1-A9OA-01A-11D-A41J-01 TCGA-V1-A9OA-01A-11D-A41L-05 TCGA-V1-A9OA-01A-11D-A41K-08 434c7cb8-d131-46e0-a068-5345b5a77fff TCGA-V1-A9OA-01 TCGA-V1-A9OA-01 TCGA-V1-A9OA-01A-11D-A41J-01 434c7cb8-d131-46e0-a068-5345b5a77fff TCGA-V1-A9OA-01 TCGA-V1-A9OA-01 434c7cb8-d131-46e0-a068-5345b5a77fff +TCGA-V1-A9OF-01 TCGA-V1-A9OF-01 TCGA-V1-A9OF TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 49 TCGA-V1-A9OF-F69400 TCGA-V1-A9OF NO M0 T1c -18250 1184 1184 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-9 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO NO NO No T2c A9OF 3 Complete Remission/Response 0.01 NO R1 Primary Tumor 01 3 NO NO YES V1 Apex Prostate LIVING Peripheral Zone e6f9cecd-b130-441d-9073-cf1df303e2ab TCGA-V1-A9OF-01A-11D-A41J-01 TCGA-V1-A9OF-01A-11D-A41L-05 TCGA-V1-A9OF-01A-11D-A41K-08 e6f9cecd-b130-441d-9073-cf1df303e2ab TCGA-V1-A9OF-01 TCGA-V1-A9OF-01 TCGA-V1-A9OF-01A-11D-A41J-01 e6f9cecd-b130-441d-9073-cf1df303e2ab TCGA-V1-A9OF-01 TCGA-V1-A9OF-01 e6f9cecd-b130-441d-9073-cf1df303e2ab +TCGA-V1-A9OH-01 TCGA-V1-A9OH-01 TCGA-V1-A9OH TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-V1-A9OH-F69402 TCGA-V1-A9OH TCGA-V1-A9OH-01A NO M0 T1c -23360 2403 1253 NO NO Scheduled Follow-up Submission 2015-1-9 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 70 NO Right NO NO NO true No T2b TCGA-V1-A9OH.8B30DB97-6EB7-42EF-8A12-C9B1F1B5251B.pdf A9OH 4 Complete Remission/Response 0.01 NO R0 Primary Tumor 01 4 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone 4d83df74-09cf-4590-a15a-c5c583cbb639 TCGA-V1-A9OH-01A-11D-A41J-01 TCGA-V1-A9OH-01A-11D-A41L-05 TCGA-V1-A9OH-01A-11D-A41K-08 4d83df74-09cf-4590-a15a-c5c583cbb639 TCGA-V1-A9OH-01 TCGA-V1-A9OH-01 3817849E-67B9-46C9-BC3E-F4A80888AE6F TCGA-V1-A9OH-01A-11D-A41J-01 4d83df74-09cf-4590-a15a-c5c583cbb639 TCGA-V1-A9OH-01 TCGA-V1-A9OH-01 4d83df74-09cf-4590-a15a-c5c583cbb639 +TCGA-V1-A9OL-01 TCGA-V1-A9OL-01 TCGA-V1-A9OL TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 65 TCGA-V1-A9OL-F69471 TCGA-V1-A9OL TCGA-V1-A9OL-01A NO M0 T2 -24090 19 105 1913 559 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-9 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 190 NO Bilateral NO YES Biochemical evidence of disease YES 9 0 true No N0 T3b TCGA-V1-A9OL.E63E681C-8E25-4C1E-8C37-9EAA2697088B.pdf A9OL 5 Complete Remission/Response 0.01 NO R0 Primary Tumor 01 4 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone e312e528-bed2-4067-a562-1c27dd93d540 TCGA-V1-A9OL-01A-11D-A41J-01 TCGA-V1-A9OL-01A-11D-A41L-05 TCGA-V1-A9OL-01A-11D-A41K-08 e312e528-bed2-4067-a562-1c27dd93d540 TCGA-V1-A9OL-01 TCGA-V1-A9OL-01 94DF3591-19A5-4C63-AC53-CA572B353AB9 TCGA-V1-A9OL-01A-11D-A41J-01 e312e528-bed2-4067-a562-1c27dd93d540 TCGA-V1-A9OL-01 TCGA-V1-A9OL-01 e312e528-bed2-4067-a562-1c27dd93d540 +TCGA-V1-A9OQ-01 TCGA-V1-A9OQ-01 TCGA-V1-A9OQ TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-V1-A9OQ-F69411 TCGA-V1-A9OQ TCGA-V1-A9OQ-01A NO M0 T1c -24820 371 371 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-9 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 60 NO Bilateral NO NO NO 0 true No T3a TCGA-V1-A9OQ.8EA3FE2C-7C76-41F8-AEC4-A89C5DD2FF7B.pdf A9OQ 3 Complete Remission/Response 0.01 NO R1 Primary Tumor 01 3 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone 46993591-8ffa-4e54-ba85-d013a7c190c9 TCGA-V1-A9OQ-01A-11D-A41J-01 TCGA-V1-A9OQ-01A-11D-A41L-05 TCGA-V1-A9OQ-01A-11D-A41K-08 46993591-8ffa-4e54-ba85-d013a7c190c9 TCGA-V1-A9OQ-01 TCGA-V1-A9OQ-01 C6475EDA-2126-4F7A-B0C9-C8A46C3E7EE2 TCGA-V1-A9OQ-01A-11D-A41J-01 46993591-8ffa-4e54-ba85-d013a7c190c9 TCGA-V1-A9OQ-01 TCGA-V1-A9OQ-01 46993591-8ffa-4e54-ba85-d013a7c190c9 +TCGA-V1-A9OT-01 TCGA-V1-A9OT-01 TCGA-V1-A9OT TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 61 TCGA-V1-A9OT-F69439 TCGA-V1-A9OT TCGA-V1-A9OT-01A YES M0 T1c -22630 292 476 349 NO NO Scheduled Follow-up Submission Partial Remission/Response 2015-1-9 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 220 NO Bilateral NO NO Biochemical evidence of disease YES true No T2c TCGA-V1-A9OT.40B928AE-1977-4077-9F44-282E85273EF2.pdf A9OT 3 Progressive Disease 0.01 NO R1 Primary Tumor 01 3 NO NO YES V1 Middle Prostate A LIVING Peripheral Zone d2f9c79e-127a-4e53-869d-3ff6b2baf0aa TCGA-V1-A9OT-01A-11D-A41J-01 TCGA-V1-A9OT-01A-11D-A41L-05 TCGA-V1-A9OT-01A-11D-A41K-08 d2f9c79e-127a-4e53-869d-3ff6b2baf0aa TCGA-V1-A9OT-01 TCGA-V1-A9OT-01 5017EF3A-7AAF-4338-80B0-FD189F273829 TCGA-V1-A9OT-01A-11D-A41J-01 d2f9c79e-127a-4e53-869d-3ff6b2baf0aa TCGA-V1-A9OT-01 TCGA-V1-A9OT-01 d2f9c79e-127a-4e53-869d-3ff6b2baf0aa +TCGA-V1-A9OX-01 TCGA-V1-A9OX-01 TCGA-V1-A9OX TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 56 TCGA-V1-A9OX-F69435 TCGA-V1-A9OX TCGA-V1-A9OX-01A NO M0 -20805 1134 256 NO NO Scheduled Follow-up Submission 2015-1-9 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 150 NO Bilateral NO YES NO 8 0 true No N0 T2c TCGA-V1-A9OX.4D42611A-3A08-4A1A-A033-13E810FCCA3E.pdf A9OX 3 Partial Remission/Response 0.04 NO R0 Primary Tumor 01 5 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone af080299-4f21-42bb-8477-8d7414cdaf9f TCGA-V1-A9OX-01A-11D-A41J-01 TCGA-V1-A9OX-01A-11D-A41L-05 TCGA-V1-A9OX-01A-11D-A41K-08 af080299-4f21-42bb-8477-8d7414cdaf9f TCGA-V1-A9OX-01 TCGA-V1-A9OX-01 76DA618F-A968-4E6B-8F60-DFBB6013FAC0 TCGA-V1-A9OX-01A-11D-A41J-01 af080299-4f21-42bb-8477-8d7414cdaf9f TCGA-V1-A9OX-01 TCGA-V1-A9OX-01 af080299-4f21-42bb-8477-8d7414cdaf9f +TCGA-V1-A9OY-01 TCGA-V1-A9OY-01 TCGA-V1-A9OY TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-V1-A9OY-F69409 TCGA-V1-A9OY TCGA-V1-A9OY-01A NO M0 T2 -21170 1067 170 NO NO Scheduled Follow-up Submission 2015-1-9 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 70 NO Bilateral NO YES NO 13 1 true No N1 T3a TCGA-V1-A9OY.93F584C1-F62C-4DA6-B2C8-755DBED9CE18.pdf A9OY 4 Complete Remission/Response 0.099 NO R1 Primary Tumor 01 3 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone 35900b9c-bc5c-49cc-acb4-410305e8ab64 TCGA-V1-A9OY-01A-11D-A41J-01 TCGA-V1-A9OY-01A-11D-A41L-05 TCGA-V1-A9OY-01A-11D-A41K-08 35900b9c-bc5c-49cc-acb4-410305e8ab64 TCGA-V1-A9OY-01 TCGA-V1-A9OY-01 AE40B37F-924C-44F4-8E4A-532A18958CEC TCGA-V1-A9OY-01A-11D-A41J-01 35900b9c-bc5c-49cc-acb4-410305e8ab64 TCGA-V1-A9OY-01 TCGA-V1-A9OY-01 35900b9c-bc5c-49cc-acb4-410305e8ab64 +TCGA-V1-A9Z7-01 TCGA-V1-A9Z7-01 TCGA-V1-A9Z7 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 54 TCGA-V1-A9Z7-F70268 TCGA-V1-A9Z7 TCGA-V1-A9Z7-01A YES M0 T2 -20075 50 874 -75 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission 2015-2-2 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 310 NO Bilateral NO YES YES 10 0 true No N0 T3b TCGA-V1-A9Z7.E50B8F61-E948-417F-A5B6-2C087A8D2B01.pdf A9Z7 5 Complete Remission/Response 28.1 NO R0 Primary Tumor 01 4 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone fa901a09-cc13-402a-aba6-f93f4242c3d1 TCGA-V1-A9Z7-01A-11D-A41J-01 TCGA-V1-A9Z7-01A-11D-A41L-05 TCGA-V1-A9Z7-01A-11D-A41K-08 fa901a09-cc13-402a-aba6-f93f4242c3d1 TCGA-V1-A9Z7-01 TCGA-V1-A9Z7-01 9F6D9542-4CDB-46DD-9494-BB3B71CB63E8 TCGA-V1-A9Z7-01A-11D-A41J-01 fa901a09-cc13-402a-aba6-f93f4242c3d1 TCGA-V1-A9Z7-01 TCGA-V1-A9Z7-01 fa901a09-cc13-402a-aba6-f93f4242c3d1 +TCGA-V1-A9Z8-01 TCGA-V1-A9Z8-01 TCGA-V1-A9Z8 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-V1-A9Z8-F70269 TCGA-V1-A9Z8 TCGA-V1-A9Z8-01A NO M0 -21900 827 181 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-2 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 120 NO Bilateral NO YES NO 18 0 true No N0 T3b TCGA-V1-A9Z8.3C543195-4F88-4FA4-A397-EDF375FCE61A.pdf A9Z8 TUMOR FREE 5 Complete Remission/Response 0.01 NO R1 Primary Tumor 01 4 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone 6eb18bd6-15f9-42fb-a8d0-91c7fb0342ff TCGA-V1-A9Z8-01A-11D-A41J-01 TCGA-V1-A9Z8-01A-11D-A41L-05 TCGA-V1-A9Z8-01A-11D-A41K-08 6eb18bd6-15f9-42fb-a8d0-91c7fb0342ff TCGA-V1-A9Z8-01 TCGA-V1-A9Z8-01 473F88C1-4380-4A99-90EF-0D70B0C40EF7 TCGA-V1-A9Z8-01A-11D-A41J-01 6eb18bd6-15f9-42fb-a8d0-91c7fb0342ff TCGA-V1-A9Z8-01 TCGA-V1-A9Z8-01 6eb18bd6-15f9-42fb-a8d0-91c7fb0342ff +TCGA-V1-A9Z9-01 TCGA-V1-A9Z9-01 TCGA-V1-A9Z9 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-V1-A9Z9-F70270 TCGA-V1-A9Z9 TCGA-V1-A9Z9-01A NO M0 T1c -23360 9 540 291 NO YES Scheduled Follow-up Submission Complete Remission/Response 2015-2-2 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 140 NO Bilateral NO YES NO 29 0 true No N0 T2c TCGA-V1-A9Z9.9D297084-0545-4D51-8D14-15754BAAB18B.pdf A9Z9 TUMOR FREE 4 Complete Remission/Response 0.015 NO R0 Primary Tumor 01 5 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone 7c626639-ebbc-472b-8ad0-239068f6d4e8 TCGA-V1-A9Z9-01A-21D-A41J-01 TCGA-V1-A9Z9-01A-21D-A41L-05 TCGA-V1-A9Z9-01A-21D-A41K-08 7c626639-ebbc-472b-8ad0-239068f6d4e8 TCGA-V1-A9Z9-01 TCGA-V1-A9Z9-01 BAB09201-DEA3-4C9C-97FC-91E001E10254 TCGA-V1-A9Z9-01A-21D-A41J-01 7c626639-ebbc-472b-8ad0-239068f6d4e8 TCGA-V1-A9Z9-01 TCGA-V1-A9Z9-01 7c626639-ebbc-472b-8ad0-239068f6d4e8 +TCGA-V1-A9ZG-01 TCGA-V1-A9ZG-01 TCGA-V1-A9ZG TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-V1-A9ZG-F70257 TCGA-V1-A9ZG TCGA-V1-A9ZG-01A NO M0 T1c -23725 1517 893 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-2 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 330 NO Bilateral NO YES NO 5 0 true No N0 T2c TCGA-V1-A9ZG.D7B1ABAE-1A72-496C-B11F-469F65B37347.pdf A9ZG TUMOR FREE 4 Complete Remission/Response 0.015 NO R0 Primary Tumor 01 5 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone e8f34083-66fe-43d4-9860-77427c481dcd TCGA-V1-A9ZG-01A-11D-A41J-01 TCGA-V1-A9ZG-01A-11D-A41L-05 TCGA-V1-A9ZG-01A-11D-A41K-08 e8f34083-66fe-43d4-9860-77427c481dcd TCGA-V1-A9ZG-01 TCGA-V1-A9ZG-01 316629DF-AFA4-4256-B0B6-55EFAAFDA60B TCGA-V1-A9ZG-01A-11D-A41J-01 e8f34083-66fe-43d4-9860-77427c481dcd TCGA-V1-A9ZG-01 TCGA-V1-A9ZG-01 e8f34083-66fe-43d4-9860-77427c481dcd +TCGA-V1-A9ZI-01 TCGA-V1-A9ZI-01 TCGA-V1-A9ZI TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 68 TCGA-V1-A9ZI-F70259 TCGA-V1-A9ZI TCGA-V1-A9ZI-01A YES M0 -25185 40 86 1640 86 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission 2015-2-2 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 120 NO Bilateral NO YES Biochemical evidence of disease YES 10 0 true No N0 T3b TCGA-V1-A9ZI.7C3EC6A6-C005-4877-A6C8-C3174709A3FF.pdf A9ZI 4 Progressive Disease 3.11 NO R0 Primary Tumor 01 5 NO NO YES V1 Middle Prostate A LIVING Peripheral Zone 01234d47-e213-401f-b4fe-f33b15bcec7d TCGA-V1-A9ZI-01A-11D-A41J-01 TCGA-V1-A9ZI-01A-11D-A41L-05 TCGA-V1-A9ZI-01A-11D-A41K-08 01234d47-e213-401f-b4fe-f33b15bcec7d TCGA-V1-A9ZI-01 TCGA-V1-A9ZI-01 7D500092-40AE-4624-8467-F75EB75FF82A TCGA-V1-A9ZI-01A-11D-A41J-01 01234d47-e213-401f-b4fe-f33b15bcec7d TCGA-V1-A9ZI-01 TCGA-V1-A9ZI-01 01234d47-e213-401f-b4fe-f33b15bcec7d +TCGA-V1-A9ZK-01 TCGA-V1-A9ZK-01 TCGA-V1-A9ZK TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-V1-A9ZK-F70261 TCGA-V1-A9ZK TCGA-V1-A9ZK-01A NO M0 T2a -25185 1383 1049 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-2 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8490/3 C61.9 YES Core needle biopsy 50 NO Left NO YES NO 6 0 true No N0 T3b TCGA-V1-A9ZK.9AD0F7C3-9DEB-427C-B8A3-007B874AB12A.pdf A9ZK TUMOR FREE 4 Complete Remission/Response 0.01 NO R0 Primary Tumor 01 4 NO NO YES V1 Middle Prostate A LIVING Peripheral Zone 4c0ca123-3b83-4a25-aa0f-fe1a593ea969 TCGA-V1-A9ZK-01A-11D-A41J-01 TCGA-V1-A9ZK-01A-11D-A41L-05 TCGA-V1-A9ZK-01A-11D-A41K-08 4c0ca123-3b83-4a25-aa0f-fe1a593ea969 TCGA-V1-A9ZK-01 TCGA-V1-A9ZK-01 TCGA-V1-A9ZK-01A-11D-A41J-01 4c0ca123-3b83-4a25-aa0f-fe1a593ea969 TCGA-V1-A9ZK-01 TCGA-V1-A9ZK-01 4c0ca123-3b83-4a25-aa0f-fe1a593ea969 +TCGA-V1-A9ZR-01 TCGA-V1-A9ZR-01 TCGA-V1-A9ZR TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-V1-A9ZR-F70265 TCGA-V1-A9ZR TCGA-V1-A9ZR-01A YES M0 T2c -25185 78 1361 54 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-2 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 430 NO Bilateral NO YES YES 7 true No N0 T4 TCGA-V1-A9ZR.DB23EC5B-D86A-4B32-8C52-E91CAD4B7695.pdf A9ZR TUMOR FREE 4 Complete Remission/Response 1.44 NO R1 Primary Tumor 01 4 NO NO YES V1 Apex Prostate A LIVING Peripheral Zone 7d74ec0f-631d-463c-820e-ce796cb3b798 TCGA-V1-A9ZR-01A-11D-A41J-01 TCGA-V1-A9ZR-01A-11D-A41L-05 TCGA-V1-A9ZR-01A-11D-A41K-08 7d74ec0f-631d-463c-820e-ce796cb3b798 TCGA-V1-A9ZR-01 TCGA-V1-A9ZR-01 1684AD7E-7035-4E50-A2FD-17DCDD78559F TCGA-V1-A9ZR-01A-11D-A41J-01 7d74ec0f-631d-463c-820e-ce796cb3b798 TCGA-V1-A9ZR-01 TCGA-V1-A9ZR-01 7d74ec0f-631d-463c-820e-ce796cb3b798 +TCGA-VN-A88I-01 TCGA-VN-A88I-01 TCGA-VN-A88I TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-VN-A88I-F62589 TCGA-VN-A88I TCGA-VN-A88I-01A NO Abnormal (not related to prostate cancer) M0 T1c -21576 9 730 -1 0 269 269 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission 2014-7-21 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 260 NO Bilateral YES YES NO 11 0 true No N0 T3a TCGA-VN-A88I.571D4E0A-97DF-4B78-8F78-81DF0C040941.pdf A88I WITH TUMOR 4 Partial Remission/Response 0.16 R0 Primary Tumor 01 4 5 NO YES VN Apex|Middle|Base Prostate A LIVING 2011 Overlapping / Multiple Zones 625d2894-bb92-450a-af72-013d81df221d TCGA-VN-A88I-01A-11D-A34T-01 TCGA-VN-A88I-01A-11D-A34V-05 TCGA-VN-A88I-01A-11D-A34U-08 625d2894-bb92-450a-af72-013d81df221d TCGA-VN-A88I-01 TCGA-VN-A88I-01 EB376578-4795-483E-AAC2-C3F268EA8434 TCGA-VN-A88I-01A-11D-A34T-01 625d2894-bb92-450a-af72-013d81df221d TCGA-VN-A88I-01 TCGA-VN-A88I-01 TCGA-VN-A88I-01A-11D-A34U-08 625d2894-bb92-450a-af72-013d81df221d +TCGA-VN-A88K-01 TCGA-VN-A88K-01 TCGA-VN-A88K TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 58 TCGA-VN-A88K-F62590 TCGA-VN-A88K TCGA-VN-A88K-01A NO Equivocal M0 T1c -21524 24 870 24 -48 0 776 776 YES No Evidence of Extraprostatic Extension YES Extraprostatic Extension Localized (e.g. seminal vesicles) Scheduled Follow-up Submission Complete Remission/Response 2014-12-22 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 300 NO Bilateral YES YES NO 37 15 true No N1 T3a TCGA-VN-A88K.C990DBAF-40D6-4D19-8345-62495C3959A0.pdf A88K 4 Complete Remission/Response 0 NO R0 Primary Tumor 01 4 YES 5 NO YES VN Apex|Middle|Base Prostate A LIVING 2011 Overlapping / Multiple Zones f7aad847-52aa-4dc8-8ea5-6f1a4f47e2aa TCGA-VN-A88K-01A-11D-A34T-01 TCGA-VN-A88K-01A-11D-A34V-05 TCGA-VN-A88K-01A-11D-A34U-08 f7aad847-52aa-4dc8-8ea5-6f1a4f47e2aa TCGA-VN-A88K-01 TCGA-VN-A88K-01 01B32A9B-FA8B-4F15-AD86-DDA939C3EDFC TCGA-VN-A88K-01A-11D-A34T-01 f7aad847-52aa-4dc8-8ea5-6f1a4f47e2aa TCGA-VN-A88K-01 TCGA-VN-A88K-01 TCGA-VN-A88K-01A-11D-A34U-08 f7aad847-52aa-4dc8-8ea5-6f1a4f47e2aa +TCGA-VN-A88L-01 TCGA-VN-A88L-01 TCGA-VN-A88L TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 54 TCGA-VN-A88L-F65022 TCGA-VN-A88L TCGA-VN-A88L-01A NO M0 T1c -20026 367 79 0 746 394 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2014-12-22 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 130 NO Bilateral NO YES NO 18 0 true No N0 T2c TCGA-VN-A88L.7247904D-2E8C-49B5-8D35-A6CE0D9687DE.pdf A88L TUMOR FREE 3 Complete Remission/Response 0 NO R0 Primary Tumor 01 4 NO NO YES VN Middle|Base Prostate A LIVING 2012 6f4d55e9-37fc-40c3-92d0-5bdabc063447 TCGA-VN-A88L-01A-11D-A34T-01 TCGA-VN-A88L-01A-11D-A34V-05 TCGA-VN-A88L-01A-11D-A34U-08 6f4d55e9-37fc-40c3-92d0-5bdabc063447 TCGA-VN-A88L-01 TCGA-VN-A88L-01 9DC21531-0542-4563-BD6C-3FDD509335D9 TCGA-VN-A88L-01A-11D-A34T-01 6f4d55e9-37fc-40c3-92d0-5bdabc063447 TCGA-VN-A88L-01 TCGA-VN-A88L-01 TCGA-VN-A88L-01A-11D-A34U-08 6f4d55e9-37fc-40c3-92d0-5bdabc063447 +TCGA-VN-A88M-01 TCGA-VN-A88M-01 TCGA-VN-A88M TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-VN-A88M-F62591 TCGA-VN-A88M M0 T1c -20157 128 0 189 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission 2014-12-22 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral YES YES NO 13 0 No N0 T2c A88M TUMOR FREE 3 Complete Remission/Response NO R0 Primary Tumor 01 4 NO NO YES VN Middle Prostate LIVING 2013 aa86654d-003d-4190-b2bc-f4b40f77474f TCGA-VN-A88M-01A-11D-A34T-01 TCGA-VN-A88M-01A-11D-A34V-05 TCGA-VN-A88M-01A-11D-A34U-08 aa86654d-003d-4190-b2bc-f4b40f77474f TCGA-VN-A88M-01 TCGA-VN-A88M-01 TCGA-VN-A88M-01A-11D-A34T-01 aa86654d-003d-4190-b2bc-f4b40f77474f TCGA-VN-A88M-01 TCGA-VN-A88M-01 aa86654d-003d-4190-b2bc-f4b40f77474f +TCGA-VN-A88N-01 TCGA-VN-A88N-01 TCGA-VN-A88N TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-VN-A88N-F72543 TCGA-VN-A88N TCGA-VN-A88N-01A NO Equivocal M0 T1c -22695 98 156 98 -117 0 766 176 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission 2015-7-13 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 50 NO Bilateral NO YES NO 50 0 true No N0 T2c TCGA-VN-A88N.CB3E6129-CCCC-4EEB-88CD-63DE78D8F163.pdf A88N TUMOR FREE 4 Complete Remission/Response 0 NO R0 Primary Tumor 01 3 NO NO YES VN Apex|Middle|Base Prostate A LIVING 2013 Overlapping / Multiple Zones 7dae2f3c-56cb-425a-8d7f-7113e1cfc72e TCGA-VN-A88N-01A-11D-A363-01 TCGA-VN-A88N-01A-11D-A365-05 TCGA-VN-A88N-01A-11D-A364-08 7dae2f3c-56cb-425a-8d7f-7113e1cfc72e TCGA-VN-A88N-01 TCGA-VN-A88N-01 TCGA-VN-A88N-01A-11D-A363-01 7dae2f3c-56cb-425a-8d7f-7113e1cfc72e TCGA-VN-A88N-01 TCGA-VN-A88N-01 TCGA-VN-A88N-01A-11D-A364-08 7dae2f3c-56cb-425a-8d7f-7113e1cfc72e +TCGA-VN-A88O-01 TCGA-VN-A88O-01 TCGA-VN-A88O TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 49 TCGA-VN-A88O-F72128 TCGA-VN-A88O TCGA-VN-A88O-01A NO M0 T1c -17945 426 70 0 481 376 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission 2015-4-17 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 60 NO Bilateral YES YES NO 34 0 true No N0 T2c TCGA-VN-A88O.E47DAF10-187B-4909-A0C5-D96231A5893F.pdf A88O TUMOR FREE 3 Complete Remission/Response 0 NO R0 Primary Tumor 01 4 NO 4 NO YES VN Apex|Middle|Base Prostate A LIVING 2012 Overlapping / Multiple Zones 621b5b13-6568-41fa-9e42-3992fa05dd1f TCGA-VN-A88O-01A-11D-A34T-01 TCGA-VN-A88O-01A-11D-A34V-05 TCGA-VN-A88O-01A-11D-A34U-08 621b5b13-6568-41fa-9e42-3992fa05dd1f TCGA-VN-A88O-01 TCGA-VN-A88O-01 TCGA-VN-A88O-01A-11D-A34T-01 621b5b13-6568-41fa-9e42-3992fa05dd1f TCGA-VN-A88O-01 TCGA-VN-A88O-01 TCGA-VN-A88O-01A-11D-A34U-08 621b5b13-6568-41fa-9e42-3992fa05dd1f +TCGA-VN-A88P-01 TCGA-VN-A88P-01 TCGA-VN-A88P TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-VN-A88P-F69078 TCGA-VN-A88P TCGA-VN-A88P-01A NO Abnormal (not related to prostate cancer) M0 T1c -21916 839 911 839 805 0 1260 917 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2014-12-29 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 140 NO Bilateral NO YES NO 65 0 true No N0 T2c TCGA-VN-A88P.9C83DFB8-B75A-40D1-B791-BE52B52BBDA6.pdf A88P TUMOR FREE 3 Complete Remission/Response 0 NO R0 Primary Tumor 01 4 NO NO YES VN Base Prostate A LIVING 2011 Overlapping / Multiple Zones e6310fd5-418f-4315-8c0a-78b05a95c214 TCGA-VN-A88P-01A-11D-A34T-01 TCGA-VN-A88P-01A-11D-A34V-05 TCGA-VN-A88P-01A-11D-A34U-08 e6310fd5-418f-4315-8c0a-78b05a95c214 TCGA-VN-A88P-01 TCGA-VN-A88P-01 F1C836D5-1E39-43AC-A0C8-800C4964E8C2 TCGA-VN-A88P-01A-11D-A34T-01 e6310fd5-418f-4315-8c0a-78b05a95c214 TCGA-VN-A88P-01 TCGA-VN-A88P-01 TCGA-VN-A88P-01A-11D-A34U-08 e6310fd5-418f-4315-8c0a-78b05a95c214 +TCGA-VN-A88Q-01 TCGA-VN-A88Q-01 TCGA-VN-A88Q TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-VN-A88Q-F68875 TCGA-VN-A88Q NO Abnormal (not related to prostate cancer) M0 T2a -22087 929 796 0 1366 1000 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2014-12-22 MALE 8 Prostate Adenocarcinoma, Other Subtype No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 12 0 No N0 T2c A88Q TUMOR FREE 4 Complete Remission/Response 0 NO R0 Primary Tumor 01 4 NO NO YES VN Apex Prostate LIVING 2010 Overlapping / Multiple Zones c44359a0-d7c7-45bc-80e7-5139d4a77234 TCGA-VN-A88Q-01A-11D-A34T-01 TCGA-VN-A88Q-01A-11D-A34V-05 TCGA-VN-A88Q-01A-11D-A34U-08 c44359a0-d7c7-45bc-80e7-5139d4a77234 TCGA-VN-A88Q-01 TCGA-VN-A88Q-01 TCGA-VN-A88Q-01A-11D-A34T-01 c44359a0-d7c7-45bc-80e7-5139d4a77234 TCGA-VN-A88Q-01 TCGA-VN-A88Q-01 TCGA-VN-A88Q-01A-11D-A34U-08 c44359a0-d7c7-45bc-80e7-5139d4a77234 +TCGA-VN-A88R-01 TCGA-VN-A88R-01 TCGA-VN-A88R TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES NO 53 TCGA-VN-A88R-F69083 TCGA-VN-A88R TCGA-VN-A88R-01A NO Abnormal (not related to prostate cancer) M0 T1c -19513 316 402 316 207 512 0 784 512 459 YES Equivocal YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission 2014-12-29 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 40 NO Bilateral NO YES Biochemical evidence of disease YES 34 0 true No N0 T2c TCGA-VN-A88R.6DDC4292-91C9-49A7-B34D-578ECA0A7F56.pdf A88R 4 Partial Remission/Response 0.15 NO R0 Primary Tumor 01 4 NO NO YES VN Apex|Middle|Base Prostate A LIVING 2012 7e0203fd-e55d-4d05-9877-6b502250ffc3 TCGA-VN-A88R-01A-11D-A363-01 TCGA-VN-A88R-01A-11D-A365-05 TCGA-VN-A88R-01A-11D-A364-08 7e0203fd-e55d-4d05-9877-6b502250ffc3 TCGA-VN-A88R-01 TCGA-VN-A88R-01 TCGA-VN-A88R-01A-11D-A363-01 7e0203fd-e55d-4d05-9877-6b502250ffc3 TCGA-VN-A88R-01 TCGA-VN-A88R-01 TCGA-VN-A88R-01A-11D-A364-08 7e0203fd-e55d-4d05-9877-6b502250ffc3 +TCGA-VN-A943-01 TCGA-VN-A943-01 TCGA-VN-A943 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 71 TCGA-VN-A943-F69100 TCGA-VN-A943 NO M0 T1c -26162 -17 0 496 132 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2014-12-29 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 10 0 No N0 T2c A943 TUMOR FREE 4 Complete Remission/Response 0.01 NO R0 Primary Tumor 01 4 NO NO YES VN Apex|Middle|Base Prostate LIVING 2013 Overlapping / Multiple Zones c83c8992-5d92-4c1e-a59d-cf890ecb9bb4 TCGA-VN-A943-01A-11D-A41J-01 TCGA-VN-A943-01A-11D-A41L-05 TCGA-VN-A943-01A-11D-A41K-08 c83c8992-5d92-4c1e-a59d-cf890ecb9bb4 TCGA-VN-A943-01 TCGA-VN-A943-01 TCGA-VN-A943-01A-11D-A41J-01 c83c8992-5d92-4c1e-a59d-cf890ecb9bb4 TCGA-VN-A943-01 TCGA-VN-A943-01 c83c8992-5d92-4c1e-a59d-cf890ecb9bb4 +TCGA-VP-A872-01 TCGA-VP-A872-01 TCGA-VP-A872 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-VP-A872-F64422 TCGA-VP-A872 NO Normal (no evidence of prostate cancer) [cM0] M0 T2 -22098 8 0 3631 3253 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-2 MALE 8 Prostate Adenocarcinoma, Other Subtype No C61 8500/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 12 0 No N0 T3a A872 TUMOR FREE 5 Complete Remission/Response 0.01 NO R0 Primary Tumor 01 3 NO 4 NO YES VP Apex|Base Prostate LIVING 2005 Overlapping / Multiple Zones f8fba04c-cd45-4f85-8b75-dcf5426b7637 TCGA-VP-A872-01A-11D-A34T-01 TCGA-VP-A872-01A-11D-A34V-05 TCGA-VP-A872-01A-11D-A34U-08 f8fba04c-cd45-4f85-8b75-dcf5426b7637 TCGA-VP-A872-01 TCGA-VP-A872-01 TCGA-VP-A872-01A-11D-A34T-01 f8fba04c-cd45-4f85-8b75-dcf5426b7637 TCGA-VP-A872-01 TCGA-VP-A872-01 TCGA-VP-A872-01A-11D-A34U-08 f8fba04c-cd45-4f85-8b75-dcf5426b7637 +TCGA-VP-A875-01 TCGA-VP-A875-01 TCGA-VP-A875 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-VP-A875-F64433 TCGA-VP-A875 TCGA-VP-A875-01A NO Abnormal (not related to prostate cancer) M0 T2a -24742 15 3124 15 0 2309 867 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-2 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 280 NO Bilateral YES YES NO 4 0 true No N0 T3a TCGA-VP-A875.2CF80467-58E9-4A65-94D5-08401BE6ACB5.pdf A875 TUMOR FREE 3 Complete Remission/Response 0.01 NO R0 Primary Tumor 01 4 NO NO YES VP Apex|Base Prostate A LIVING 2005 Overlapping / Multiple Zones c47f8609-65d3-4cca-b599-58add67672c7 TCGA-VP-A875-01A-31D-A34T-01 TCGA-VP-A875-01A-31D-A34V-05 TCGA-VP-A875-01A-31D-A34U-08 c47f8609-65d3-4cca-b599-58add67672c7 TCGA-VP-A875-01 TCGA-VP-A875-01 077ECEE0-AF3D-4F34-8D82-E058B953C53F TCGA-VP-A875-01A-31D-A34T-01 c47f8609-65d3-4cca-b599-58add67672c7 TCGA-VP-A875-01 TCGA-VP-A875-01 TCGA-VP-A875-01A-31D-A34U-08 c47f8609-65d3-4cca-b599-58add67672c7 +TCGA-VP-A876-01 TCGA-VP-A876-01 TCGA-VP-A876 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 46 TCGA-VP-A876-F64436 TCGA-VP-A876 TCGA-VP-A876-01A NO Normal (no evidence of prostate cancer) [cM0] T1c -16934 13 3054 13 0 3333 2576 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-2 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 20 NO Bilateral NO YES NO 12 0 true No N0 T2c TCGA-VP-A876.A10667AF-8A71-492D-B71C-95160DE9EEE6.pdf A876 TUMOR FREE 3 Complete Remission/Response 0.1 NO R0 Primary Tumor 01 5 NO NO YES VP Apex|Base Prostate A LIVING 2005 Overlapping / Multiple Zones 2099f0da-0318-4b94-a418-d6e6cf65454b TCGA-VP-A876-01A-11D-A34T-01 TCGA-VP-A876-01A-11D-A34V-05 TCGA-VP-A876-01A-11D-A34U-08 2099f0da-0318-4b94-a418-d6e6cf65454b TCGA-VP-A876-01 TCGA-VP-A876-01 TCGA-VP-A876-01A-11D-A34T-01 2099f0da-0318-4b94-a418-d6e6cf65454b TCGA-VP-A876-01 TCGA-VP-A876-01 TCGA-VP-A876-01A-11D-A34U-08 2099f0da-0318-4b94-a418-d6e6cf65454b +TCGA-VP-A878-01 TCGA-VP-A878-01 TCGA-VP-A878 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES NO 58 TCGA-VP-A878-F64439 TCGA-VP-A878 TCGA-VP-A878-01A NO Normal (no evidence of prostate cancer) [cM0] T1c -21402 35 2725 44 1843 0 3130 2354 2704 1934 2011 YES Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1] NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-2 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 220 NO Bilateral NO YES Bone Distant Metastasis YES 3 1 true No N1 T2c TCGA-VP-A878.635464F3-6A6B-4574-8413-058651AB4068.pdf A878 WITH TUMOR 4 Partial Remission/Response 0.1 NO R1 Primary Tumor 01 5 NO NO YES VP Apex|Base NO Prostate A LIVING 2006 Overlapping / Multiple Zones 2405edaf-b4cc-4292-92a3-8b890ffaa70f TCGA-VP-A878-01A-31D-A34T-01 TCGA-VP-A878-01A-31D-A34V-05 TCGA-VP-A878-01A-31D-A34U-08 2405edaf-b4cc-4292-92a3-8b890ffaa70f TCGA-VP-A878-01 TCGA-VP-A878-01 5A467EBB-657B-4B94-8901-424E02563537 TCGA-VP-A878-01A-31D-A34T-01 2405edaf-b4cc-4292-92a3-8b890ffaa70f TCGA-VP-A878-01 TCGA-VP-A878-01 TCGA-VP-A878-01A-31D-A34U-08 2405edaf-b4cc-4292-92a3-8b890ffaa70f +TCGA-VP-A879-01 TCGA-VP-A879-01 TCGA-VP-A879 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 70 TCGA-VP-A879-F64442 TCGA-VP-A879 TCGA-VP-A879-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -25799 8 2578 728 8 0 688 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-2 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 110 NO Right NO YES NO 2 0 true No N0 T2b TCGA-VP-A879.526F7E5C-B681-46B7-B118-10AB3F2DD30E.pdf A879 TUMOR FREE 4 Complete Remission/Response 0.01 NO R0 Primary Tumor 01 5 Medical Record NO NO YES VP Apex|Base Prostate A DECEASED 2006 Overlapping / Multiple Zones 1cba2729-ee83-44a3-a21a-ad5359a2bbe3 TCGA-VP-A879-01A-11D-A34T-01 TCGA-VP-A879-01A-11D-A34V-05 TCGA-VP-A879-01A-11D-A34U-08 1cba2729-ee83-44a3-a21a-ad5359a2bbe3 TCGA-VP-A879-01 TCGA-VP-A879-01 TCGA-VP-A879-01A-11D-A34T-01 1cba2729-ee83-44a3-a21a-ad5359a2bbe3 TCGA-VP-A879-01 TCGA-VP-A879-01 TCGA-VP-A879-01A-11D-A34U-08 1cba2729-ee83-44a3-a21a-ad5359a2bbe3 +TCGA-VP-A87B-01 TCGA-VP-A87B-01 TCGA-VP-A87B TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES NO 63 TCGA-VP-A87B-F64449 TCGA-VP-A87B NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -23271 2310 0 2722 2473 2309 2459 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-3 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Right NO YES Lung New Primary Tumor YES 2 0 No N0 T2b A87B WITH TUMOR 4 Progressive Disease 3.37 YES R0 Primary Tumor 01 4 NO 3 NO YES VP Apex|Base NO Prostate LIVING 2007 Overlapping / Multiple Zones a899dca6-deb0-49f8-8c8b-2854b108de5a TCGA-VP-A87B-01A-11D-A34T-01 TCGA-VP-A87B-01A-11D-A34V-05 TCGA-VP-A87B-01A-11D-A34U-08 a899dca6-deb0-49f8-8c8b-2854b108de5a TCGA-VP-A87B-01 TCGA-VP-A87B-01 TCGA-VP-A87B-01A-11D-A34T-01 a899dca6-deb0-49f8-8c8b-2854b108de5a TCGA-VP-A87B-01 TCGA-VP-A87B-01 TCGA-VP-A87B-01A-11D-A34U-08 a899dca6-deb0-49f8-8c8b-2854b108de5a +TCGA-VP-A87C-01 TCGA-VP-A87C-01 TCGA-VP-A87C TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-VP-A87C-F64470 TCGA-VP-A87C NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -24608 14 14 0 1690 1690 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-3 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral YES YES NO 12 0 No N0 T2c A87C TUMOR FREE 4 Complete Remission/Response 0.5 NO R0 Primary Tumor 01 3 NO NO YES VP Apex|Base Prostate LIVING 2007 Overlapping / Multiple Zones e6e404f0-3317-496c-b4f8-555408a3dfd6 TCGA-VP-A87C-01A-11D-A34T-01 TCGA-VP-A87C-01A-11D-A34V-05 TCGA-VP-A87C-01A-11D-A34U-08 e6e404f0-3317-496c-b4f8-555408a3dfd6 TCGA-VP-A87C-01 TCGA-VP-A87C-01 TCGA-VP-A87C-01A-11D-A34T-01 e6e404f0-3317-496c-b4f8-555408a3dfd6 TCGA-VP-A87C-01 TCGA-VP-A87C-01 TCGA-VP-A87C-01A-11D-A34U-08 e6e404f0-3317-496c-b4f8-555408a3dfd6 +TCGA-VP-A87D-01 TCGA-VP-A87D-01 TCGA-VP-A87D TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 54 TCGA-VP-A87D-F64469 TCGA-VP-A87D YES Normal (no evidence of prostate cancer) [cM0] M0 T1c -19818 14 12 1194 0 1853 1853 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2014-9-3 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral YES YES NO 12 3 No N1 T3a A87D TUMOR FREE 4 Complete Remission/Response 0.2 NO R0 Primary Tumor 01 5 YES NO YES VP Apex|Base Prostate LIVING 2007 Overlapping / Multiple Zones ca36f013-1f5d-41f4-85a5-2b8a149a5cfa TCGA-VP-A87D-01A-11D-A34T-01 TCGA-VP-A87D-01A-11D-A34V-05 TCGA-VP-A87D-01A-11D-A34U-08 ca36f013-1f5d-41f4-85a5-2b8a149a5cfa TCGA-VP-A87D-01 TCGA-VP-A87D-01 TCGA-VP-A87D-01A-11D-A34T-01 ca36f013-1f5d-41f4-85a5-2b8a149a5cfa TCGA-VP-A87D-01 TCGA-VP-A87D-01 TCGA-VP-A87D-01A-11D-A34U-08 ca36f013-1f5d-41f4-85a5-2b8a149a5cfa +TCGA-VP-A87E-01 TCGA-VP-A87E-01 TCGA-VP-A87E TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-VP-A87E-F64474 TCGA-VP-A87E TCGA-VP-A87E-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -21811 15 2059 15 0 2037 2037 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-3 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 220 NO Bilateral YES YES NO 12 0 true No N0 T2c TCGA-VP-A87E.6B46F895-B5CD-40B8-8962-AA8DF2505446.pdf A87E TUMOR FREE 3 Complete Remission/Response 0.11 NO R0 Primary Tumor 01 3 NO NO YES VP Apex|Base Prostate A LIVING 2008 Overlapping / Multiple Zones ecbb33ff-c485-485f-a169-6bb7c1c84baf TCGA-VP-A87E-01A-31D-A34T-01 TCGA-VP-A87E-01A-31D-A34V-05 TCGA-VP-A87E-01A-31D-A34U-08 ecbb33ff-c485-485f-a169-6bb7c1c84baf TCGA-VP-A87E-01 TCGA-VP-A87E-01 8175BE77-BA0B-4FB2-A6AA-6DF5A8D0C04B TCGA-VP-A87E-01A-31D-A34T-01 ecbb33ff-c485-485f-a169-6bb7c1c84baf TCGA-VP-A87E-01 TCGA-VP-A87E-01 TCGA-VP-A87E-01A-31D-A34U-08 ecbb33ff-c485-485f-a169-6bb7c1c84baf +TCGA-VP-A87H-01 TCGA-VP-A87H-01 TCGA-VP-A87H TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 76 TCGA-VP-A87H-F64478 TCGA-VP-A87H TCGA-VP-A87H-01A NO M0 T2 -28060 1714 24 0 663 663 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-3 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 50 NO Bilateral YES YES NO 16 0 true No N0 T3b TCGA-VP-A87H.B2B58670-AE26-43A0-8D3C-AAF354958727.pdf A87H TUMOR FREE 4 Complete Remission/Response 0.01 NO R2 Primary Tumor 01 5 NO NO YES VP Apex|Base Prostate A LIVING 2009 Overlapping / Multiple Zones 3aba16f9-47fe-419a-92d3-c73049adce2b TCGA-VP-A87H-01A-11D-A34T-01 TCGA-VP-A87H-01A-11D-A34V-05 TCGA-VP-A87H-01A-11D-A34U-08 3aba16f9-47fe-419a-92d3-c73049adce2b TCGA-VP-A87H-01 TCGA-VP-A87H-01 TCGA-VP-A87H-01A-11D-A34T-01 3aba16f9-47fe-419a-92d3-c73049adce2b TCGA-VP-A87H-01 TCGA-VP-A87H-01 TCGA-VP-A87H-01A-11D-A34U-08 3aba16f9-47fe-419a-92d3-c73049adce2b +TCGA-VP-A87J-01 TCGA-VP-A87J-01 TCGA-VP-A87J TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 56 TCGA-VP-A87J-F64485 TCGA-VP-A87J TCGA-VP-A87J-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2a -20792 11 1379 13 0 1774 1296 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-3 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 130 NO Bilateral NO YES NO 11 1 true No N1 T3a TCGA-VP-A87J.03F4F8F1-ACE1-4391-85AC-A10B2F56CDD0.pdf A87J TUMOR FREE 3 Complete Remission/Response 0.13 NO R2 Primary Tumor 01 4 NO NO YES VP Apex|Base Prostate A LIVING 2010 Overlapping / Multiple Zones eecb9837-09fc-4e99-93d3-d3686c9783da TCGA-VP-A87J-01A-11D-A34T-01 TCGA-VP-A87J-01A-11D-A34V-05 TCGA-VP-A87J-01A-11D-A34U-08 eecb9837-09fc-4e99-93d3-d3686c9783da TCGA-VP-A87J-01 TCGA-VP-A87J-01 30BCCEFD-980E-43C1-B9BB-243B1FCE44C3 TCGA-VP-A87J-01A-11D-A34T-01 eecb9837-09fc-4e99-93d3-d3686c9783da TCGA-VP-A87J-01 TCGA-VP-A87J-01 TCGA-VP-A87J-01A-11D-A34U-08 eecb9837-09fc-4e99-93d3-d3686c9783da +TCGA-VP-A87K-01 TCGA-VP-A87K-01 TCGA-VP-A87K TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO YES 63 TCGA-VP-A87K-F64502 TCGA-VP-A87K TCGA-VP-A87K-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T1c -23030 13 1112 13 467 0 1306 697 655 533 655 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-3 MALE 8 Prostate Adenocarcinoma, Other Subtype No C61 8500/3 C61.9 YES Core needle biopsy 130 NO Bilateral NO YES Biochemical evidence of disease YES 12 0 true No N0 T3b TCGA-VP-A87K.6B2C5B8F-61B5-4D8B-A091-B28066A1629A.pdf A87K TUMOR FREE 4 Complete Remission/Response 0.3 NO R1 Primary Tumor 01 4 NO NO YES VP Apex|Base Prostate A LIVING 2010 Overlapping / Multiple Zones 1a9b6614-f2fd-4a0f-9586-a8b7d339c7ca TCGA-VP-A87K-01A-11D-A34T-01 TCGA-VP-A87K-01A-11D-A34V-05 TCGA-VP-A87K-01A-11D-A34U-08 1a9b6614-f2fd-4a0f-9586-a8b7d339c7ca TCGA-VP-A87K-01 TCGA-VP-A87K-01 ACBE85E8-D46E-4C20-B7D4-D48BC8E3B5AA TCGA-VP-A87K-01A-11D-A34T-01 1a9b6614-f2fd-4a0f-9586-a8b7d339c7ca TCGA-VP-A87K-01 TCGA-VP-A87K-01 TCGA-VP-A87K-01A-11D-A34U-08 1a9b6614-f2fd-4a0f-9586-a8b7d339c7ca +TCGA-VP-AA1N-01 TCGA-VP-AA1N-01 TCGA-VP-AA1N TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 70 TCGA-VP-AA1N-F64506 TCGA-VP-AA1N TCGA-VP-AA1N-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -25781 17 2112 17 0 1365 542 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-3 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 250 NO Bilateral YES YES NO 5 0 true No N0 T3a TCGA-VP-AA1N.B76B30C1-F87D-494B-A95A-3F9E511ED3B1.pdf AA1N TUMOR FREE 5 Complete Remission/Response 0.01 YES R1 Primary Tumor 01 4 NO NO YES VP Apex|Base Prostate A LIVING 2008 Overlapping / Multiple Zones 81f85c7b-5262-466b-b4fb-a4fe9febfe0a TCGA-VP-AA1N-01A-31D-A41J-01 TCGA-VP-AA1N-01A-31D-A41L-05 TCGA-VP-AA1N-01A-31D-A41K-08 81f85c7b-5262-466b-b4fb-a4fe9febfe0a TCGA-VP-AA1N-01 TCGA-VP-AA1N-01 5FEE1D08-009A-4CAA-801E-0EF953031332 TCGA-VP-AA1N-01A-31D-A41J-01 81f85c7b-5262-466b-b4fb-a4fe9febfe0a TCGA-VP-AA1N-01 TCGA-VP-AA1N-01 81f85c7b-5262-466b-b4fb-a4fe9febfe0a +TCGA-WW-A8ZI-01 TCGA-WW-A8ZI-01 TCGA-WW-A8ZI TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 70 TCGA-WW-A8ZI-F67645 TCGA-WW-A8ZI TCGA-WW-A8ZI-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2c -25593 13 135 20 0 449 176 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-7 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 170 NO Bilateral NO YES NO 4 0 true No N0 T2c TCGA-WW-A8ZI.91350D32-096F-4839-ABE4-6AC4354E7B68.pdf A8ZI TUMOR FREE 4 Complete Remission/Response 0 NO R0 Primary Tumor 01 4 NO YES NO WW Apex Prostate A LIVING 2013 effc8583-559f-4e01-bd93-11b39d95a290 TCGA-WW-A8ZI-01A-11D-A376-01 TCGA-WW-A8ZI-01A-11D-A378-05 TCGA-WW-A8ZI-01A-11D-A377-08 effc8583-559f-4e01-bd93-11b39d95a290 TCGA-WW-A8ZI-01 TCGA-WW-A8ZI-01 A3E7C63B-AF98-4A27-9FB2-DB59FAB8B814 TCGA-WW-A8ZI-01A-11D-A376-01 effc8583-559f-4e01-bd93-11b39d95a290 TCGA-WW-A8ZI-01 TCGA-WW-A8ZI-01 TCGA-WW-A8ZI-01A-11D-A377-08 effc8583-559f-4e01-bd93-11b39d95a290 +TCGA-X4-A8KQ-01 TCGA-X4-A8KQ-01 TCGA-X4-A8KQ TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-X4-A8KQ-F67716 TCGA-X4-A8KQ TCGA-X4-A8KQ-01A NO M0 T1c -23999 1078 883 0 1383 963 NO NO Scheduled Follow-up Submission Stable Disease 2014-11-10 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 250 NO Right NO YES Biochemical evidence of disease YES 3 0 true No N0 T3b TCGA-X4-A8KQ.978B4E1F-FDA4-41FA-8341-ED6E851168A6.pdf A8KQ WITH TUMOR 4 Progressive Disease .25 YES RX Primary Tumor 01 5 YES NO YES X4 Prostate A LIVING 2010 Peripheral Zone cff667cc-724f-4f8a-96c0-cdd6512805a2 TCGA-X4-A8KQ-01A-12D-A363-01 TCGA-X4-A8KQ-01A-12D-A365-05 TCGA-X4-A8KQ-01A-12D-A364-08 cff667cc-724f-4f8a-96c0-cdd6512805a2 TCGA-X4-A8KQ-01 TCGA-X4-A8KQ-01 C1BE9473-E561-4DCF-8238-4EF36DFAC1BB TCGA-X4-A8KQ-01A-12D-A363-01 cff667cc-724f-4f8a-96c0-cdd6512805a2 TCGA-X4-A8KQ-01 TCGA-X4-A8KQ-01 cff667cc-724f-4f8a-96c0-cdd6512805a2 +TCGA-X4-A8KS-01 TCGA-X4-A8KS-01 TCGA-X4-A8KS TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-X4-A8KS-F67714 TCGA-X4-A8KS TCGA-X4-A8KS-01A NO M0 T2c -22571 735 0 979 797 NO NO Scheduled Follow-up Submission Partial Remission/Response 2014-11-10 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 160 NO Bilateral NO NO NO true No T2c TCGA-X4-A8KS.30844429-3F9C-4AD0-8A23-64012532347C.pdf A8KS TUMOR FREE 3 Partial Remission/Response .01 NO RX Primary Tumor 01 4 NO NO YES X4 Prostate A LIVING 2011 Peripheral Zone 984a3498-4b0b-4242-9fd3-640175da22ec TCGA-X4-A8KS-01A-12D-A363-01 TCGA-X4-A8KS-01A-12D-A365-05 TCGA-X4-A8KS-01A-12D-A364-08 984a3498-4b0b-4242-9fd3-640175da22ec TCGA-X4-A8KS-01 TCGA-X4-A8KS-01 TCGA-X4-A8KS-01A-12D-A363-01 984a3498-4b0b-4242-9fd3-640175da22ec TCGA-X4-A8KS-01 TCGA-X4-A8KS-01 984a3498-4b0b-4242-9fd3-640175da22ec +TCGA-XA-A8JR-01 TCGA-XA-A8JR-01 TCGA-XA-A8JR TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-XA-A8JR-F69794 TCGA-XA-A8JR TCGA-XA-A8JR-01A NO M0 -25090 223 0 376 69 Scheduled Follow-up Submission 2015-1-20 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 110 NO Bilateral NO YES NO 7 0 true No N0 T2c TCGA-XA-A8JR.587379B6-9AF9-471D-834C-668555ABC32A.pdf A8JR TUMOR FREE 4 Complete Remission/Response 0 NO R2 Primary Tumor 01 3 NO 5 YES NO XA Prostate A LIVING 2013 419e456e-40fc-4bc7-8b9f-c54d9935b7e2 TCGA-XA-A8JR-01A-11D-A363-01 TCGA-XA-A8JR-01A-11D-A365-05 TCGA-XA-A8JR-01A-11D-A364-08 419e456e-40fc-4bc7-8b9f-c54d9935b7e2 TCGA-XA-A8JR-01 TCGA-XA-A8JR-01 B774F7F2-5B17-4FC0-8A84-815EF5D03067 TCGA-XA-A8JR-01A-11D-A363-01 419e456e-40fc-4bc7-8b9f-c54d9935b7e2 TCGA-XA-A8JR-01 TCGA-XA-A8JR-01 TCGA-XA-A8JR-01A-11D-A364-08 419e456e-40fc-4bc7-8b9f-c54d9935b7e2 +TCGA-XJ-A83F-01 TCGA-XJ-A83F-01 TCGA-XJ-A83F TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-XJ-A83F-F57164 TCGA-XJ-A83F NO 0 1127 762 NO NO Scheduled Follow-up Submission 2014-10-3 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Transurethral resection (TURBT) Right NO YES NO 7 0 No N0 T3a A83F TUMOR FREE 3 Complete Remission/Response 0.01 NO RX Primary Tumor 01 4 NO NO YES XJ Middle|Base Prostate LIVING 2011 Peripheral Zone ef59f19f-f7c0-4cf3-b686-a0cd09a996b3 TCGA-XJ-A83F-01A-11D-A34T-01 TCGA-XJ-A83F-01A-11D-A34V-05 TCGA-XJ-A83F-01A-11D-A34U-08 ef59f19f-f7c0-4cf3-b686-a0cd09a996b3 TCGA-XJ-A83F-01 TCGA-XJ-A83F-01 TCGA-XJ-A83F-01A-11D-A34T-01 ef59f19f-f7c0-4cf3-b686-a0cd09a996b3 TCGA-XJ-A83F-01 TCGA-XJ-A83F-01 ef59f19f-f7c0-4cf3-b686-a0cd09a996b3 +TCGA-XJ-A83G-01 TCGA-XJ-A83G-01 TCGA-XJ-A83G TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 51 TCGA-XJ-A83G-F56698 TCGA-XJ-A83G TCGA-XJ-A83G-01A NO T1c 1114 0 1461 1126 NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-3 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 40 NO Bilateral NO YES NO 4 0 false No N0 T3b TCGA-XJ-A83G.F5DB0EA7-336E-4A5E-9BFD-3291A5DB4D3D.pdf A83G TUMOR FREE 4 Complete Remission/Response 0.01 NO Primary Tumor 01 3 NO 5 NO YES XJ Apex|Middle Prostate A LIVING 2010 Peripheral Zone 585bed4d-5d57-4308-ab8e-7a0f97e48153 TCGA-XJ-A83G-01A-11D-A34T-01 TCGA-XJ-A83G-01A-11D-A34V-05 TCGA-XJ-A83G-01A-11D-A34U-08 585bed4d-5d57-4308-ab8e-7a0f97e48153 TCGA-XJ-A83G-01 TCGA-XJ-A83G-01 TCGA-XJ-A83G-01A-11D-A34T-01 585bed4d-5d57-4308-ab8e-7a0f97e48153 TCGA-XJ-A83G-01 TCGA-XJ-A83G-01 TCGA-XJ-A83G-01A-11D-A34U-08 585bed4d-5d57-4308-ab8e-7a0f97e48153 +TCGA-XJ-A83H-01 TCGA-XJ-A83H-01 TCGA-XJ-A83H TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-XJ-A83H-F66192 TCGA-XJ-A83H TCGA-XJ-A83H-01A NO M0 T2a 2241 0 0 1280 NO NO Scheduled Follow-up Submission 2014-10-3 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 40 NO Bilateral YES NO NO false No T2c TCGA-XJ-A83H.B4E981CF-B54B-422D-9FD4-E867FAB1FAA8.pdf A83H 3 Partial Remission/Response 0.03 NO R0 Primary Tumor 01 4 NO NO YES XJ Middle|Base Prostate A LIVING 2007 Peripheral Zone 617f26fb-18d8-44dc-8ced-bf3a32428fc9 TCGA-XJ-A83H-01A-11D-A34T-01 TCGA-XJ-A83H-01A-11D-A34V-05 TCGA-XJ-A83H-01A-11D-A34U-08 617f26fb-18d8-44dc-8ced-bf3a32428fc9 TCGA-XJ-A83H-01 TCGA-XJ-A83H-01 TCGA-XJ-A83H-01A-11D-A34T-01 617f26fb-18d8-44dc-8ced-bf3a32428fc9 TCGA-XJ-A83H-01 TCGA-XJ-A83H-01 TCGA-XJ-A83H-01A-11D-A34U-08 617f26fb-18d8-44dc-8ced-bf3a32428fc9 +TCGA-XJ-A9DI-01 TCGA-XJ-A9DI-01 TCGA-XJ-A9DI TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-XJ-A9DI-F66555 TCGA-XJ-A9DI TCGA-XJ-A9DI-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -61 1443 0 1461 1461 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-20 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 20 NO NO YES NO 5 0 false No N0 T3b TCGA-XJ-A9DI.8D5547ED-4864-4CE1-87D0-2FE7621B9B7C.pdf A9DI TUMOR FREE 5 Complete Remission/Response 0.10 YES R0 Primary Tumor 01 4 YES NO YES XJ Base Prostate A LIVING 2009 Peripheral Zone 4eaaf094-c0d8-476e-ba5b-7d9861c1dd5b TCGA-XJ-A9DI-01A-11D-A376-01 TCGA-XJ-A9DI-01A-11D-A378-05 TCGA-XJ-A9DI-01A-11D-A377-08 4eaaf094-c0d8-476e-ba5b-7d9861c1dd5b TCGA-XJ-A9DI-01 TCGA-XJ-A9DI-01 TCGA-XJ-A9DI-01A-11D-A376-01 4eaaf094-c0d8-476e-ba5b-7d9861c1dd5b TCGA-XJ-A9DI-01 TCGA-XJ-A9DI-01 TCGA-XJ-A9DI-01A-11D-A377-08 4eaaf094-c0d8-476e-ba5b-7d9861c1dd5b +TCGA-XJ-A9DK-01 TCGA-XJ-A9DK-01 TCGA-XJ-A9DK TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-XJ-A9DK-F66561 TCGA-XJ-A9DK NO M0 T1c 0 275 275 NO NO Scheduled Follow-up Submission 2014-10-20 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Right YES NO NO No T2c A9DK TUMOR FREE 4 Complete Remission/Response 0.10 NO R0 Primary Tumor 01 4 NO NO YES XJ Apex Prostate LIVING 2007 Peripheral Zone f4024393-b3f0-43b4-916e-4e92cb95c084 TCGA-XJ-A9DK-01A-11D-A376-01 TCGA-XJ-A9DK-01A-11D-A378-05 TCGA-XJ-A9DK-01A-11D-A377-08 f4024393-b3f0-43b4-916e-4e92cb95c084 TCGA-XJ-A9DK-01 TCGA-XJ-A9DK-01 TCGA-XJ-A9DK-01A-11D-A376-01 f4024393-b3f0-43b4-916e-4e92cb95c084 TCGA-XJ-A9DK-01 TCGA-XJ-A9DK-01 TCGA-XJ-A9DK-01A-11D-A377-08 f4024393-b3f0-43b4-916e-4e92cb95c084 +TCGA-XJ-A9DQ-01 TCGA-XJ-A9DQ-01 TCGA-XJ-A9DQ TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 48 TCGA-XJ-A9DQ-F66562 TCGA-XJ-A9DQ TCGA-XJ-A9DQ-01A NO M0 T1c 2265 0 91 NO NO Scheduled Follow-up Submission 2014-10-20 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 20 NO Right YES NO NO false No T2a TCGA-XJ-A9DQ.CAD1C3A1-9EF6-4253-AEEB-C6D80A07C8E7.pdf A9DQ 3 NO R0 Primary Tumor 01 3 NO NO YES XJ Apex|Base Prostate A LIVING 2007 Peripheral Zone 8a7c238f-3e35-4156-b84d-44a95f8653bc TCGA-XJ-A9DQ-01A-11D-A376-01 TCGA-XJ-A9DQ-01A-11D-A378-05 TCGA-XJ-A9DQ-01A-11D-A377-08 8a7c238f-3e35-4156-b84d-44a95f8653bc TCGA-XJ-A9DQ-01 TCGA-XJ-A9DQ-01 TCGA-XJ-A9DQ-01A-11D-A376-01 8a7c238f-3e35-4156-b84d-44a95f8653bc TCGA-XJ-A9DQ-01 TCGA-XJ-A9DQ-01 8a7c238f-3e35-4156-b84d-44a95f8653bc +TCGA-XJ-A9DX-01 TCGA-XJ-A9DX-01 TCGA-XJ-A9DX TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES YES 51 TCGA-XJ-A9DX-F66568 TCGA-XJ-A9DX TCGA-XJ-A9DX-01A NO M1c T1c 651 151 0 973 790 NO NO Scheduled Follow-up Submission Partial Remission/Response 2014-10-20 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 40 NO Bilateral NO YES Biochemical evidence of disease YES 22 2 false No N1 T3b TCGA-XJ-A9DX.FB120749-2C3B-4760-82F2-73C630BF0346.pdf A9DX TUMOR FREE 5 Partial Remission/Response 0.05 R1 Primary Tumor 01 4 NO YES XJ Base Prostate A LIVING 2012 Peripheral Zone 66635f8c-2731-4231-9b71-f68f7d5f8072 TCGA-XJ-A9DX-01A-11D-A376-01 TCGA-XJ-A9DX-01A-11D-A378-05 TCGA-XJ-A9DX-01A-11D-A377-08 66635f8c-2731-4231-9b71-f68f7d5f8072 TCGA-XJ-A9DX-01 TCGA-XJ-A9DX-01 TCGA-XJ-A9DX-01A-11D-A376-01 66635f8c-2731-4231-9b71-f68f7d5f8072 TCGA-XJ-A9DX-01 TCGA-XJ-A9DX-01 66635f8c-2731-4231-9b71-f68f7d5f8072 +TCGA-XK-AAIR-01 TCGA-XK-AAIR-01 TCGA-XK-AAIR TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 75 TCGA-XK-AAIR-F68320 TCGA-XK-AAIR NO M0 T1c -27703 0 972 953 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-14 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 10 0 No N0 T2c AAIR TUMOR FREE 4 Complete Remission/Response 0.09 NO R0 Primary Tumor 01 4 NO NO YES XK Apex|Middle Prostate LIVING 2011 daca8915-ce62-4c6b-a268-c23de4aed85e TCGA-XK-AAIR-01A-11D-A41J-01 TCGA-XK-AAIR-01A-11D-A41L-05 TCGA-XK-AAIR-01A-11D-A41K-08 daca8915-ce62-4c6b-a268-c23de4aed85e TCGA-XK-AAIR-01 TCGA-XK-AAIR-01 TCGA-XK-AAIR-01A-11D-A41J-01 daca8915-ce62-4c6b-a268-c23de4aed85e TCGA-XK-AAIR-01 TCGA-XK-AAIR-01 daca8915-ce62-4c6b-a268-c23de4aed85e +TCGA-XK-AAIV-01 TCGA-XK-AAIV-01 TCGA-XK-AAIV TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-XK-AAIV-F66999 TCGA-XK-AAIV TCGA-XK-AAIV-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -23325 16 898 20 42 0 1133 85 YES No Evidence of Extraprostatic Extension YES Extraprostatic Extension Localized (e.g. seminal vesicles) Scheduled Follow-up Submission Complete Remission/Response 2014-10-29 MALE 10 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 70 NO Bilateral NO YES NO 18 2 true No N1 T3b TCGA-XK-AAIV.84F5F45E-FE71-407C-A892-996B8A6CC0B6.pdf AAIV TUMOR FREE 5 Complete Remission/Response 0.32 YES R1 Primary Tumor 01 5 YES NO YES XK Apex|Middle|Base Prostate A LIVING 2011 822773fd-5a37-49ea-8064-c20738ecc24a TCGA-XK-AAIV-01A-11D-A41J-01 TCGA-XK-AAIV-01A-11D-A41L-05 TCGA-XK-AAIV-01A-11D-A41K-08 822773fd-5a37-49ea-8064-c20738ecc24a TCGA-XK-AAIV-01 TCGA-XK-AAIV-01 TCGA-XK-AAIV-01A-11D-A41J-01 822773fd-5a37-49ea-8064-c20738ecc24a TCGA-XK-AAIV-01 TCGA-XK-AAIV-01 822773fd-5a37-49ea-8064-c20738ecc24a +TCGA-XK-AAIW-01 TCGA-XK-AAIW-01 TCGA-XK-AAIW TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 78 TCGA-XK-AAIW-F67892 TCGA-XK-AAIW TCGA-XK-AAIW-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -28721 7 884 7 0 1218 769 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-12 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 90 NO Bilateral NO YES NO 7 0 true No N0 T3b TCGA-XK-AAIW.A6E4263E-CFAA-4704-B143-095BA0E8DABF.pdf AAIW TUMOR FREE 5 Complete Remission/Response 0.09 NO R1 Primary Tumor 01 4 NO NO YES XK Middle|Base Prostate A LIVING 2011 7f94c422-c322-46d8-be7a-eab05ea534af TCGA-XK-AAIW-01A-11D-A41J-01 TCGA-XK-AAIW-01A-11D-A41L-05 TCGA-XK-AAIW-01A-11D-A41K-08 7f94c422-c322-46d8-be7a-eab05ea534af TCGA-XK-AAIW-01 TCGA-XK-AAIW-01 TCGA-XK-AAIW-01A-11D-A41J-01 7f94c422-c322-46d8-be7a-eab05ea534af TCGA-XK-AAIW-01 TCGA-XK-AAIW-01 7f94c422-c322-46d8-be7a-eab05ea534af +TCGA-XK-AAJ3-01 TCGA-XK-AAJ3-01 TCGA-XK-AAJ3 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 56 TCGA-XK-AAJ3-F66870 TCGA-XK-AAJ3 TCGA-XK-AAJ3-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -20604 13 1185 6 0 1262 863 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission 2014-10-24 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 20 NO Bilateral NO YES NO 6 0 true Yes, History of Prior Malignancy N0 T3a TCGA-XK-AAJ3.6DAD48EB-0C26-4417-A2C1-57332165EEF2.pdf AAJ3 TUMOR FREE 4 Complete Remission/Response 0.09 NO R0 Primary Tumor 01 4 NO NO YES XK Apex|Middle|Base Prostate A LIVING 2010 81674433-89de-4024-aadc-fd8fede17699 TCGA-XK-AAJ3-01A-11D-A41J-01 TCGA-XK-AAJ3-01A-11D-A41L-05 TCGA-XK-AAJ3-01A-11D-A41K-08 81674433-89de-4024-aadc-fd8fede17699 TCGA-XK-AAJ3-01 TCGA-XK-AAJ3-01A-11D-A41J-01 81674433-89de-4024-aadc-fd8fede17699 TCGA-XK-AAJ3-01 81674433-89de-4024-aadc-fd8fede17699 +TCGA-XK-AAJA-01 TCGA-XK-AAJA-01 TCGA-XK-AAJA TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-XK-AAJA NO Normal (no evidence of prostate cancer) [cM0] M0 T2a -22771 15 0 930 712 NO NO 2014-5-12 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral YES NO 7 0 No N0 T3a AAJA 4 Complete Remission/Response 0.09 NO R0 Primary Tumor 01 3 NO NO YES XK Apex|Middle|Base Prostate LIVING 2010 ec7657a0-88da-482a-90d1-1fd03578e11b TCGA-XK-AAJA-01A-11D-A41J-01 TCGA-XK-AAJA-01A-11D-A41L-05 TCGA-XK-AAJA-01A-11D-A41K-08 ec7657a0-88da-482a-90d1-1fd03578e11b TCGA-XK-AAJA-01 TCGA-XK-AAJA-01 TCGA-XK-AAJA-01A-11D-A41J-01 ec7657a0-88da-482a-90d1-1fd03578e11b TCGA-XK-AAJA-01 TCGA-XK-AAJA-01 ec7657a0-88da-482a-90d1-1fd03578e11b +TCGA-XK-AAJP-01 TCGA-XK-AAJP-01 TCGA-XK-AAJP TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-XK-AAJP-F66882 TCGA-XK-AAJP NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -24320 18 18 0 1259 889 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Complete Remission/Response 2014-10-24 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Left NO YES NO 6 0 No N0 T3a AAJP TUMOR FREE 4 Complete Remission/Response 0.09 NO R0 Primary Tumor 01 3 NO NO YES XK Middle|Base Prostate LIVING 2011 Peripheral Zone b426dd0e-446d-4738-a608-beaa368920bf TCGA-XK-AAJP-01A-11D-A41J-01 TCGA-XK-AAJP-01A-11D-A41L-05 TCGA-XK-AAJP-01A-11D-A41K-08 b426dd0e-446d-4738-a608-beaa368920bf TCGA-XK-AAJP-01 TCGA-XK-AAJP-01 TCGA-XK-AAJP-01A-11D-A41J-01 b426dd0e-446d-4738-a608-beaa368920bf TCGA-XK-AAJP-01 TCGA-XK-AAJP-01 b426dd0e-446d-4738-a608-beaa368920bf +TCGA-XK-AAJR-01 TCGA-XK-AAJR-01 TCGA-XK-AAJR TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-XK-AAJR-F67901 TCGA-XK-AAJR TCGA-XK-AAJR-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T1c -22643 12 776 10 131 0 1124 753 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-12 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 10 NO Bilateral NO YES NO 8 0 true No N0 T3a TCGA-XK-AAJR.2FB129E0-B651-4F2F-96DA-B2CCECD4F432.pdf AAJR TUMOR FREE 4 Complete Remission/Response 0.09 NO R0 Primary Tumor 01 3 NO 5 NO YES XK Apex|Middle|Base Prostate A LIVING 2011 15850809-45e4-400d-89c0-20d313f699cb TCGA-XK-AAJR-01A-11D-A41J-01 TCGA-XK-AAJR-01A-11D-A41L-05 TCGA-XK-AAJR-01A-11D-A41K-08 15850809-45e4-400d-89c0-20d313f699cb TCGA-XK-AAJR-01 TCGA-XK-AAJR-01 TCGA-XK-AAJR-01A-11D-A41J-01 15850809-45e4-400d-89c0-20d313f699cb TCGA-XK-AAJR-01 TCGA-XK-AAJR-01 15850809-45e4-400d-89c0-20d313f699cb +TCGA-XK-AAJT-01 TCGA-XK-AAJT-01 TCGA-XK-AAJT TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 75 TCGA-XK-AAJT-F66883 TCGA-XK-AAJT TCGA-XK-AAJT-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -27428 19 1135 14 0 1434 566 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-24 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 10 NO Bilateral NO YES NO 4 0 true No N0 T3a TCGA-XK-AAJT.7596C336-6BF6-4188-9C8B-90C0EC840911.pdf AAJT TUMOR FREE 4 Partial Remission/Response 0.09 NO R1 Primary Tumor 01 3 NO 5 NO YES XK Base Prostate A LIVING 2010 Peripheral Zone 4caa2b59-1435-4e64-9cf5-1658b3e9c147 TCGA-XK-AAJT-01A-11D-A41J-01 TCGA-XK-AAJT-01A-11D-A41L-05 TCGA-XK-AAJT-01A-11D-A41K-08 4caa2b59-1435-4e64-9cf5-1658b3e9c147 TCGA-XK-AAJT-01 TCGA-XK-AAJT-01 TCGA-XK-AAJT-01A-11D-A41J-01 4caa2b59-1435-4e64-9cf5-1658b3e9c147 TCGA-XK-AAJT-01 TCGA-XK-AAJT-01 4caa2b59-1435-4e64-9cf5-1658b3e9c147 +TCGA-XK-AAJU-01 TCGA-XK-AAJU-01 TCGA-XK-AAJU TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-XK-AAJU-F66884 TCGA-XK-AAJU TCGA-XK-AAJU-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -23958 9 1276 0 1576 1206 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-24 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 130 NO Bilateral NO YES NO 5 0 true No N0 T2c TCGA-XK-AAJU.08C5834B-E57D-4182-86DE-4B83314D6799.pdf AAJU TUMOR FREE 4 Complete Remission/Response 0.09 NO R0 Primary Tumor 01 3 NO NO YES XK Apex|Middle|Base Prostate A LIVING 2010 45f7bba9-5bf4-4b9c-b749-996e4b8d5582 TCGA-XK-AAJU-01A-11D-A41J-01 TCGA-XK-AAJU-01A-11D-A41L-05 TCGA-XK-AAJU-01A-11D-A41K-08 45f7bba9-5bf4-4b9c-b749-996e4b8d5582 TCGA-XK-AAJU-01 TCGA-XK-AAJU-01 TCGA-XK-AAJU-01A-11D-A41J-01 45f7bba9-5bf4-4b9c-b749-996e4b8d5582 TCGA-XK-AAJU-01 TCGA-XK-AAJU-01 45f7bba9-5bf4-4b9c-b749-996e4b8d5582 +TCGA-XK-AAK1-01 TCGA-XK-AAK1-01 TCGA-XK-AAK1 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-XK-AAK1-F68316 TCGA-XK-AAK1 NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -22965 -2 0 979 614 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-14 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 6 0 Yes, History of Prior Malignancy N0 T2c AAK1 TUMOR FREE 4 Complete Remission/Response 0.09 NO R0 Primary Tumor 01 3 NO NO YES XK Apex|Middle|Base Prostate LIVING 2012 ec4f5770-275f-494f-af91-b82e62f19f1a TCGA-XK-AAK1-01A-11D-A41J-01 TCGA-XK-AAK1-01A-11D-A41L-05 TCGA-XK-AAK1-01A-11D-A41K-08 ec4f5770-275f-494f-af91-b82e62f19f1a TCGA-XK-AAK1-01 TCGA-XK-AAK1-01A-11D-A41J-01 ec4f5770-275f-494f-af91-b82e62f19f1a TCGA-XK-AAK1-01 ec4f5770-275f-494f-af91-b82e62f19f1a +TCGA-XQ-A8TA-01 TCGA-XQ-A8TA-01 TCGA-XQ-A8TA TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-XQ-A8TA-F69992 TCGA-XQ-A8TA YES Prostate Cancer Metastases Present [cM1b] M1b T3a -21889 146 -10 0 62 YES Distant Metastasis [e.g. cM1] YES Distant Metastasis [e.g. cM1] Scheduled Follow-up Submission Progressive Disease 2015-1-26 MALE 10 Prostate Adenocarcinoma Acinar Type Yes, Pharmaceutical Treatment Prior to Resection C61 8140/3 C61.9 YES Transurethral resection (TURBT) Bilateral NO NO No Prostate Cancer A8TA WITH TUMOR 5 Progressive Disease 323.0 NO Primary Tumor 01 5 Medical Record YES XQ YES Prostate Distant Metastasis DECEASED 2012 Peripheral Zone ae50d91a-35e2-4b18-8089-b18844a63b5e TCGA-XQ-A8TA-01A-11D-A363-01 TCGA-XQ-A8TA-01A-11D-A365-05 TCGA-XQ-A8TA-01A-11D-A364-08 ae50d91a-35e2-4b18-8089-b18844a63b5e TCGA-XQ-A8TA-01 TCGA-XQ-A8TA-01 TCGA-XQ-A8TA-01A-11D-A363-01 ae50d91a-35e2-4b18-8089-b18844a63b5e TCGA-XQ-A8TA-01 TCGA-XQ-A8TA-01 TCGA-XQ-A8TA-01A-11D-A364-08 ae50d91a-35e2-4b18-8089-b18844a63b5e +TCGA-XQ-A8TB-01 TCGA-XQ-A8TB-01 TCGA-XQ-A8TB TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-XQ-A8TB-F69995 TCGA-XQ-A8TB NO Abnormal (not related to prostate cancer) M0 T2a -24623 -24 0 770 674 NO NO Complete Remission/Response 2015-1-26 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO YES NO 4 0 No N0 T3b A8TB TUMOR FREE 4 Complete Remission/Response 0.0 YES R1 Primary Tumor 01 5 NO XQ Apex|Middle|Base Prostate LIVING 2012 Peripheral Zone ad733fd8-9c1f-4552-88de-3bc50ec1a9ac TCGA-XQ-A8TB-01A-11D-A363-01 TCGA-XQ-A8TB-01A-11D-A365-05 TCGA-XQ-A8TB-01A-11D-A364-08 ad733fd8-9c1f-4552-88de-3bc50ec1a9ac TCGA-XQ-A8TB-01 TCGA-XQ-A8TB-01 TCGA-XQ-A8TB-01A-11D-A363-01 ad733fd8-9c1f-4552-88de-3bc50ec1a9ac TCGA-XQ-A8TB-01 TCGA-XQ-A8TB-01 TCGA-XQ-A8TB-01A-11D-A364-08 ad733fd8-9c1f-4552-88de-3bc50ec1a9ac +TCGA-Y6-A8TL-01 TCGA-Y6-A8TL-01 TCGA-Y6-A8TL TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-Y6-A8TL-F68020 TCGA-Y6-A8TL TCGA-Y6-A8TL-01A NO T2a -23776 677 328 0 992 775 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-13 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 370 NO Right NO YES NO 5 0 true No N0 T3a TCGA-Y6-A8TL.8DE4AB1E-913E-4763-81EE-272430E5CC4A.pdf A8TL TUMOR FREE 3 0 NO R0 Primary Tumor 01 3 NO NO YES Y6 Apex Prostate A LIVING 2012 Peripheral Zone baeaec83-29cf-4fcd-b6b4-6054510d9d86 TCGA-Y6-A8TL-01A-21D-A376-01 TCGA-Y6-A8TL-01A-21D-A378-05 TCGA-Y6-A8TL-01A-21D-A377-08 baeaec83-29cf-4fcd-b6b4-6054510d9d86 TCGA-Y6-A8TL-01 TCGA-Y6-A8TL-01 316A3F78-1775-436F-94F1-F0031123CEAE TCGA-Y6-A8TL-01A-21D-A376-01 baeaec83-29cf-4fcd-b6b4-6054510d9d86 TCGA-Y6-A8TL-01 TCGA-Y6-A8TL-01 TCGA-Y6-A8TL-01A-21D-A377-08 baeaec83-29cf-4fcd-b6b4-6054510d9d86 +TCGA-Y6-A9XI-01 TCGA-Y6-A9XI-01 TCGA-Y6-A9XI TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 72 TCGA-Y6-A9XI-F68012 TCGA-Y6-A9XI TCGA-Y6-A9XI-01A NO -26471 413 0 526 519 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-12-1 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 210 NO Bilateral NO YES NO 4 0 true No N0 [Discrepancy] TCGA-Y6-A9XI.FA6B58B3-B9C2-437D-9041-B0179F1386ED.pdf A9XI TUMOR FREE 4 Complete Remission/Response 0.06 NO R1 Primary Tumor 01 4 NO NO YES Y6 Apex Prostate A LIVING 2012 Peripheral Zone 20e1a03e-b18b-41ed-aaf4-95a5aefb4fbf TCGA-Y6-A9XI-01A-11D-A41J-01 TCGA-Y6-A9XI-01A-11D-A41L-05 TCGA-Y6-A9XI-01A-11D-A41K-08 20e1a03e-b18b-41ed-aaf4-95a5aefb4fbf TCGA-Y6-A9XI-01 TCGA-Y6-A9XI-01 BC7C4D91-B5A0-4C7F-81BC-A23494859232 TCGA-Y6-A9XI-01A-11D-A41J-01 20e1a03e-b18b-41ed-aaf4-95a5aefb4fbf TCGA-Y6-A9XI-01 TCGA-Y6-A9XI-01 20e1a03e-b18b-41ed-aaf4-95a5aefb4fbf +TCGA-YJ-A8SW-01 TCGA-YJ-A8SW-01 TCGA-YJ-A8SW TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-YJ-A8SW TCGA-YJ-A8SW-01A YES T1c 2051 148 0 148 148 2014-5-13 MALE 9 Prostate Adenocarcinoma, Other Subtype No C61.9 8480/3 C61.9 YES Core needle biopsy 1000 NO Right YES 2 0 true No N0 T3b TCGA-YJ-A8SW.33D6587B-0289-49B5-9D16-497B6C17EFD9.pdf A8SW 5 0.38 R1 Primary Tumor 01 4 NO YES YJ Prostate A LIVING 2008 6fc325bf-9627-45d7-9081-28df74e79bdb TCGA-YJ-A8SW-01A-11D-A376-01 TCGA-YJ-A8SW-01A-11D-A378-05 TCGA-YJ-A8SW-01A-11D-A377-08 6fc325bf-9627-45d7-9081-28df74e79bdb TCGA-YJ-A8SW-01 TCGA-YJ-A8SW-01 64E65412-50A3-43A1-8853-E0BFC8D5DB06 TCGA-YJ-A8SW-01A-11D-A376-01 6fc325bf-9627-45d7-9081-28df74e79bdb TCGA-YJ-A8SW-01 TCGA-YJ-A8SW-01 TCGA-YJ-A8SW-01A-11D-A377-08 6fc325bf-9627-45d7-9081-28df74e79bdb +TCGA-YL-A8HJ-01 TCGA-YL-A8HJ-01 TCGA-YL-A8HJ TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 58 TCGA-YL-A8HJ-F67253 TCGA-YL-A8HJ TCGA-YL-A8HJ-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -21416 54 1653 -34 0 1611 1589 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-3 MALE 9 Prostate Adenocarcinoma, Other Subtype No C61 8140/3 C61.9 YES Core needle biopsy 370 NO Bilateral NO NO NO true No T3b TCGA-YL-A8HJ.A4B8AFC5-774E-4FB2-8191-735949EC3E42.pdf A8HJ TUMOR FREE 4 Complete Remission/Response 0.03 YES R0 Primary Tumor 01 5 YES 3 NO YES YL Apex|Middle|Base Prostate A LIVING 2009 Overlapping / Multiple Zones de7d6e8a-7408-4011-be1a-52e3cc9fa61b TCGA-YL-A8HJ-01A-11D-A363-01 TCGA-YL-A8HJ-01A-11D-A365-05 TCGA-YL-A8HJ-01A-11D-A364-08 de7d6e8a-7408-4011-be1a-52e3cc9fa61b TCGA-YL-A8HJ-01 TCGA-YL-A8HJ-01 760FF949-8735-411A-B53C-371FDA18CB60 TCGA-YL-A8HJ-01A-11D-A363-01 de7d6e8a-7408-4011-be1a-52e3cc9fa61b TCGA-YL-A8HJ-01 TCGA-YL-A8HJ-01 TCGA-YL-A8HJ-01A-11D-A364-08 de7d6e8a-7408-4011-be1a-52e3cc9fa61b +TCGA-YL-A8HK-01 TCGA-YL-A8HK-01 TCGA-YL-A8HK TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-YL-A8HK-F56601 TCGA-YL-A8HK TCGA-YL-A8HK-01A YES Normal (no evidence of prostate cancer) [cM0] M0 -21850 27 1477 195 1376 0 1491 1376 1491 YES No Evidence of Extraprostatic Extension NO Additional New Tumor Event 2014-3-13 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 140 NO Bilateral NO YES Biochemical evidence of disease YES 1 0 true No N0 T3b TCGA-YL-A8HK.AB7217AC-ABF7-4704-9413-9298DDE688EE.pdf A8HK WITH TUMOR 4 Complete Remission/Response 1.0 YES R1 Primary Tumor 01 5 YES NO YES YL Apex|Middle|Base Prostate A LIVING 2009 Overlapping / Multiple Zones 8697017a-b4d9-4f19-8887-168e80124ebd TCGA-YL-A8HK-01A-11D-A363-01 TCGA-YL-A8HK-01A-11D-A365-05 TCGA-YL-A8HK-01A-11D-A364-08 8697017a-b4d9-4f19-8887-168e80124ebd TCGA-YL-A8HK-01 TCGA-YL-A8HK-01 B61841FE-2C11-4DC3-9426-E1029351F7C0 TCGA-YL-A8HK-01A-11D-A363-01 8697017a-b4d9-4f19-8887-168e80124ebd TCGA-YL-A8HK-01 TCGA-YL-A8HK-01 TCGA-YL-A8HK-01A-11D-A364-08 8697017a-b4d9-4f19-8887-168e80124ebd +TCGA-YL-A8HL-01 TCGA-YL-A8HL-01 TCGA-YL-A8HL TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 58 TCGA-YL-A8HL-F67258 TCGA-YL-A8HL TCGA-YL-A8HL-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -21249 25 1387 27 0 1565 1173 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Stable Disease 2014-11-3 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 170 NO Bilateral NO YES NO 8 2 true No N1 T3b TCGA-YL-A8HL.0C91388C-CCC6-4BBD-B13A-E543A8FC2E5F.pdf A8HL 4 Stable Disease 0.03 YES R1 Primary Tumor 01 5 YES NO YES YL Apex|Middle|Base Prostate A LIVING 2010 Overlapping / Multiple Zones c291389a-1dfd-4eef-9542-7269a8bd797a TCGA-YL-A8HL-01A-11D-A363-01 TCGA-YL-A8HL-01A-11D-A365-05 TCGA-YL-A8HL-01A-11D-A364-08 c291389a-1dfd-4eef-9542-7269a8bd797a TCGA-YL-A8HL-01 TCGA-YL-A8HL-01 9C580829-CF49-4346-9F40-B94334C0C2B0 TCGA-YL-A8HL-01A-11D-A363-01 c291389a-1dfd-4eef-9542-7269a8bd797a TCGA-YL-A8HL-01 TCGA-YL-A8HL-01 TCGA-YL-A8HL-01A-11D-A364-08 c291389a-1dfd-4eef-9542-7269a8bd797a +TCGA-YL-A8HM-01 TCGA-YL-A8HM-01 TCGA-YL-A8HM TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-YL-A8HM-F67260 TCGA-YL-A8HM TCGA-YL-A8HM-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -24121 26 1323 1473 0 1482 1473 1124 NO NO Additional New Tumor Event 2014-11-3 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 160 NO Bilateral NO YES Biochemical evidence of disease YES 10 0 true No N0 T3b TCGA-YL-A8HM.4CDB8D1D-D1F1-4A78-A0C0-CA56CBC0689C.pdf A8HM WITH TUMOR 4 Complete Remission/Response 0.03 YES R0 Primary Tumor 01 5 YES NO YES YL Apex|Middle|Base YES Prostate Biochemical Recurrence A LIVING 2010 Overlapping / Multiple Zones 49e0744c-4f4c-4cac-bc4e-2a11f1cf6a45 TCGA-YL-A8HM-01A-11D-A363-01 TCGA-YL-A8HM-01A-11D-A365-05 TCGA-YL-A8HM-01A-11D-A364-08 49e0744c-4f4c-4cac-bc4e-2a11f1cf6a45 TCGA-YL-A8HM-01 TCGA-YL-A8HM-01 C2CF4E4E-85B5-42C6-AF19-AB61018CD23C TCGA-YL-A8HM-01A-11D-A363-01 49e0744c-4f4c-4cac-bc4e-2a11f1cf6a45 TCGA-YL-A8HM-01 TCGA-YL-A8HM-01 TCGA-YL-A8HM-01A-11D-A364-08 49e0744c-4f4c-4cac-bc4e-2a11f1cf6a45 +TCGA-YL-A8HO-01 TCGA-YL-A8HO-01 TCGA-YL-A8HO TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO YES 67 TCGA-YL-A8HO-F67262 TCGA-YL-A8HO TCGA-YL-A8HO-01A NO Abnormal (not related to prostate cancer) M0 -24509 62 2100 117 1068 0 2304 1068 2168 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Stable Disease 2014-11-3 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 330 NO Bilateral NO YES Biochemical evidence of disease YES 18 0 true No N0 T3a TCGA-YL-A8HO.3C690B20-F9EC-456D-B397-928E39B3FFE2.pdf A8HO WITH TUMOR 4 Stable Disease 0.01 NO R1 Primary Tumor 01 3 NO 5 NO YES YL Middle|Base Prostate A LIVING 2008 Overlapping / Multiple Zones 35e62a79-9fa0-4ff9-a8c3-d163817d7f08 TCGA-YL-A8HO-01A-11D-A363-01 TCGA-YL-A8HO-01A-11D-A365-05 TCGA-YL-A8HO-01A-11D-A364-08 35e62a79-9fa0-4ff9-a8c3-d163817d7f08 TCGA-YL-A8HO-01 TCGA-YL-A8HO-01 FF75F68F-2BCF-4801-A541-FCA9EAB9EEA4 TCGA-YL-A8HO-01A-11D-A363-01 35e62a79-9fa0-4ff9-a8c3-d163817d7f08 TCGA-YL-A8HO-01 TCGA-YL-A8HO-01 TCGA-YL-A8HO-01A-11D-A364-08 35e62a79-9fa0-4ff9-a8c3-d163817d7f08 +TCGA-YL-A8S8-01 TCGA-YL-A8S8-01 TCGA-YL-A8S8 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO YES 68 TCGA-YL-A8S8-F58862 TCGA-YL-A8S8 TCGA-YL-A8S8-01A YES Normal (no evidence of prostate cancer) [cM0] M0 -25119 18 2146 28 679 0 1890 679 1890 YES No Evidence of Extraprostatic Extension NO Additional New Tumor Event Progressive Disease 2014-4-25 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 130 NO Bilateral NO YES Biochemical evidence of disease YES 10 0 true No N0 T3a TCGA-YL-A8S8.6D4A3078-4C6B-4E94-B859-CCA473B09CF9.pdf A8S8 WITH TUMOR 4 Stable Disease 1.36 NO R1 Primary Tumor 01 5 NO NO YES YL Apex|Middle|Base Prostate A LIVING 2008 Overlapping / Multiple Zones 8a1e40cc-f9be-4df4-9958-53c97d7fd794 TCGA-YL-A8S8-01A-11D-A376-01 TCGA-YL-A8S8-01A-11D-A378-05 TCGA-YL-A8S8-01A-11D-A377-08 8a1e40cc-f9be-4df4-9958-53c97d7fd794 TCGA-YL-A8S8-01 TCGA-YL-A8S8-01 4F6FED0C-A461-4100-8C47-9A3C2A35F49B TCGA-YL-A8S8-01A-11D-A376-01 8a1e40cc-f9be-4df4-9958-53c97d7fd794 TCGA-YL-A8S8-01 TCGA-YL-A8S8-01 TCGA-YL-A8S8-01A-11D-A377-08 8a1e40cc-f9be-4df4-9958-53c97d7fd794 +TCGA-YL-A8S9-01 TCGA-YL-A8S9-01 TCGA-YL-A8S9 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO YES 63 TCGA-YL-A8S9-F58868 TCGA-YL-A8S9 TCGA-YL-A8S9-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -23204 20 1891 0 1842 1006 1839 NO NO Additional New Tumor Event Complete Remission/Response 2014-4-25 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 110 NO Bilateral NO YES Locoregional Recurrence YES 5 0 true No N0 T3a TCGA-YL-A8S9.7E33F018-6494-413F-A68D-AC4013916756.pdf A8S9 4 Stable Disease 0.03 NO R1 Primary Tumor 01 5 NO 3 NO YES YL Apex|Middle Prostate A LIVING 2008 Overlapping / Multiple Zones ada9616f-c9d1-46cd-bccc-29d2e4e0d1ea TCGA-YL-A8S9-01A-11D-A376-01 TCGA-YL-A8S9-01A-11D-A378-05 TCGA-YL-A8S9-01A-11D-A377-08 ada9616f-c9d1-46cd-bccc-29d2e4e0d1ea TCGA-YL-A8S9-01 TCGA-YL-A8S9-01 63BEAF58-7656-4FE0-9DF3-E6A28DF3B6DF TCGA-YL-A8S9-01A-11D-A376-01 ada9616f-c9d1-46cd-bccc-29d2e4e0d1ea TCGA-YL-A8S9-01 TCGA-YL-A8S9-01 TCGA-YL-A8S9-01A-11D-A377-08 ada9616f-c9d1-46cd-bccc-29d2e4e0d1ea +TCGA-YL-A8SA-01 TCGA-YL-A8SA-01 TCGA-YL-A8SA TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 69 TCGA-YL-A8SA-F67565 TCGA-YL-A8SA TCGA-YL-A8SA-01A NO M0 T2b -25340 1465 0 512 467 NO NO Scheduled Follow-up Submission 2014-11-6 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 200 NO Bilateral YES YES NO 9 0 true No N0 T3b TCGA-YL-A8SA.F837EF53-FF44-4F51-8764-27B00168B113.pdf A8SA 4 Stable Disease 0.06 YES R1 Primary Tumor 01 4 NO 5 NO YES YL Apex|Middle|Base Prostate A LIVING 2009 Overlapping / Multiple Zones 42b3e255-38df-41f7-a4b8-77510d467dd2 TCGA-YL-A8SA-01A-21D-A376-01 TCGA-YL-A8SA-01A-21D-A378-05 TCGA-YL-A8SA-01A-21D-A377-08 42b3e255-38df-41f7-a4b8-77510d467dd2 TCGA-YL-A8SA-01 TCGA-YL-A8SA-01 B73AC452-1030-4998-80D4-95AE09266783 TCGA-YL-A8SA-01A-21D-A376-01 42b3e255-38df-41f7-a4b8-77510d467dd2 TCGA-YL-A8SA-01 TCGA-YL-A8SA-01 TCGA-YL-A8SA-01A-21D-A377-08 42b3e255-38df-41f7-a4b8-77510d467dd2 +TCGA-YL-A8SB-01 TCGA-YL-A8SB-01 TCGA-YL-A8SB TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES NO 62 TCGA-YL-A8SB-F67264 TCGA-YL-A8SB NO Normal (no evidence of prostate cancer) [cM0] M0 -22991 27 52 1384 0 1719 1384 1384 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission 2014-11-3 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral NO YES Biochemical evidence of disease YES 3 0 No N0 T3a A8SB WITH TUMOR 4 Stable Disease 0.23 YES R1 Primary Tumor 01 5 YES NO YES YL Apex|Middle|Base YES Prostate Biochemical Recurrence LIVING 2010 Overlapping / Multiple Zones d593d47e-581a-4da3-bb3a-648b2bfb4cae TCGA-YL-A8SB-01A-31D-A376-01 TCGA-YL-A8SB-01A-31D-A378-05 TCGA-YL-A8SB-01A-31D-A377-08 d593d47e-581a-4da3-bb3a-648b2bfb4cae TCGA-YL-A8SB-01 TCGA-YL-A8SB-01 TCGA-YL-A8SB-01A-31D-A376-01 d593d47e-581a-4da3-bb3a-648b2bfb4cae TCGA-YL-A8SB-01 TCGA-YL-A8SB-01 TCGA-YL-A8SB-01A-31D-A377-08 d593d47e-581a-4da3-bb3a-648b2bfb4cae +TCGA-YL-A8SC-01 TCGA-YL-A8SC-01 TCGA-YL-A8SC TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-YL-A8SC-F58906 TCGA-YL-A8SC TCGA-YL-A8SC-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -24206 40 1387 47 152 0 1261 152 1261 YES No Evidence of Extraprostatic Extension NO Additional New Tumor Event Partial Remission/Response 2014-4-27 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 100 NO Bilateral NO YES Biochemical evidence of disease YES 6 0 true No N0 T3a TCGA-YL-A8SC.557F4A89-87FC-44FA-9460-F8D1BCA759AE.pdf A8SC WITH TUMOR 4 Partial Remission/Response 0.65 NO R1 Primary Tumor 01 5 YES NO YES YL Apex|Middle|Base YES Prostate Biochemical Recurrence A LIVING 2010 Overlapping / Multiple Zones cc9dfa83-d316-4455-bd08-967fb33a54ff TCGA-YL-A8SC-01A-11D-A376-01 TCGA-YL-A8SC-01A-11D-A378-05 TCGA-YL-A8SC-01A-11D-A377-08 cc9dfa83-d316-4455-bd08-967fb33a54ff TCGA-YL-A8SC-01 TCGA-YL-A8SC-01 5B646A8D-2B8F-42CC-B54B-2E5D1DAB2B51 TCGA-YL-A8SC-01A-11D-A376-01 cc9dfa83-d316-4455-bd08-967fb33a54ff TCGA-YL-A8SC-01 TCGA-YL-A8SC-01 TCGA-YL-A8SC-01A-11D-A377-08 cc9dfa83-d316-4455-bd08-967fb33a54ff +TCGA-YL-A8SF-01 TCGA-YL-A8SF-01 TCGA-YL-A8SF TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 62 TCGA-YL-A8SF-F67270 TCGA-YL-A8SF TCGA-YL-A8SF-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -22844 29 1271 22 0 1373 1247 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Stable Disease 2014-11-3 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 520 NO Bilateral NO YES NO 2 0 true No N0 T3b TCGA-YL-A8SF.9E568211-305B-4F23-8B31-59D80E0EE174.pdf A8SF 4 Stable Disease 0.01 NO R1 Primary Tumor 01 4 NO 5 NO YES YL Apex|Middle|Base Prostate A LIVING 2010 Overlapping / Multiple Zones bac074d2-4e5b-4450-baee-749fc4a93c7a TCGA-YL-A8SF-01A-11D-A376-01 TCGA-YL-A8SF-01A-11D-A378-05 TCGA-YL-A8SF-01A-11D-A377-08 bac074d2-4e5b-4450-baee-749fc4a93c7a TCGA-YL-A8SF-01 TCGA-YL-A8SF-01 E9B96DB5-B4B4-443D-9745-33D8779C2A5A TCGA-YL-A8SF-01A-11D-A376-01 bac074d2-4e5b-4450-baee-749fc4a93c7a TCGA-YL-A8SF-01 TCGA-YL-A8SF-01 TCGA-YL-A8SF-01A-11D-A377-08 bac074d2-4e5b-4450-baee-749fc4a93c7a +TCGA-YL-A8SH-01 TCGA-YL-A8SH-01 TCGA-YL-A8SH TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 69 TCGA-YL-A8SH TCGA-YL-A8SH-01B NO M0 -25395 1481 875 0 617 NO NO 2014-4-25 MALE 7 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 510 NO Bilateral YES NO 21 0 true No N0 T3a TCGA-YL-A8SH.62FF9B6A-9C3E-4E29-9D57-10CC2025C5B7.pdf Other, non-malignant disease A8SH TUMOR FREE 4 Complete Remission/Response 0.06 NO R0 Primary Tumor 01 3 Death Certificate NO NO YES YL Apex|Middle|Base Prostate B DECEASED 2009 Overlapping / Multiple Zones 905e6c11-d8d7-40a3-a933-f450c544714e TCGA-YL-A8SH-01B-11D-A376-01 TCGA-YL-A8SH-01B-11D-A378-05 TCGA-YL-A8SH-01B-11D-A377-08 905e6c11-d8d7-40a3-a933-f450c544714e TCGA-YL-A8SH-01 TCGA-YL-A8SH-01 3F15A275-B61C-4E93-8ECF-B41F9867B3DC TCGA-YL-A8SH-01B-11D-A376-01 905e6c11-d8d7-40a3-a933-f450c544714e TCGA-YL-A8SH-01 TCGA-YL-A8SH-01 TCGA-YL-A8SH-01B-11D-A377-08 905e6c11-d8d7-40a3-a933-f450c544714e +TCGA-YL-A8SI-01 TCGA-YL-A8SI-01 TCGA-YL-A8SI TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES YES 69 TCGA-YL-A8SI-F67703 TCGA-YL-A8SI TCGA-YL-A8SI-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -25292 47 1345 62 1423 0 1614 1423 1441 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-10 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 390 NO Bilateral NO YES Biochemical evidence of disease YES 15 0 true No N0 T3a TCGA-YL-A8SI.30B3AC4A-A7B0-4257-BFEB-15AD2F66ADAE.pdf A8SI TUMOR FREE 4 Complete Remission/Response 0.48 NO R0 Primary Tumor 01 5 NO NO YES YL Apex|Middle|Base Prostate A LIVING 2010 Overlapping / Multiple Zones 968c1021-d6c1-4e0e-8417-43b78a6bdf6d TCGA-YL-A8SI-01A-11D-A41J-01 TCGA-YL-A8SI-01A-11D-A41L-05 TCGA-YL-A8SI-01A-11D-A41K-08 968c1021-d6c1-4e0e-8417-43b78a6bdf6d TCGA-YL-A8SI-01 TCGA-YL-A8SI-01 1B7F9946-3F8D-4B06-A2E0-2DF917E6DA05 TCGA-YL-A8SI-01A-11D-A41J-01 968c1021-d6c1-4e0e-8417-43b78a6bdf6d TCGA-YL-A8SI-01 TCGA-YL-A8SI-01 968c1021-d6c1-4e0e-8417-43b78a6bdf6d +TCGA-YL-A8SJ-01 TCGA-YL-A8SJ-01 TCGA-YL-A8SJ TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO YES 60 TCGA-YL-A8SJ-F58899 TCGA-YL-A8SJ TCGA-YL-A8SJ-01B YES M0 -21916 1306 752 0 1395 752 1426 NO NO Additional New Tumor Event Partial Remission/Response 2014-4-25 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 460 NO Bilateral NO YES Biochemical evidence of disease YES 29 0 true No N0 T3b TCGA-YL-A8SJ.86F65B00-7E83-4013-85E8-A4AE42686ACF.pdf A8SJ WITH TUMOR 4 Complete Remission/Response 0.24 NO R0 Primary Tumor 01 5 NO NO YES YL Middle|Base Prostate B LIVING 2010 Overlapping / Multiple Zones 146b24ab-44b3-4b64-80c2-7ced0f829501 TCGA-YL-A8SJ-01B-11D-A376-01 TCGA-YL-A8SJ-01B-11D-A378-05 TCGA-YL-A8SJ-01B-11D-A377-08 146b24ab-44b3-4b64-80c2-7ced0f829501 TCGA-YL-A8SJ-01 TCGA-YL-A8SJ-01 97C40C9F-600A-42BC-8163-A7AE095DCB85 TCGA-YL-A8SJ-01B-11D-A376-01 146b24ab-44b3-4b64-80c2-7ced0f829501 TCGA-YL-A8SJ-01 TCGA-YL-A8SJ-01 TCGA-YL-A8SJ-01B-11D-A377-08 146b24ab-44b3-4b64-80c2-7ced0f829501 +TCGA-YL-A8SK-01 TCGA-YL-A8SK-01 TCGA-YL-A8SK TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-YL-A8SK-F67551 TCGA-YL-A8SK TCGA-YL-A8SK-01B NO Normal (no evidence of prostate cancer) [cM0] M0 -24759 38 1208 0 1408 924 NO NO Scheduled Follow-up Submission Stable Disease 2014-11-6 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 410 NO Bilateral NO YES NO 20 4 true No N1 T3b TCGA-YL-A8SK.F332F5AD-A0BE-455D-9523-13BDF275DB2A.pdf A8SK 4 Stable Disease 0.03 YES R1 Primary Tumor 01 5 YES NO YES YL Apex|Middle|Base Prostate B LIVING 2010 Overlapping / Multiple Zones 530578d1-044b-4423-bd9c-ae80a2d7fda1 TCGA-YL-A8SK-01B-21D-A376-01 TCGA-YL-A8SK-01B-21D-A378-05 TCGA-YL-A8SK-01B-21D-A377-08 530578d1-044b-4423-bd9c-ae80a2d7fda1 TCGA-YL-A8SK-01 TCGA-YL-A8SK-01 EAFB0B83-81C8-4243-9CB4-E1D7EDB895DF TCGA-YL-A8SK-01B-21D-A376-01 530578d1-044b-4423-bd9c-ae80a2d7fda1 TCGA-YL-A8SK-01 TCGA-YL-A8SK-01 TCGA-YL-A8SK-01B-21D-A377-08 530578d1-044b-4423-bd9c-ae80a2d7fda1 +TCGA-YL-A8SL-01 TCGA-YL-A8SL-01 TCGA-YL-A8SL TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 74 TCGA-YL-A8SL-F67548 TCGA-YL-A8SL TCGA-YL-A8SL-01B NO Normal (no evidence of prostate cancer) [cM0] M0 -27033 41 835 43 0 987 623 YES Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1] NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-6 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 760 NO Bilateral NO YES NO 19 3 true No N1 T3b TCGA-YL-A8SL.561D6EB5-1E61-4134-B6F6-96B1B9A27163.pdf A8SL TUMOR FREE 4 Complete Remission/Response 0 NO R0 Primary Tumor 01 4 YES 3 NO YES YL Apex|Middle|Base Prostate B LIVING 2011 Overlapping / Multiple Zones 20f7a673-eb82-4bfc-a757-096b2fc3f98b TCGA-YL-A8SL-01B-21D-A376-01 TCGA-YL-A8SL-01B-21D-A378-05 TCGA-YL-A8SL-01B-21D-A377-08 20f7a673-eb82-4bfc-a757-096b2fc3f98b TCGA-YL-A8SL-01 TCGA-YL-A8SL-01 CEBD0D90-99F5-44B4-A778-DEA5C97562CD TCGA-YL-A8SL-01B-21D-A376-01 20f7a673-eb82-4bfc-a757-096b2fc3f98b TCGA-YL-A8SL-01 TCGA-YL-A8SL-01 TCGA-YL-A8SL-01B-21D-A377-08 20f7a673-eb82-4bfc-a757-096b2fc3f98b +TCGA-YL-A8SO-01 TCGA-YL-A8SO-01 TCGA-YL-A8SO TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-YL-A8SO-F67275 TCGA-YL-A8SO TCGA-YL-A8SO-01B NO M0 T1a -23584 3329 0 3479 3247 Scheduled Follow-up Submission Stable Disease 2014-11-3 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Transurethral resection (TURBT) 1270 NO Bilateral NO NO NO true No T3a TCGA-YL-A8SO.3B555422-C4AD-4FCC-A241-34D33F0DE82B.pdf A8SO 4 Stable Disease 0 NO R1 Primary Tumor 01 5 YES NO YES YL Apex|Middle Prostate B LIVING 2004 Overlapping / Multiple Zones 7471bd76-b32f-41a3-bf95-8752745a7e70 TCGA-YL-A8SO-01B-31D-A376-01 TCGA-YL-A8SO-01B-31D-A378-05 TCGA-YL-A8SO-01B-31D-A377-08 7471bd76-b32f-41a3-bf95-8752745a7e70 TCGA-YL-A8SO-01 TCGA-YL-A8SO-01 TCGA-YL-A8SO-01B-31D-A376-01 7471bd76-b32f-41a3-bf95-8752745a7e70 TCGA-YL-A8SO-01 TCGA-YL-A8SO-01 TCGA-YL-A8SO-01B-31D-A377-08 7471bd76-b32f-41a3-bf95-8752745a7e70 +TCGA-YL-A8SP-01 TCGA-YL-A8SP-01 TCGA-YL-A8SP TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 58 TCGA-YL-A8SP-F67706 TCGA-YL-A8SP TCGA-YL-A8SP-01B NO M0 T2a -21455 2125 0 2366 2155 Scheduled Follow-up Submission Progressive Disease 2014-11-10 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 1680 NO Bilateral NO NO NO true No T3b TCGA-YL-A8SP.C2465F7D-3F73-4DB5-BD34-370978480408.pdf A8SP WITH TUMOR 4 Stable Disease 0.38 NO R1 Primary Tumor 01 5 YES 3 NO YES YL Apex|Middle|Base Prostate B LIVING 2008 Overlapping / Multiple Zones 2974a881-8198-4c55-89b9-822b8f8c94b0 TCGA-YL-A8SP-01B-11D-A376-01 TCGA-YL-A8SP-01B-11D-A378-05 TCGA-YL-A8SP-01B-11D-A377-08 2974a881-8198-4c55-89b9-822b8f8c94b0 TCGA-YL-A8SP-01 TCGA-YL-A8SP-01 6310206D-974B-4AE4-BC59-E327773DB9C7 TCGA-YL-A8SP-01B-11D-A376-01 2974a881-8198-4c55-89b9-822b8f8c94b0 TCGA-YL-A8SP-01 TCGA-YL-A8SP-01 TCGA-YL-A8SP-01B-11D-A377-08 2974a881-8198-4c55-89b9-822b8f8c94b0 +TCGA-YL-A8SQ-01 TCGA-YL-A8SQ-01 TCGA-YL-A8SQ TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES NO 61 TCGA-YL-A8SQ-F67567 TCGA-YL-A8SQ TCGA-YL-A8SQ-01B YES Normal (no evidence of prostate cancer) [cM0] M0 -22482 19 1898 329 0 2083 329 1943 1445 NO NO Scheduled Follow-up Submission Stable Disease 2014-11-6 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 2630 NO Bilateral NO YES Biochemical evidence of disease YES 5 0 true No N0 T3b TCGA-YL-A8SQ.A714B71D-3E37-4C89-908B-1C1F0AA49DEA.pdf A8SQ WITH TUMOR 4 Stable Disease 1.1 NO R1 Primary Tumor 01 5 NO 3 NO YES YL Apex|Middle|Base Prostate B LIVING 2008 Overlapping / Multiple Zones 8da55b3d-99f9-4ab4-8ee3-35bafb8d624f TCGA-YL-A8SQ-01B-11D-A376-01 TCGA-YL-A8SQ-01B-11D-A378-05 TCGA-YL-A8SQ-01B-11D-A377-08 8da55b3d-99f9-4ab4-8ee3-35bafb8d624f TCGA-YL-A8SQ-01 TCGA-YL-A8SQ-01 8C212508-7CF5-4305-AD25-80C5A92E9D5C TCGA-YL-A8SQ-01B-11D-A376-01 8da55b3d-99f9-4ab4-8ee3-35bafb8d624f TCGA-YL-A8SQ-01 TCGA-YL-A8SQ-01 TCGA-YL-A8SQ-01B-11D-A377-08 8da55b3d-99f9-4ab4-8ee3-35bafb8d624f +TCGA-YL-A8SR-01 TCGA-YL-A8SR-01 TCGA-YL-A8SR TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-YL-A8SR-F67281 TCGA-YL-A8SR TCGA-YL-A8SR-01B NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -23488 -1060 884 -1062 0 273 222 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission 2014-11-7 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 560 NO Bilateral YES YES NO 6 0 true No N0 T3a TCGA-YL-A8SR.0E86A40B-1A40-494F-B3CC-603E2F96A03D.pdf A8SR 4 Stable Disease 0.06 NO R1 Primary Tumor 01 5 NO 3 NO YES YL Apex|Middle|Base Prostate B LIVING 2011 Overlapping / Multiple Zones c3d6c3bb-8882-4033-855e-f164c03799cd TCGA-YL-A8SR-01B-11D-A376-01 TCGA-YL-A8SR-01B-11D-A378-05 TCGA-YL-A8SR-01B-11D-A377-08 c3d6c3bb-8882-4033-855e-f164c03799cd TCGA-YL-A8SR-01 TCGA-YL-A8SR-01 64900762-5159-4109-AA38-60CBD80422E6 TCGA-YL-A8SR-01B-11D-A376-01 c3d6c3bb-8882-4033-855e-f164c03799cd TCGA-YL-A8SR-01 TCGA-YL-A8SR-01 TCGA-YL-A8SR-01B-11D-A377-08 c3d6c3bb-8882-4033-855e-f164c03799cd +TCGA-YL-A9WH-01 TCGA-YL-A9WH-01 TCGA-YL-A9WH TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-YL-A9WH-F67282 TCGA-YL-A9WH NO Normal (no evidence of prostate cancer) [cM0] M0 -24755 55 0 427 349 NO NO Scheduled Follow-up Submission Stable Disease 2014-11-3 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy Bilateral YES YES NO 2 1 No N1 T3b A9WH 4 Stable Disease 0.03 YES R1 Primary Tumor 01 5 YES NO YES YL Apex|Middle|Base Prostate LIVING 2011 Overlapping / Multiple Zones abef0f85-b339-476f-bc5b-faded3ad6cf7 TCGA-YL-A9WH-01A-11D-A376-01 TCGA-YL-A9WH-01A-11D-A378-05 TCGA-YL-A9WH-01A-11D-A377-08 abef0f85-b339-476f-bc5b-faded3ad6cf7 TCGA-YL-A9WH-01 TCGA-YL-A9WH-01 TCGA-YL-A9WH-01A-11D-A376-01 abef0f85-b339-476f-bc5b-faded3ad6cf7 TCGA-YL-A9WH-01 TCGA-YL-A9WH-01 TCGA-YL-A9WH-01A-11D-A377-08 abef0f85-b339-476f-bc5b-faded3ad6cf7 +TCGA-YL-A9WI-01 TCGA-YL-A9WI-01 TCGA-YL-A9WI TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 63 TCGA-YL-A9WI-F67552 TCGA-YL-A9WI TCGA-YL-A9WI-01A NO Normal (no evidence of prostate cancer) [cM0] M0 -23184 93 1325 99 0 1623 1259 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Stable Disease 2014-11-6 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 680 NO Bilateral NO YES NO 15 1 true No N1 T3a TCGA-YL-A9WI.746DB832-C507-4FD6-8B8A-09E6268BACC9.pdf A9WI TUMOR FREE 4 Stable Disease 0.03 NO R0 Primary Tumor 01 5 NO NO YES YL Apex|Middle|Base Prostate A LIVING 2010 Overlapping / Multiple Zones 2bb8de70-7555-4409-b667-c11b1fb716b5 TCGA-YL-A9WI-01A-11D-A376-01 TCGA-YL-A9WI-01A-11D-A378-05 TCGA-YL-A9WI-01A-11D-A377-08 2bb8de70-7555-4409-b667-c11b1fb716b5 TCGA-YL-A9WI-01 TCGA-YL-A9WI-01 38EDCB63-EA73-4A8D-A381-055C55747815 TCGA-YL-A9WI-01A-11D-A376-01 2bb8de70-7555-4409-b667-c11b1fb716b5 TCGA-YL-A9WI-01 TCGA-YL-A9WI-01 TCGA-YL-A9WI-01A-11D-A377-08 2bb8de70-7555-4409-b667-c11b1fb716b5 +TCGA-YL-A9WJ-01 TCGA-YL-A9WJ-01 TCGA-YL-A9WJ TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 47 TCGA-YL-A9WJ-F58534 TCGA-YL-A9WJ TCGA-YL-A9WJ-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T4 -17322 19 2017 1855 21 51 76 0 1476 838 YES No Evidence of Extraprostatic Extension YES Extraprostatic Extension Localized (e.g. seminal vesicles) 2014-4-14 MALE 8 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 360 NO Bilateral NO YES Other, specify Distant Metastasis Neck YES 10 1 true No N1 T3b TCGA-YL-A9WJ.EC025153-CB9C-4683-82B4-985AAA9E80AC.pdf Prostate Cancer A9WJ WITH TUMOR 4 Partial Remission/Response 3.1 YES R1 Primary Tumor 01 4 Medical Record 3 NO YES YL Apex|Middle Prostate A DECEASED 2008 Overlapping / Multiple Zones 79169be4-6386-4c36-9330-c56b6c9e6ebd TCGA-YL-A9WJ-01A-11D-A376-01 TCGA-YL-A9WJ-01A-11D-A378-05 TCGA-YL-A9WJ-01A-11D-A377-08 79169be4-6386-4c36-9330-c56b6c9e6ebd TCGA-YL-A9WJ-01 TCGA-YL-A9WJ-01 7E6633B5-FAEF-4ACE-A7EF-93EF26F436AC TCGA-YL-A9WJ-01A-11D-A376-01 79169be4-6386-4c36-9330-c56b6c9e6ebd TCGA-YL-A9WJ-01 TCGA-YL-A9WJ-01 TCGA-YL-A9WJ-01A-11D-A377-08 79169be4-6386-4c36-9330-c56b6c9e6ebd +TCGA-YL-A9WK-01 TCGA-YL-A9WK-01 TCGA-YL-A9WK TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate YES NO 63 TCGA-YL-A9WK-F67283 TCGA-YL-A9WK TCGA-YL-A9WK-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T2b -23272 329 1865 1009 0 2136 1009 1871 1687 NO NO Scheduled Follow-up Submission Partial Remission/Response 2014-11-3 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 2085 NO Bilateral NO YES Biochemical evidence of disease YES 1 0 true No N0 T3b TCGA-YL-A9WK.B963A02D-0AE8-494C-A522-376AFABA374A.pdf A9WK WITH TUMOR 4 Stable Disease 15.6 NO R1 Primary Tumor 01 5 YES NO YES YL Middle YES Prostate Biochemical Recurrence A LIVING 2008 Overlapping / Multiple Zones 0da1e08f-d489-4579-a1ac-5cd79072ce9a TCGA-YL-A9WK-01A-11D-A376-01 TCGA-YL-A9WK-01A-11D-A378-05 TCGA-YL-A9WK-01A-11D-A377-08 0da1e08f-d489-4579-a1ac-5cd79072ce9a TCGA-YL-A9WK-01 TCGA-YL-A9WK-01 1D1D50EC-9802-4AE7-AEE9-6CDAE1506547 TCGA-YL-A9WK-01A-11D-A376-01 0da1e08f-d489-4579-a1ac-5cd79072ce9a TCGA-YL-A9WK-01 TCGA-YL-A9WK-01 0da1e08f-d489-4579-a1ac-5cd79072ce9a +TCGA-YL-A9WL-01 TCGA-YL-A9WL-01 TCGA-YL-A9WL TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 59 TCGA-YL-A9WL-F58511 TCGA-YL-A9WL TCGA-YL-A9WL-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T2a -21626 28 755 39 740 0 740 740 740 YES No Evidence of Extraprostatic Extension NO Additional New Tumor Event 2014-4-12 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 1300 NO Bilateral NO YES Biochemical evidence of disease YES 15 0 true No N0 T3a TCGA-YL-A9WL.F309E64F-E31C-478A-9F2B-B33AAD6BE37A.pdf A9WL WITH TUMOR 4 Complete Remission/Response 6.4 YES R0 Primary Tumor 01 5 YES 3 NO YES YL Apex|Middle|Base Prostate A LIVING 2011 Overlapping / Multiple Zones a63b38f7-5d53-4556-a7dc-4e6c3f75ec9b TCGA-YL-A9WL-01A-11D-A41J-01 TCGA-YL-A9WL-01A-11D-A41L-05 TCGA-YL-A9WL-01A-11D-A41K-08 a63b38f7-5d53-4556-a7dc-4e6c3f75ec9b TCGA-YL-A9WL-01 TCGA-YL-A9WL-01 B7FFE92B-1509-46A8-9BA7-DA462D3EF08E TCGA-YL-A9WL-01A-11D-A41J-01 a63b38f7-5d53-4556-a7dc-4e6c3f75ec9b TCGA-YL-A9WL-01 TCGA-YL-A9WL-01 a63b38f7-5d53-4556-a7dc-4e6c3f75ec9b +TCGA-YL-A9WX-01 TCGA-YL-A9WX-01 TCGA-YL-A9WX TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 68 TCGA-YL-A9WX-F58515 TCGA-YL-A9WX TCGA-YL-A9WX-01A YES Abnormal (not related to prostate cancer) M0 T3a -25008 34 1520 37 41 1506 0 1518 1506 1610 YES No Evidence of Extraprostatic Extension YES Extraprostatic Extension Localized (e.g. seminal vesicles) Additional New Tumor Event 2014-4-12 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 960 NO Bilateral NO YES Biochemical evidence of disease YES 11 1 true No N1 T3b TCGA-YL-A9WX.F7A04AAE-D1E0-4842-82AD-64F2813454F2.pdf A9WX WITH TUMOR 4 Complete Remission/Response 0.76 NO R1 Primary Tumor 01 5 NO 3 NO YES YL Middle Prostate A LIVING 2009 Overlapping / Multiple Zones 31f4a718-276b-4bf1-a61b-b6d946a91c32 TCGA-YL-A9WX-01A-21D-A41J-01 TCGA-YL-A9WX-01A-21D-A41L-05 TCGA-YL-A9WX-01A-21D-A41K-08 31f4a718-276b-4bf1-a61b-b6d946a91c32 TCGA-YL-A9WX-01 TCGA-YL-A9WX-01 0CBC8995-ED23-4D97-93C5-7BA497715BFB TCGA-YL-A9WX-01A-21D-A41J-01 31f4a718-276b-4bf1-a61b-b6d946a91c32 TCGA-YL-A9WX-01 TCGA-YL-A9WX-01 31f4a718-276b-4bf1-a61b-b6d946a91c32 +TCGA-YL-A9WY-01 TCGA-YL-A9WY-01 TCGA-YL-A9WY TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-YL-A9WY-F67290 TCGA-YL-A9WY TCGA-YL-A9WY-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T3a -21164 50 785 62 765 0 1098 975 765 NO YES Extraprostatic Extension Localized (e.g. seminal vesicles)|Extraprostatic Extension (regional lymphadenopathy) [e.g. cN1] Scheduled Follow-up Submission 2014-11-3 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 970 NO Bilateral NO YES Bone Distant Metastasis YES 19 11 true No N1 T3b TCGA-YL-A9WY.50396173-9B31-42A1-81BC-9D2B5905E54A.pdf A9WY WITH TUMOR 5 Stable Disease 1.8 NO R1 Primary Tumor 01 4 YES NO YES YL Apex|Middle|Base YES Prostate Distant Metastasis A LIVING 2011 Overlapping / Multiple Zones 93dcc430-967c-4410-97ec-c3c814d9b826 TCGA-YL-A9WY-01A-11D-A41J-01 TCGA-YL-A9WY-01A-11D-A41L-05 TCGA-YL-A9WY-01A-11D-A41K-08 93dcc430-967c-4410-97ec-c3c814d9b826 TCGA-YL-A9WY-01 TCGA-YL-A9WY-01 D3C6C2E4-ABDF-4657-9911-F58B6B1BC7D7 TCGA-YL-A9WY-01A-11D-A41J-01 93dcc430-967c-4410-97ec-c3c814d9b826 TCGA-YL-A9WY-01 TCGA-YL-A9WY-01 93dcc430-967c-4410-97ec-c3c814d9b826 +TCGA-ZG-A8QW-01 TCGA-ZG-A8QW-01 TCGA-ZG-A8QW TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 72 TCGA-ZG-A8QW-F67802 TCGA-ZG-A8QW TCGA-ZG-A8QW-01A Normal (no evidence of prostate cancer) [cM0] M0 T3a -26632 8 156 43 0 94 NO YES Extraprostatic Extension Localized (e.g. seminal vesicles) Scheduled Follow-up Submission Stable Disease 2014-11-12 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 270 NO Bilateral NO YES NO 13 1 true No N1 T3b TCGA-ZG-A8QW.6883BDF0-68B9-4D35-8A55-025C98AD2FCA.pdf A8QW TUMOR FREE 4 Progressive Disease NO R0 Primary Tumor 01 5 NO NO YES ZG Middle Prostate A LIVING 2013 Overlapping / Multiple Zones b3079945-f405-4810-b7cc-efa81b3b46ad TCGA-ZG-A8QW-01A-11D-A376-01 TCGA-ZG-A8QW-01A-11D-A378-05 TCGA-ZG-A8QW-01A-11D-A377-08 b3079945-f405-4810-b7cc-efa81b3b46ad TCGA-ZG-A8QW-01 TCGA-ZG-A8QW-01 69C5F470-7A6C-4C78-A6FF-3169267C2E61 TCGA-ZG-A8QW-01A-11D-A376-01 b3079945-f405-4810-b7cc-efa81b3b46ad TCGA-ZG-A8QW-01 TCGA-ZG-A8QW-01 TCGA-ZG-A8QW-01A-11D-A377-08 b3079945-f405-4810-b7cc-efa81b3b46ad +TCGA-ZG-A8QX-01 TCGA-ZG-A8QX-01 TCGA-ZG-A8QX TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 56 TCGA-ZG-A8QX-F67804 TCGA-ZG-A8QX TCGA-ZG-A8QX-01A M0 T1c -20683 167 0 442 NO NO Scheduled Follow-up Submission Stable Disease 2014-11-12 MALE 6 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 210 NO Bilateral NO YES NO 18 0 true No N0 T2c TCGA-ZG-A8QX.153CAD0D-4566-4BC2-B33D-FF1B44BA8E2B.pdf A8QX TUMOR FREE 3 Stable Disease NO R0 Primary Tumor 01 3 NO NO YES ZG Middle Prostate A LIVING 2013 Overlapping / Multiple Zones 1727eb06-107a-4b21-97d7-20cabf1826ac TCGA-ZG-A8QX-01A-11D-A376-01 TCGA-ZG-A8QX-01A-11D-A378-05 TCGA-ZG-A8QX-01A-11D-A377-08 1727eb06-107a-4b21-97d7-20cabf1826ac TCGA-ZG-A8QX-01 TCGA-ZG-A8QX-01 62766243-996D-41B4-8268-5B0ECF3BD2E1 TCGA-ZG-A8QX-01A-11D-A376-01 1727eb06-107a-4b21-97d7-20cabf1826ac TCGA-ZG-A8QX-01 TCGA-ZG-A8QX-01 TCGA-ZG-A8QX-01A-11D-A377-08 1727eb06-107a-4b21-97d7-20cabf1826ac +TCGA-ZG-A8QY-01 TCGA-ZG-A8QY-01 TCGA-ZG-A8QY TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-ZG-A8QY-F67806 TCGA-ZG-A8QY TCGA-ZG-A8QY-01A Normal (no evidence of prostate cancer) [cM0] M0 T2c -24731 5 250 5 0 404 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Stable Disease 2014-11-12 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 160 NO Bilateral NO YES NO 14 1 true No N1 T3b TCGA-ZG-A8QY.4A09ACD5-F433-4F49-A47A-8DC4D5807E7A.pdf A8QY WITH TUMOR 5 Stable Disease NO RX Primary Tumor 01 4 NO 3 NO YES ZG Base Prostate A LIVING 2013 Overlapping / Multiple Zones bd991045-7c0f-404b-b9e6-63086f9c816f TCGA-ZG-A8QY-01A-11D-A376-01 TCGA-ZG-A8QY-01A-11D-A378-05 TCGA-ZG-A8QY-01A-11D-A377-08 bd991045-7c0f-404b-b9e6-63086f9c816f TCGA-ZG-A8QY-01 TCGA-ZG-A8QY-01 A8BBB1CC-9ABF-4560-AB3A-5AC05EA2B195 TCGA-ZG-A8QY-01A-11D-A376-01 bd991045-7c0f-404b-b9e6-63086f9c816f TCGA-ZG-A8QY-01 TCGA-ZG-A8QY-01 TCGA-ZG-A8QY-01A-11D-A377-08 bd991045-7c0f-404b-b9e6-63086f9c816f +TCGA-ZG-A8QZ-01 TCGA-ZG-A8QZ-01 TCGA-ZG-A8QZ TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-ZG-A8QZ-F67807 TCGA-ZG-A8QZ TCGA-ZG-A8QZ-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2a -23980 12 322 42 0 308 239 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Stable Disease 2014-11-12 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 110 NO Bilateral NO YES NO 8 1 true No N1 T3b TCGA-ZG-A8QZ.930A234B-9B7E-4F2C-905C-AF4CCB5570CB.pdf A8QZ TUMOR FREE 4 Stable Disease 0.01 YES R1 Primary Tumor 01 5 YES 3 NO YES ZG Middle Prostate A LIVING 2013 Overlapping / Multiple Zones 8d4a6058-e687-4bb7-afdc-e9936fdc49b1 TCGA-ZG-A8QZ-01A-11D-A376-01 TCGA-ZG-A8QZ-01A-11D-A378-05 TCGA-ZG-A8QZ-01A-11D-A377-08 8d4a6058-e687-4bb7-afdc-e9936fdc49b1 TCGA-ZG-A8QZ-01 TCGA-ZG-A8QZ-01 372C0BA9-E7D1-4121-9B3E-57EF147FBC27 TCGA-ZG-A8QZ-01A-11D-A376-01 8d4a6058-e687-4bb7-afdc-e9936fdc49b1 TCGA-ZG-A8QZ-01 TCGA-ZG-A8QZ-01 TCGA-ZG-A8QZ-01A-11D-A377-08 8d4a6058-e687-4bb7-afdc-e9936fdc49b1 +TCGA-ZG-A9KY-01 TCGA-ZG-A9KY-01 TCGA-ZG-A9KY TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 73 TCGA-ZG-A9KY-F67809 TCGA-ZG-A9KY TCGA-ZG-A9KY-01A Normal (no evidence of prostate cancer) [cM0] M0 T1c -27000 14 112 14 0 130 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Stable Disease 2014-11-12 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 120 NO Bilateral NO YES NO 16 2 true No N1 T4 TCGA-ZG-A9KY.2E48E905-FCAF-4A5F-A2E0-600276051562.pdf A9KY 5 Stable Disease NO R1 Primary Tumor 01 4 NO NO YES ZG Apex|Middle|Base Prostate A LIVING 2013 Overlapping / Multiple Zones 8083711c-418c-49d4-9717-0e494b50103e TCGA-ZG-A9KY-01A-11D-A41J-01 TCGA-ZG-A9KY-01A-11D-A41L-05 TCGA-ZG-A9KY-01A-11D-A41K-08 8083711c-418c-49d4-9717-0e494b50103e TCGA-ZG-A9KY-01 TCGA-ZG-A9KY-01 61934BAA-E8B2-4A8F-8CC9-FB7E9CE948A7 TCGA-ZG-A9KY-01A-11D-A41J-01 8083711c-418c-49d4-9717-0e494b50103e TCGA-ZG-A9KY-01 TCGA-ZG-A9KY-01 8083711c-418c-49d4-9717-0e494b50103e +TCGA-ZG-A9L0-01 TCGA-ZG-A9L0-01 TCGA-ZG-A9L0 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 71 TCGA-ZG-A9L0-F67810 TCGA-ZG-A9L0 TCGA-ZG-A9L0-01A Normal (no evidence of prostate cancer) [cM0] M0 -26055 -16 152 -119 0 355 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Stable Disease 2014-11-12 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 420 NO Bilateral NO YES NO 20 7 true No N1 T3b TCGA-ZG-A9L0.F5D6CACB-458D-4C16-972E-EF6848DEC4D8.pdf A9L0 TUMOR FREE 5 Stable Disease NO R1 Primary Tumor 01 4 NO 3 NO YES ZG Apex|Middle|Base Prostate A LIVING 2013 Overlapping / Multiple Zones 02fc78ec-68ae-4326-8df1-4f69850b5edd TCGA-ZG-A9L0-01A-11D-A41J-01 TCGA-ZG-A9L0-01A-11D-A41L-05 TCGA-ZG-A9L0-01A-11D-A41K-08 02fc78ec-68ae-4326-8df1-4f69850b5edd TCGA-ZG-A9L0-01 TCGA-ZG-A9L0-01 B7665C69-C511-4B00-B4CB-4569CFF2586A TCGA-ZG-A9L0-01A-11D-A41J-01 02fc78ec-68ae-4326-8df1-4f69850b5edd TCGA-ZG-A9L0-01 TCGA-ZG-A9L0-01 02fc78ec-68ae-4326-8df1-4f69850b5edd +TCGA-ZG-A9L1-01 TCGA-ZG-A9L1-01 TCGA-ZG-A9L1 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-ZG-A9L1-F67811 TCGA-ZG-A9L1 TCGA-ZG-A9L1-01A NO M0 T1c -24214 1246 0 1302 1147 Scheduled Follow-up Submission Stable Disease 2014-11-12 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 750 NO Bilateral NO YES NO 7 1 true No N1 T3b TCGA-ZG-A9L1.1F620B81-F034-4F28-8DE0-6B19D181D24F.pdf A9L1 WITH TUMOR 4 Progressive Disease 0.07 YES R1 Primary Tumor 01 5 NO NO YES ZG Apex|Middle|Base Prostate A LIVING 2010 Peripheral Zone adda35fc-181d-4a0c-9afe-f2bdd83ab087 TCGA-ZG-A9L1-01A-11D-A41J-01 TCGA-ZG-A9L1-01A-11D-A41L-05 TCGA-ZG-A9L1-01A-11D-A41K-08 adda35fc-181d-4a0c-9afe-f2bdd83ab087 TCGA-ZG-A9L1-01 TCGA-ZG-A9L1-01 18D1E7A6-D33C-472A-A504-F8E0B978B262 TCGA-ZG-A9L1-01A-11D-A41J-01 adda35fc-181d-4a0c-9afe-f2bdd83ab087 TCGA-ZG-A9L1-01 TCGA-ZG-A9L1-01 adda35fc-181d-4a0c-9afe-f2bdd83ab087 +TCGA-ZG-A9L2-01 TCGA-ZG-A9L2-01 TCGA-ZG-A9L2 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 70 TCGA-ZG-A9L2-F67812 TCGA-ZG-A9L2 TCGA-ZG-A9L2-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T3a -25573 6 1056 180 0 1154 1137 NO NO Scheduled Follow-up Submission Stable Disease 2014-11-12 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 390 NO NO YES NO 14 0 true No N0 T3b TCGA-ZG-A9L2.CA9BA514-709C-48BA-B620-48BFBBA35493.pdf A9L2 WITH TUMOR 4 Stable Disease 0.01 NO R1 Primary Tumor 01 5 NO 3 NO YES ZG Prostate A LIVING 2011 Peripheral Zone 08fc16b8-f635-4e11-9ee7-afc7e3ea084c TCGA-ZG-A9L2-01A-31D-A41J-01 TCGA-ZG-A9L2-01A-31D-A41L-05 TCGA-ZG-A9L2-01A-31D-A41K-08 08fc16b8-f635-4e11-9ee7-afc7e3ea084c TCGA-ZG-A9L2-01 TCGA-ZG-A9L2-01 TCGA-ZG-A9L2-01A-31D-A41J-01 08fc16b8-f635-4e11-9ee7-afc7e3ea084c TCGA-ZG-A9L2-01 TCGA-ZG-A9L2-01 08fc16b8-f635-4e11-9ee7-afc7e3ea084c +TCGA-ZG-A9L4-01 TCGA-ZG-A9L4-01 TCGA-ZG-A9L4 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 61 TCGA-ZG-A9L4-F67814 TCGA-ZG-A9L4 TCGA-ZG-A9L4-01A NO M0 T1c -22388 986 0 1108 1108 Scheduled Follow-up Submission Stable Disease 2014-11-12 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 170 NO Bilateral NO YES NO 10 0 true No N0 T3b TCGA-ZG-A9L4.BC344956-732B-4A0A-9493-299442B05CD1.pdf A9L4 5 Stable Disease 0.03 NO R1 Primary Tumor 01 4 NO 3 NO YES ZG Apex|Middle|Base Prostate A LIVING 2011 Overlapping / Multiple Zones 52371577-673b-43b9-ae0b-5dd12bd2dc32 TCGA-ZG-A9L4-01A-11D-A41J-01 TCGA-ZG-A9L4-01A-11D-A41L-05 TCGA-ZG-A9L4-01A-11D-A41K-08 52371577-673b-43b9-ae0b-5dd12bd2dc32 TCGA-ZG-A9L4-01 TCGA-ZG-A9L4-01 F849CCAA-6DC7-499B-84BF-1DDCBC739068 TCGA-ZG-A9L4-01A-11D-A41J-01 52371577-673b-43b9-ae0b-5dd12bd2dc32 TCGA-ZG-A9L4-01 TCGA-ZG-A9L4-01 52371577-673b-43b9-ae0b-5dd12bd2dc32 +TCGA-ZG-A9L5-01 TCGA-ZG-A9L5-01 TCGA-ZG-A9L5 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 58 TCGA-ZG-A9L5-F67815 TCGA-ZG-A9L5 TCGA-ZG-A9L5-01A NO M0 T2a -21293 953 11 0 908 YES Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1] NO Scheduled Follow-up Submission Stable Disease 2014-11-12 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 460 NO Bilateral NO YES NO 3 1 true No N1 T4 TCGA-ZG-A9L5.FE097411-281D-4804-BAB4-D732A95EC689.pdf A9L5 WITH TUMOR 5 Progressive Disease NO R1 Primary Tumor 01 4 YES 3 NO YES ZG Apex|Middle|Base Prostate A LIVING 2011 Overlapping / Multiple Zones 8778e5a4-d61f-4fe0-a917-1f8036f85907 TCGA-ZG-A9L5-01A-12D-A41J-01 TCGA-ZG-A9L5-01A-12D-A41L-05 TCGA-ZG-A9L5-01A-12D-A41K-08 8778e5a4-d61f-4fe0-a917-1f8036f85907 TCGA-ZG-A9L5-01 TCGA-ZG-A9L5-01 8D0E8768-C83B-46BC-8ED9-CFAC222887BC TCGA-ZG-A9L5-01A-12D-A41J-01 8778e5a4-d61f-4fe0-a917-1f8036f85907 TCGA-ZG-A9L5-01 TCGA-ZG-A9L5-01 8778e5a4-d61f-4fe0-a917-1f8036f85907 +TCGA-ZG-A9L6-01 TCGA-ZG-A9L6-01 TCGA-ZG-A9L6 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate NO NO 64 TCGA-ZG-A9L6-F67817 TCGA-ZG-A9L6 TCGA-ZG-A9L6-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T1c -23681 13 733 13 664 0 687 664 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Stable Disease 2014-11-12 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 520 NO Bilateral NO YES NO 25 0 true No N0 T3b TCGA-ZG-A9L6.1EAD6485-88D7-467C-8E00-335B3D7056B7.pdf A9L6 WITH TUMOR 5 Partial Remission/Response 0.36 NO R1 Primary Tumor 01 4 NO 3 NO YES ZG Apex|Middle|Base Prostate A LIVING 2011 Overlapping / Multiple Zones 6cd409f7-0933-4fa5-a998-735eadfb30ab TCGA-ZG-A9L6-01A-11D-A41J-01 TCGA-ZG-A9L6-01A-11D-A41L-05 TCGA-ZG-A9L6-01A-11D-A41K-08 6cd409f7-0933-4fa5-a998-735eadfb30ab TCGA-ZG-A9L6-01 TCGA-ZG-A9L6-01 19BE2718-6344-4281-B3E6-A6972613DCE5 TCGA-ZG-A9L6-01A-11D-A41J-01 6cd409f7-0933-4fa5-a998-735eadfb30ab TCGA-ZG-A9L6-01 TCGA-ZG-A9L6-01 6cd409f7-0933-4fa5-a998-735eadfb30ab +TCGA-ZG-A9L9-01 TCGA-ZG-A9L9-01 TCGA-ZG-A9L9 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-ZG-A9L9-F67816 TCGA-ZG-A9L9 TCGA-ZG-A9L9-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -22108 -4 665 0 51 0 617 NO YES Extraprostatic Extension Localized (e.g. seminal vesicles) Scheduled Follow-up Submission Stable Disease 2014-11-12 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 270 NO Bilateral NO YES NO 15 3 true No N1 T3b TCGA-ZG-A9L9.89DB264B-7026-4A51-BF05-A0629F25CFF6.pdf A9L9 WITH TUMOR 4 Progressive Disease YES R1 Primary Tumor 01 5 NO NO YES ZG Apex|Middle|Base Prostate A LIVING 2012 Overlapping / Multiple Zones 2718ed2d-63b0-4699-b23d-dacb86e6c926 TCGA-ZG-A9L9-01A-11D-A41J-01 TCGA-ZG-A9L9-01A-11D-A41L-05 TCGA-ZG-A9L9-01A-11D-A41K-08 2718ed2d-63b0-4699-b23d-dacb86e6c926 TCGA-ZG-A9L9-01 TCGA-ZG-A9L9-01 532C9277-1271-4C8A-8DB1-F27D23774854 TCGA-ZG-A9L9-01A-11D-A41J-01 2718ed2d-63b0-4699-b23d-dacb86e6c926 TCGA-ZG-A9L9-01 TCGA-ZG-A9L9-01 2718ed2d-63b0-4699-b23d-dacb86e6c926 +TCGA-ZG-A9LB-01 TCGA-ZG-A9LB-01 TCGA-ZG-A9LB TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 72 TCGA-ZG-A9LB-F67821 TCGA-ZG-A9LB TCGA-ZG-A9LB-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2a -26447 21 629 31 0 583 485 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Stable Disease 2014-11-12 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 380 NO Right NO YES NO 9 0 true No N0 T3b TCGA-ZG-A9LB.224AC4AB-11CC-4832-90FD-937C3C7B4C8E.pdf A9LB WITH TUMOR 5 Partial Remission/Response 0.02 NO R1 Primary Tumor 01 4 NO NO YES ZG Apex|Middle|Base Prostate A LIVING 2012 Overlapping / Multiple Zones 5eef1fb4-f7a7-4e33-bb83-5f589f9a4642 TCGA-ZG-A9LB-01A-11D-A41J-01 TCGA-ZG-A9LB-01A-11D-A41L-05 TCGA-ZG-A9LB-01A-11D-A41K-08 5eef1fb4-f7a7-4e33-bb83-5f589f9a4642 TCGA-ZG-A9LB-01 TCGA-ZG-A9LB-01 FBD53A68-B330-46D3-99B3-A780B80CFDCC TCGA-ZG-A9LB-01A-11D-A41J-01 5eef1fb4-f7a7-4e33-bb83-5f589f9a4642 TCGA-ZG-A9LB-01 TCGA-ZG-A9LB-01 5eef1fb4-f7a7-4e33-bb83-5f589f9a4642 +TCGA-ZG-A9LM-01 TCGA-ZG-A9LM-01 TCGA-ZG-A9LM TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 72 TCGA-ZG-A9LM-F67938 TCGA-ZG-A9LM TCGA-ZG-A9LM-01A NO M0 T2b -26377 251 14 0 378 121 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-13 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 170 NO Right NO YES NO 11 2 true No N1 T3a TCGA-ZG-A9LM.C66F9B46-7652-4BB9-B554-B9AB372EC7BC.pdf A9LM TUMOR FREE 4 Complete Remission/Response 0.0 NO R0 Primary Tumor 01 5 NO 3 NO YES ZG Middle|Base Prostate A LIVING 2013 Peripheral Zone a79de49e-9b1c-4512-b6ed-df4a858c4875 TCGA-ZG-A9LM-01A-11D-A41J-01 TCGA-ZG-A9LM-01A-11D-A41L-05 TCGA-ZG-A9LM-01A-11D-A41K-08 a79de49e-9b1c-4512-b6ed-df4a858c4875 TCGA-ZG-A9LM-01 TCGA-ZG-A9LM-01 DA03B6A0-2B3C-4D85-9C7B-C1B8411A478D TCGA-ZG-A9LM-01A-11D-A41J-01 a79de49e-9b1c-4512-b6ed-df4a858c4875 TCGA-ZG-A9LM-01 TCGA-ZG-A9LM-01 a79de49e-9b1c-4512-b6ed-df4a858c4875 +TCGA-ZG-A9LN-01 TCGA-ZG-A9LN-01 TCGA-ZG-A9LN TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 57 TCGA-ZG-A9LN-F67937 TCGA-ZG-A9LN TCGA-ZG-A9LN-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -21050 3 76 9 7 0 115 90 YES No Evidence of Extraprostatic Extension YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Stable Disease 2014-11-13 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 60 NO Bilateral NO YES NO 10 6 true No N1 T3b TCGA-ZG-A9LN.3B5E5429-7D1E-4AD2-8329-DC784D412393.pdf A9LN WITH TUMOR 5 Partial Remission/Response 7.42 NO R1 Primary Tumor 01 4 YES NO YES ZG Apex|Middle|Base Prostate A LIVING 2013 Overlapping / Multiple Zones 60e9a97e-8cf7-465c-9a31-7c0b714fbf95 TCGA-ZG-A9LN-01A-11D-A41J-01 TCGA-ZG-A9LN-01A-11D-A41L-05 TCGA-ZG-A9LN-01A-11D-A41K-08 60e9a97e-8cf7-465c-9a31-7c0b714fbf95 TCGA-ZG-A9LN-01 TCGA-ZG-A9LN-01 TCGA-ZG-A9LN-01A-11D-A41J-01 60e9a97e-8cf7-465c-9a31-7c0b714fbf95 TCGA-ZG-A9LN-01 TCGA-ZG-A9LN-01 60e9a97e-8cf7-465c-9a31-7c0b714fbf95 +TCGA-ZG-A9LS-01 TCGA-ZG-A9LS-01 TCGA-ZG-A9LS TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 64 TCGA-ZG-A9LS-F67932 TCGA-ZG-A9LS TCGA-ZG-A9LS-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2a -23540 16 215 16 0 516 147 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-13 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 190 NO Bilateral NO YES NO 47 3 true No N1 T3b TCGA-ZG-A9LS.C08F26E6-5CC1-42FC-9533-D4199A5CE8B4.pdf A9LS TUMOR FREE 5 Complete Remission/Response 0.03 YES R1 Primary Tumor 01 4 NO NO YES ZG Apex|Middle|Base Prostate A LIVING 2013 Central Zone 580772bc-57d8-4be2-ad7f-e4d0a8d754a4 TCGA-ZG-A9LS-01A-12D-A41J-01 TCGA-ZG-A9LS-01A-12D-A41L-05 TCGA-ZG-A9LS-01A-12D-A41K-08 580772bc-57d8-4be2-ad7f-e4d0a8d754a4 TCGA-ZG-A9LS-01 TCGA-ZG-A9LS-01 30B90749-1BE3-4C06-8506-A180B5AA129B TCGA-ZG-A9LS-01A-12D-A41J-01 580772bc-57d8-4be2-ad7f-e4d0a8d754a4 TCGA-ZG-A9LS-01 TCGA-ZG-A9LS-01 580772bc-57d8-4be2-ad7f-e4d0a8d754a4 +TCGA-ZG-A9LU-01 TCGA-ZG-A9LU-01 TCGA-ZG-A9LU TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 67 TCGA-ZG-A9LU-F67851 TCGA-ZG-A9LU TCGA-ZG-A9LU-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -24742 37 617 40 0 579 549 NO YES No Evidence of Extraprostatic Extension Scheduled Follow-up Submission Stable Disease 2014-11-12 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 380 NO Bilateral NO YES NO 7 0 true No N0 T3a TCGA-ZG-A9LU.DC8CC307-723F-4E7F-AD59-4936BFA55789.pdf A9LU WITH TUMOR 5 Partial Remission/Response 0.70 YES R1 Primary Tumor 01 4 NO NO YES ZG Apex|Middle|Base Prostate A LIVING 2012 Overlapping / Multiple Zones 39c01e87-6cb4-47f5-9ecd-be16781ef1f2 TCGA-ZG-A9LU-01A-11D-A41J-01 TCGA-ZG-A9LU-01A-11D-A41L-05 TCGA-ZG-A9LU-01A-11D-A41K-08 39c01e87-6cb4-47f5-9ecd-be16781ef1f2 TCGA-ZG-A9LU-01 TCGA-ZG-A9LU-01 A0185263-3366-42BD-AD0F-2B61EC64B0FB TCGA-ZG-A9LU-01A-11D-A41J-01 39c01e87-6cb4-47f5-9ecd-be16781ef1f2 TCGA-ZG-A9LU-01 TCGA-ZG-A9LU-01 39c01e87-6cb4-47f5-9ecd-be16781ef1f2 +TCGA-ZG-A9LY-01 TCGA-ZG-A9LY-01 TCGA-ZG-A9LY TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 60 TCGA-ZG-A9LY-F67845 TCGA-ZG-A9LY TCGA-ZG-A9LY-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2b -21942 20 404 12 0 370 288 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-12 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 100 NO Bilateral NO YES NO 11 1 true No N1 T3b TCGA-ZG-A9LY.E4B3E97A-9587-47C2-BE35-C67B268CA133.pdf A9LY TUMOR FREE 4 Complete Remission/Response 0.01 YES R1 Primary Tumor 01 5 NO 3 NO YES ZG Apex|Middle|Base Prostate A LIVING 2012 Overlapping / Multiple Zones c672c2b4-da56-4584-9126-4d59b5cecc1b TCGA-ZG-A9LY-01A-11D-A41J-01 TCGA-ZG-A9LY-01A-11D-A41L-05 TCGA-ZG-A9LY-01A-11D-A41K-08 c672c2b4-da56-4584-9126-4d59b5cecc1b TCGA-ZG-A9LY-01 TCGA-ZG-A9LY-01 97F5F5F2-5652-47F1-8108-A8DFDE7819CB TCGA-ZG-A9LY-01A-11D-A41J-01 c672c2b4-da56-4584-9126-4d59b5cecc1b TCGA-ZG-A9LY-01 TCGA-ZG-A9LY-01 c672c2b4-da56-4584-9126-4d59b5cecc1b +TCGA-ZG-A9LZ-01 TCGA-ZG-A9LZ-01 TCGA-ZG-A9LZ TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 66 TCGA-ZG-A9LZ-F67847 TCGA-ZG-A9LZ TCGA-ZG-A9LZ-01A YES Normal (no evidence of prostate cancer) [cM0] M0 T3a -24132 -15 817 -9 310 0 692 692 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Stable Disease 2014-11-12 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 170 NO Bilateral NO YES NO 5 0 true No N0 T3b TCGA-ZG-A9LZ.D8F34923-C864-4CCC-9012-E74DE7A483CE.pdf A9LZ WITH TUMOR 4 Partial Remission/Response 2.19 YES R1 Primary Tumor 01 5 NO 3 NO YES ZG Apex|Middle|Base Prostate A LIVING 2011 Overlapping / Multiple Zones 0e33492b-b79a-42cc-8820-f077875a9384 TCGA-ZG-A9LZ-01A-11D-A41J-01 TCGA-ZG-A9LZ-01A-11D-A41L-05 TCGA-ZG-A9LZ-01A-11D-A41K-08 0e33492b-b79a-42cc-8820-f077875a9384 TCGA-ZG-A9LZ-01 TCGA-ZG-A9LZ-01 CB1BEFDC-A7BC-4989-A390-F8C000D8652E TCGA-ZG-A9LZ-01A-11D-A41J-01 0e33492b-b79a-42cc-8820-f077875a9384 TCGA-ZG-A9LZ-01 TCGA-ZG-A9LZ-01 0e33492b-b79a-42cc-8820-f077875a9384 +TCGA-ZG-A9M4-01 TCGA-ZG-A9M4-01 TCGA-ZG-A9M4 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 65 TCGA-ZG-A9M4-F67945 TCGA-ZG-A9M4 TCGA-ZG-A9M4-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2a -24030 21 509 22 0 547 218 YES Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1] NO Scheduled Follow-up Submission Stable Disease 2014-11-13 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 150 NO Bilateral NO YES NO 18 1 true No N1 T3b TCGA-ZG-A9M4.86764ADF-5B8B-4989-99AA-595616A115A4.pdf A9M4 WITH TUMOR 5 Partial Remission/Response 0.95 NO R1 Primary Tumor 01 4 NO NO YES ZG Apex|Middle|Base Prostate A LIVING 2012 Overlapping / Multiple Zones 9c1dbf62-a42a-4a60-84bb-98715d9a4b60 TCGA-ZG-A9M4-01A-11D-A41J-01 TCGA-ZG-A9M4-01A-11D-A41L-05 TCGA-ZG-A9M4-01A-11D-A41K-08 9c1dbf62-a42a-4a60-84bb-98715d9a4b60 TCGA-ZG-A9M4-01 TCGA-ZG-A9M4-01 691D3F9B-5F1D-4D41-B54E-ECC3D69DB7C2 TCGA-ZG-A9M4-01A-11D-A41J-01 9c1dbf62-a42a-4a60-84bb-98715d9a4b60 TCGA-ZG-A9M4-01 TCGA-ZG-A9M4-01 9c1dbf62-a42a-4a60-84bb-98715d9a4b60 +TCGA-ZG-A9MC-01 TCGA-ZG-A9MC-01 TCGA-ZG-A9MC TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 69 TCGA-ZG-A9MC-F67960 TCGA-ZG-A9MC TCGA-ZG-A9MC-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2a -25477 3 434 0 0 455 427 NO YES Extraprostatic Extension Localized (e.g. seminal vesicles) Scheduled Follow-up Submission Stable Disease 2014-11-13 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 230 NO Bilateral NO YES NO 14 2 true No N1 T3b TCGA-ZG-A9MC.1B48B5AE-27A9-4D79-923C-14AF6DE4B4E0.pdf A9MC WITH TUMOR 5 Partial Remission/Response 31.85 YES R1 Primary Tumor 01 4 NO 3 NO YES ZG Apex|Middle|Base Prostate A LIVING 2012 Peripheral Zone d992a3c1-fe30-4d15-a4e6-4e250e834da2 TCGA-ZG-A9MC-01A-31D-A41J-01 TCGA-ZG-A9MC-01A-31D-A41L-05 TCGA-ZG-A9MC-01A-31D-A41K-08 d992a3c1-fe30-4d15-a4e6-4e250e834da2 TCGA-ZG-A9MC-01 TCGA-ZG-A9MC-01 70BAE419-1B3E-4245-831B-D8B87E9F019C TCGA-ZG-A9MC-01A-31D-A41J-01 d992a3c1-fe30-4d15-a4e6-4e250e834da2 TCGA-ZG-A9MC-01 TCGA-ZG-A9MC-01 d992a3c1-fe30-4d15-a4e6-4e250e834da2 +TCGA-ZG-A9N3-01 TCGA-ZG-A9N3-01 TCGA-ZG-A9N3 TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 73 TCGA-ZG-A9N3-F68209 TCGA-ZG-A9N3 TCGA-ZG-A9N3-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -26902 7 69 7 0 349 244 NO YES Extraprostatic Extension Localized (e.g. seminal vesicles) Scheduled Follow-up Submission Stable Disease 2014-11-14 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 210 NO Bilateral NO YES NO 30 1 true No N1 T3b TCGA-ZG-A9N3.C97CA9D4-71F2-4068-9959-BF8F7829189C.pdf A9N3 WITH TUMOR 5 Partial Remission/Response 0.1 NO R1 Primary Tumor 01 4 YES 3 NO YES ZG Apex|Middle|Base Prostate A LIVING 2013 Overlapping / Multiple Zones 2ee45f38-cb92-4e91-acea-e454a13f59d9 TCGA-ZG-A9N3-01A-11D-A41J-01 TCGA-ZG-A9N3-01A-11D-A41L-05 TCGA-ZG-A9N3-01A-11D-A41K-08 2ee45f38-cb92-4e91-acea-e454a13f59d9 TCGA-ZG-A9N3-01 TCGA-ZG-A9N3-01 BC0DA73E-2A1F-4853-8AD0-FB8649A7FD48 TCGA-ZG-A9N3-01A-11D-A41J-01 2ee45f38-cb92-4e91-acea-e454a13f59d9 TCGA-ZG-A9N3-01 TCGA-ZG-A9N3-01 2ee45f38-cb92-4e91-acea-e454a13f59d9 +TCGA-ZG-A9ND-01 TCGA-ZG-A9ND-01 TCGA-ZG-A9ND TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 55 TCGA-ZG-A9ND-F68219 TCGA-ZG-A9ND TCGA-ZG-A9ND-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T1c -20428 7 283 10 0 410 184 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission Stable Disease 2014-11-14 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 80 NO Bilateral NO YES NO 8 0 true No N0 T3a TCGA-ZG-A9ND.89122E71-1246-44A5-9D44-4F95284EB02E.pdf A9ND TUMOR FREE 5 Complete Remission/Response 0.08 NO R0 Primary Tumor 01 4 NO 3 NO YES ZG Apex|Middle Prostate A LIVING 2013 Overlapping / Multiple Zones 35a82435-e313-4206-b328-b2b1db736aef TCGA-ZG-A9ND-01A-11D-A41J-01 TCGA-ZG-A9ND-01A-11D-A41L-05 TCGA-ZG-A9ND-01A-11D-A41K-08 35a82435-e313-4206-b328-b2b1db736aef TCGA-ZG-A9ND-01 TCGA-ZG-A9ND-01 TCGA-ZG-A9ND-01A-11D-A41J-01 35a82435-e313-4206-b328-b2b1db736aef TCGA-ZG-A9ND-01 TCGA-ZG-A9ND-01 35a82435-e313-4206-b328-b2b1db736aef +TCGA-ZG-A9NI-01 TCGA-ZG-A9NI-01 TCGA-ZG-A9NI TCGA Prostate Cancer (PRAD) prostate adenocarcinoma Prostate 73 TCGA-ZG-A9NI-F67955 TCGA-ZG-A9NI TCGA-ZG-A9NI-01A NO Normal (no evidence of prostate cancer) [cM0] M0 T2a -26697 22 139 22 0 132 99 YES No Evidence of Extraprostatic Extension NO Scheduled Follow-up Submission 2014-11-13 MALE 9 Prostate Adenocarcinoma Acinar Type No C61 8140/3 C61.9 YES Core needle biopsy 160 NO Bilateral NO YES NO 21 0 true No N0 T3b TCGA-ZG-A9NI.70DD94DF-13D1-40FC-A52B-43E2229563E3.pdf A9NI TUMOR FREE 5 Complete Remission/Response 0.03 NO R1 Primary Tumor 01 4 NO 3 NO YES ZG Apex|Middle|Base Prostate A LIVING 2013 Overlapping / Multiple Zones ed5fb1bc-ffb9-4946-89e0-73635d84f448 TCGA-ZG-A9NI-01A-11D-A41J-01 TCGA-ZG-A9NI-01A-11D-A41L-05 TCGA-ZG-A9NI-01A-11D-A41K-08 ed5fb1bc-ffb9-4946-89e0-73635d84f448 TCGA-ZG-A9NI-01 TCGA-ZG-A9NI-01 6341FCBF-06E0-43F2-80AE-FDDB1C7D120F TCGA-ZG-A9NI-01A-11D-A41J-01 ed5fb1bc-ffb9-4946-89e0-73635d84f448 TCGA-ZG-A9NI-01 TCGA-ZG-A9NI-01 ed5fb1bc-ffb9-4946-89e0-73635d84f448